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The majority of neurological diseases (such as Parkinson’s and Huntington’s diseases) are 
progressive, debilitating and currently incurable. In an ageing population, the prevalence of such 
diseases will only increase over time, creating a need for better pre-clinical tools that allow for more 
research into such diseases, as clinical trails are expensive and time-consuming. In this thesis I 
describe the development and optimisation of a pre-clinical in vitro neural model of functional basal 
ganglia circuitry. When this circuitry in the basal ganglia breaks down or is damaged, it can result in 
Parkinson’s or Huntington’s diseases, and by modelling these areas in both a healthy and damaged 
state in vitro we create a powerful platform for pre-clinical research into neurological disease. The 
model described here is a microfluidic compartmentalised device consisting of five sections linked by 
micro-scale channels, designed in AutoCAD and fabricatd by soft lithography. The design of this 
model allows for neural cell populations to be simultaneously isolated and connected, as axons grow 
through the channels to adjacent sections and create a neural circuit. The design of the device, 
chemical coating and microchannel width were all optimised in order for the device to better mimic 
the basal ganglia, culturing primary cells obtained from the cortex, striatum, globus pallidus and 
substantia nigra of rat embryos within the device. Extracellular recording methods were also 
introduced, using a multi-electrode array (MEA) in order to record spontaneous electrophysiological 
activity from the neural cultures (whether seperate or connected) and determine that the cells were 
functional. The effects of connectivity on functionality was determined across all relevant co-
cultures. In order to make the device a mimic of Parkinson’s disease, 6-OHDA was used to 
damage/destroy nigrostriatal dopamine neurons, and the effects of this loss on functionality were 
also assessed. The device is a powerful pre-clinical platform for research, modelling aspects of a 
healthy physiological basal ganglia and aspects of a damaged pathological Parkinsonian basal ganglia. 
The novel findings presented in this thesis show the potential of this microfluidic model to study basal 
ganglia circuitry and accelerate Parksinon’s research. 
  
 iii 
Table of Contents 
Abstract ................................................................................................................................................................. ii 
List of abbreviations ............................................................................................................................................ vii 
List of tables ....................................................................................................................................................... viii 
List of figures ...................................................................................................................................................... viii 
Acknowledgements .............................................................................................................................................. x 
Disclaimer ............................................................................................................................................................. x 
Chapter One: Introduction .................................................................................................................................... 1 
1.0 Modelling the central nervous system ........................................................................................................... 1 
1.0.1 Neurological diseases and disorders ....................................................................................................... 5 
1.1 Parkinson’s disease ......................................................................................................................................... 7 
1.1.1 Prevalence ............................................................................................................................................... 7 
1.1.2 Genetic component ................................................................................................................................. 7 
1.1.3 Symptoms ................................................................................................................................................ 8 
1.1.4 Pathology ................................................................................................................................................. 8 
1.1.5 Potential causes ....................................................................................................................................... 9 
1.2 The basal ganglia ........................................................................................................................................... 11 
1.2.1 Anatomy of the basal ganglia ................................................................................................................ 12 
1.2.1.1 Cortex ............................................................................................................................................. 12 
1.2.1.2 Striatum .......................................................................................................................................... 13 
1.2.1.3 Globus pallidus ............................................................................................................................... 13 
1.2.1.4 Substantia nigra ............................................................................................................................. 14 
1.2.1.5 Subthalamic nucleus ...................................................................................................................... 15 
1.2.1.6 Summary ........................................................................................................................................ 15 
1.2.2 Development of the basal ganglia ......................................................................................................... 16 
1.2.2.1 Cortical, striatal and pallidal development .................................................................................... 16 
1.2.2.2 Nigral development ........................................................................................................................ 17 
1.2.2.3 Development of GABA as a neurotransmitter ............................................................................... 19 
1.2.2.4 Synapse development .................................................................................................................... 20 
1.3 Modelling of Parkinson’s disease .................................................................................................................. 22 
1.3.1 Neurotoxin-based animal models ......................................................................................................... 23 
1.3.1.1 MPTP .............................................................................................................................................. 24 
1.3.1.2 6-OHDA .......................................................................................................................................... 25 
1.3.2 Gene-based animal models ................................................................................................................... 27 
1.3.2.1 Α-synuclein ..................................................................................................................................... 27 
1.3.3 Cell/tissue in vitro models ..................................................................................................................... 28 
1.3.3.1 Cell line models .............................................................................................................................. 29 
1.3.3.2 Stem cell models ............................................................................................................................ 30 
1.3.3.3 Primary cell models ........................................................................................................................ 31 
1.3.3.4 Tissue slice/organotypic models .................................................................................................... 33 
1.3.3.5 Organoids and 3D models .............................................................................................................. 34 
1.4 Bioengineering complexity into in vitro models ........................................................................................... 36 
1.4.1 Modelling with reduced complexity ...................................................................................................... 36 
1.4.2 Surface parameters to control cell responses ....................................................................................... 38 
1.4.3 Determining electrophysiological functionality .................................................................................... 41 
1.4.4 Measuring electrophysiological activity ................................................................................................ 42 
1.4.5 Multi-electrode arrays (MEAs) .............................................................................................................. 45 
1.4.5.1 Examples of MEAs combined with in vitro neural models ............................................................. 46 
1.5 Organ-on-a-chip ............................................................................................................................................ 49 
1.5.1 Fabrication techniques .......................................................................................................................... 50 
1.6 Brain-on-a-chip ............................................................................................................................................. 51 
1.6.1 Compartmentalised microfluidic neural cell models ............................................................................. 53 
1.7 Concluding Remarks ..................................................................................................................................... 56 
1.8 Aims and objectives ...................................................................................................................................... 56 
Chapter Two: Materials and Methods ................................................................................................................ 58 
2.0 Device fabrication ......................................................................................................................................... 58 
2.0.1 Software design ..................................................................................................................................... 58 
2.0.2 Two-stage photolithography ................................................................................................................. 61 
2.0.3 Bonding and sealing .............................................................................................................................. 64 
2.0.3.1 Permanent bonding via exposure to oxygen plasma ..................................................................... 64 
 iv 
2.0.3.2 Semi-permanent bonding via chemical coating with PEI ............................................................... 65 
2.1 Device preparation: chemical coating .......................................................................................................... 65 
2.1.1 Chemical coating: PDL/LAM .................................................................................................................. 65 
2.1.2 Chemical coating: PEI/PDL .................................................................................................................... 65 
2.2 Primary cell culture ....................................................................................................................................... 67 
2.2.1 Brain tissue dissection ........................................................................................................................... 67 
2.2.2 Brain tissue microdissection ................................................................................................................. 68 
2.2.3 Cell suspension preparation .................................................................................................................. 68 
2.2.4 6-OHDA treatment ................................................................................................................................ 69 
2.2.5 Live/dead staining ................................................................................................................................. 69 
2.3 Immunocytochemistry .................................................................................................................................. 70 
2.4 Fluorescent microscopy ................................................................................................................................ 71 
2.5 MEA extracellular electrophysiological recording ........................................................................................ 71 
2.5.1 MEA: Hardware ..................................................................................................................................... 71 
2.5.2 MEA: Recordings ................................................................................................................................... 72 
2.5.3 MEA: Analysis ........................................................................................................................................ 75 
2.6 Statistics ........................................................................................................................................................ 77 
Chapter 3: Design and optimisation of a five-port microfluidic neural device ................................................... 78 
3.0 Introduction .................................................................................................................................................. 78 
3.0.1 Designing a basal-ganglia-on-a-chip ...................................................................................................... 78 
3.0.2 Five-Port Device Fabrication ................................................................................................................. 82 
3.0.3 Device Optimisation .............................................................................................................................. 84 
3.0.3.1 Chemical coating ............................................................................................................................ 84 
3.0.3.2 Physical channel width ................................................................................................................... 85 
3.0.3.3 Presence of dopaminergic neurons in both SNc and SNr ports ..................................................... 87 
3.0.4 Chapter Three Aims and Objectives ...................................................................................................... 87 
3.1 Experimental Methods ................................................................................................................................. 88 
3.1.1 Device fabrication ................................................................................................................................. 88 
3.1.2 Primary cell culture ............................................................................................................................... 88 
3.1.3 Immunocytochemistry .......................................................................................................................... 88 
3.1.4 Statistical analysis ................................................................................................................................. 88 
3.2 Results .......................................................................................................................................................... 89 
3.2.1 Device fabrication ................................................................................................................................. 89 
3.2.2 Cell characterisation .............................................................................................................................. 90 
3.2.2.1 Cell specific markers ...................................................................................................................... 90 
3.2.2.2 Neuron-astrocyte ratio .................................................................................................................. 93 
3.2.2.3 Dopaminergic neuron analysis ....................................................................................................... 93 
3.2.3 Chemical coating optimisation .............................................................................................................. 94 
3.2.3.1 Cell body migration ........................................................................................................................ 94 
3.2.3.2 Cell monolayer morphology........................................................................................................... 98 
3.2.3.3 Neuronal process outgrowth ......................................................................................................... 98 
3.2.4 Primary cell culture ............................................................................................................................... 99 
3.2.4.1 Rate of axonal outgrowth ............................................................................................................ 103 
3.2.5 Channel directionality assessment ...................................................................................................... 104 
3.3 Discussion ................................................................................................................................................... 106 
3.3.1 Chemical coating ................................................................................................................................. 106 
3.3.2 Characterising specific neural subtypes .............................................................................................. 107 
3.3.3 Channel directionality assessment ...................................................................................................... 108 
3.4 Conclusions ................................................................................................................................................. 110 
Chapter Four: Long term study of separate neural culture functionality ......................................................... 111 
4.0 Introduction ................................................................................................................................................ 111 
4.0.1 Typical electrophysiology of basal ganglia nuclei ................................................................................ 111 
4.0.1.1 Cortex (CTX) ................................................................................................................................. 111 
4.0.1.2 Striatum (STR) .............................................................................................................................. 112 
4.0.1.3 Globus Pallidus (GP) ..................................................................................................................... 113 
4.0.1.4 Substantia nigra (SN) ................................................................................................................... 114 
4.0.2 Extracellular recording ........................................................................................................................ 115 
4.0.3 MEAs ................................................................................................................................................... 119 
4.0.4 In vitro models with extracellular recording ....................................................................................... 121 
4.0.5 Chapter Four aims and objectives ....................................................................................................... 124 
 v 
4.1 Experimental Methods ............................................................................................................................... 125 
4.1.1 MEA surface preparation .................................................................................................................... 125 
4.1.2 Primary cell culture.............................................................................................................................. 125 
4.1.3 Electrical activity measurement with MEA .......................................................................................... 125 
4.1.4 MEA data management and analysis .................................................................................................. 125 
4.2 Results ......................................................................................................................................................... 126 
4.2.1 Primary cell culture.............................................................................................................................. 126 
4.2.2 Spatial activity localisation on MEAs ................................................................................................... 128 
4.2.2.1 Heatmaps ..................................................................................................................................... 129 
4.2.2.2 Percentage activity across the MEA ............................................................................................. 132 
4.2.3 Average spike frequency ..................................................................................................................... 133 
4.2.4 Maximum spike frequency .................................................................................................................. 134 
4.2.5 MEA bursting activity .......................................................................................................................... 136 
4.2.6 Centroid number ................................................................................................................................. 137 
4.2.7 Centroid shapes ................................................................................................................................... 139 
4.2.7.1 Centroid shape over time ............................................................................................................. 140 
4.2.7.2 Whole-MEA centroid shape assessment ...................................................................................... 142 
4.2.7.3 Centroid shape categorisation ..................................................................................................... 143 
4.2.7.4 Centroid full duration at half maximum ....................................................................................... 145 
4.3 Discussion ................................................................................................................................................... 146 
4.3.1 Primary cell culture.............................................................................................................................. 146 
4.3.2 Electrophysiological assessment ......................................................................................................... 147 
4.3.2.1 Differences in onset of activity..................................................................................................... 147 
4.3.3 Localisation of activity ......................................................................................................................... 147 
4.3.4 Spiking and bursting frequencies ........................................................................................................ 149 
4.3.4.1 Greater nigral spiking frequencies ............................................................................................... 152 
4.3.4.2 Bursting activity ............................................................................................................................ 153 
4.3.5 Centroid assessment ........................................................................................................................... 153 
4.3.5.1 Amplitude differences: intracellular vs extracellular ................................................................... 156 
4.4 Conclusions ................................................................................................................................................. 156 
Chapter Five: Long-term study of connected neural co-culture functionality.................................................. 158 
5.0 Introduction ................................................................................................................................................ 158 
5.0.1 Corticostriatal (CTX-STR) signal pathway............................................................................................. 158 
5.0.1.1 Corticostriatal structure ............................................................................................................... 158 
5.0.1.2 Corticostriatal function ................................................................................................................ 160 
5.0.1.3 Corticostriatal electrophysiology ................................................................................................. 160 
5.0.2 Striatopallidal (STR-GPe/i) signal pathway .......................................................................................... 161 
5.0.2.1 Striatopallidal structure ............................................................................................................... 161 
5.0.2.2 Striatopallidal function ................................................................................................................. 161 
5.0.3 Striatonigral (STR-SNr) ......................................................................................................................... 162 
5.0.4 Nigrostriatal (SNc-STR) ........................................................................................................................ 162 
5.0.5 Designing connected co-cultures ........................................................................................................ 164 
5.0.6 Chapter Five Aims and Objectives ....................................................................................................... 165 
5.1 Experimental Methods ............................................................................................................................... 166 
5.1.1 Device surface preparation ................................................................................................................. 166 
5.1.2 Primary cell culture.............................................................................................................................. 166 
5.1.3 Electrical activity measurement with MEA .......................................................................................... 166 
5.1.4 MEA data management and analysis .................................................................................................. 166 
5.2 Results ......................................................................................................................................................... 167 
5.2.1 Primary cell culture.............................................................................................................................. 167 
5.2.2 Heatmaps ............................................................................................................................................ 168 
5.2.3 Percentage activity, average and maximum spiking frequency .......................................................... 170 
5.2.3.1 Percentage activity ....................................................................................................................... 171 
5.2.3.2 Average spiking frequency ........................................................................................................... 171 
5.2.3.2 Maximum spiking frequency ........................................................................................................ 171 
5.2.4 Bursting activity ................................................................................................................................... 172 
5.2.5 Centroid number ................................................................................................................................. 173 
5.2.6 Centroid shape categorisation ............................................................................................................ 174 
5.2.7 Centroid full duration at half maximum .............................................................................................. 175 
5.3 Comparisons of separate cultures and connected co-cultures .................................................................. 176 
 vi 
5.3.1 Percentage activity .............................................................................................................................. 176 
5.3.2 Average spike frequency ..................................................................................................................... 177 
5.3.3 Maximum spike frequency .................................................................................................................. 178 
5.3.4 Bursting ............................................................................................................................................... 179 
5.3.5 Centroid shape categorisation ............................................................................................................ 181 
5.3.6 Centroid full duration at half maximum .............................................................................................. 182 
5.4 Discussion ................................................................................................................................................... 183 
5.4.1 Co-culturing ......................................................................................................................................... 183 
5.4.2 MEA electrode location ....................................................................................................................... 184 
5.4.3 Activity localisation ............................................................................................................................. 185 
5.4.4 Spiking activity..................................................................................................................................... 185 
5.4.4.1 CTX vs CTX-STR ............................................................................................................................. 186 
5.4.4.2 GP vs STR-GP ................................................................................................................................ 186 
5.4.4.3 SNc vs SNc-STR ............................................................................................................................. 187 
5.4.4.4 STR vs CTX-STR vs STR-GP vs SNc-STR .......................................................................................... 187 
5.4.5 Centroid assessment ........................................................................................................................... 189 
5.5 Conclusions ................................................................................................................................................. 189 
Chapter Six: Mimicking Parkinson’s disease ..................................................................................................... 191 
6.0 Introduction ................................................................................................................................................ 191 
6.0.1 Electrophysiology of Parkinson’s disease ............................................................................................ 192 
6.0.2 Chapter Six Aims and Objectives ......................................................................................................... 194 
6.1 Experimental Methods ............................................................................................................................... 195 
6.1.1 Device surface preparation ................................................................................................................. 195 
6.1.2 Primary cell culture ............................................................................................................................. 195 
6.1.3 Electrical activity measurement with MEA ......................................................................................... 195 
6.1.4 6-OHDA treatment .............................................................................................................................. 195 
6.2 Results ........................................................................................................................................................ 196 
6.2.1 Primary cell culture ............................................................................................................................. 196 
6.2.2 6-OHDA optimisation .......................................................................................................................... 197 
6.2.2.1 Vehicle ......................................................................................................................................... 199 
6.2.2.2 Dosage concentration .................................................................................................................. 200 
6.2.2.3 Exposure time .............................................................................................................................. 200 
6.2.2.4 Exposure length with 0-70 DIV MEA cultures .............................................................................. 201 
6.2.2.5 Serum-free assessment ............................................................................................................... 204 
6.2.3 Activity heatmaps ................................................................................................................................ 205 
6.2.4 Percentage activity across MEA .......................................................................................................... 207 
6.2.5 Average spike frequency ..................................................................................................................... 208 
6.2.6 Maximum spike frequency .................................................................................................................. 209 
6.2.7 Bursting activity ................................................................................................................................... 210 
6.2.8 Centroid number ................................................................................................................................. 211 
6.2.9 Centroid shape categorisation ............................................................................................................ 213 
6.2.9.2 Centroid full duration at half maximum ...................................................................................... 215 
6.2.10 Late 6-OHDA exposure ...................................................................................................................... 215 
6.3 Discussion ................................................................................................................................................... 216 
6.3.1 6-OHDA optimisation .......................................................................................................................... 216 
6.3.2 Effects of 6-OHDA on functionality ..................................................................................................... 219 
6.3.2.1 Localisation .................................................................................................................................. 219 
6.3.2.2 Spiking/bursting ........................................................................................................................... 219 
6.3.2.3 Centroid assessment .................................................................................................................... 220 
6.3.2.4 Summary ...................................................................................................................................... 221 
6.4 Conclusion .................................................................................................................................................. 221 
Chapter 7: General discussion and conclusions ............................................................................................... 222 
7.0 General discussion ...................................................................................................................................... 222 
7.0.1 Chapter Three: Device design and optimisation ................................................................................. 222 
7.0.1.1 Engineering the five-port device .................................................................................................. 222 
7.0.1.2 Biology of neurons cultured within devices ................................................................................. 223 
7.0.2 Chapter Four: Long-term study of separate neural culture functionality ........................................... 224 
7.0.3 Chapter Five: Long-term study of connected neural co-culture functionality .................................... 226 
7.0.4 Chapter Six: Modelling Parkinson’s disease ........................................................................................ 228 
7.1 Limitations of the model ............................................................................................................................ 230 
 vii 
7.2 Future work................................................................................................................................................. 231 
7.3 Conclusion ................................................................................................................................................... 234 
7.4 References .................................................................................................................................................. 235 
Appendices ....................................................................................................................................................... 265 
Appendix One ............................................................................................................................................... 266 
Appendix Two ............................................................................................................................................... 270 
Appendix Three ............................................................................................................................................ 273 
Appendix Four .............................................................................................................................................. 276 
 
List of abbreviations 
5PD  Five-port device 
6-OHDA 6-hydroxydopamine 
AD  Alzheimer’s disease 
ALS  Amyotrophic lateral sclerosis 
AMPAR  α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 
ANOVA  Analysis of variance 
AP  Action potential 
BG  Basal ganglia 
CAD  Computer-aided design 
CNS  Central nervous system 
CNT  Carbon nanotubes 
CTX  Cortex 
D1-5  Dopmaine receptor 1-5 
DA  Dopamine 
DAPI  4’,6-diamidino-2-phenylindole 
DAT  Dopamine transporter 
DIV  Days in vitro 
DMEM  Dulbecco’s modified Eagle medium 
E  Embryonic day 
EAP  Extracellular action potential 
ECM  Extracellular matrix 
FSN  Fast-spiking neuron 
GABA  Gamma aminobutyric acid 
GDNF  Glial-derived neurotrophic factor 
GFAP  Glial fibrillary acidic protein 
GPi/e  Globus pallidus internal/external 
HD  Huntington’s disease 
IMS  Industrial methylated spirit 
iPSC  Induced pluripotent stem cell 
IT  Intratelencepahlic 
LAM  Laminin 
LGE  Lateral ganglionic eminence 
LTD  Long-term depression 
LTP  Long-term potentiation 
MAP2  Microtubule-associated protein II 
MEA  Multi-electrode array 
MGE  Medial ganglionic eminence 
MPTP  1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
MSN  Medium spiny neuron 
NCM  Neural culture media 
NMDAR  N-methyl-D-aspartate receptor 
NSC  Neural stem cell 
PAN  Phasically activate neuron 
PBS Phosphate-buffered saline 




PNS Peripheral nervous system 
PT Pyramidal type 
PY Phosphotyrosine 
RMS Root mean square 
ROS Reactive oxygen species 
SEM Scanning electron 
microscopy 
SNc/r Substantia nigra pars 
compactra/reticulate 
STD Standard deviation 
STN Subthalamic nucleus 
STR Striatum 
TAN Tonically activate neuron 
TBS Tris-buffered saline 
TH Tyrosine hydroxylase 
UV Ultraviolet 
VGLUT2 Vesicular glutamine 
transporter II 
VM Ventral midbrain 
VTA Ventral tegmental area 
 
 viii 
List of tables 
Table 1.1: Instances of the GABA switch (excitatory to inhibitory) observed in vitro 21 
Table 1.2: What to consider when planning an in vitro model of the brain  39 
Table 2.1: Antibodies used for immunocytochemistry and fluorescent imaging  71 
Table 4.1: Assessing in vitro neural devices with extracellular recording   124 
Table 4.2: Predicted vs actual spike frequencies     152 
Table 6.1: Comparing centroids between control and 6-OHDA SNc-STR devices  213 
Table 7.1: The effects of 6-OHDA treatment to the SNc port of SNc-STR devices  230 
 
List of figures 
Figure 1.1: Complexity within the central nervous system (CNS)  ....................................................................... 6 
Figure 1.2: On the basal ganglia ......................................................................................................................... 13 
Figure 1.3: Projections to and from the substantia nigra pars compacta (SNc)  ................................................ 15 
Figure 1.4: Diagram of the connectivity within the BG as well as immediate inputs and outputs .................... 16 
Figure 1.5: Anatomical patterning of the ventral diencephalon/mesencephalon during development  ........... 18 
Figure 1.6: The embryonic brain and its development into different nuclei of the BG ...................................... 19 
Figure 1.7: Neurotoxins used in Parkinson’s disease research ........................................................................... 24 
Figure 1.8: Different methods used to model Parkinson’s disease in vitro ........................................................ 37 
Figure 1.9: A diagram of a synapse between two neurons ................................................................................ 43 
Figure 1.10: Intracellular and extracellular recording ........................................................................................ 44 
Figure 1.11: Images of two different Multi electrode arrays (MEAs) ................................................................. 47 
Figure 1.12: Different design approaches to fabricating 3D MEAs .................................................................... 50 
Figure 1.13: Progress of compartmentalised neural models over time ............................................................. 55 
Figure 1.14: Microfluidic device designed by (Peyrin et al. 2011)  ..................................................................... 56 
Figure 2.1: The design of the 5PD in schematics  ............................................................................................... 60 
Figure 2.2: 5PD redesign to accommodate MEA hardware ............................................................................... 61 
Figure 2.3: Photolithographic mask designs for the larger 5PD, made with AutoCAD software ....................... 62 
Figure 2.4: The two-step lithography process  ................................................................................................... 63 
Figure 2.5: 5PD fabrication via soft lithography ................................................................................................. 65 
Figure 2.6: The 5PD fabrication process in images ............................................................................................. 67 
Figure 2.7: Dissecting E15/16 rat embryos ......................................................................................................... 69 
Figure 2.8: Concerning MEA design .................................................................................................................... 73 
Figure 2.9: MOBIUS modules involved in the spontaneous RECORDING process.............................................. 75 
Figure 2.10: MOBIUS modules involved in the ANALYSIS process ..................................................................... 77 
Figure 3.1: From an in vivo circuit to an in vitro model ...................................................................................... 81 
Figure 3.2: Schematics detailing the design of the five-port model ................................................................... 83 
Figure 3.3: Photolithography masks and final result .......................................................................................... 84 
Figure 3.4: The finished five-port device compared to the original five-port device design .............................. 85 
Figure 3.5: Unidirectional connectivity ............................................................................................................... 87 
Figure 3.6: SEM images from a 5PD with 5 µm to 50 µm width channels .......................................................... 90 
Figure 3.7: The conservation of a pattern (cross) throughout the 5PD fabrication process ............................ 91 
Figure 3.8: Quantified data from cell specific staining experiment (Fig.3.9).  .................................................... 92 
Figure 3.9: Cell specific staining of CTX, STR, GP and SN cells.  .......................................................................... 93 
Figure 3.10: The neuron/astrocyte percentage proportion across all four cell types after 4 DIV.  .................... 94 
Figure 3.11: Changes in SN neural cultures over in vitro culture time ............................................................... 95 
Figure 3.12: The effect of different chemical coatings on migration of E16 CTX cells ....................................... 96 
Figure 3.13: Cell migration of all four cell types when seeded into the centre port of 5PDs ............................. 98 
Figure 3.14: Brightfield of E16 CTX cells cultured on PDL/LAM and PEI/PDL coated surfaces.  ......................... 99 
Figure 3.15: Effect of chemical coating and channel width on axons per channel within 5PDs. ..................... 100 
Figure 3.16: Fluorescent images of E16 CTX cells on PEI/PDL coated coverslips ............................................. 101 
Figure 3.17: Fluorescent images of E16 CTX cells seeded into the centre port of PEI/PDL coated 5PDs ......... 102 
Figure 3.18: Whole 5PD imaging via XY tile scan .............................................................................................. 103 
Figure 3.19: Cell number and axonal outgrowth compared between all four cell types,channel widths ........ 104 
Figure 3.20: Effect of channel width on number of axons extending down the entire length of a channel .... 105 
Figure 3.21: The directional pressure exerted by channels of different widths, for all four cell types ........... 106 
Figure 4.1: Simultaneous intra- and extracellular recording of an action potential......................................... 116 
Figure 4.2: Extracellular current sinks and sources .......................................................................................... 117 
 ix 
Figure 4.3: Diagram showing how different types of extracellular signals are generated ............................... 118 
Figure 4.4: Simultaneous recording from six extracellular electrodes of a CA1 pyramidal neuron ................. 119 
Figure 4.5: A microfluidic compartmentalised in vitro neural model with extracellular recording capabilities 
within microchannels ........................................................................................................................................ 123 
Figure 4.6: STR cells at DIV 6 on an MEA .......................................................................................................... 127 
Figure 4.7: CTX cells after 120 DIV .................................................................................................................... 128 
Figure 4.8: Live/dead data for CTX cells after 120 DIV ..................................................................................... 129 
Figure 4.9: CTX activity heatmaps ..................................................................................................................... 131 
Figure 4.10: STR activity heatmaps ................................................................................................................... 131 
Figure 4.11: GP activity heatmaps .................................................................................................................... 132 
Figure 4.12: SNc activity heatmaps ................................................................................................................... 132 
Figure 4.13: Average percentage of MEA electrodes receiving spontaneous activity over time ................... 133 
Figure 4.14: Average spike frequency across MEA over time for CTX, STR, GP and SNc  ................................. 134 
Figure 4.15: Maximum spike frequency across MEA over time for CTX, STR, GP and SNc  ........................... 136 
Figure 4.16: Locations of maximum activity for each day of activity, on each cell type, across the MEA ........ 137 
Figure 4.17: Bursting activity across the MEA over time .................................................................................. 138 
Figure 4.18: How a centroid is generated ......................................................................................................... 139 
Figure 4.19: Number of centroids formed from spike sorting of the spontaneous activity ............................. 140 
Figure 4.20: CTX centroid waveforms over time from an active electrode, E50 .............................................. 141 
Figure 4.21: STR centroid waveforms over time from an active electrode, E19 .............................................. 142 
Figure 4.22: GP centroid waveforms over time from an active electrode, E64 ................................................ 142 
Figure 4.23: SNc centroids over time from an active electrode, E44 ............................................................... 143 
Figure 4.24: Centroid waveforms across a whole MEA, from CTX DIV 44 ........................................................ 144 
Figure 4.25: The six centroid types generated by cells on MEAs throughout this experiment ........................ 145 
Figure 4.26: Centroid shape categorisation ...................................................................................................... 146 
Figure 4.27: Centroid full duration half maximum over time for each cell type .............................................. 147 
Figure 5.1: Example pathways within the basal ganglia ................................................................................... 160 
Figure 5.2: Diagram of connectivity within the basal ganglia ........................................................................... 165 
Figure 5.3: Layout of co-cultures on MEAs ....................................................................................................... 166 
Figure 5.4: 100,000 E16 CTX cells cultured on MEAs (8 DIV)  ........................................................................... 168 
Figure 5.5: 100,000 E16 CTX and STR cells culture on MEAs ............................................................................ 169 
Figure 5.6: Averaged representative heatmaps (n=4) from CTX-STR, STR-GP and SNc-STR  ............................ 170 
Figure 5.7: Percentage actvitiy, average spike frequency and maximum spike frequency over time (0-70 DIV) 
for CTX-STR, STR-GP and SNc-STR co-cultures on MEAs  .................................................................................. 171 
Figure 5.8: Bursting activity (number of bursts and spikes per burst) across all co-cultures ........................... 173 
Figure 5.9: Number of centroids for CTX-STR, STR-GP and SNc-STR co-cultures.............................................. 174 
Figure 5.10: Centroid shape categorisation ...................................................................................................... 175 
Figure 5.11: Centroid full duration at half maximum over time ....................................................................... 176 
Figure 5.12: A comparison between the percentages of active electrodes over time ..................................... 177 
Figure 5.13: A comparison between the average spike frequency (Hz) over time ........................................... 178 
Figure 5.14: A comparison between the maximum spike frequencies (Hz) over time ..................................... 179 
Figure 5.15: A comparison between the average number of bursts over time ................................................ 180 
Figure 5.16: A comparison between the average numbers of spikes per burst over time ............................... 181 
Figure 5.17: Centroid shape categorisation ...................................................................................................... 182 
Figure 5.18: Centroid full duration half maximum over time for each cell type .............................................. 183 
Figure 5.19: Location of the MEA within the 5PD ............................................................................................. 185 
Figure 6.1: Illustrations of DA synapses on the spine of a STR MSN ................................................................. 193 
Figure 6.2: Changes in BG circuitry during PD .................................................................................................. 194 
Figure 6.3: STR and SNc primary cells cultured onto MEAs .............................................................................. 197 
Figure 6.4: Fluorescent imaging of primary SN cultures to identify GAPA and DOPA neurons ........................ 198 
Figure 6.5: Fluorescent imaging of 6-OHDA optimisation process ................................................................... 199 
Figure 6.6: Efficacy of 0.15% ascorbic acid as an antioxidant vehicle for 6-OHDA ........................................... 200 
Figure 6.7: 6-OHDA dosage concentration optimisation .................................................................................. 201 
Figure 6.8: 6-OHDA exposure length optimisation ........................................................................................... 202 
Figure 6.9: Effect of 6-OHDA on more mature cultures (25 DIV)...................................................................... 203 
Figure 6.10: SNc cultures treated with 100 µM 6-OHDA for 20 minutes or 24 hours (25 DIV) ........................ 204 
Figure 6.11: 24-hour serum-free assessment ................................................................................................... 205 
Figure 6.12: Heatmaps from SNc-STR MEAs, treated with 6-OHDA on 25 DIV vs control ................................ 207 
Figure 6.13: Percentage activity of SNc-STR MEAs treated with 6-OHDA on day 25........................................ 208 
Figure 6.14: Average spiking activity of SNc-STR MEAs treated with 6-OHDA on day 25 ................................ 209 
 x 
Figure 6.15 Maximum spiking activity of SNc-STR MEAs treated with 6-OHDA on day 25 .............................. 210 
Figure 6.16: Bursting activity from SNc-STR control devices and devices treated with 6-OHDA ..................... 211 
Figure 6.17: Centroid number for SNc-STR centroids, both 6-OHDA-treated and control............................... 213 
Figure 6.18: Centroid shape categorisation...................................................................................................... 215 
Figure 6.19: Centroid full duration at half maximum over time ....................................................................... 216 
Figure 6.20: Effect of 6-OHDA treatment on day 65 ........................................................................................ 217 
Figure 7.1: MEA redesign for future experimentation ..................................................................................... 233 
 
Acknowledgements 
First and foremost, I’d like to thank my excellent supervisory team in Professor Rosemary Fricker and 
Dr Paul Roach, along with my gifted senior Dr Munyaradzi Kamudzandu, without them this thesis 
would not have been possible as they have been supportive and insightful throughout the whole 
process. 
I am also deeply grateful to Keele University, both the staff and students of the Huxley building and 
everyone at the Guy Hilton Research Centre, who I know will be dear friends for many years to come. 
Special thanks to Dr Dimitra Blana, whos expertise at writing Python code and handling large data 
sets saved me many weeks of fumbling around in the dark and generated some very pretty graphs. 
Finally, I’d like to thank my wonderful wife Hati Köse-Dunn, we met thanks to this PhD and I would 
never have completed it without your support, love and warmth at all times. 
Disclaimer 
I declare that this is an original work and all sources of information are fully acknowledged and cited. 
Dr Dimitra Blana assisted in data processing by writing Python code to perform the complex analysis. 
 
 1 
Chapter One: Introduction 
The current development models for drugs designed to counteract or treat neurological and 
neurodegenerative diseases are insufficient to predict what pharmaceuticals will work on human 
disease patients. More efficient pre-clinical models are required, particularly at an in vitro level where 
a high level of control can be asserted, using cells in order to mimic specific areas of the brain in both 
a healthy and diseased state. By combining cell culture and scaffold fabrication, diverse in vitro 
models can be created to mimic in vivo systems, organs and disease states. The advancement from 
simple cell monolayer culture models to complex multilayer organ-on-a-chip models to multiple 
organ modelling systems shows the great promise of potentially mimicking the brain, the most 
complex functional organ. Microfluidic models and organ-on-a-chip models represent a 
multidisciplinary approach to fulfilling these criteria, with the ability to exert control over shape, size, 
biochemical and physical factors and gradients, the inclusion of 3D elements and flow and the 
integration with current cell culture systems. These models are far more efficient than current in vivo 
animal models, being high throughput, cheaper, faster and far more customisable. The model 
described in this thesis is fabricated to a high degree of accuracy and reproducibility, resulting in a 
device that can model both healthy brain circuitry and the transition that occurs during a disease 
state, all while retaining a high degree of control over all components within the model that would 
be lost in in vivo research. This chapter focuses on such in vitro neural modelling devices and their 
potential for researching neurological and neurodegenerative diseases. This modelling paradigm is 
discussed in relation to the brain, with an end goal of being able to create an in vitro model of the 
brain, specifically the basal ganglia, to study neurodegenerative diseases caused by damage to this 
area such as Parkinson’s and Huntington’s diseases. Once a functioning basal ganglia can be 
reproduced in vitro, the model can further be used as a platform for disease study. 
1.0 Modelling the central nervous system 
A detailed and comprehensive understanding of the structure and function of specific cells and 
tissues is vital for countering disorders and dysfunction within the human body. Gathering data on 
physiology and pathology in vivo is challenging due to issues with observing, accessing and 
manipulating cells and tissues while still retaining a reliable in vivo environment for the specific niche 
of study. One solution to these issues involves ex vivo research, studying biological models such as 
model organisms and cell/tissue cultures (Martinez-Morales and Liste. 2012, Meyer et al. 2013). 
Whilst animal testing on model organisms such as mice and rats is an established alternative 
technique to studying the human body itself, it has numerous shortcomings. Despite certain genetic 
and developmental similarities, rodent models are not sufficient for study of the human body. These 
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animals can develop artificial diseases and have unacceptably high risks of tumorigenesis and cancer, 
which means that the use of these animals as models can lead to unrealistic treatments with sub-par 
results which are often not reproducible, with only 11-25% of academic pre-clinical studies on animal 
models being reproducible in industry (Begley and Ellis. 2012). In addition, these models can lack 
heterogeneity compared to humans, especially important when modelling disease (Morgan et al. 
2013, Simmons et al. 2013). For these reasons there are pressures to find alternatives and move away 
from using animal models. The 3R concept to replace, reduce and refine animal experiments has 
been established for over 50 years, and alternatives have been in constant development (Russell and 
Burch. 1959). 
Cell and/or tissue models are far easier to access and modulate when compared to animal models, 
but they can lack the complexity of the in vivo environment (Yum et al. 2014). Due to this 
compromise, only the most simple, robust and reproducible models which also accurately mimic the 
in vivo environment can be considered for study. The more factors accounted for and sufficiently 
mimicked, the closer the model comes to representing the in vivo environment and being a suitable 
replacement for study (Bhatia and Ingber. 2014). Important factors to consider include: recreating 
the multicellular 3D niche of the tissue of interest (C. P. Huang et al. 2009), the interfaces and 
interactions with other cells and tissues such as cell-cell and tissue-tissue interaction (Strand et al. 
2010), involving a suitable concentration of chemicals and growth factors (and when necessary, 
including a physiochemical gradient) (Almodovar et al. 2013), the inclusion of a perfusion system 
(similar to vascular perfusion in vivo) (Bergh et al. 2005, Kelly et al. 2013), using a material of a similar 
stiffness to that found in vivo (Klein et al. 2009, Tse and Engler. 2011), and use of micro- and 
nano-scale physical topographical features to mechanically stimulate and manipulate cells and 
tissues (Curtis et al. 2001), as in vivo areas are rarely as uniform and featureless as typical tissue 
culture surfaces. 
Such a wide range of factors are necessary to consider when developing an in vitro model due to the 
inherent complexity and chaos in biology. Biological systems are composed of many proteins and 
chemical factors supporting millions of cells, which themselves are held in specific biochemical and 
physical environments, and interact with both neighbouring cells and any new or foreign factors. 
These systems exhibit a hierarchy ranging from proteins and other biological molecules/biochemical 
factors to cells which form tissues, to multicellular systems combining several tissues that form 
organs and organ systems, finally to multi-organ systems and the entire physiological mechanisms 
that form a complete organism. Organs and bodily systems are composed of not just cells, but cells 
arranged in a specific 3D manner, with structural scaffolds, blood supply to maintain nutrient levels 
and deliver signals, and the ability to respond to internal and external cues to modulate the function 
of the organ. This makes the creation of an accurate in vitro mimic of an in vivo microenvironment 
an extremely difficult task (Marx. 2015). 
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Systematic complexity reaches a peak when considering the nervous system, the most complex 
system of the body. This system is broadly split into two parts, the central nervous system (CNS, 
consists of the brain and spinal cord) and the peripheral nervous system (PNS consists of nerves that 
connect the CNS to the rest of the body, chiefly the limbs and organs). Neurons of the PNS carry 
information to the CNS, where complex decisions and functional changes are made (Laight. 2013). As 
a result, the PNS is functionally simplistic while structurally complex as PNS nerves need to innervate 
to the very peripheries of the body. These PNS neurons can be sensory or motor neurons, with the 
former carrying information to the CNS while the latter send CNS information to muscles and/or 
glands where orders are carried out. As PNS neurons often need to travel long distances and are 
unprotected by bone (unlike the CNS that has the skull for protection), the PNS is not dense and 
consists of long nerves stretching to peripheries and clusters of nerves in certain locations termed 
ganglia. 
Unlike the PNS, the CNS is both structurally and functionally complex. Briefly, the brain contains both 
neuronal and non-neuronal cells (collectively referred to as neural cells). The neuronal cells 
(henceforth referred to as neurons) are the functional cells of the brain, carrying information in the 
form of electrical signals and chemical messengers (termed neurotransmitters) to other neurons, 
joined by junctions termed synapses to create the many neural networks/circuits within and between 
different areas of the brain. These neurons are mainly grouped by the kind of neurotransmitter they 
produce, as signals can be excitatory or inhibitory. Sufficient excitation results in an action potential 
being sent along the neuron, activating other neurons connected by synapses, whereas inhibition 
can reduce or halt these signals, making different neuron types vital when modulating signals in the 
brain. With this in mind, neurons can be classified as GABAergic (main inhibitory type, produce 
gamma aminobutyric acid (GABA)), glutamatergic, (main excitatory type, produce glutamate), 
cholinergic (produce acetylcholine), dopaminergic (produce dopamine, which modulates neuron 
signals) and serotonergic (produce serotonin, which can be excitatory or inhibitory). These neuronal 
subtypes can be found in different concentrations in different areas of the brain, and carefully 
modulate the wildly complex signals of the brain. 
Non-neuronal cells (henceforth referred to as glia) are a family of different cell types, including 
oligodendrocytes that insulate neurons from misfiring by covering their axons with a myelin sheath; 
microglia that destroy pathogens and remove dead neurons, and astrocytes (also called astroglia).  
Astrocytes are cells with complex structural and functional roles in the brain, despite classical ideas 
that they were simply structural ‘glue’ (hence glia) that held the brain together. Astrocytes can be 
morphologically classified as either protoplasmic or fibrous and are typically found in grey and white 
matter of the brain respectively (Sofroniew and Vinters. 2010). There is no CNS region where 
astrocytes cannot be found, they occupy non-overlapping domains throughout their anatomical 
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regions and interact with CNS vasculature to form a complex gliovascular network, defining cortical 
and subcortical functional regions while also regulating blood flow (Nedergaard et al. 2003). 
Protoplasmic astrocytes extend 5-10 main branches and are shaped like a star (hence astro), with 
each branch further branching to very fine points, resulting in a single astrocyte in the hippocampus 
or cortex being in contact with several hundred dendrites from multiple neurons and enveloping 
more than 100,000 synapses (Halassa et al. 2007). Despite this contact with neurons, astrocytes do 
not fire or propagate action potentials, but feature changes in their intracellular Ca2+ concentration, 
which allows for astrocyte-astrocyte and astrocyte-neuron communication and signalling. These 
internal Ca2+ changes can be intrinsic, triggered by neurotransmitter (especially glutamate) release 
from either neurons or astrocytes and propagated to nearby astrocytes, allowing for astrocytes to 
play a direct role in synaptic transmission (with astrocytes forming gap junctions with adjacent 
astrocytes) (Perea et al. 2009). 
With astrocytes in contact with and enveloping virtually every synapse in the brain, it is clear that 
astrocytes play both an important structural and functional role. Other roles of astrocytes include 
maintaining homeostasis of the interstitial fluid in the brain (regulating fluid, ion, pH and 
neurotransmitter levels), delivering glucose and other energy metabolites from blood vessels to 
neurons (to allow sustained high neuronal activity), regulation of the blood brain barrier, and reactive 
gliosis/glial scar formation. Reactive gliosis is a response of astrocytes to CNS injury, varying with the 
severity of the injury, where astrocyte function is altered and regulated. Reactive gliosis can range 
from upregulation of glial proteins such as glial fibrillary acidic protein (GFAP) and reduced 
proliferation to tissue reorganisation and formation of a glial scar (astrocyte processes overlap across 
domains and deposit dense ECM to form a dense, narrow scar, which acts as a neuroprotective 
barrier to inflammatory cells and infectious agents) (Sofroniew and Vinters. 2010). Neurons and glia 
are maintained in a sensitive ratio, and numerous types of both families of cells exist within the brain. 
A generic 1.5 kg human brain contains approximately 90 billion neurons and 90 billion glia 
(Herculano-Houzel. 2009). In addition, each neuron can connect with other neurons (and astrocytes, 
forming tripartite synapses (Perea et al. 2009, Bernardinelli et al. 2014)) via synapses, at an average 
of 7000 connections per neuron, resulting in approx. 100 trillion connections in the adult human 
brain (Drachman. 2005, Horn et al. 2014). Surely in vivo work with a system this complex would 
bypass the need to recreate this level of complexity in the lab, in vitro? Unfortunately, due to the 
innate complexity, heterogeneity and dense structure of the brain, in vivo work on a specific area of 
the brain is virtually impossible without damaging or influencing other areas of the brain and 
therefore changing its physiological state (Bilston. 2011). Thorough study of human and animal brains 
is sometimes only possible after death and dissection but due to a large number of physiological 
changes in the brain after death, data gleaned from a dead brain cannot be compared to a live brain 
and is limited (Szabo. 2004, Gordon and McKinlay. 2012). A better approach to take in order to 
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understand the brain is the ‘bottom-up’ in vitro approach as opposed to the ‘top-down’ in vivo 
approach. In line with this view, successes with brain study in vivo have largely been due to the use 
of micro-scale neural devices and models fabricated in vitro (Takehara et al. 2014). 
Development of in vitro cell therapies and pre-clinical models aiming to better understand the brain 
are extremely active areas of research, partly in due to the fact that mature neurons in the CNS do 
not divide and consequently do not regrow functional axons after damage, resulting in degeneration 
and cell death over time after injury or throughout aging (Horner and Gage. 2000, Shoichet et al. 
2008). Due to this lack of regeneration, injury in the CNS is a serious issue and the cause of many 
major neurological diseases. 
1.0.1 Neurological diseases and disorders 
There are multiple ways to categorise neurological diseases, but the major types of neurological 
diseases include those caused by:  
 Genetic disorders such as Huntington’s disease (HD) (Pringsheim et al. 2012) and muscular 
dystrophy (Mah et al. 2014) 
 Cellular degeneration such as Parkinson’s disease (PD) (Pringsheim et al. 2014) and 
Alzheimer’s disease (AD) (Reitz. 2012) 
 Peripheral movement disorders such as amyotrophic lateral sclerosis (ALS) (Robberecht and 
Philips. 2013) and multiple sclerosis (Goldenberg. 2012) 
 Damage to CNS blood supply resulting in stroke (Sahathevan et al. 2012) 
 Electrophysiological disorders such as epilepsy (Acharya et al. 2013) 
 Physical injury resulting in spinal cord injury (Silva et al. 2014) and/or traumatic brain injury 
(Blennow et al. 2012) 
 Cancers including glial and non-glial tumours (Crocetti et al. 2012) 
 Infections such as bacterial meningitis (van de Beek et al. 2012). 
The vast majority of neurological conditions have unknown causes. This lack of knowledge concerning 
causative mechanisms of human neurodegenerative disease further outlines the vital importance of 
developing efficient research methods, especially when taking into account the prevalence and 
fatality of some of the conditions. More effective pre-clinical assessment is required in order to 
produce more relevant clinical trials and make further discoveries about these diseases and 
disorders, so as to further refine the process from the pre-clinical phase. 
Of these diseases, Parkinson’s disease will be the focus of the work in this thesis. 
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Figure 1.1: Complexity within the central nervous system (CNS). Tissue level: rat barrel corticies, cellular 
level, image shows neurons in green (β-tubulin stain), astrocytes in red (GFAP stain) and cell nuclei in blue 
(DAPI stain) (scale bar 100 µm). Images from Wikimedia Commons: central nervous system.svg (by Grm wnr), 
brain human sagittal section.svg (by Patrick J Lynch), CO40xComplete.jpg (by Imbrickle). Images released into 
the public domain. 
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1.1 Parkinson’s disease 
First described in 1817 by James Parkinson as a shaking palsy, Parkinson’s disease (PD) is caused by 
the loss of nigrostriatal dopamine (DA) neurons in the substantia nigra pars compacta (SNc) resulting 
in striatum (STR) DA deficiency (Lees. 2007). With DA not identified in the brain until 1958 (Montagu. 
1957) and PD still without a reliable cure or treatment today (at time of writing), PD represents the 
second most common age-related neurodegenerative disease (first being Alzheimer’s disease). 
Accelerated research is sorely needed in order to make some headway towards a solution, now over 
200 years after the discovery of PD. 
1.1.1 Prevalence 
PD is a progressive disease with the mean age of onset being 55, incidence increasing with age from 
2/10,000 overall to 12/10,000 by age 70 (Dauer and Przedborski. 2003, Pringsheim et al. 2012), in 
general affecting 1-2% of all individuals above the age of 65 (Van Den Eeden et al. 2003). The 
symptoms of PD worsen from onset over time, with the mortality rate of PD patients up to three 
times greater than normal subjects of the same age. In a persistently ageing population, the incidence 
of PD will only increase, leading to exponentially more cases. Approximately 95% of PD cases have 
an unknown cause, with the remaining 5% having a heritable genetic component (Lazaro et al. 2017). 
1.1.2 Genetic component  
As with other neurological diseases (such as Alzheimer’s and Huntington’s), PD is a complex disorder 
involving both genetic, environmental and unknown factors. Numerous genetic mutations are linked 
to PD and are associated with familial PD susceptibility: dominant mutations in leucine-rich repeat 
kinase 2 (LRRK2) and α-synuclein, as well as recessive mutations in Parkin, PTEN-induced putative 
kinase (PINK1), DJ-1 and glucocerebrosidase (Lazaro et al. 2017). Alongside these mutations, 
genome-wide association studies have identified over 25 genetic risk factors associated with PD 
(Verstraeten et al. 2015). 
Of all these mutations, there has been a particular focus of study on α-synuclein, due to the fact that 
a classic pathological hallmark of PD is the accumulation of protein aggregates termed Lewy Bodies 
(LBs), and these LBs are mainly composed of α-synuclein protein. Notably, α-synuclein protein is 
highly abundant in both CNS and PNS neurons (up to 1% of the total protein content) (Mizuno et al. 
2012) and is associated with synaptic vesicles (Nemani et al. 2010). In addition, α-synuclein exists in 
multiple forms and can act in a prion-like manner, spreading from Parkinsonian neurons to healthy 
neurons and recruiting healthy α-synuclein into aggregates and LBs, propagating throughout cell 
cultures in vitro and CNS tissue in vivo (Recasens et al. 2014). Despite this wealth of knowledge 
concerning PD genetic components and α-synuclein mechanisms, there is still a limited 
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understanding of how these mutations lead to the cytotoxicity seen in PD (Lazaro et al. 2017), again 
highlighting the need for better pre-clinical cell-based models that can mimic aspects of PD for 
accelerated research. 
1.1.3 Symptoms 
PD symptoms include but are not limited to (Dauer and Przedborski. 2003, Hague et al. 2005, 
Jankovic. 2008, Benam et al. 2015): 
 Tremor at rest (which decreases with voluntary movement) 
 Rigidity (an increased resistance to passive movement of limbs) 
 Bradykinesia (slowness of movement, impairs normal daily activities such as dressing and 
eating significantly) 
 Hypokinesia (reduced movement amplitude) 
 Akinesia (absence of normal unconscious movements such as arm swinging while walking).  
These main symptoms lead to a constellation of other symptoms such as hypomimia (lack of normal 
facial expressions), hypophonia (decreased voice volume), drooling (failure to swallow 
automatically), micrographia (decreased size), decreased stride length while walking and slower 
handwriting speed. PD patients also exhibit other general motor symptoms such as loss of reflexes, 
a stooped posture, tendency to fall (resulting in eventual confinement to wheelchairs) and freezing 
during voluntary movement. In addition, there are numerous non-motor symptoms such as abnormal 
cognition, lack of initiative (becoming passive and withdrawn), delayed responses to questions, 
slower cognitive processes, gradual loss of taste, depression and dementia (especially in older 
patients). 
1.1.4 Pathology 
PD pathology involves loss of nigrostriatal DA SNc neurons that usually project to the STR and deliver 
DA, and presence of LB protein aggregates within select neurons (Cronin-Furman et al. 2013, Cipriani 
et al. 2014). These LBs are spherical and are composed of numerous proteins including α-synuclein, 
parkin, ubiquitin and neurofilaments and are found within the cells of all affected areas (Dauer and 
Przedborski. 2003). 
Cell bodies in the SN contain neuromelanin, a complex polymer pigment that gave the SN region its 
name: substantia nigra, literally black substance. The loss of these neurons during PD results in a 
depigmented and less black SN, the classical method of diagnosing PD post-mortem. Neuromelanin 
is also associated with the oxidation of dopamine within the SN and with PD itself, as LBs are found 
within the boundaries of the pigment (Dauer and Przedborski. 2003). One study on neuromelanin 
treated cells with both neuromelanin and synthetic dopamine melanin, with the data suggesting a 
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protective role for neuromelanin under conditions of high oxidative load (J. Li et al. 2005). Findings 
such as this constantly provide new evidence for a physiological role of essential components in the 
SNc, dopamine or the BG itself both in vitro and in vivo and highlights the caution with which data 
based upon model systems should be interpreted. 
By the time PD symptoms appear 60% of SNc DA neurons have been lost and levels of DA in the STR 
have decreased by 80%. This cell loss is distinct to PD and different to age-related cell loss (despite 
age being a major factor in PD), affecting nigrostriatal terminals in the STR more than cell bodies in 
the SNc (suggesting that the DA neuron terminals in the STR are dying back) (Dauer and Przedborski. 
2003). Destruction of nigrostriatal terminals at the STR occurs first and SNc neuron death occurs later, 
protecting these STR terminals has been shown to prevent SNc neuron death in mice (Wu et al. 2003). 
Notably, DA neurons in the nearby ventral tegmental area (VTA) are largely unaffected by PD and 
continue to project to the caudate nucleus. This may be related to the fact that the SNc mainly 
projects to the STR and the VTA projects mainly to the prefrontal cortex, where synaptic DA uptake 
in the STR is dependent solely on DAT while the prefrontal cortex has other transporters that take up 
DA more efficiently (Dauer and Przedborski. 2003). 
While PD is mainly focused on the SNc-STR nigrostriatal pathway, the consequence of losing this 
pathway in PD has major impacts on other nuclei of the basal ganglia (BG). PD can be characterised 
by hyperactivity and synchronised oscillations in the subthalamic nucleus (STN) and globus pallidus 
internal/external (GPi/e), with the STN potentially being involved with inhibition, impulsivity and 
executive control in PD (Jahanshahi et al. 2015). Loss of SNc-STR connections also leads to a doubling 
of the number and strength of synaptic connections between GPe-STN, opposing hyperactivity but 
contributing to abnormal firing patterns in the STN during PD (Fan et al. 2012). These downstream 
changes are a consequence of the nigrostriatal pathway being an early input to the BG, changes in 
this pathway result in changes to all downstream nuclei. However, upstream nuclei are also affected, 
such as the CTX. D1 and D2 receptors are expressed in CTX intratelencepahlic (IT) neurons (but not 
pyramidal type (PT) neurons) and DA has a huge influence on corticostriatal connectivity and 
modulation of IT and PT CTX neurons. There are IT/PT-specific changes in response to PD, such as a 
reduced PT neuron firing rate while IT neurons are largely unaffected, resulting in a reduction of 
excitatory input to STR medium spiny neurons (MSNs) of the indirect pathway. Reduced PT neuron 
firing is significant as they are a part of the motor system and project to the STN (which becomes 
hypersensitive to input during PD). Deep brain stimulation of the STN and optogenetic stimulation of 
PT neurons have both been used to alleviate PD symptoms (Shepherd. 2013). 
1.1.5 Potential causes 
While the exact cause and mechanism of action of sporadic PD is still unknown, two centuries of 
experimentation and speculation have led to several robust theories. 
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The earliest was the environmental toxin theory, that the neurodegeneration found in PD was due 
to exposure to an exogenous neurotoxin. This theory was given weight by the existence of several 
chemicals that caused similar pathologies to PD upon exposure, such as 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), paraquat (herbicide similar to MPTP’s metabolised form, MPP+) and 
rotenone (insecticide, also similar to MPP+) (Langston et al. 1999). These are mitochondrial and 
cellular toxins found in the environment and were often used as insecticides or to remove unwanted 
organisms, resulting in human exposure and resultant damage. However, while MPTP can cross the 
blood brain barrier, the toxic metabolite ionic form MPP+ cannot pass the blood brain barrier due to 
the charge. In addition, rotenone and paraquat are unstable in solution and chronic environmental 
exposure has not been linked to causing PD, resulting in a lack of convincing data to support the 
environmental toxin theory (Dauer and Przedborski. 2003). Despite this, environmental and lifestyle 
factors are still important considerations, for example cigarette smoking and coffee are associated 
with decreased PD risk (Hernan et al. 2002).  
Another theory also relies on toxins, but endogenous rather than exogenous. Metabolic processes 
can produce harmful waste products in the body, and DA metabolism generates reactive oxygen 
species (ROS) that can cause mitochondrial damage (Cohen. 1984). Patients who lack enzyme 
cytochrome P450 (which has a role in in detoxification) have a greater risk of developing early-onset 
PD (Sandy et al. 1996), and Parkinsonian brains have been found to contain substances toxic to DA 
neurons such as isoquinoline (interestingly, these substances can be derived from exogenous MPTP) 
(Nagatsu. 1997). 
Regardless of initial causative source, studies have suggested two major mechanisms for PD 
pathogenesis: protein misfolding and aggregatioin, and mitochondrial dysfunction linked to oxidative 
stress (Dauer and Przedborski. 2003). These theories are not mutually exclusive and may well act in 
concert, with oxidative damage to α-synuclein shown to result in misfolding and aggregation 
(Giasson et al. 2000). Notably, these potential mechanisms are shared with other neurodegenerative 
diseases, specifically Alzheimer’s disease and Huntington’s disease (Rajput et al. 1993, 
Rosen et al. 2007), and data from these fields is a useful perspective on age-related 
neurodengerative diseases. 
In sporadic PD, it is uncertain if protein aggregates are neurotoxic (by causing direct damage, 
deforming cells, interfering with intracellular trafficking, hoarding proteins that are important for 
neuronal survival, etc) and aggregation formation results in neurodegeneration, or if protein 
misfolding and subsequent aggregation is not associated with cell death and is a cellular defense 
mechanism (Cummings et al. 2001). Soluble misfolded proteins (such as α-synuclein) have been 
shown to be neurotoxic, and while protein aggergates and LBs are a classic sign of PD, it is unclear 
how these aggregates affect sporadic PD (Auluck et al. 2002). In heritable PD, mutations either 
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directly induce abnormal protein conformations, or indirectly interfere with chaperone processes 
that would normally recognise and process toxic misfolded proteins. 
There is abnormal activity in mitochondrial complex I in PD, suggesting that the neurons are subject 
to oxidative stress and increased production of ROS. These ROS cause cellular damage by reacting 
with biochemical factors with the cell, resulting in further damage to mitochondria and further 
production of ROS, a cascade that causes serious oxidative damage to the cell (Cohen. 2000). SNc 
dopaminergic neurons in PD patients have demonstrated signs of oxidative damage and reduced 
glutathione, indicating that oxidative stress may also be responsible for PD 
(Jackson-Lewis et al. 2012). In addition, increased ROS also increases the amount of misfolded 
proteins, and DA neurons inparticular are at greater risk due to DA metabolism also generating ROS 
(Cohen. 1984, Giasson et al. 2000). However, it should be noted that this data was gathered from 
post-mortem or PD models with extremely low numbers of DA neurons, as these have been 
destroyed in the disease, and this data was mostly gleaned from glial and non-DA neurons. In 
addition, diseases where oxidative phosphorylation and mitochondrial function are directly affected 
are rarely associated with subsequent PD, suggesting that abnormal levels of ROS in PD may be due 
to the dying cells, and not causative of cell death (Dauer and Przedborski. 2003). 
1.2 The basal ganglia 
Neurons within the brain are highly organised, both structurally – cells can organise into dense groups 
termed ‘nuclei’ or layered sheet structures such as the cortex – and functionally, with both excitatory 
and inhibitory signals travelling between brain areas in hierarchical or cyclical fashions, controlling 
and modulating signals from other brain areas, both directly and indirectly. An area that exemplifies 
this standard of both structural and functional organisation is the basal ganglia (BG), a group of 
subcortical nuclei. The main nuclei of the BG include the striatum (STR), the largest structure of the 
BG; the globus pallidus (GP), consisting of functionally distinct internal (GPi) and external (GPe) 
sections; the subthalamic nucleus (STN), the only excitatory structure of the BG; and the substantia 
nigra (SN), which consists of two functionally distinct parts, namely the pars compacta (SNc) and the 
pars reticulata (SNr). These BG nuclei receive input from the cortex (CTX) and output to the thalamus, 
the brainstem and the spinal cord, outlining the importance of the BG in movement (Blandini et al. 
2000, Smeets et al. 2000, H. F. Kim and Hikosaka. 2015). The location of the BG within the brain is 
seen in Fig.1.2A while a basic diagram of BG connectivity is reproduced in Fig.1.2B. 
The importance of carefully regulated signals in the BG is highlighted when the system breaks down. 
Damage to certain areas of the BG results in a number of infamous neurological diseases: 
Huntington’s disease (HD), caused by a degeneration of GABAergic neurons in the STR (Walker. 2007) 
and Parkinson’s disease (PD), caused by a loss of dopaminergic neurons in the SNc (Blandini et al. 
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2000, Hague et al. 2005). Due to the currently incurable, progressive and prevalent nature of these 
diseases, the BG has received a great deal of scientific attention. Creating an in vitro model of this 
area would result in a pre-clinical model and a powerful platform for study, both of a physiologically 
healthy and pathologically damaged BG. 
 
1.2.1 Anatomy of the basal ganglia 
As the BG is a complex circuit of excitation and inhibition, it is necessary to appreciate the 
neurotransmitters involved in causing each type of specific response from certain BG nuclei. Upon 
being excited by an AP, neurons release neurotransmitters across synapses to communicate signals 
to other synapsed neurons. In the BG, there are three main types of neurotransmitter: glutamate, 
the principal and most abundant excitatory neurotransmitter in vertebrates (Meldrum. 2000); 
γ-aminobutyric acid (GABA), the principal inhibitory neurotransmitter (K. Li and Xu. 2008); and 
dopamine, a neuromodulatory chemical that maintains balance across the BG (Bezzi and Volterra. 
2001). While dopamine is only found in the SNc within the BG, each of the other nuclei of interest 
express a majority of either glutamate or GABA neurons and are excitatory or inhibitory respectively. 
1.2.1.1 Cortex 
The cerebral cortex, or specifically in the case of the basal ganglia, the motor areas of the neocortex, 
consists of both diverse excitatory glutamatergic pyramidal projection neurons and inhibitory 
GABAergic interneurons, all separated into well-defined layers (Marin and Muller. 2014). The 
glutamatergic neurons have dense dendritic trees, with studies showing a single cell in the CTX 
receives 30,000 excitatory inputs compared to 1700 inhibitory inputs (Megias et al. 2001). These 
glutamatergic neurons project to different areas depending on their layer within the CTX, with some 
Figure 1.2: On the basal ganglia. A) Location of BG nuclei in the brain. B) Diagram of the connectivity of BG 
nuclei (the boundaries of the BG indicated by the dashed grey box). Arrows indicating connections are 
coloured as follows: green for excitatory connections, red for inhibitory connections, and blue for 
dopaminergic connections. Acronyms are explained in text above. Image A from Wikimedia Commons (user 
Anaru), under Gnu Free Documentation License. 
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populations projecting to the STR and others to the STN, forming the two excitatory inputs to the BG. 
The STR input features projections from pyramidal neurons of layers III and V (the corticostriatal 
pathway) in a unidirectional manner; while the STN input features projections from CTX layer V (the 
‘hyperdirect’ pathway), which are then relayed to the GPi and SNr (Mathai and Smith. 2011). 
1.2.1.2 Striatum 
The STR is a major part of the BG, receiving massive inputs from the CTX (glutatmatergic) and SNc 
(dopaminergic) and as such the STR has a large number of neurotransmitter receptors for dopamine, 
glutamine and others such as acetylcholine, endocannabinoids and endogenous opiates (Crittenden 
and Graybiel. 2011). In particular, the STR contains five types of dopamine receptor, with the majority 
consisting of dopamine receptor 1 (D1) and 2 (D2), which act excitatory and inhibitory in response to 
dopamine binding respectively (Gerfen and Surmeier. 2011). More information on DA receptor 
distribution in the forebrain can be found in the following review (Tritsch and Sabatini. 2012). 
95% of the STR is made up of GABAergic medium spiny projection neurons (MSNs), with the 
remainder being smaller cholinergic and/or parvalbumin (PV, a calcium binding protein) -expressing 
interneurons (Ellens and Leventhal. 2013). The MSNs express either D1, D2 or both (both in 40% of 
cases), with D1-type promoting movement and being part of the direct pathway (projecting directly 
to BG output nuclei GPi and SNr) and the D2-type suppressing movement and being part of the 
indirect pathway (projecting to the intermediate BG nuclei GPe, which then projects to the STN and 
the output nuclei GPi and SNr), meaning that an influx of dopamine to the STR would excite the 
D1-type promoting circuits and inhibit the D2-type suppressing circuits, therefore being doubly 
pro-movement (Yager et al. 2015). Reassuringly, MSNs grown in organotypic cultures in vitro show 
morphological and electrophysiological characteristics similar to those seen in vivo, reinforcing the 
idea of an in vitro model of the BG (Plenz and Kitai. 1998, Sharott et al. 2012). 
1.2.1.3 Globus pallidus 
The GP is often categorised anatomically into two sections, the internal (GPi) and external (GPe), 
both mostly consisting of inhibitory GABAergic neurons. The GPi is an output nucleus of the BG that 
receives GABAergic projections from both the STR direct pathway (D1 MSNs) and the indirect 
pathway via the GPe (D2 MSNs), as such the GPi is rich in GABA receptors. The GPi also receives 
glutamatergic projections from the STN and (along with the SNr) projects inhibitory GABAergic 
neurons out of the BG to the motor relay nuclei of the thalamus and brain stem/spinal cord (Bergman 
et al. 1994, Kliem et al. 2007, Nambu. 2007). The GPe is an intermediate nucleus that receives 
inhibitory GABAergic D1 MSNs from the STR indirect pathway and excitatory glutamatergic neurons 
from the subthalamic nucleus (STN). The GPe projects inhibitory GABAergic neurons to the GPi, STN, 
SNr and back to the STR, giving the GPe a considerable co-ordination role in the BG (Kita. 2007). 
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1.2.1.4 Substantia nigra 
The substantia nigra (SN) is often categorised anatomically into two sub-nuclei with markedly 
different functions and connectivity, namely the pars compacta (SNc) and pars reticulata (SNr). 
Similarly to the GPi, the SNr consists mostly of GABAergic inhibitory neurons which project to the 
thalamus and the brainstem/spinal cord, and acts as an output nucleus for the BG. However, unlike 
the GPi, the SNr is in close proximity to the SNc and as such dendrites from dopaminergic neurons of 
the SNc supply dopamine to the SNr over several hundred microns distance, directly depolarising SNr 
GABAergic neurons (Hausser et al. 1995, Ford et al. 2010, Rommelfanger and Wichmann. 2010) as 
the neurons in the SNr have mostly D1-like receptors (Kliem et al. 2010). Axons from the SNr project 
to the SNc in return, allowing for the SNr to regulate nigrostriatal DA neurons (Tepper et al. 1995, F. 
M. Zhou and Lee. 2011). 
The SNc is a vital and unique structure of the BG in that it is mostly composed of dopaminergic 
neurons which project to their principal target, the STR (creating the nigrostriatal system), but other 
projections also exist to the CTX, thalamus and other BG nuclei (Ellens and Leventhal. 2013). These 
dopaminergic neurons are heavily regulated by upstream processes outside the BG (S. Hong et al. 
2011, Beeler et al. 2012). The importance of these dopaminergic projections from SNc to STR are 
highlighted in Parkinson’s disease, which is caused by the loss of these projections. Inputs to the SNc 
are mostly inhibitory (70% GABAergic), including afferent projections from the STR (Fujiyama et al. 
2011) and SNr (Tepper et al. 1995), along with some excitatory afferent projections from the STN 
(Morikawa and Paladini. 2011) and other nuclei as seen in Fig.1.3. 
 
Figure 1.3: Projections to and from the substantia nigra pars compacta (SNC). PFC: prefrontal cortex, 
SMCtx: sensorimotor cortex, STR: striatum, GP: globus pallidus, STN: subthalamic nucleus, SNR: substantia 
nigra pars reticulate, PPTg: pedunculopontine tegmental nucleus, LC: locus coeruleus, RMTg: rostromedial 
tegmental nucleus. Coloured projections shown in key. 
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1.2.1.5 Subthalamic nucleus 
The STN is the only glutamatergic nuclei of the BG, giving it a unique excitatory role in signalling. The 
STN receives excitatory input directly from the motor CTX via the hyperdirect pathway 
(cortico-subthalamo-pallidal or CTX-STN-GP), bypassing the STR and working alongside the other 
major signal pathways of the BG, namely the direct and indirect pathways (Nambu et al. 2002), also 
taking part in the latter. Other inputs to the STN include inhibitory GABAergic neurons from the GPe 
and a small number of dopaminergic afferents from the SNc (Rommelfanger and Wichmann. 2010, 
Ellens and Leventhal. 2013). In turn, STN glutamatergic neurons project to the GPe (creating a 
GPe-STN feedback loop where the two nuclei are reciprocally connected) and the two BG output 
nuclei, GPi and SNr. 
1.2.1.6 Summary 
Taking into account this anatomical information, the signal connectivity diagram of the BG seen in 
Fig.1.2B at the beginning of this section can be updated with a more accurate diagram, seen below 
in Fig.1.4. 
 
Figure 1.4: Diagram of the connectivity within the basal ganglia as well as immediate inputs and outputs. The 
basal ganglia is indicated by the dashed grey square. Green, red and blue arrows indicate excitatory 
glutamatergic, inhibitory GABAergic and modulatory dopaminergic connections respectively. Most 
connetions are unidirectional but cortex to thalamus is bidirectional. SNc/r: substantia nigra pars 




Fig.1.4 highlights the importance of the BG as a functional bridge between the CTX and the thalamus, 
brainstem and spinal cord. Information is input into the BG via the CTX, where it is then processed 
by the STR and GPe, then output via the GPi and SNr. The SNc and STN input dopaminergic and 
glutamatergic signals into this process. For the purpose of studying PD, the vital nuclei are the CTX 
(input), STR (intermediate), GP/SNr (output) and SNc, seeing as the nigrostriatal pathway contains 
all the dopaminergic neurons lost in PD. Containing these five nuclei within an in vitro model would 
make for a powerful platform for study of PD and the BG. 
1.2.2 Development of the basal ganglia 
The BG anatomy described above is typical for an adult human or rodent, but how does the BG form 
and change throughout development? If neural cells for an in vitro model are taken prenatally it is 
vital to ensure that the correct neurons are cultured in the correct place. The early CNS first has the 
form of a neural plate, containing all neural progenitor cells. This plate forms ridges and grooves and 
folds inwards, fusing together into a hollow tube termed the neural tube, which then closes at both 
ends. This forms the three sections of the early CNS, namely the prosencephalon, mesencephalon 
and rhombencephalon, which develop into the forebrain, midbrain and hindbrain respectively. The 
prosencephalon and rhombencephalon further subdivide, forming the five areas that make up the 
primary organisation of the CNS: the telencephalon and diencephalon (from the prosencephalon), 
the metencephalon and myelencephalon (from the rhombencephalon) and the mesencephalon 
(Stiles and Jernigan. 2010). 
1.2.2.1 Cortical, striatal and pallidal development 
The telencephalon divides into dorsal and basal ventricular zones, which develop into the CTX and 
STR/GP respectively (Medina et al. 2014). The basal ventricular zone forms a dome shaped 
protuberance into the ventricular cavity, termed a ganglionic eminence. This eminence is split into 
two sections by a sulcus (or groove), the lateral ganglionic eminence (LGE) and the medial ganglionic 
eminence (MGE) (Lavdas et al. 1999), with the LGE developing into the STR, and the MGE developing 
into the GP. This development has been demonstrated classically (Holmgren. 1925) with 
autoradiography (Marchand and Lajoie. 1986) and more recently with genetic fate mapping and 
transcription factors (Medina and Abellán. 2012), with only LGE-derived cells expressing PAX6+ and 
ISLET1+, and only MGE-derived cells expressing NKX2.1 and LHX6/7/8 (Medina et al. 2014). 
60% of CTX GABAergic interneurons originate from the MGE but not the LGE, as the neurons cannot 
migrate across the separating sulcus, while the pyramidal glutamatergic neurons of the CTX develop 
from local radial glia in the ventricular zone and radially migrate along radial glial fibres to the 
developing cerebral cortex (Medina and Abellán. 2012, Marin and Muller. 2014, Medina et al. 2014). 
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Five distinct progenitor zones were identified in the MGE, named pMGE1-5. These zones give rise to 
different classes of neurons, due to the tight spatial control of neurogenesis and migration within the 
brain (Wonders et al. 2008). Not only do the dorsal (1-2) and ventral (3-5) MGE zones give rise to 
GABAergic interneurons respectively, the extent of migration origin also differs, with pMGE5 being 
the source of GABAergic neurons in the GP and similar interneurons from pMGE3-4 migrating to the 
CTX (Gelman and Marin. 2010). As a result, after birth both the GP and CTX contain GABAergic 
interneurons originally from the MGE. This migration and development is particularly important as 
GABA receptors are excitatory during development, rather than inhibitory (Sanes et al. 2012). 
Development of the CTX, STR and GP precursors all occur at well-defined times, following the 
development of a rat embryo (where E signifies embryonic day and P signifies postnatal day). The 
MSNs of the STR are generated in the LGE from E12 to P2, peaking at E15, while GP GABAergic 
neurons are generated in the MGE between E12-15, peaking at E14 (Marchand and Lajoie. 1986). 
1.2.2.2 Nigral development 
SNc dopaminergic cells develop from an entirely separate area of the early CNS tube, namely the 
floor plate of the ventral midbrain (or ventral mesencephalon, both VM). This floor plate is the most 
ventral part of the neural tube and contains radial glia-like cells that develop into postmitotic 
migratory dopaminergic precursors, which differentiate into dopaminergic neurons (Bonilla et al. 
2008). This neurogenesis process takes place in the rodent from E10-14, peaking around E12 (Gates 
et al. 2006). Notably, the VM floor plate extends from the mesencephalon to the diencephalon, with 
the most rostral section of the plate giving rise to glutamatergic STN neurons. Both these 
glutamatergic neurons and the dopaminergic neurons express transcription factors 
FOXA2+/LMX1A+/OTX2+, unlike neurons derived from the LGE or MGE (Nelander et al. 2009, Nolbrant 
et al. 2017). More information can be seen in Fig.1.5 below. 
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Figure 1.5: Anatomical patterning of the ventral diencephalon/mesencephalon during development. Both 
STN and SNc progenitors originate from the floor plate of the VM, expressing LMX1A+/FOXA2+/OTX2+. 
Proximity to FGF8 expression regions appear to cause this change in progenitor, at the midbrain–hindbrain 
boundary. Image from (Nolbrant et al. 2017). 
The GABAergic neurons of the SNr are partly generated in the VM and partly from the 
rhombencephalon. VM-generated SNr GABAergic neurons are generated by unknown mechanisms 
but express TAL2/GATA2 proteins (Madrigal et al. 2016, Nolbrant et al. 2017), while 
rhombencephalon-generated SNr GABAergic neurons are generated in a region named 
rhombomere 1 (R1) and express TAL1/GATA2 proteins (Achim et al. 2012). In this manner, the SNr 
can be split into anterior and posterior sections based on the distinct development of the GABAergic 
neurons of each section, but it is unknown how this is related to the functional diversity of the SNr 
GABAergic neurons of the BG. 
The CTX, STR, GP and SN can therefore be obtained by dissecting from the cortex, LGE, MGE and VM, 
areas anatomically and developmentally distinct (as seen in Fig.1.6). 
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Figure 1.6: The embryonic brain and its development into different nuclei of the BG. Blue for dopaminergic, 
red for GABAergic, and green for glutamatergic.  
 
1.2.2.3 Development of GABA as a neurotransmitter 
There are three other notable facts to consider during brain development, all concerning the 
neurotransmitter GABA. Firstly, there is an absence of a GABA uptake system in the early stages of 
development, which causes GABA to accumulate in the extracellular space and reach concentrations 
sufficient to affect even distal neurons (Ben-Ari. 2014). Secondly, GABAergic synapses form before 
glutamatergic synapses, a feature that is conserved in multiple species (Tyzio et al. 1999) and across 
different brain regions (Ben-Ari. 2002). Lastly, during development GABA is initially excitatory, able 
to elevate intracellular Ca2+ concentration and trigger action potentials. Later in development, there 
is a ‘GABA switch’ where the action of GABA switches from excitatory to the more standard 
inhibitory, changing electrophysiological action from depolarising to hyperpolarising. The presence 
of inhibitory signals in the brain is necessary as it allows for more complex and diverse activity within 
the neural networks (Maric et al. 2001, Ben-Ari. 2002). 
Initial excitatory action of GABA is as a result of high intracellular concentration of chloride ions (Cl-) 
(Ben-Ari et al. 2012). The GABA switch to inhibitory action has been observed to occur in two phases, 
shortly before and shortly after birth. The first phase is temporary, oxytocin-dependent and occurs 
during labour/delivery (can be blocked with oxytocin antagonists) in a period extending from E20 to 
P0 (postnatal day zero, the day of birth), peaking at E21, 1-2 hours before delivery (Tyzio et al. 2006). 
The second and permanent phase begins soon after birth and completes by the end of the first 
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postnatal week (P0-P7) (Valeeva et al. 2013) using Cl- transporters such as GABA receptor A and KCC2 
(a K+-Cl- cotransporter) to decrease the concentration of intracellular Cl- and completing the switch 
to inhibitory action by P7 (Leonzino et al. 2016). This change is detectable with both intracellular and 
extracellular electrophysiological measurements (Khalilov et al. 1999). However, while this has been 
shown to occur in vivo and in the presence of oxytocin, does this excitatory/inhibitory switch occur 
in cells taken at early embryonic age, then grown and matured in vitro? Most work on the topic of 
the GABA switch in vitro has taken place using rat hippocampus tissue which, when grown in vitro, 
shows a switch after ~11 DIV (Ganguly et al. 2001, Khazipov et al. 2004, Mohajerani and Cherubini. 
2005). However, work done in other brain areas shows a similar trend, as seen in Table 1.1 below. 
GABA can also regulate the GABA switch itself (Ganguly et al. 2001). Significantly, the developmental 
switch to Ca2+ mediated signalling is itself GABA-mediated and triggered by endogenous GABAergic 
transmission. The increase in GABAergic activity throughout development promotes the switch of 
GABA signalling. This switch is not dependent on electrophysiological spiking activity from neurons, 
as it still occurs in the presence of tetrodotoxin (TTX), which blocks Na+-dependent APs in neurons. 
GABAergic activity also modulates the mRNA levels of KCC2, expression of which correlates with the 
GABA switch. In summary, GABA itself can also promote the GABA switch from excitation to 
inhibition, meaning neuronal cells taken at embryonic ages and grown in vitro can undergo a GABA 
switch, even in just a population of GABAergic neurons. 
1.2.2.4 Synapse development 
When taking cells at developmental ages (such as E12-16 in the rat), it is possible that synapses have 
not fully formed or functionally matured. At birth, approx. E22/P0, 80% of interneurons have 
functional GABAergic and glutamatergic synapses, but less than 20% of pyramidal neurons have 
formed synapses, which decreases further to almost none at E19/20 (Ben-Ari. 2014). In addition, in 
the CNS glutamate binds to ionotropic receptor ion channels, such as 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors (AMPARs) and 
N-methyl-D-aspartate receptors (NMDARs), which are highly expressed and evolutionarily conserved 
(Lauder. 1993, Gallo et al. 1995, Ulrich and Majumder. 2006). However, neonatal rat glutamatergic 
synapses lack AMPARs, NMDARS are present but remain closed at the resting membrane potential. 
This leads to ‘silent synapses’, which do not become fully active until around P3, when glutamate and 
GABA transporters first appear in the rat (increasing to adult levels over the next two weeks) (Sanes 
et al. 2012). 
Therefore, neurons from the developing rat can lack both synapses and the vital transmembrane 
proteins that support synapses, which would lead to difficulties when constructing a functional 
neural circuit in vitro. In the in vivo rodent, these synapses form in the few weeks after birth, so it is 
vital to ensure that they also form as the cells mature in vitro. 
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Table 1.1: Instances of the GABA switch (excitatory to inhibitory) observed in vitro. 




P0-7 Gramicidin perforated 
patch 
Excitatory in 40% of neurons 






(dorsal horn L1 
slices) 
P0-60 Gramicidin perforated 
patch, whole cell 
patch, Ca2+ imaging 
Depolarizing for first week, 
switched by P7, Cl- extrusion 









Intracellular recording Depolarising at E18-P4, 





P4-26 Gramicidin perforated 
patch 
Inhibitory at embryonic ages, 
switch occurred in males at 










Ca2+ imaging Excitatory/inhibitory switch 
occurs between 8-13 DIV 
(Obrietan 
and van den 
Pol. 1995) 
Neocortex 




Excitatory from P4-10, 













Transient decrease in 
intracellular 36Cl after 11 DIV 
(Schomberg 
et al. 2003) 
Neocortex 
(slices of layer 
II/III) 
P1-21 Gramicidin perforated 
patch, Ca2+ imaging, 
single cell RT-PCR 
Depolarising at P1-3, 




In the developing rat cerebral cortex in vivo, the number of synapses and synapse density is low at 
birth but increases rapidly to adult levels by P16-21. This is closely followed by the time course of 
synapse formation in primary rat cortical cultures in vitro, shown by experimentation where E18 
neurons cultured for up to 35 days in vitro (DIV) demonstrated increased synapse: number, density, 
morphological development, contact zone size and vesicles per terminal (Ichikawa et al. 1993), along 
with more recent studies showing similar results (Ulrich and Majumder. 2006, Goyal and Nam. 2011), 
concerning in vitro maturation of primary neurons from embryonic rodents. This in vitro maturation 
can also be observed with cell lines, such as the P19 embryonic carcinoma cell line. These cells can 
be differentiated into neuron-like cells which mature in vitro once differentiated and are capable of 
neurotransmitter release and formation of functional synapses. This maturation occurs in a culture 
density-dependent manner, with more dense cultures demonstrating up-regulation of synaptic 
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vesicle proteins, enhanced glutamate and H-aspartate release and accelerated neuronal maturation 
(Parnas and Linial. 1997). In addition, after approx. 10 days of in vitro growth, these cells are capable 
of Ca2+ depolarization-dependent acetylcholine release and express all major proteins implicated in 
synapse functionality at both at RNA and protein levels (including cytoskeletal proteins, synaptic 
vesicle proteins and terminal specific proteins) (Parnas and Linial. 1995), along with carrying high-
affinity uptake sites for GABA (McBurney et al. 1988). This type of in vitro maturation and 
differentiation is also seen in embryonic stem and embryonic body stages, with these cell types 
developing into neurons with functional synapses (Barberi et al. 2003) that can integrate into the 
in vivo brain, in this case migrating into the residual cortex (Chiba et al. 2003). Finally, this has also 
been shown with induced pluripotent stem cells (iPSCs), in order to develop in vivo-quality 
dopaminergic neurons in vitro (Nolbrant et al. 2017). Functional synapses can therefore develop 
in vitro as cell cultures functionally mature. 
1.3 Modelling of Parkinson’s disease 
In order to understand the underlying mechanisms at play in PD and develop more effective drugs, 
treatments strategies or therapies, it is vital to have the ability to reproduce the disease symptoms 
and progression in a model for study. However, as the cause of sporadic PD is unknown it is difficult 
to create models that can entirely model PD, or to create models that can model aspects of PD within 
an acceptable timeframe, as PD takes years and decades to develop in the human brain in vivo. The 
main materials for accurate study of human PD are post-mortem tissues which only represent the 
end-stage of the disease and are fundamentally different to live tissue (Martinez-Morales and Liste. 
2012). 
An important distinction to make at this point is that non-human animals do not naturally develop 
PD, with the possible exception of mild PD in aged non-human primates in captivity (Terzioglu and 
Galter. 2008). Due to this limitation, while many different PD models have been developed in many 
different species, PD cannot be entirely modelled or accurately simulated in current animal, cell or 
tissue models. The ideal sporadic PD model would be a model of progressive nigrostriatal 
neurodegeneration, with similar mechanistic changes in the brain and onset of PD symptoms with 
time, along with the formation of α-synuclein-containing LBs and emergent behavioural changes 
(Dauer and Przedborski. 2003). Once PD symptoms had manifested sufficiently, drugs or other 
treatments could be applied to the model and tested for effectiveness. For genetic PD, these drugs 
or other treatments could be applied before onset to test prevention. 
In the search for this ideal PD model many animal species have been utilised, including relatively 
simple worms (C. elegans) (Harrington et al. 2010) and flies (Drosophila) (Botella et al. 2009) that 
have been modified to express human genes. These models have been used to study aspects of 
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cellular processes involved in PD, such as apoptosis, oxidative stress, protein misfolding, and protein 
aggregation. However, while these models are far cheaper and easier to use than more complex 
animal species, they cannot replicate loss of neurons in the brain, PD disease progression or 
manifestation of PD symtpoms (Maetzler et al. 2009). 
Larger animal species such as dogs, cats and non-human primates have also been used to model PD, 
but are limited by difficult ethical concerns, far higher costs and much greater timescales 
(Potashkin et al. 2010). Non-human primates are of particular interest as they can develop mild 
PD-like symptoms when aged and have the same bipedal motor organisation as humans, but as they 
are the most complex they are also the most expensive and ethically unjustifiable in most cases. The 
most widespread and popular models for PD are rodents (rats and mice), which are readily available, 
genetically malleable and low cost, and have been used to study PD for over 40 years (Ungerstedt. 
1968), despite having different motor system organisation in the brain (Dauer and Przedborski. 
2003). As these rodent models will not naturally develop PD symptoms, PD must be induced in these 
models, with the the two main methods used being neurotoxins and genetics. 
1.3.1 Neurotoxin-based animal models 
Certain neurotoxins can be applied to models in order to acutely damage the nigrostriatal pathway 
and mimic PD pathology. Thus, it is necessary to first understand the range of key neurotoxins 
available to mimic PD in animal models, namely 6-hydroxydopamine (6-OHDA), MPTP, paraquat and 
rotenone (the latter three were mentioned briefly in the ‘potential causes’ section as exogenous 
environmental toxins). These toxins inhibit mitochondrial fuction and create ROS (Terzioglu and 
Galter. 2008), but feature three major drawbacks. Firstly, none of these toxins reproduce all the 
symptoms and pathology of human PD in rodent models. Secondly, this toxic effect is very acute and 
not at all progressive as in PD, where similar changes occur over many years. Lastly, the rodent 
models are often very young due to the inconvenience and increased cost of using aged animals, 
despite aged models being a better model for PD which occurs mainly in elderly patients over 60 
years of age (Potashkin et al. 2010). Structures of the relevant neurotoxins can be seen in Fig.1.7. 
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Figure 1.7: Neurotoxins used in PD research. A) Dopamine itself, included by way of comparison as most 
neurotoxins bear some similarity to dopamine structure in order for dopaminergic neurons to mistake them 
for dopamine and take them up. B) 6-OHDA, only differs from dopamine due to the extra hydroxyl (OH) 
group on the 6th carbon of the ring, making it very specific to dopaminergic neurons. C) MPTP, the non-toxic 
precursor of MPP+. D) MPP+, the metabolised form of MPTP and a neurotoxin that is taken up by 
dopamingergic neurons. E) Paraquat, a highly toxic pesticide that can lead to Parkinson’s-like symptoms, 
note the similarity to MPP+. F) Rotenone, a more complex pesticide that also leads to Parkinson’s-like 
symptoms developing. 
1.3.1.1 MPTP 
MPTP, paraquat and rotenone all resemble each other in structure and have all been shown to induce 
DA neuron degeneration and death. Humans are sensitive to MPTP and MPTP application has been 
shown to incude PD-like symptoms, in the case where MPTP was mistaken for synthetic heroin and 
injected by several people (Langston et al. 1983). Using MPTP on both cell (SN4741 dopaminergic cell 
line) and animal models (C57BL/6 mouse models) has resulted in increased ROS activity (including 
hydrogen peroxides, superoxides and hydroxyl radicals), activation of JNK1/2 MAP kinases, activation 
of caspases and eventual apoptotic cell death (Brooks et al. 1999), along with inhibition of 
mitochondrial complex I (Betarbet et al. 2000). Use of antioxidants and caspase inhibitors exerted a 
significant neuroprotective effect on ROS-induced DA neuron death (Chun et al. 2001).  
In animal models, MPTP administered outside the brain can easily cross the blood brain barrier, 
where astrocytes and serotonergic neurons convert it into the toxic metabolite MPP+ over time via 
monoamine oxidase-B (MOA-B) (neither MPTP nor MPP+ being neurotoxic to astrocytes) (Marini et 
al. 1992) and release MPP+ into the extracellular space. MPP+ has a high affinity for the dopamine 
transporter (DAT) along with noradrenaline and serotonin transporters, and can therefore affect 
serotonergic and catecholaminergic neurons, but has the most pronounced effect in DA neurons. 
MPP+ itself cannot cross the blood brain barrier, but can be administered directly to the brain, and 
once in the brain (either by direct administration or by MOA-B metabolism of MPTP) it has a 
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significant and selective neurotoxic effect on SN DA neurons due to uptake by DATs and movement 
along a number of possible pathways. Once within DA neurons, MPP+ can be concentrated into 
mitochondria where it inhibits mitochondrial complex I, translocated into synaptic vesicles (a possible 
defense mechanism as this protects MPP+ from accessing mitochondria) or remain in the cytosol and 
interact with enzymes/other biochemical factors (Dauer and Przedborski. 2003). 
As a result MPTP/MPP+ have a significant toxic effect on SN DA neurons. For example, pumping MPP+ 
into the left cerebral ventricle of rats for 28 days caused a selective ipsilateral loss of 35% of SN DA 
neurons, increasing to 65% after a further 14 days (Yazdani et al. 2006). LB-like aggregates were 
found in STR neurons near the infusion site, and surviving SN DA neurons had swollen and abnormal 
mitochondria. There was no animal death, meaning that this study modelled a progressive 
neurodegeneration of SN DA neurons, more similar to PD than other acute toxin models and showing 
why MPTP is a popular neurotoxin to model PD in animals. 
Despite these desired effects of MPTP/MPP+ on animal and cell models, it is only effective in select 
conditions. If MPTP is administered outside the brain the activity of astrocytic MOA-B is necessary 
for conversion to the toxic MPP+ (once MPTP crosses the blood brain barrier). However, levels of 
MOA-B in the brain differ wildly between animal models, even between specific strains of rats and 
mice. Only specific stains of mice are sensitive to MPTP activity, with all rat strains and some mouse 
strains being entirely resistant (Sedelis et al. 2000), with resistant defined as MPTP resulting in less 
than 25% SN DA neuron loss (Meredith and Rademacher. 2011) (while humans are very sensitive to 
MPTP). The reason for these resistances is largely unknown, likely to be differences in MOA-B levels, 
different tolerances to oxidative changes, differential DAT uptake and kinetics, astrocytic activity and 
even coat colour (albino strains are more resistant to MPTP). The mouse strain C57BL/6 is most 
widely used in research as it is the most sensitive to MPTP. In summary, unless specifically using 
C57BL/6 mice or applying MPP+ directly to the brain or neural cultures, MPTP is unsuitable for use 
as a neurotoxin in this project, as it also demonstrates non-specific damage once past the blood brain 
barrier (Meredith and Rademacher. 2011). Similar toxins such as paraquat/rotenone are also 
unsuitable for modelling as they are not specific to DA neurons and cause high mortality and high 
experimental variability (Bove et al. 2005). These major physiological differences between rodents 
and humans are always represent a point for caution when interpreting results from rodent models. 
1.3.1.2 6-OHDA 
6-OHDA has been in use to successfully selectively damage DA neurons for over 40 years (Ungerstedt. 
1968, Michel and Hefti. 1990, Jellinger et al. 1995, Pietz et al. 1996, Kramer et al. 1999, von Coelln et 
al. 2001, Barkats et al. 2002, Ding et al. 2004, Hernandez-Baltazar et al. 2015). 6-OHDA is a structural 
analogue of DA, the only difference being an additional hydroxyl (-OH) group on the sixth carbon 
(Hanrott et al. 2006). Due to 6-OHDA being so similar in structure to DA, 6-OHDA exhibits a high 
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affinity for DATs (similarly to MPP+) and other catecholaminergic transports, and is taken up 
selectively via DAT into DA neurons. Once within DA neurons, 6-OHDA has a cytotoxic effect due to 
a number of possible mechanisms (Hernandez-Baltazar et al. 2017). 6-OHDA can rapidly oxidise in 
solution, producing hydrogen peroxide (H2O2), superoxides, hydroxyl radicals, para-quinones and 
other ROS. This results in oxidative damage to DA neurons either intra- or extracellularly, depending 
on whether 6-OHDA is taken up by DA neurons before or after auto-oxidation takes place (Blum et 
al. 2001). Alongside auto-oxidation, 6-OHDA can also directly inhibit mitochondrial complex I (Jenner 
et al. 1992), and it is likely that a combination of these two mechanisms result in overall oxidative 
stress and damage to DA neurons. Further loss of mitochondrial membrane permeability may lead 
to increased cytoplasmic free calcium, intensifying the oxidative stress and inducing cell death by 
apoptosis (Singh et al. 2010). It should be noted that these mechanisms of 6-OHDA in DA neurons do 
not involve the generation or presence of LBs 
In addition to 6-OHDA being selective for DA neurons, 6-OHDA also is a good mimic for PD as it affects 
SNc DA neurons more than other DA neuron populations in the brain (such as DA neurons in the 
ventral tegmental area (VTA)). SNc DA neurons are particularly affected by 6-OHDA-induced oxidative 
stress as they have higher baseline ROS levels and low levels of glutathione peroxidase, which 
converts H2O2 to H2O and lessens ROS damage (Hirsch et al. 1997, Double. 2012, Surmeier et al. 
2017). In addition, the SN contains a high concentration of neuromelanin, which can combine with 
iron and affect the ability of SN DA neurons to remove OH radicals and ROS (Gerlach et al. 2008). This 
specific selectivity of 6-OHDA for SNc DA neurons makes it an ideal neurotoxin for mimicking the 
effects of PD, depending on dosage concentration and exposure time (Bove et al. 2005). 6-OHDA 
neurotoxicity provokes molecular alterations comparable to those seen in PD, thus supporting the 
meaningfulness of 6-OHDA when exploring the mechanisms of neurodegeneration in PD. It should 
be noted, however, that 6-OHDA creates acute models of PD by rapidly damaging and killing only DA 
neurons, rather than the slow progressive loss of DA neurons and degeneration of other neuron types 
seen in PD in vivo (Ellens and Leventhal. 2013). 
In PD animal models, 6-OHDA is typically injected directly into the SN or STR (as it cannot cross the 
blood brain barrier), where it selectively damages DA neurons in these areas. When 6-OHDA is 
injected into the SN, DA neurons degenerate within 24 hours, compared to 1-3 weeks of retrograde 
degeneration of DA neurons when 6-OHDA is injected into the STR. Unilateral injections of 6-OHDA 
can be used to mimic the early-to-mid-stages of the disease (Mercanti et al. 2012) (with the 
contralateral side serving as an internal control), and can also result in behavioural changes in 
rodents, such as circling, fine motor tasks and walking across a rotating cylinder (Emborg. 2004). 
However, it is unclear if DA neurons are damaged/destroyed in the same way as they are in PD, and 
these 6-OHDA models also lack the formation of LBs. While limited, 6-OHDA animal models have 
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been widely used to assess anti-PD pharmaceuticals, neuroprotective agents and therapies (Dauer 
and Przedborski. 2003). 
1.3.2 Gene-based animal models 
As mentioned in 1.1.2 Genetic component, approximately 5-10% of PD cases are caused by 
hereditary genetic mutations, with over 25 genetic factors associated with risk of PD. Knowing which 
specific genes have been altered allows for the development of very specific animal models that 
directly apply to human PD from a genetic point of view, with the potential to apply data generated 
from these models to sporadic PD. Despite the genotypic differences between sporadic and heritable 
PD patients, there are many phenotypic similarities which indicate both forms of the disease follow 
similar mechanisms. 
Animal models of heritable PD are typically genetically modified mice, with recessive mutations in 
Parkin, DJ-1 and PINK1 made by knockout mice (null mutations), and dominant mutations in 
α-synuclein and LRRK2 made using transgenic mice (where extra copies of the gene are inserted into 
the mouse genome, usually by viral vector transfection) (Fleming et al. 2005). In general, genetic 
animal models of PD have demonstrated subtle effects on the DA system but no loss of DA neurons, 
indicating how these models are useful for study of heritable PD but very different to toxin-based 
models. When used in combination (administering toxins to genetically modified animal models) 
there are interesting effects, such as α-synuclein knockout mice being less sensitive to MPTP, while 
α-synuclein transgenic and DJ-1 knockout mice being more sensitive (Terzioglu and Galter. 2008). 
Genes implicated in PD are often associated with mitochondrial function, with PINK1, DJ-1, Parkin 
and LRRK2 being localised to mitochondria. This interplay between toxin-based models of sporadic 
PD and gene-based models of heritable PD indicate the value in both types of model being used 
together. 
1.3.2.1 Α-synuclein 
A-synuclein protein makes up LBs in sporadic PD, with further implications for a role in synaptic 
vesicle function, particularly significant as this means α-synuclein protein participates in movement 
of DA at DA neuron terminals in the STR (Kahle et al. 2002). As for the α-synuclein gene, two different 
mutations in α-synuclein (sometimes called PARK1) cause dominantly-inherited PD (A53T and A30P), 
and both have been recreated in transgenic mice. This resulted in abnormal DA neuron 
axons/terminals, age-related impairment in motor coordination and age-related reductions in DA 
(Richfield et al. 2002). When observing α-synuclein knockout mice, they have decreased DA in the 
STR, decreased vesicles in the hippocampus and rearing behaviour in open areas (Fleming et al. 
2005). However, when overexpressing α-synuclein in mice, very few models show alternations in the 
nigrostriatal DA system, instead showing affected spinal cord and neuromuscular junctions 
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(Giasson et al. 2002). But the models that do show alterations are valuable experimental tools for 
study of PD. Overexpression of wild-type human α-synuclein (with Thy1 promoter) in mouse models 
resulted in a SN that was more vulnerable to MPTP, progressive sensorimotor impairment (measured 
with behavioural motor tests, worsened with age after 2 months), decreased levels of DAT binding 
in the STR, abnormal behavioural response to DA agonists, and impairments to smell and 
gastrointestinal function (both associated with non-motor PD symptoms) (Fleming et al. 2004). 
Models such as these are extremely useful for study of heritable PD as the impairments worsen with 
age, even the lack of DA nigrostriatal neuron loss is useful as the model simulates the early stages of 
the disease (Terzioglu and Galter. 2008). 
However, despite the numerous α-synuclein-based genetic models of PD, very few models show the 
same α-synuclein pathology and progressive neurodegeneration as seen in human PD, with the 
exception of a mouse prion promoter A53T transgenic mouse (Chesselet. 2008). These models 
remain speculative but useful platforms for study of heritable PD. 
While animal models have been widely used to study both sporadic and heritable PD, they are 
limited. In vivo rodent models (toxin or genetic) still cannot completely reproduce the 
pathophysiology of PD seen in humans, and there is a lack of control and reproducibility seen in these 
models. Current pre-clinical assessment is insufficient to predict what pharmaceuticals and 
treatments will work on human PD patients, potentially due to this lack of in vivo animal models that 
duplicate the causes, symptoms and progression of a human neural disorder (Pinel. 2013). 
Alternative in vitro modelling has the potential to lead to development of less expensive and less 
time-consuming clinical trials by improving study at a pre-clinical level. 
1.3.3 Cell/tissue in vitro models 
The ability to recreate a disease such as PD in defined cell populations in vitro would allow for the 
creation of models where it is far easier to observe, modify and understand cellular/molecular 
mechanisms of neurodegeneration and other aspects of PD. While in vivo animal models represent 
a competent experimental platform for study of PD, there is a lack of control. For example, not 
knowing if sufficient SN DA neurons have been destroyed by neurotoxins and only being able to 
observe behavioural changes or cell characterisation post-mortem. With an in vitro model, some 
complexity is lost but a great deal of control over the model and experimental design is gained. Other 
advantages of in vitro cell models include: models are cheaper, develop pathologies faster (cutting 
down on experimental time), less constrained by ethics, can be subject to large-scale and 
high-throughput testing, are easier to manipulate with genetics or pharmaceuticals and are easier to 
observe with microscopy (Falkenburger et al. 2016). 
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By using these in vitro models it is possible to model specific components of PD, such as SN DA 
neurodegeneration, LBs, α-synuclein protein aggregates and changes in functional 
electrophysiological activity. In addition, there are numerous choices for the cell source to use, which 
are discussed in more detail below. All summarised in Fig.1.8. 
1.3.3.1 Cell line models 
Cell lines are immortalised populations of cells that can proliferate indefinitely (given sufficient 
growth media and space), due to most lines being derived from mutant or cancerous cells (but still 
displaying similar genotypic and phenotypic characteristics as normal cells of the same type). Cell 
lines can be derived from numerous different species, most significantly humans, and have numerous 
advantages when it comes to in vitro study. Cell lines are suitable tools for prolonged periods of 
research in vitro, can be used for high-throughput studies (such as drug screening studies where 
numerous drugs can be pre-clinically tested before use in vivo), are highly reproducible due to being 
derived from a homogenous population and display features relevant for PD study, such as enzymes 
for DA metabolism and synapse formation (Lopes et al. 2017). However, the fact that cell lines can 
proliferate (indefinitely) makes them highly different to neurons in vivo, which are post-mitotic and 
do not divide (Luchtman and Song. 2010). Cell lines also differe greatly from in vivo neurons in 
morphology, physiology, protein levels and changes over time in culture. Despite this, cell lines are 
widely used in research to make in vitro models of PD. 
The most widely used cell line for in vitro modelling of PD is the human neuroblastoma line SH-SY5Y, 
due to the fact that this cell line can synthesise DA (as they contain tyrosine hydroxylase (TH) and 
dopamine-β-hydrozylase enzymes), expresses DATs, can grow axons/dendrites and is a human cell 
line, so a better mimic of a human disease (Alberio et al. 2012, Lazaro et al. 2017, Xicoy et al. 2017). 
While SH-SY5Ys do not resemble neurons if cultured in vitro, they can be differentiated into a DAergic 
neuronal phenotype that better resembles in vivo DAergic neurons and decreases their levels of 
proliferation (Lopes et al. 2017). With the application of retinoic acid and brain-derived neurotrophic 
factor (BDNF), as well as a reduction in the concentration of serum in cell growth media, SH-SY5Y 
cells can be differentiated into neuron-like cells with a DAergic phenotype. However, this 
differentiation procedure is lengthy and challenging, with the majority of cells killed in order to select 
for a small surviving neuronal minority. 
Once differentiated these cells can be subject to toxins or genetic manipulation in order to mimic PD, 
in a similar manner to previously mentioned animal models. 6-OHDA and MPTP remain the most 
commonly used toxins to induce PD-like neurodegeneration in vitro, but 6-OHDA use is more 
widespread as SH-SY5Y cells cannot metabolise MPTP into MPP+ themselves (Xicoy et al. 2017). The 
greater levels of DATs on differentiated SH-SY5Ys makes 6-OHDA use very effective in modelling PD 
neurodegeneration in vitro. The majority of genetic manipulation models involved overexpression of 
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α-synuclein (whether the wildtype form or the A53T/A30P mutant forms) which result in aggregates 
forming within SH-SY5Y cells and inducing toxicity in some cases (Liangliang et al. 2010). Notably, SH-
SY5Y cells also demonstrate spontaneous α-synuclein aggregation even after no tranfection (Xin et 
al. 2015). SH-SY5Ys have been used to model abnormal mitochondrial function, oxidative stress, 
autophagy, protein dysfunction and more, highlighting SH-SY5Y as a popular and attractive tool for 
in vitro study of PD. However, this widespread use of SH-SY5Y as a cell line has highlighted how each 
study has used different conditons (for cell source, growth, differentiaton, inducing PD-like 
degeneration, etc) and how results have widly varied between studies with many contradictions, 
making data produced by these cell lines borderline unreliable unless sufficient characterisation and 
differentiaton methodologies are in place (Xicoy et al. 2017). 
While there are many other notable examples of cell lines used to study PD, there are relatively few 
human-derived lines, the only other commonly used human line being the Lund human 
mesencephalic (LUHMES) line. Other lines are typically rodent-derived, such as the PC12 rat 
pheochromocytoma line, the mouse neuronal progenitor (MN9D) line and rat dopaminergic (N27) 
line, all of which are immortalised (Falkenburger et al. 2016). Unlike SH-SY5Y, LUHMES cells need to 
be differentiated to aquire a DAergic phenotype, with undifferentiated LUHMES cells expressing no 
DA, TH or DATs (Zhang et al. 2014). In addition, LUHMES are slow-growing and need numerous 
expensive growth media supplements to survive, making LUHMES use more time-consuming and 
costly than SH-SY5Y. But experimentally, LUHMES cells are not derived from a tumour as SH-SY5Y 
cells are and are more similar to primary neurons in vivo. In essense, there are many types of cell line 
to choose from when attempting to model PD 
1.3.3.2 Stem cell models 
Stem cells are cells that have the ability to renew themselves through cell division and differentiate 
into different cell types. Stem cells vary in potency, namely how many different classes of cell they 
can differentiate into, but this is of limited usefulness when only the cells of the brain (specifically 
BG) are needed to best mimic PD. Embryonic stem cells are pluripotent cells can differ into virtually 
any cell type but require a lengthy and difficult differentiation process in order to develop into 
functional midbrain DA neurons. These cells also come with a whole host of ethical issues as their 
isolation involves destruction of the embryo, consequently their use is controversial, especially when 
human stem cells are desired (Martinez-Morales and Liste. 2012). A better source of human 
pluripotent stem cells are induced pluripotent stem cells (iPSCs) that have the same potency but can 
be established from any cell (Takahashi et al. 2007). This is especially useful as not only can human 
iPSCs be obtained, iPSCs can be derived directly from PD patients and compared with healthy iPSCs, 
studying any changes in biochemical factors or genetic backgrounds. However, in order to obtain glia, 
neurons and specifically DAergic midbrain neurons, there is still an unavoidably lengthy, expensive 
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and difficult differentiation procedure. By using stem cells that are less potent and further down a 
differentiaton path (that can only differentiate into a few cell types), it is easier to obtain neural cells. 
The specific multipotent cell type is the neural stem cell (NSC) that can be derived from neural tissues 
and differentiates into neurons, astrocytes or oligodendrocytes. NSC use for PD modelling is less 
popular as while they can generate DAergic neurons, they grow poorly in culture and their properties 
change over time (generating neurons becomes more difficult), making them hard to use in large-
scale or long-term experiments (Martínez-Serrano and Liste. 2010). Of these potential stem cell 
sources, the most widely used to model PD are iPSCs. 
As iPSCs can be generated from any cell type, usually an easily accessible human source such as skin 
is used. Fibroblasat from skin biopsies are converted into iPSCs, then differentiated into the relevant 
type of neural cell. This differentiation process has numerous stages and produces mature neural 
cells within approximately 4-10 weeks (Lopes et al. 2017). iPSC-derived DAergic neurons express high 
levels of DA, TH and DAT and develop spontaneous functional synaptic activity (Hartfield et al. 2014). 
The human source of the initial skin fibroblasts is significant: by obtaining iPSCs from healthy patients 
or patients with sporadic or heritable PD, different experiments can be developed to observe changes 
based on the patient genetic background and PD susceptibility. As age does not seem to interfere 
with the reprogramming process, primary fibroblasts can be isolated from patients at any stage of 
the disease, including late-onset PD (Marchetto et al. 2010). iPSCs derived from PD patients have 
demonstrated mitochondria with reduced oxygen consumption, altered mobility and increased 
vulnerability to neurotoxins. When iPSCs were generated from a heritable PD patient with a mutation 
in the LRRK2 gene, the differentiated DA neurons (55 day differentiaton protocol) displayed increased 
susceptibility to oxidative stress and higher levels of cell death than controls (Nguyen et al. 2011). 
Major drawbacks are due to the relevent recent development of iPSC technology, such as the lengthy 
differentiation protcols, technical difficulty of differenatiaton (requires experienced researchers) and 
loss of ageing-related effects due to the introduction of pluripotency (Lopes et al. 2017). Despite 
these drawbacks, iPSCs are a useful model to study PD due to the ability to replicate DA neuron 
physiology on a patient-specific basis (latter being dependent on patient consent and ethical 
approval), including effective isolation and modelling of specific mutations in heritable PD, studying 
the pathogenesis of PD at a cellular level (Martinez-Morales and Liste. 2012). 
1.3.3.3 Primary cell models 
Primary cells are cells that are directly cultured in vitro after isolation from their in vivo source organ, 
in this case the brain. As the brain becomes more complex throughout development, this isolation 
process is easier in embryonic brain tissue, before specific cell populations have migrated. Due to the 
ethical issues surrounding human embryonic tissue, most primary cells are extracted from rodent 
models. In this case, primary DA cultures can be obtained from the embryonic midbrain of rodents. 
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Precursors of SN DA neurons are found in the ventral midbrain (VM), and are best isolated during 
peak neurogenesis, which for the VM is embryonic day (E) 14 in rats and E13 in mice 
(Gates et al. 2006). DAergic cells are isolated via dissection and enzymatically digested to dissociate 
the tissue into individual cells that can be cultured in vitro (Schmidt et al. 2012). These primary cell 
cultures differ to cell line and stem cell cultures as they are extracted directly from the embryonic 
brain, and therefore: differentiate rapidly, do not undergo mitosis (similar proliferation rates to in 
vivo), form developed axons/dendrites (referred to collectively as neurites), contain large numbers 
of glial cells, and highly express TH and DAT. Due to these characteristics, primary cells most closely 
resemble DA neuron morphology and physiology in vivo, and make for very effective models of PD in 
vitro (Lopes et al. 2017). 
However, there are several drawbacks to using primary cells. The cell source is rodent-based and 
lacks similarity to human cells and human PD, preparation of primary cultures is technically 
challenging as the VM and other brain subregions are very small at E13-14 (even taking less than 
1 mm extra tissue during dissection can result in widly different neural cultures), the process is time 
consuming, the VM is a highly heterogenous environment resulting in experimental variability and 
lack of reproducibility, and finally DA neurons consist of the minority of in vitro cultures of primary 
cells (5-10%) making it difficult to specifically manipulate a neuronal sub-type (Lopes et al. 2017). 
Once a primary VM culture is established in vitro, in order to model PD pathology the same 
neurotoxins (6-OHDA or MPTP) or genetic manipulations are used. For neurotoxins, it is important to 
consider the sensitivity of primary cells to neurotoxins, resulting in the need for low dosages at 
carefully optimised times and concentrations. Use of MPTP is more viable than other models due to 
the presence of glial cells, as the MOA-B in astrocytes in culture can metabolise the MPTP into the 
active metabolite MPP+ (Segura-Aguilar and Kostrzewa. 2015). The use of 6-OHDA can be very 
effective if optimised correctly, and until 2004, 6-OHDA effects in vitro were not restricted to DA 
neurons or were observed to be non-specific, limiting the effectiveness of in vitro models of DA 
neuron loss. However, Ding et al. produced a methodology wherein primary DA neurons from the 
VM were selectively damaged by 6-OHDA-induced apoptosis, the effect of which could be reversed 
by use of glial-derived neurotrophic factor (GDNF). 6-OHDA-induced morphological and biochemical 
signs of cell death in DA neurons after less than 3 hours, followed by loss of tyrosine hydroxylase (TH) 
immunoreactive neurons within 2 days. In SN cultures, DA neurons were affected and GABA neurons 
unaffected, showing that 6-OHDA can selectively destroy DA neurons in in vitro primary cell cultures 
of SN, acting at least in part by initiating caspase-dependent apoptosis, and this effect can be 
attenuated early but not late by GDNF (Y. M. Ding et al. 2004). This ability to recapitulate PD-like 
neurodegeneration in in vitro primary cell models highlights their usefulness as tools for in vitro 
research into PD. In addition, observing the effects of neurotoxins and other 
chemicals/pharmaceuticals on mixed neuronal/glial (and indeed, mixed neuronal as the majority of 
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neurons are GABAergic with5-10% being DAergic) cultures gives data that is more relevant to the 
in vivo situation (Griggs et al. 2014). 
As for genetic manipulation in order to mimic PD, lentiviral vectors have been used to manipulate 
levels of certain genes. Overexpressing α-synuclein in primary cultures resulted in a significant 
decrease in numbers of DA neurons (~50% loss) (Cooper et al. 2006), while expression of DJ-1 rescued 
primary DA neurons from rotenone and mutant α-synuclein toxicity (Liu et al. 2008). Primary 
midbrain cultures from rat embryos have been used as very effective in vitro models, as they replicate 
many of the morphological and physiological features of mature neurons in vivo. If animal models 
cannot be used, primary cells represent the most complex cell model that is the closest to the in vivo 
midbrain. 
1.3.3.4 Tissue slice/organotypic models 
Despite the direct access and ease of observation offered by in vitro cell models, there are also 
general drawbacks such as the lack of relevant environmental cues and tissue organization (such as 
input/output connections) which have a role in disease progression. By taking slices of primary tissue 
(rather than dissociating the tissue into primary cultures) and culturing them, an in vitro model is 
created where there is still direct access and manipulation, but in an organotypically relevant model 
where 3D structure and cellular interactions are preserved (Kearns et al. 2006, Lopes et al. 2017). 
This technique is typically performed on postnatal rodents, usually from postnatal day (P)2 up to P15, 
as the brain needs to be of sufficient size to obtain slices (embryonic brains not typically used). By 
taking slices of the VM the architecture of the BG is preserved, meaning that tissue slice in vitro 
models are often used to study connections between the SN and other areas such as the STR and 
cortex, including their functional connectivity and electrophysiological activity. However, these slices 
age rapidly in culture, are very difficult to reliably reproduce due to transverse changes in brain 
structure, lose the degree of control found in primary cell cultures, and as more mature rodents are 
necessary, there are increased ethical concerns as large numbers of animals are required for 
experimental reproducibility (Polikov et al. 2008, Lopes et al. 2017). 
Tissue slice models have shown that DA neurons in VM slices will project axons to an adjacent STR 
slice (Gates et al. 2004) and form functional synapses (Tseng et al. 2007). Lyng et al. used E14 VM 
and E21 STR tissue slices from rats to model the nigrostriatal system in development, analysing DA 
neurochemistry, numbers of DA neurons as well as protein expression of TH, DAT, and glutamic acid 
decarboxylase (GAD 65/67) over 17 DIV. Experiments showed that DA neurons developed in a similar 
way as in vivo, with the the numbers of VM DA neurons remaining relatively constant while levels of 
VM DA progressively increased. After 3 DIV, the levels of striatal DA increased substantially, both 
indicating that release and metabolism of DA are similar to these characteristics observed in vivo 
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(Lyng et al. 2007). These studies also demonstrated the disadvantages of using postnatal tissue 
(tissue slice models) vs embryonic tissue (primary cell models), due to the DA neurons having fully 
differentiated or fully projected to the STR, limiting the ability to model this development in vitro and 
the ability to better direct neurodegeneration. 
In order to incude PD pathology, neurotoxins are the most commonly used method (again 
MPTP/MPP+ and 6-OHDA preferentially used). Typically, brain slices are incubated in a neurotoxin 
bath for up to 60 min (acute exposure) or for a few weeks (chronic exposure). These treatments result 
in degeneration of neurons in both SNpc and striatum, leading to decreased TH expression (Kearns 
et al. 2006, Stahl et al. 2009). Alteratively, PD pathology can be induced by mechanical damage of 
the nigrostriatal pathway. Such lesions have been shown to induce asynuclein aggregation and 
nigrostriatal neuron degeneration in organotypic slice models (Cavaliere et al. 2010, Daviaud et al. 
2014). 
Developing in vitro models that include DA neurons allows for the creation of powerful platforms for 
PD research, both for neurodegeneration and potential therapeutics such as pharmaceuticals and 
neuroprotective factors. The potential options for such a model (decreasing in biological complexity 
in order) are as follows: organotypic tissue slices; neural primary cells; neuronal-only primary cells; 
stem/progenitor cells (including iPSCs and NSCs) and neural cell lines (such as SH-SY5Y, LUHMES etc). 
While in vitro cell culture alone offers great models for PD, combining cell models with 
bioengineering allows for more efficient and improved in vitro models of PD. 
1.3.3.5 Organoids and 3D models 
Most cell models are 2D cultures that lack cell-cell and cell-matrix interactions, limiting their ability 
to best mimic cellular functions within tissues in vivo. While tissue slices better mimic the structural 
organisation, they quickly lose their phenotyoe and are difficult to maintain over long periods of time 
(Yin et al. 2016). But by placing stem cells into a scaffold hydrogel in the presence of suitable 
exogenous factors, the stem cells can form organised and structured clusters of cells, termed 
‘organoids’. 3D neural tissues can therefore be generated from stem cells, termed brain/cerebral 
organoids. Cells in aggregates exhibit an innate self-organising capacity and can be grown into brain 
organoids with structural features resembling the developing brain in vivo, including specific genetic 
backgrounds (Nakano et al. 2012, Muguruma et al. 2015). If grown without inductive cues, multiple 
brain regions can randomly develop, as seen in a model from Lancaster et al., who reported a culture 
system involving neuroectodermal tissues maintained in 3D Matrigel scaffold, resulting in 
heterogenous organoids that contained multiple independent brain regions (such as dorsal cortex, 
ventral telencephalon, choroid plexus, hippocampus and retina) and growing to 4 mm long in 2 
months (Lancaster et al. 2013). If grown with specific combinations, concentrations and timings of 
exogenous substances and signalling molecules, the resultant brain organoids can be more directed, 
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involving multiple brain regions that can be fused into ‘assembloids’ to model brain region 
connectivity (Amin and Pasca. 2018). 
These brain organoids make effective models of the in vivo brain as they contain multiple cell types, 
heterogenous tissue-specific cells, cell-cell and cell-matrix interactions, as well as functionality, 
making them better mimics of brain physiology than 2D cultures. In addition, some organoids 
demonstrate neuronal functionality, development and maturation in vitro in a similar manner to the 
in vivo brain (Yin et al. 2016). Future work with organoids aims to include vascularisation, presence 
of an immune system (by inclusion of microglia-like cells in assembloids), circuitry and 
microenvironments to better mimic the brain (Mansour et al. 2018), as well as inclusion of sensory 
and motor outputs (via functional integration into mouse models) (Amin and Pasca. 2018). 
Complex brain architectures have been recreated by organoids in vitro using serum-free floating 
culture of embryoid body-like aggregates, such as cerebral cortex (Kadoshima et al. 2013) (exhibited 
self-organisation along an axis and an inside-out pattern, similarly to the developing human cortex in 
vivo), (Mariani et al. 2012) (used iPSCs to generate multi-layered structures that expressed a gene 
profile typical to that of the embryonic telencephalon) and pitruitary (Suga et al. 2011). By including 
customisable/responsive biomaterials, patterned/gradient signalling and microfluidic networks, 
brain organoids can future develop spatially, becoming better mimics of the in vivo brain (Yin et al. 
2016). 
Despite the fact that most brain organoids are best suited for studying brain development, such as 
corticogenesis and neurodevelopmental disorders, some directed differentiation can result in 
organoids that can be used for study of PD. Jo et al. developed a brain organoid resembling the 
midbrain and containing functional DA neurons, making it a relevant model for PD. The group 
differentiated hPSCs into human midbrain-like organoids (expressed midbrain markers) that 
recapitulated features of the midbrain. Midbrain DA and TH+ neurons were electrically active and 
functionally mature, producing dopamine and neuromelanin-like granules (similar to substantia nigra 
in vivo), resulting in a potentially powerful model of the healthy midbrain for study of PD (Jo et al. 
2016). These midbrain organoids can be maintained for very long periods of time (months-years), 
allowing for a potentially better mimic of the slow progression of PD over time. 
In addition, these organoids can be assessed functionally, albiet in a destructive manner. Pasca et al. 
generated pyramidal neurons from human iPSCs in a 3D cortex-like structure. These human cortical 
organoids only generated excitatory glutamatergic neurons of the dorsal telencephalon, but the 
internal structure was similar to a laminated neocortex with deep- and superficial-layer cortical 
markers. After two and a half months the organoids resembled the prenatal brain at 19-24 weeks 
post-conception, with networks of nonreactive astrocytes and spontaneously active neurons that 
formed functional synapses. These matured organoids were sliced in a similar manner to organotypic 
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slice cultures, allowing for the recording and electrical stimulation of neurons. Electrophysiological 
analysis via calcium imaging and patch clamping indicated that the neurons participated in network 
activity and produced complex synaptic events in the presence and absence of stimulation (Amin and 
Pasca. 2018). 
While brain organoids can model more physiologically relevant cellular interactions and feature 
structural and organisational features of the brain not present in 2D monolayer cultures, there are 
some downsides. Organoids are time-consuming, expensive and technically challenging to develop 
and maintain, lack homogeneity and scalability (less suitable for high-throughput studies and 
screenings), and have less uniform access to nutrients/biochemical factors than monolayers (the 
centre of an organoid may be starved of resources) (Amin and Pasca. 2018). In comparison to 
compartmentalised microfluidic devices functional testing methods are challenging and destructive, 
making it difficult to assess the functionality of neural cells in organoids over time across the whole 
population, whereas this is a simple manner with an MEA. Organoids form complex yet isolated 
structures, unlike the desired networks of different brain subregions needed to model the basal 
ganglia. 
1.4 Bioengineering complexity into in vitro models 
1.4.1 Modelling with reduced complexity 
Current pre-clinical assessment is insufficient to predict what pharmaceuticals and treatments will 
work on human disease patients, with a lack of in vivo animal models that duplicate the causes, 
symptoms and progression of a human neural disorder (Pinel. 2013). In some cases, the models are 
non-existent, such as rodents not naturally acquiring PD (Meredith and Rademacher. 2011). Better 
in vitro modelling would lead to less expensive and time-consuming clinical trials by improving study 
on a pre-clinical level. 
In vitro cell or tissue models involve culturing large numbers of cells or an intact slice of tissue and 
using the resulting cell/tissue culture as a platform for experimental study. With tissue models, the 
tissue is extracted directly from an animal model and kept alive ex vivo for an extended period of 
time for study by recreating an environment similar to that found in vivo, both using specialised 
biochemical methods such as culturing the tissue in a specific nutrient rich medium and using 
specialised equipment including a tissue culture incubator to maintain physiological temperature 
(37°C) and gas concentrations (5% CO2) and a laminar flow cabinet to maintain sterility and avoid 
infection (Morrison et al. 2011). It should be noted that there is often a considerable lack of diseased 
neural tissue for study, especially concerning human models, due to biopsies involving limited 
environmental control, variable sample thickness, and destruction of countless input/output 
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connections from both neural and non-neural cells upon biopsy (Arbab et al. 2014). Therefore, it is 
preferable to go to the most ‘bottom-up’ approach available, by working with the neuronal and 
non-neuronal cells themselves. 
 
Figure 1.8: Different methods to use in order to generate in vitro models of PD (ordered from lowest to 
highest in terms of cost, technical difficulty and time). A) Cell lines: can be human-based, reproducible, and 
easily scaled up, but require differentiation and are oncogenic. B) Primary cells: provide accurate neuronal 
physiology and morphology, also contain glial cells so are more accurate as mimics of in vivo brains, but are 
non-human, time-consuming and unsuitable for genetic manipulation. C) Organotypic cultures: better mimic 
3D in vivo connectivity, but are non-human, time-consuming, technically challenging to obtain and rapidly 
degenerate in culture. D) iPSCs: Can be derived from both healthy and PD humans and produce accurate 
neurons, but is very time-consuming, expensive and carries additional ethical considerations. All images from 
Wikimedia Creative Commons, based on a figure from (Lopes et al. 2017). 
With cell models, cells are cultured in the same manner as tissue but there are multiple sources 
available, namely primary cells, stem cells (Paspala et al. 2011), pluripotent cells created in a 
laboratory setting (Takahashi and Yamanaka. 2006) and cell lines. This results in in vitro cell models 
being very simplistic in comparison to tissue models and in vivo animal studies. By using neural tissue 
engineering, surface modifications, specialised culture conditions and a similar nutrient medium, 
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in vitro models can be modified and improved so that they may attempt to represent a select area of 
the brain. It should be noted that while modelling smaller isolated portions of the brain makes for 
more accurate and focused models, it should take into account that connections with other brain 
areas are unrepresented and this lack of inter-neural connections may affect the model 
(Chiappalone et al. 2006). With the success of an in vitro model hinging on the design process, a 
summation of considerations for design can be seen in Table 1.2.  
Neural circuitry is delicate, morphologically and functionally complex and exerts numerous chemical 
and mechanical forces on other cells and material present in culture. However, the relative impact 
of these issues is dependent on the design and ingenuity of the model, meaning that good awareness 
of these issues alongside improvements in design of experimental techniques and relevant 
technological advances should alleviate these problems. By taking advantage of the in vitro model’s 
simplicity and exerting control over neurons and glia, the model can become more flexible and 
complex as it mimics the in vivo environment within the brain. 
1.4.2 Surface parameters to control cell responses 
In order to develop in vitro neural cell models, it is vital to consider the surface that the cells will be 
in contact with, and how the characteristics of this surface can be used to control cell responses. 
Surface characteristics of biomaterials supporting cell culture are a major factor when culturing 
neurons and glia. These adherent cells anchor to the growth surface, this can be influenced by using 
certain chemicals to change the characteristics of the surface, such as the hydrophobicity or charge. 
The latter is important to consider as cells have a negatively charged membrane due to glycoproteins 
and glycolipids on the surface of the plasma membrane and display enhanced adhesion to positively 
charged polymers (Lakard et al. 2004, B. Liu et al. 2008). As a result, most surface coatings have a net 
positive charge. 
Chemical factors are used to modify surfaces to modify cell culture. For instance, proteins in the cell 
media adsorb to the growth surface within a fraction of a second, creating an intermediary between 
the cell and the surface (Ma et al. 2005), making pre-treatment of a culture surface a viable option 
for cell culture work as cell-protein interactions can be used to encourage or discourage cell growth 
(Vroman and Adams. 1969, Roach et al. 2010). Chemical factors are used to modify surfaces to modify 
cell culture. For instance, proteins in the cell media adsorb to the growth surface within a fraction of 
a second, creating an intermediary between the cell and the surface (Ma et al. 2005), making pre-
treatment of a culture surface a viable option for cell culture work as cell-protein interactions can be 
used to encourage or discourage cell growth (Vroman and Adams. 1969, Roach et al. 2010). 
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Table 1.2: What to consider when planning an in vitro model of the brain, adapted from (Fedoroff 
and Richardson. 2001) 
Design Consideration Options 
Cell culture class Primary cells are isolated directly from tissues and therefore best 
represent the endogenous phenotype but difficult to maintain. 




Certain cell types are only available past certain developmental times, 
but too many days of development leads to a more challenging dissection 
process. Less developed networks are easier to extract and culture, but 
are potentially less functionally mature. 
Similarities to human 
brain 
Comparison to the in vivo system. Can use adult human iPS cells, 
embryonic/foetal human cells, animal cell lines or primary animal cells. 
Culture type Can culture tissue/organ slices or individual cells. 
Preservation of in vivo 
organisation 
(2D or 3D?) 
Neural cells can grow effectively in a 2D planar culture (monolayer) or 3D 
matrix (neurosphere), but this doesn’t represent the anatomy in vivo. 
Cell-cell and cell-matrix interactions are numerous in 3D but limited in 
2D. Can disaggregate or re-aggregate cells. 
Electrophysiological 
integrity 
Neural cells within the model should have similar electrical activity as the 
same cell type in vivo. Recording devices should discriminate between 
signals and have a low signal-noise ratio, so as to isolate spikes and other 
activity (Faisal et al. 2008, Avila Akerberg and Chacron. 2009). 
Culture environment  Extracellular fluid composition, temperature, pH, gas phase, substrate, 
dimensions. 
Model material Non-toxic, non-inflammatory, non-allergenic, non-carcinogenic, light, 
soft, mechanically durable, chemically stable and simple to fabricate. 
Model fabrication What technology will be used to fabricate the model, is it reproducible, 
high-throughput? Can modifications be easily made, and will any 
interface will exist between the cultured cells and inorganic devices? 
 
Some biological substances can also be used on surfaces to induce a cell response, usually by 
presenting cell binding domains that interact with integrin receptors on the cell surface (Cooke et al. 
2008). An example of this are the positively charged peptide sequences RGD, IKVAV and YIGSR, found 
in a protein called laminin (LAM) (Freire et al. 2002, Durbeej. 2010, Domogatskaya et al. 2012). As a 
result, tissue culture plastic can be pre-treated with LAM (itself a positively charged polymer of amino 
acids) before cell seeding (Bledi et al. 2000), which has been shown to induce axon growth (T. Esch 
et al. 1999). Another popular surface treatment is the positively charged polymer poly-lysine (either 
optical isomer poly-L-lysine (PLL) or poly-D-lysine (PDL), often used in tandem with LAM) due to its 
anime group, which have been shown to increase neural cell attachment and growth (Yavin and 
Yavin. 1974, Kleinfeld et al. 1988, B. Liu et al. 2008, Roach et al. 2010). It should be noted that PDL is 
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more widely used compared to PLL, with the latter shown to interfere with certain biological 
functions (Lelong et al. 1992), whereas PDL does not occur naturally and interacts with fewer 
biological systems. However, coating surfaces with PDL and LAM needs be done with great care due 
to how different factors can influence the effectiveness of the coating, especially when using the 
surface for culturing neurons and glia. LAM pH influences neurite outgrowth (Freire et al. 2002), the 
presence of LAM and proteoglycans together can suppress neurite outgrowth (Hynds and Snow. 
1999), and LAM is dependent on the presence and concentration of serum in cell media (Blau et al. 
2001, Kam et al. 2001), indicating that protein-protein interactions can have just as much effect as 
protein-surface and subsequent cell-surface interactions. 
The range of different chemicals for coating a cell culture surface results in some chemicals/polymers 
being better for specific situations and models of specific areas than others. For example, while 
organic polypeptides such as PDL/PLL are very popular and effective as a surface treatment, they 
feature amide bonds in the backbone and can thus be hydrolyzed and broken down with relative 
ease (Garza et al. 2005). Synthetic polymers present an alternative to organics. One such example is 
polyethylenimine (PEI), a positively charged synthetic polymer that lacks amide linkages, and has long 
been shown to support attachment, growth and maturation of neural cells (Lelong et al. 1992, Ruegg 
and Hefti. 1984, Bledi et al. 2000, Lakard et al. 2004, Vancha et al. 2004, B. F. Liu et al. 2006, B. Liu et 
al. 2008), in most cases more effectively than PDL/PLL or LAM. In addition, PEI can be either linear or 
branched, meaning that changing variables during synthesis can modify the positive charge density 
and molecular weight of PEI (Jeong et al. 2001), allowing PEI to be more attractive for neurons by 
using electrostatic attraction due to the high charge density, making PEI a very effective and powerful 
chemical for use as a coating for neural cell culture. 
Pre-treating surfaces with specific chemicals that mimic the chemical composition of the neural niche 
within the brain allow for in vitro work to more accurately represent the in vivo neural environment, 
and neuron growth can be improved (Roach et al. 2010). By using a bioactive polymer based on the 
neurotransmitter dopamine, neurite outgrowth was significantly improved (comparatively, when 
dopamine itself was added to culture media, no such effect was seen), compared to a surface treated 
with tissue culture polystyrene, laminin and PDL (J. Gao et al. 2006). A follow-up experiment using a 
tyrosine-based polymer (dopamine being synthesized from tyrosine in vivo) showed no effect, 
indicating that an in vitro model designed to mimic the in vivo environment will need to be designed 
with great precision, due to the preferences of the cells. 
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1.4.3 Determining electrophysiological functionality 
When developing an in vitro neural model it is vital to ensure that the cells are electrophysiologically 
active in a similar manner to in vivo. Neural cells must be demonstrably producing their own 
spontaneous electrical signals and forming synapses in order to be labelled as functional, and to 
better mimic the behaviour of neural cell in vivo. A good in vitro neural model therefore needs a 
method to record and quantify the spontaneous electrical signals spontaneously produced by neural 
cells to ensure they are functional, without this ability the model will be insufficient no matter how 
well developed the cells are or how morphologically desirable the network may be.  
Electrical activity in the brain is caused by a number of transmembrane proteins that form pores, 
termed ion channels. These channels are found in the membrane of every cell in the CNS and allow 
specific ions to travel across the cell membrane in a controlled manner, which establishes a resting 
membrane potential. These ion channels also create the dynamic voltage changes seen in action 
potentials (APs), namely the electrical signalling measured in neural electrophysiology. 
The resting membrane potential of a neuron is determined by the uneven concentration gradients 
of sodium (Na+) and potassium (K+) ions across the cell membrane, making the membrane polarised. 
With Na+ and K+ ion channels regulating the flow of each respective ion across the membrane, it can 
become more positively charged (depolarised) or more negatively charged (hyperpolarised). In an 
AP, the membrane becomes rapidly depolarised upon stimulus (classically from -70 mV to 40 mV), 
then rapidly hyperpolarises and overshoots the resting potential (classically to -90 mV) and then re-
establishes the resting membrane potential, returning to a resting state. Due to the rapid nature of 
these APs (~3.5 ms) and the sharp increase and decrease of voltage, these signals are often referred 
to as ‘spikes’ in activity. The AP travels down the entire axon of a neuron, and then passes across a 
synapse to connected neurons. Neurons communicate cell-to-cell via APs: receiving signals, 
integrating them, and passing the signal along to other cells. 
The AP signal passes from neuron to neuron via neurotransmitters (more information seen below in 
Fig.1.9). These chemicals are triggered by an AP depolarising the membrane and respond by 
travelling across the synaptic cleft from the presynaptic membrane to the postsynaptic membrane 
within a vesicle, where they will bind to receptors and trigger one of two responses: excitatory or 
inhibitory, increasing or decreasing the chance of a AP in the postsynaptic cell respectively. Within 
the brain, the main inhibitory and excitatory neurotransmitters are GABA and glutamate respectively. 




Figure 1.9: A diagram of a synapse between two neurons, A and B. 1: mitochondrion, 2: pre-synaptic vesicle 
with neurotransmitter, 3: autoreceptor, 4: cleft between the presynaptic and postsynaptic membranes, 
5: transmembrane neurotransmitter receivers on the postsynaptic neuron, 6: Ca2+ ion channel, 7: a fused 
vesicle releasing neurotransmitter into the synaptic cleft, 8: neurotransmitter re-uptake pump. Image from 
Wikimedia Commons (user Mouagip) permission granted under Gnu Free Documentation License. 
1.4.4 Measuring electrophysiological activity 
There are several established methods for quantifying electrophysiological signals in neuron 
populations, mostly involving electrodes, either inserted into the cell interior (intercellular recording) 
or in contact with the exterior of the cell (extracellular recording). Examples include patch-clamping 
and whole call clamping (intercellular), voltage/ion sensitive dyes, acutely isolated neuron models, 
and multi-electrode arrays (MEAs) (extracellular) (Aston-Jones and Siggins. 2000). 
Inserting electrodes into cells (e.g. patch-clamping) is a classic methodology and therefore 
well-established technique (Hodgkin and Huxley. 1939) that provides electrical coupling with the cell 
and very accurate intracellular readouts with little noise, but it should be noted that it is a technically 
difficult and time-consuming process that usually records electrical activity from a single cell over the 
short-term while stressing them mechanically (Jokinen et al. 2013). While recent advances in patch 
clamping technology allow for assessment of multiple cells, these processes are expensive and 
require advanced specialised equipment (Franz et al. 2017). Even with these advanced techniques it 
would be too time-consuming to acquire enough information to determine the functionality of a 
whole cell population. An alternative is extracellular recording, which in comparison to intracellular 
recordings cannot provide electrical data from within the cell and therefore lacks signal resolution 
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and amplitude (see Fig.1.10) and often features more noise. On the other hand, extracellular 
recording can record from large numbers of cells simultaneously over long-term experiments 
(timescale of months), is non-invasive and causes no damage to the cells, which are usually cultured 
in a monolayer directly on top of the electrodes (Spira and Hai. 2013). 
 
Figure 1.10: Intracellular and extracellular electrical recording. (A) A diagram of a neuron showing 
intracellular (top orange electrode) and extracellular (bottom orange electrode) with amplifiers in yellow. 
(B) Action potentials (APs) generated endogenously by a neuron, with the intracellular reading on the left 
and the extracellular reading on the right. The latter is only sensitive enough to pick up the tips of the peaks 
of the AP whereas the former can record the entire process. Image adapted from (Spira and Hai. 2013). 
If recordings cannot be taken constantly, it is always possible that some neurons may not be active 
and producing electrical signals during the recording time and may be seen as non-functional, and 
indeed in vivo there are brain areas where neurons do not produce electrophysiological spikes or 
produce them at such a low rate that they are not recorded and are thus termed ‘dark neurons’ 
(Shoham et al. 2006). It is therefore important to select electrophysiological recording methods that 
allow for continuous recording over whole neuronal networks in vitro, which would produce the most 
relevant data for determining the functionality of an in vitro neural model, compared to intercellular 
recording methods. 
The most challenging type of recording would be to obtain single cell resolution over a large cell 
population over the long term, combining the best factors of intra- and extracellular recordings 
methods. One potential method that can achieve this are Ca2+ indicators. 
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Unlike small molecule fluorescent Ca2+ dyes (used to analyse changes in cell Ca2+ signalling), which 
often feature poor loading and poor long-term retention (Perry et al. 2015), genetically encoded 
calcium ion (Ca2+) indicators (GECIs) are optical sensors that are produced by translation of a specific 
nucleic-acid sequence, comprising of a fluorescent protein and a Ca2+-binding element. When Ca2+ 
binds to a GECI, it changes the optical properties in a detectable manner (Palmer and Tsien. 2006). 
The appeal of GECIs is twofold, based on their genetic and optical nature. From the genetic side 
comes the considerations that GECIs can be delivered to target organisms/tissues/cells via minimally 
invasive methods such as tranfection or trangenesis, and are sensitive enough to detect single APs in 
vivo or in vitro over the long-term (months) (Tian et al. 2012, Akerboom et al. 2013), and as such 
could be used to track disease progression. In addition, genetic encoding allows for GECIs to be 
targeted to neuronal subtypes or even neurons with specific anatomical connectivity (via axonal or 
trans-synaptic labelling) (Lin and Schnitzer. 2016). From the optical side, loading a whole neural 
population with GECIs and using optical imaging allows for thousands of neurons to be 
simultaneously observed in vitro or in vivo in an unbiased manner (Sofroniew et al. 2016). 
However, both the genetic and optical components of GECIs have associated disadvantages. For 
long-term expression of GECIs, viral infection or transgenesis are required, both of which are 
challenging techniques requiring heavy optimisation, appropriate laboratory settings and limited 
construct size, as GECIs need to be expressed at sufficiently high levels to function (Perez Koldenkova 
and Nagai. 2013, Lin and Schnitzer. 2016). From the optical side, the fidelity of detecting neural 
signalling and the accuracy of timing this signalling are both limited by photon emission/detection 
quantum mechanics. To counteract this, complex calculations and equipment are required, such as 
two-photon confocal microscopy or laser-scanning. Due to the wide variety of uses for GECIs there 
are many types available (Akerboom et al. 2013), with each requiring re-optimisation, such as 
different illumination/acquisition parameters and photobleaching, both of which limit the length of 
time each experiment can run for (photobleaching occurring after ~15 mins for single-cell studies) 
(St-Pierre et al. 2014). 
Additional drawbacks to GECIS involve the numerous calibration steps required when using GECIs to 
measure neural activity, such as attached-cell recording and patch clamping, in order to verify that 
GECI expression does not alter the physiological properties or network interactions of the neurons 
(Tian et al. 2012). As neuronal signalling and action potentials (APs) involve rapid Ca2+ influx, when 
using GECIs to analyse neural models it is vital to choose a GECI with fast response kinetics. 
Engineering of GECIs with an improved signal-to-noise ratio (SNR) has been shown to alter the fast 
kinetics and cytotoxicity of newer GECIs, requiring inducible/reversible expression cassettes (Tian et 
al. 2012). Due to these factors, GECIs may not be suitable for long-term experiments across a whole 
population. 
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1.4.5 Multi-electrode arrays (MEAs) 
One of the best examples of extracellular recording across a cell culture is the MEA, an ordered array 
of electrodes typically arranged into grids. Cells can be seeded directly onto MEAs and are cultured 
in contact with the electrodes, which can record extracellular electrophysiological activity from the 
cells (see Fig.1.11A-B). MEAs record spontaneous activity and activity in response to stimulation, 
both over a long time-frame and across an entire culture, giving MEAs vast temporal and spatial 
ability (Gross et al. 1977, Pine. 1980, Fejtl et al. 2006). 
A limitation of MEAs is that they can only stimulate or record from cells that are in physical contact 
with electrodes or cells that are functionally networked to cells in physical contact with electrodes. 
Due to the size and position of MEA electrodes, some electrodes may be in contact with no cells, 
whereas some may be in contact with more than ten neurons, resulting in variable signal quality and 
amplified noise (Kanagasabapathi et al. 2011). However, with dense cultures and the many 
connections that neurons typically make, very large portions of a neural culture can still be assessed 
with an MEA, constantly recording electrophysiological signals from the majority of an entire culture. 
Therefore, MEAs can record and analyse the spatiotemporal distribution of electrical activity across 
a monolayer of neuronal and glial cells. Changes in morphology in the cell monolayer can be easily 
monitored with imaging techniques (as the MEA is transparent with the exception of the electrodes), 
with cells cultured on MEAs surviving for the long term (in some cases over a year) which removes 
certain time limitations on studies (Hales et al. 2010). Due to the numerous advantages of using MEA 
systems, there are a great deal of studies using MEAs with a variety of different cells from the CNS in 
order to assess the functionality of neuronal models and cultures (Keefer et al. 2001, Gramowski et 
al. 2004, Gramowski et al. 2006, van Vliet et al. 2007, Heikkilä et al. 2009, Yla-Outinen et al. 2010, 
Hogberg et al. 2011, Makinen et al. 2013). MEAs can also record oscillations in neural activity, most 
useful in identifying diseases such as schizophrenia which can result in disturbed gamma oscillations 
(Gonzalez-Burgos and Lewis. 2012). 
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Figure 1.11: Two different MEAs. A) An MEA with 60 circular electrodes (20 µm diameter with 200 µm 
spacing), scale bar 200 µm, adapted from (Yla-Outinen et al. 2010). B) An MEA with 64 square electrodes (50 
µm diameter with 200 µm spacing), scale bar 200 µm, from AlphaMED and used in this project. 
The ability to record network activity from different neuronal subtypes in different spatiotemporal 
conditions in vitro and to simultaneously qualify the functionality of these neurons as well as the 
timing of that functionality and any connections between the neural networks demonstrates the 
huge potential of the MEA. When used as a recording device in in vitro neural models, MEAs can 
characterise and manipulate neural subtypes in vitro to form and analyse more complex circuits 
representing different CNS areas, playing an important role in studying neural networks and their 
dynamics. 
1.4.5.1 Examples of MEAs combined with in vitro neural models 
Combining an in vitro neural model with an MEA allows for functional testing of neural cells cultured 
in the model, reinforcing the accuracy of the in vitro model. Previous studies have shown that neural 
activity in vitro matures over time (Goyal and Nam. 2011), particularly from the first week to the third 
week, the characteristic timing of synapse maturation and increase in synapse density in vivo (Jimbo. 
2007). These studies took place in microfluidic devices, allowing for long-term culture of neural cells 
with MEA readings taken throughout, this long-term culture (multiple weeks) allows for the 
assessment of functionally mature neural network formation. 
MEAs have also been used to determine the differences in spontaneous electrophysiological activity 
between neural cells cultured in isolation and neural cells cultured together in an in vitro model with 
two compartments (Takayama et al. 2012). When grown separately, primary cortex neurons 
demonstrated periodic bursts of activity with long quiescent periods for the first two weeks and high 
frequency patterns of activity from three weeks onward (timings were compatible with development 
changes normally seen in these neurons (van Pelt et al. 2005)). When grown together with P19 
neurons in a microfluidic device, activity was more widespread across the MEA and spike frequency 
was significantly increased after three weeks in vitro. This means that any functional connections and 
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interactions between the neurons in the microfluidic device occurred between two and three weeks 
in vitro. This trend was also seen in in vitro hippocampal primary networks joined to MEAs (Brewer 
et al. 2013), where the frequency and duration of spiking increased when cell populations were 
connected This spiking was also directional, with >99% of spikes propagating in one direction only, 
showing a preference of certain cell types to form functional synapses with other cell types. This 
experiment indicated that hippocampal sub-regions can self-wire in anatomically appropriate 
patterns compared to in vivo and maintain a distinct phenotype profile in vitro. 
MEAs can also be chemically coated, with studies coating the surface of MEAs with PEI to promote 
cell-surface attachment over cell-cell attachment and stop rafts of cells lifting off the surface after 
long-term culture (Kanagasabapathi et al. 2013). This experiment also showed cortical cells in one 
compartment initiating bursts of electrical activity which then occurred in the other compartment 
(containing thalamic cells), indicating a functional connection between these neuronal subtypes in a 
similar manner to their connectivity in vivo. The use of PEI with MEAs is established in the literature, 
as well as increasing cell attachment, depositing PEI on the surface of electrodes can also improve 
the signal to noise ratio by providing an insulating layer between the sensitive membrane of the 
neuron and the material of the electrode (Zairi et al. 2002, McMahon et al. 2007). 
One limitation of MEAs is their lack of interaction with 3D cultures. Recent in vitro neural models 
have developed in ways that make it difficult to integrate MEAs or other methods of extracellular 
electrophysiological recording. While these models have great complexity, they lack the ability to 
functionally assess the neural cells cultured within. Some examples include networked neurospheres 
(used to test neurotoxicity of the amyloid beta protein, a causative factor of Alzheimer’s disease) by 
(Choi et al. 2013b), a 3D micro-physiological system (or ‘mini-brain’, that exhibit migration, neuronal 
differentiation, network elaboration, cell-cell interactions (both neuron-neuron and neuron-glia), 
myelination and synapse formation) by (Bal-Price et al. 2010) and (Pamies et al. 2014), as well as an 
organoid model by (Lancaster et al. 2013). All these models involve a 3D aggregate of cells, which 
may act as a good mimic for the in vivo brain but makes it far more challenging to assess the function 
of all the neural cells within, as MEAs and other extracellular electrode systems work best with 2D 
cell monolayers. This can result in otherwise impressive 3D in vitro models having no functional 
assessment or method of recording electrical activity throughout the culture, limiting the usefulness 
as a model of the in vivo brain. One solution to this issue would be the use of MEAs compatible with 
3D cultures, and indeed 3D MEA systems are in development (Musick et al. 2009, Frega et al. 2014a), 
but have not seen much use outside of select cases and mostly consist of stacks of 2D MEAs or glass 
beads respectively rather than a ‘true’ 3D MEA. Some MEA manufacturers have developed several 
MEA types that involve spiked or raised MEAs that protrude up to 50 µm out of the MEA surface and 
into sample tissues/cells, but these are pseudo-3D at best and unnecessarily damage samples at 
worst. Examples can be seen in Fig.1.12. 
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A recent in vitro study compared a 2D neural culture directly on a MEA with a 3D neural culture within 
a 3D scaffold (such as collagen), with the base of the 3D structure in contact with the MEA, and noted 
several differences between 2D and 3D, including that the 3D cultures better mimicked native brain 
activity. However, note that all cells were in contact with electrodes in 2D, while in 3D only the 
‘lowest’ cells were in contact with electrodes (Bourke et al. 2018). 
Early ‘true’ 3D MEAs involved some interesting designs, such as a push-pull actuated capillary-wire 
mechanism where wires could penetrate into tissue slices at different z-axis points in order to record 
from different planes. This mechanical actuation appears to have similar drawbacks to intracellular 
recording, where the cells are physically pierced repeatedly in order to move up and down the z-axis 
(Zuo et al. 2017). 
Other examples of ‘true’ 3D MEAs include those developed via low-temperature co-fired ceramic 
(LTCC) and miniaturised ceramic circuit boards (MCBB) technologies, allowing for 3D MEAs up to 
2 mm in height, as well as flow and control of temperature (typically kept at 37 ⁰C). This allows for 
maintenance and investigation of neural tissues hundreds of micrometres in height, and culture of 
primary neural cells over the long term (over six months). These arrays can also be functionalised 
with coatings (such as laminin or titanium oxynitride on gold electrodes), making them suitable for 
signal recording in 3D in vitro cultures (Bartsch et al. 2018). It should be noted that as the base of this 
device is co-fired ceramic, it is not transparent and imaging may be challenging. A summary of these 




Figure 1.12: Different design approaches to fabricating 3D MEAs. A) a typical 2D MEA. B) MEA with raised or 
‘spiked’ electrodes, these can pierce up to 50 µm into a sample for recording beyond the outer layer of cells, 
but can do significant damage to the sample. C) Culturing a 3D scaffold of cells (blue, typically a hydrogel 
scaffold) on a typical MEA, signals received from base layer of cells only (based on work from (Bourke et al. 
2018)). D) Culturing cells on a 3D array of glass beads (blue), has similar issues to C, where only the base bead 
layer can be recorded from (based on work from (Frega et al. 2014)). E) Capillary-wire mechanism, where 
two wires can be positioned throughout the z-axis of a tissue slice in order to give recordings from multiple 
planes (based on work by (Zuo et al. 2017)). F) Stacks of 2D MEAs supported by PDMS (grey) and silicon, 
allow for recording from multiple cell monolayers throughout the z-axis, but not ‘true’ 3D (based on work 
from (Musick et al. 2009)). G) Recent work involving fabricating ceramic circuits into z-axis extensions, 
resulting in a 2D MEA with interspersed electrode-studded pillars (blue) that can measure cell activity 
throughout a 3D area (based on work by (Bartsch et al. 2018)). 
Rather than increasing complexity of in vitro models via a move from 2D to 3D, it may be better to 
increase the complexity of a 2D monolayer model in order to retain functional assessment. 
1.5 Organ-on-a-chip 
For in vitro 2D cell models to better mimic in vivo physiology, one of the most successful approaches 
is to combine microfabricated devices, cell culture and microfluidics. By utilising techniques from the 
microchip industry, these devices can be remarkably efficient while still retaining a small size (Huh et 
al. 2011). These devices represent a collaboration between biosciences and engineering, resulting in 
powerful experimental platforms, and are often referred to as lab-on-a-chip or organ-on-a-chip 
devices. For this project the model of interest is a brain-on-a-chip, but areas of the body successfully 
modelled in vitro include the heart, cartilage and skin, as well as functional systems such as the 
vascular, endocrine, musculoskeletal, and nervous systems, as well as models of infectious diseases 
and cancer, reviewed in (Benam et al. 2015). 
When designing a model as an organ-on-a-chip, considerations include: the multicellular niche of a 
relevant tissue (Huh et al. 2011, Baker and Chen. 2012a), interfaces and interactions with other cells 
and tissues, a suitable concentration or gradient of chemicals and growth factors (Almodovar et al. 
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2013), a perfusion/flow system similar to vascular perfusion and interstitial flow in vivo (Kelly et al. 
2013), using a material of a similar stiffness to that found in vivo (Tse and Engler. 2011, Sur et al. 
2013), and use of micro- and nano-scale physical features (topographies) such as channels or pits to 
mechanically stimulate neural cells and tissues for alignment, elongation or differentiation 
(Bugnicourt et al. 2014). As such, there are numerous ways to fabricate such devices.  
1.5.1 Fabrication techniques 
Common micro-engineering techniques used to develop organs-on-chip devices include soft 
photolithography, micro-contact printing (µCP) and injection moulding, all of which are able to create 
micro-scale structures with specific shapes, which are then used to control cell proliferation, 
morphology, elongation and interactivity. However, as µCP and replica moulding fall under the 
category of soft lithography only lithographical techniques will be discussed here. 
In general terms, photolithography uses UV to transfer a pattern from a mask to a substrate which 
has been coated with a photoresist (a substance that becomes soluble or insoluble to developer upon 
exposure to UV). Different photoresist materials have different viscosities, with more viscous 
photoresists being able to create thicker layers for larger surface features, and less viscous 
photoresists being used to create micron-thickness layers and micro-scale surface features. This 
transfer of patterns from masks to substrates is highly reproducible, reliable and has a very high 
resolution, creating sub-micron sized features with a lower resolution limit of approx. 0.5 µm (T. Pan 
and Wang. 2011). However, to achieve this resolution requires expensive machinery, custom-made 
geometric patterned masks, exposure systems, toxic photo-reactive chemicals, special environments 
such as dark rooms (to avoid activating the photo-reactive chemicals) and clean rooms (any dust or 
particulates will interfere with the process), meaning there is a compromise between the high quality 
of pattern produced by this technique with the cost and difficulty of doing so. 
Highly-customised designs from lithography techniques have been used in on-chip cell culture, 
starting as simple cell arrays and developing into organs-on-chips. Microfluidic devices are created 
by bonding a polymer (usually polydimethylsiloxane, PDMS) containing micro-channels (created by 
soft lithography) to glass or plastic. This then creates a semi-closed environment where micro-scale 
amounts of liquid can flow through the micro-channels by laminar flow/capillary action, and where 
cells can be cultured (Therriault et al. 2003). This kind of in vitro cell model is not as limited as previous 
static 2D cell monolayer in vitro models (Pamies et al. 2014). Due to the high resolution and 
customisable nature of these techniques, devices produced in this manner can be specifically 
designed for mimicking neural in vivo microenvironments. Previous success has been had with 
modelling complex functional organs, such as the intestine (Imura et al. 2009), lung (Huh et al. 2011, 
Douville et al. 2011) and kidney (Jang and Suh. 2010). 
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The majority of organ-on-a-chip models are fabricated using soft lithography and PDMS, to create a 
microfluidic model with a compartmentalised design. The compartments represent different 
experimental modules for further development (for example, a porous membrane and dynamic fluid 
flow can be added) and can maintain viable cell populations. These factors make for the design of an 
efficient organ-on-a-chip model, and have been combined into multiple organs-on-a-chip (Luni et al. 
2014), with accurate tissue-to-tissue size ratios, extremely useful models for drug development as a 
physiologically based pharmacokinetic model (M. B. Esch et al. 2011). 
1.6 Brain-on-a-chip 
A brain-on-a-chip model is required to accurately mimic neural conditions such as: neuron plasticity, 
neuronal development, the presence of glia to guide neuronal growth, the correct ratio of neurons 
and glia, using typse of neuron with suitable neurotransmitters (excitatory vs inhibitory), precise cell-
cell communication both chemical (ions) and electrical (action potentials), synapse morphology, cell 
migration, accurate ECM composition and neurogenesis, all whilst mimicking the functional neuron 
processes in the brain (Pamies et al. 2014) and recording electrophysiological signals from the 
neurons to assure functionality. 
Neglecting to include certain factors when designing a brain-on-a-chip can result in a model that 
accurately mimics certain features of the in vivo CNS while ignoring other features. A good example 
is a model that focused on including both 3D cytoarchitecture and interstitial flow (J. Park et al. 2014), 
the former due to the lack of cell-cell contact in 2D monolayer cultures and the subsequent decrease 
in mechanical cell signalling (Smalley et al. 2006, Baker and Chen. 2012b), and the latter due to the 
interstitial fluid delivering nutrients, removing waste from the brain, and affecting cell-cell 
communication between neurons that do not form synapses, even at a slow flow rate of 
0.1-0.3 µL min-1 (Abbott. 2004). Park et al have previously used concave microwell arrays to grow 
size-controllable networked neurospheres (designed to mimic the 3D cytoarchitecture of the cortex) 
and used this model to test the toxicity of amyloid beta (Choi et al. 2013b). By combining this model 
with other models that could mimic physiological speeds of interstitial flow (Choi et al. 2013a, J. Park, 
Koito, Li and Han. 2009b), Park et al developed a brain-on-a-chip. Despite the advantages of including 
both 3D cell culture and interstitial fluid flow, this brain-on-a-chip model is still limited: 
 The model only includes E16 primary cortical neurons that are cultured into neurospheres, 
no glial cells are included. Without glial cells the model is a less accurate mimic of the in vivo 
brain, as astrocytes, oligodendrocytes and microglia all have vital structural, functional and 
immune roles in the brain. The same group has stated that inclusion of oligodendrocytes in 
a model allows for myelin production and a more physiologically relevant model compared 
to in vivo (J. Park, Koito, Li and Han. 2009a). 
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 The model has no ability to control the direction and length of neurite growth from the 
neuron cell body. The ability to direct growth of neurites allows for control over which cell 
populations form synapses and link together, to form a functional and morphological 
connection between neurons. This kind of control can be achieved by using chemical or 
physical patterns to guide neurite growth in a specific direction, as seen in work by (Peyrin 
et al. 2011), who used asymmetric tapered micro-scale channels to impose unidirectional 
neurite growth with 97% selectivity. Without this degree of control, the model is limited by 
the formation of a stochastic network rather than a specific network in order to better mimic 
brain subregions. 
 The model has no consideration of the extracellular materials. The extracellular matrix (ECM) 
of the brain is unique compared to other ECM materials and plays a large role in regulating 
function and growth of cells in the brain in vivo (Frischknecht and Gundelfinger. 2012). One 
study cultured cells with an ECM mimic consisting of a 3D collagen type I-hyaluronan scaffold, 
which resulted in a 70% increase in the number of neurons generated (Brannvall et al. 2007). 
However, it should be noted that primary neuronal and glial cells can generate ECM 
components to a limited degree (Dzyubenko et al. 2016), but this further highlights the 
importance of including glial cells in such a model, as with only neurons less ECM is 
generated. 
 The model lacks any method to test the functionality of neurons by measuring their 
electrophysiological activity. Only the viability, differentiation status and morphology were 
analysed, excluding a large portion of data and resulting in no firm idea if the neurons in the 
model are functional. By taking into account functional testing, these models can be 
improved and be more accurate mimics of the in vivo brain. Neurospheres are challenging to 
fully assess with electrophysiological methods, as most methods could only record from the 
exterior cells. 
Considering these flaws when designing a new model would allow for a model that better mimics the 
in vivo brain. These changes would increase complexity, and it is reasonable to assume that in the 
future a device can be fabricated with flow, cell culture abilities and an electrophysiological testing 
device such as an MEA, resulting in a powerful in vitro device for pre-clinical research. The ideal 
in vitro model would be able to align neural cells to create unidirectional circuits, test the circuits are 
functional, and then use this circuit model to mimic existing circuits in vivo and therefore study both 
physiological and pathological brain circuit states. 
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1.6.1 Compartmentalised microfluidic neural cell models 
With a standard monolayer culture of neural cells, it is difficult to isolate data from single cells or 
groups of cells that have differentiated into a specific subpopulation of neurons (GABAergic vs 
dopaminergic, or cortical vs hippocampal). A solution was developed in the 1980s by designing 
compartmentalised cultures (Campenot. 1982) to isolate processes of various types of long-
projection neurons (see Fig.1.13A). This model was later refined to have smaller chambers to 
accommodate neurons with shorter processes (see Fig.1.13B) (Ivins et al. 1998). However, whilst 
these two models allow for direct study of neurites from various types of neurons, they do not allow 
study of neurons interacting with each other, they support the growth of only one neuronal subtype, 
and they do not allow for live cell imaging. By using photolithography fabrication techniques it was 
possible to make the fabrication process more reproducible and allow for a more flexible structure 
including micro-scale grooves and wells linked by channels (see Fig.1.13C) (Taylor et al. 2003). 
Fabrication involved creating a mould and then casting the device using PDMS (Taylor et al. 2003, 
J. W. Park et al. 2006). This type of model was a better mimic of the neural microenvironment that 
cells face in vivo and was further developed to accommodate more than two types of cell (see 
Fig.1.13D), so that astrocytes could also be used in co-culture with neurons (Y. H. Kim et al. 2011). 
The model in Fig.1.13C has become a popular method for culturing two neuronal subtypes together, 
connecting the cell populations via axons grown through channels while isolating the cell bodies in 
chambers to prevent contamination. This model has been used in numerous studies of different cell 
types, with recent examples including: cortical neurons (Kanagasabapathi et al. 2009, 
Kanagasabapathi et al. 2011), cortical-cortical and cortical-thalamic co-culture systems 
(Kanagasabapathi et al. 2012, Kanagasabapathi et al. 2013), hippocampal-glial co-culture systems 
(Majumdar et al. 2011, Shi et al. 2013), cortical neurons co-cultured with genetically modified 
astrocytes (Kunze et al. 2013), embryonic forebrain neurons co-cultured with oligodendrocytes (J. 
Park, Koito, Li and Han. 2009b), primary CNS neurons co-cultured with oligodendrocytes and 
astrocytes (J. Park et al. 2012), dendrite growth (Taylor et al. 2010), hippocampal axon compression 
injury (Hosmane et al. 2011), synapse formation in hippocampal neurons (Y. Gao et al. 2011), 
embryonic neurons (Dworak and Wheeler. 2009) and P19-derived neurons co-cultured with mouse 
cortical neurons (Takayama et al. 2012). 
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Figure 1.13: Progress of compartmentalised neural models over time. (A) The Campenot chamber, neurons 
are plated in the centre area and neurites grow and align into the other chambers where they can be studied. 
(B) The Ivins chamber, neurons are plated outside the ring and grow under the coverslip into the main 
chamber, where they can be studied. This model is limited to neurons with short neurites. (C) Two chambers 
connected by 120 micro-scale channels (image not to scale). Neurons can be cultured in either chamber and 
grow through the channels to the other chamber, creating a rudimentary neural circuit. (D) A more advanced 
version of the previous model, including a third chamber in the centre, allowing for use of three different 
neural subtypes at once. The four small red chambers were designed to supply collagen mixed with primary 
astrocytes to the other chambers, allowing for neuronal-glial co-culture as well as ECM study. From 
(Kose-Dunn et al. 2017). 
 
By modifying the microchannel width it is possible to create unidirectional connections, mimicking 
certain input-output connections in the brain where there is projection but no return. Unidirectional 
channels (also referred to as tapered/asymmetrical/diode channels) had modified widths that 
created a physical pressure for a preferential direction of axonal growth (Peyrin et al. 2011), 
specifically by having channels from 15 µm wide to 3 µm wide at the other (seen in Fig.1.14), 
selecting for axons growing from the larger to smaller ends. 
 55 
 
Figure 1.14: Microfluidic device designed by (Peyrin et al. 2011) (A) an overall view of the model, consisting 
of two chambers linked by channels (channels not to scale), (B) asymmetrical ‘diode’ channels, starting at 
15  µm and terminating at between 1-3 µm, in order to select for axonal growth in one direction. 
Compartmentalised microfluidic models can mimic the in vivo brain microenvironment with 
increased accuracy whilst still being accessible and customisable (Whitesides. 2006). Other 
advantages of these compartmentalised models include (Harris et al. 2007, Robertson et al. 2014):  
 Specific localisation of cells and/or chemicals 
 Potential for high-throughput if scaled up 
 Exhibit highly sequential/parallel experimentation 
 Involve extremely small volumes of media/chemicals per experiment (reducing cost) 
 Fabricated via lithography and can therefore be virtually any shape/size 
 Microchannels allow fluidic isolation between compartments, stopping the spread of 
treatments between chambers 
 Greater control over cell patterning/manipulation 
 Greater control over extracellular and cellular microenvironments 
 Visible to conventional microscopes when made with optically transparent material (e.g. 
PDMS) and are low-cost disposable devices. 
As mentioned in section 1.1.5 Potential causes, misfolded proteins may be responsible for numerous 
neurodegenerative diseases, which highlights another advantage for compartmentalised microfluidic 
devices, namely controlling the flow of misfolded proteins. The compartments are fluidically isolated 
and consequently any misfolded protein won’t spread between compartments, allowing for effective 
modelling of the effects of misfolded proteins. Altering the channel sizes will allow misfolded protein 
to spread, further allowing modelling of misfolded protein spread. 
Compartmentalised microfluidic models represent a significant platform for studying neurobiology 
in vitro. These in vitro models offer a solution for studying specific parts of the brain in a simpler, 
more versatile and customisable way than current in vivo protocols. By combining models with 
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different surface chemistries and electrophysiological techniques they can be further improved and 
tailored to neurobiology, a review of microfluidic-based neurobiology can be found in (Wang et al. 
2009). 
With these established and advanced models available, it is necessary to decide which area of the 
brain should be subject to in vitro study. The main motivation for study has always been neurological 
disease, with the majority of conditions still incurable and mostly misunderstood. Epilepsy, 
Alzheimer’s disease (AD), schizophrenia, Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), 
autism, Huntington’s disease (HD), stroke and trauma from brain injuries affect up to one billion 
people worldwide (WHO (World Health Organisation). 2006). Both PD and HD are caused by damage 
to the same area of the brain, the basal ganglia. Pre-clinical in vitro research into these diseases is 
lacking, and the development of a microfluidic compartmentalised model with functional testing 
would represent a powerful and accessible platform for study into both PD and HD. This thesis 
describes the development and optimisation of such a model, and its power as an experimental tool. 
Aims and objectives are presented in section 1.8. 
1.7 Concluding Remarks 
Neurological and neurodegenerative diseases are incurable and debilitating progressive conditions 
that currently have no cure, due to the difficulty of researching an organ as complex as the brain, the 
long timeline of the disease, the lack of fundamental understanding and the lack of clinically 
translated research. These difficulties can be mostly abated by studying the brain in vitro at a 
pre-clinical level, but current pre-clinical assessment is insufficient to predict which treatments will 
work on human disease patients. The solution is to develop more efficient in vitro models, where 
there is a high level of control and the complexity can be increased to make the model more relevant 
as a mimic. These models are low-cost and reproducible, combining cells with biomaterials and 
microfluidics to make lab-on-a-chip devices, which are the efficient in vitro models necessary for 
progress in research at a pre-clinical level, with the resulting data driving clinical trials in a more 
relevant direction, and contributing towards potential treatments for neurological or 
neurodegenerative diseases. 
1.8 Aims and objectives 
The aim of this project was to engineer a functional in vitro model of basal ganglia circuitry. Damage 
to areas of the basal ganglia can result in Parkinson’s or Huntington’s disease, and by modelling this 
area I could create a pre-clinical platform to accelerate research into these diseases. The chapters of 
this thesis all contribute towards this goal. The working hypothesis of this thesis was that engineering 
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principles could be applied to fabricate a functional in vitro model of basal ganglia neural circuitry, 
and by extension Parkinson’s disease. 
Key objectives: 
 Design and fabricate a compartmentalised microfluidic device for modelling the basal ganglia 
 Isolate cells from specific brain regions specific to the basal ganglia and successfully culture 
these cells within the device 
 Ensure the device can physically isolate cell bodies of separate neural cell populations whilst 
connecting them in a manner relevant to the in vivo brain 
 Ensure this connectivity is unidirectional and can be controlled 
 Determine the functionality of cells within the model and track this function across the long 
term 
 Track any changes to this functionality upon the introduction of different factors to the 
device 
 Create a living neural in vitro model of a healthy physiological basal ganglia 
 Create a living neural in vitro model of a damaged pathological Parkinsonian basal ganglia 
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Chapter Two: Materials and Methods 
This chapter details the techniques used throughout this project and the protocols followed, detailing 
reagents and suppliers. 
2.0 Device fabrication 
2.0.1 Software design 
The original five port device (5PD) design was based on previous work by Dr Munyaradzi Kamudzandu 
(Keele University, 2015), designed to model the in vivo circuitry of the basal ganglia and cortex. The 
5PD was designed using AutoCAD software [Autodesk 2015]. As indicated in Fig.2.1A, in the area 
between the two input ports (left hand side) and the centre port, as well as between the centre port 
and the two output ports (right hand side) are micro-scale channels. These were designed to provide 
directed guidance to orient the outgrowth of axons, encouraging cells to grow axons through the 
channels in a certain direction, from input, to centre, to output, in an effort to control the direction 
of axonal elongation to connect cell populations into the desired circuit. These microchannels, based 
on previous publications (Peyrin et al. 2011), were tapered from a larger width – either 15 µm, 25 µm 
or 50 µm – to a smaller width, 5 µm. The channels were 450 µm long in order to select against 
dendrites (which range between 100 and 300 µm) and only allow axons through, which can grow up 
to a few millimetres (Brunello et al. 2013, Jokinen et al. 2013). More information on the 
microchannels can be seen in Fig.2.1C. 
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Figure 2.1: The design of a 5PD in schematics (A) the 5PD device as a whole, showing five separate ports 
linked with tapered channels (channels represented by black triangles, not to scale). Cells in the left-hand 
input ports and right-hand output ports have only one direction for axonal outgrowth, and cells in the centre 
port have two possible directions for axonal outgrowth as they are presented with two sets of channels. The 
arrow shows the desired direction of growth. The labels indicate what cell type is seeded where, CTX: cortex, 
SNc: substantia nigra pars compacta, STR: striatum, SNr: substantia nigra pars reticulata, GP: globus pallidus 
(B) Magnified version of the centre port. Cells growing in this port are presented with a larger channel 
entrance for the ‘correct’ direction for axonal outgrowth (to the right-hand output ports), and a smaller 
channel entrance for the opposite, undesired direction. This aims to create a directional pressure, ensuring 
that the cells connect in the same manner as in vivo, with no backtalk. (C) The three types of tapered 
microchannel available for the 5P device. 
 
The introduction of the multi-electrode array (MEA) to experimentation added a further limitation 
to the design of the 5PD, as the circular MEA bracket could only accommodate a device that was 
smaller than 30 mm in diameter. This resulted in a redesign of the original model, as seen in Fig.2.2. 
This smaller device was used for experiments involving MEAs (Chapters Four, Five and Six), whilst 




Figure 2.2: 5PD redesign to accommodate MEA hardware. A) The original 5PD design including a scaled 
30 mm diameter circle to indicate the maximum size that the MEA bracket can accommodate. This design 
was too large for the MEA, but better suited for non-MEA cell culture. B) 5PD redesign. This new device easily 
fits into a 30 mm diameter circle and is suitable for MEA experimentation. C) A photograph of both finished 
5PD types, original on the left and redesigned on the right (attached to MEA for scale). For A and B all 
dimensions are in millimetres, R: radius. 
The 5PD designs were arranged into templates, in order to develop photolithographic masks for the 
next stage of fabrication. The intended design had ~5 μm channel feature height while ports had 
much larger feature height of ~150 μm. Due to these differences in size between channels and ports 
two stage lithography was needed (one lithography step each for small scale elements and larger 
scale elements), therefore two lithography masks were needed. These two masks were designed 
using AutoCAD: one for microchannels and one for ports, as seen in Fig.2.3. Each mask also features 
alignment crosses at the extremities of each device and set of channels in order to align the ports 
onto the channels. These mask designs were printed onto chrome/soda lime glass by JD PhotoTools 
LTD at high resolution. 
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Figure 2.3: Photolithographic mask designs for the larger 5PD, made with AutoCAD software. The left image 
shows the ports layer, and the right image shows the microchannels layer, with the top set of channels being 
50 µm to 5 µm in width, the middle three sets being 15 µm to 5 µm in width, and the bottom set being 25 µm 
to 5 µm in width. These designs were fabricated into masks for use in lithography. 
2.0.2 Two-stage photolithography 
Briefly, the two-stage photolithography process involved using i-line (265 nm) UV light to transfer the 
mask design onto a surface coated with a photo-reactive substance, termed a photoresist. An 
epoxy-based SU-8 negative resist [A-GAS Electronic Materials, UK] was used so that the resulting 
patterns could be used as templates for soft lithography. The channels layer (Fig.2.3 right image) was 
exposed first with the ports layer (Fig.2.3 left image) superimposed onto the channels layer, the two 
layers were aligned using a Canon PLA-500F parallel light mask aligner via the alignment crosses on 
both masks, creating the master template for the devices. A schematic of the two-stage lithography 




Figure 2.4: The two-step lithography process (legend at top). A) Channels stage. 1) Silicon wafer, 2) wafer 
coated with SU-8 10, 3) coated wafer exposed to UV through the channel mask, 4) after development, the 
inverse of the channel pattern remains on the wafer. B) Ports stage. 1) Wafer with channels from A, 2) wafer 
coated with SU-8 50, 3) coated wafer exposed to UV through ports mask, 4) after development, the inverse 
of the ports remain, aligned to channels. C) PDMS casting. 1) Wafer with channels and ports from A and B. 
2) PDMS is cast onto the patterns, 3) PDMS is removed and sealed to glass to create the microfluidic device. 
The chosen substrate surface for the photolithographic process was a circular 100 mm diameter 
silicon wafer [PI-KEM, UK]. Firstly, the wafer was washed with acetone and then propanol 
[both Fisher Scientific, UK], removing any dust or particulates, to prepare the wafer for the 
photoresist. Two types of SU-8 negative epoxy series photoresist were used: SU-8 10 for the tapered 
microchannels (feature height 5 µm) and SU-8 50 for the ports (feature height 150 µm). These SU-8 
photoresists become insoluble in developer upon exposure to UV and formed the features of the 
master device template. 
The photoresist was spread onto the cleaned silicon wafer using a WS-650HZB-23NPP Modular Spin 
Processor [Laurell Technologies Corporation, USA], spinning the wafer at 500 rpm to spread the 
photoresist evenly across the surface. The wafer was then spun at high speeds to determine the 
thickness of the photoresist layer, which would become the feature height. After spinning, the wafer 
was heated to set the photoresist, and then exposed to UV light through the appropriate 
photolithographic mask in order to transfer the pattern to the wafer. The wafer was heated again to 
set the pattern. This whole process differed for SU-8 10 (for channels) and SU-8 50 (for ports) 
photoresists and is detailed overleaf. 
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 Spin stage 
o SU-8 10: wafer spun at 4400 rpm for 30 seconds (resulting in 5 µm height) 
o SU-8 50: wafer spun at 1000 rpm for 30 seconds (resulting in 150 µm height) 
 Pre-bake 
o SU-8 10: wafer heated at 95 °C for 60 seconds 
o SU-8 50: wafer heated at 65 °C for 10 minutes, 95 °C for 30 minutes then 110 °C for 
10 minutes 
 Exposure 
o SU-8 10: wafer exposed to UV light for 50 seconds through the channel mask (Fig.2.3 
right image, also see Fig.2.4A) 
o SU-8 50: wafer exposed to UV light for 50 seconds through ports mask (Fig.2.3 left 
image, also see Fig.2.4B) 
 Post-exposure bake 
o SU-8 10: wafer heated at 65 °C, 95 °C, then 110 °C for one minute each, then slowly 
cooled to room temperature 
o SU-8 50: wafer heated at 65 °C for one minute and then 95 °C for 10 minutes, then 
slowly cooled to room temperature 
After the post-exposure bake, wafers were immersed in developer solvent [A-GAS Electronic 
Materials, UK] to remove any unexposed photoresist, leaving only the exposed structures. After this 
the wafer was washed with propanol and air dried. 
For a complete master template, the SU-8 10 process for the microchannels was performed first, and 
then the SU-8 50 process was performed on the same wafer, aligning and superimposing the ports 
over the microchannels. This process can be seen in Fig.2.4A-B and Fig.2.5. 
Once the master template was complete, the final devices were fabricated by using the wafer with 
the SU-8 template features as a mould for polydimethylsiloxane (PDMS), seen in Fig.2.4C. Quantum 
silicone 216 (QSil 216) [ACC Silicones, UK], composed of PDMS (A) and crosslinker (B), was mixed in 
a 10:1 ratio (A:B). The mixture was poured onto completed master templates and incubated at 50 °C 
for one hour to set. The cured PDMS was then cut away from the wafer, excess PDMS was shaved off 
and access holes were punched in each end of each port to form wells. The PDMS casts were then 
stored in sterile petri dishes, in preparation for sealing to a glass surface. This process can be seen in 
Fig.2.5 and 2.6. 
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Figure 2.5: 5PD fabrication via soft lithography. A) SU-8 10 channels on wafer after exposure through 
channels mask, B) SU-8 50 ports superimposed onto channels, aligning the two patterns using alignment 
crosses and mask aligner, (C) crosslinked PDMS was cast onto the exposed patterns, creating the inverted 
pattern, D) once set, the PDMS was cut away from the pattern and inverted pattern side up, E) holes were 
punched in each end of each port and the PDMS cast is inverted again and bonded onto glass, pattern side 
down, before sterilisation. 
2.0.3 Bonding and sealing 
Once the PDMS cast was completed, the 5PDs needed to be sealed to a surface, pattern side down, 
to finish the microfluidic device and allow for cell culture. 5PDs were sealed to either a glass 
microscope slide or an MEA. For early experiments with microscope slides, 5PDs were permanently 
bonded via oxygen plasma, and for later experiments with microscope slides and MEAs, 5PDs were 
semi-permanently bonded via polyethylenimine (PEI). 
2.0.3.1 Permanent bonding via exposure to oxygen plasma 
Glass slides were cleaned with propanol and air dried. The slides and PDMS casts were exposed to a 
13.65 MHz RF oxygen plasma within a Deiner plasma unit [Diener Electronic, Germany] for 30 
seconds (oxygen pressure was set to 300 pressure). After exposure, the PDMS was immediately 
placed onto microscope slides [Fisher Scientific, UK] pattern side down, forming a permanent bond 
and sealing the two together, forming a microfluidic device. The plasma also sterilised the devices, 
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which were then flooded with 2% penicillin/streptomycin/fungizone [Fisher Scientific, UK] and kept 
under UV light for one hour for further sterilisation immediately prior to chemical coating. 
2.0.3.2 Semi-permanent bonding via chemical coating with PEI  
Glass sides were immersed in 70% ethanol [Fisher Scientific, UK] to sterilise and clean, then air dried. 
The slides were then immersed in 0.05% polyethylenimine (PEI) [Sigma-Aldrich, UK], diluted using 
25 mM borate buffer (sodium tetraborate [Sigma-Aldrich, UK] dissolved in dH2O and pH set to 8.0), 
for one hour at room temperature. The slides were then washed four times with distilled water 
(dH2O) to clear any excess PEI, and then air dried. Once dry, the PDMS casts were placed onto the 
slides (pattern side down), forming a seal when slight pressure was applied. The PDMS could be 
attached and detached as many times as necessary, as the PEI makes the slides very attractive due 
to the dense positive charges. The sealed devices were then sterilised by flooding with 2% 
penicillin/streptomycin/fungizone and kept under UV light for one hour immediately prior to 
chemical coating. 
The full device fabrication process is pictured in Fig.2.6. 
2.1 Device preparation: chemical coating 
Prior to cell seeding, the completed devices were chemically treated by incubating with either a 
combination of poly-d-lysine (PDL) and laminin (LAM), or polyethylenimine (PEI) and PDL [all listed 
reagents obtained from Sigma-Aldrich, UK]. 
2.1.1 Chemical coating: PDL/LAM 
Devices were flooded with 0.1 mM PDL solution in distilled water and incubated overnight at 37° C, 
then washed three times with dH2O and incubated with 0.01 mM laminin solution in distilled water 
for two hours at 37 °C. After this incubation, the laminin was removed and immediately prior to cell 
seeding. 
2.1.2 Chemical coating: PEI/PDL 
Devices were flooded with 0.05% PEI (diluted in solution with 25 mM borate buffer from sodium 
tetraborate [Sigma-Aldrich, UK] adjusted to pH 8.0) and left for one hour at room temperature, then 
washed four times in dH2O and incubated with 0.1 mM PDL in distilled water overnight at 37 °C, again 
washed three times with dH2O. After these washes, devices were ready for cell seeding. It should be 
noted that devices sealed with PEI only needed PDL coating, whereas oxygen plasma sealed devices 
needed both the PEI and PDL coatings steps. 
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Figure 2.6: The 5PD fabrication process in images. A) The original AutoCAD software design, B) a completed 
master template wafer after a full photolithography process, featuring seven 5PDs, the top four covered in 
PDMS, C) PDMS from B, removed from the wafer before individual devices were cut out, D) a single 5PD 
before and after access holes were punched, E) a 5PD sealed to a glass  microscope slide and filled with 
coloured dye to indicate the five ports and their fluidic isolation, F) a 5PD after 21 days of cell culture, stained 
and imaged in an XY tile scan on a fluorescent microscope. Blue for DAPI, green for β-tubulin, red for GFAP. 
All scale bars are 10 mm. 
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2.2 Primary cell culture 
2.2.1 Brain tissue dissection 
The cells used throughout this project were primary cells from rat embryos, requiring several stages 
of dissection. The four areas dissected from the developing brain for experimentation were the 
cortex (CTX), medial and lateral ganglionic eminences (MGE and LGE) and ventral midbrain (VM). The 
MGE, LGE and VM develop into the globus pallidus (GP), striatum (STR) and substantia nigra (SN) 
nuclei respectively and were used in order to mimic the basal ganglia circuitry (with SN containing 
both SNc and SNr, making five cell types, one for each port of the devices). These brain areas were 
dissected from rat embryos ranging from 12 to 16 days old (E12-E16) depending on the type of 
experiment being seeded, with E0 being the date of identifying the vaginal plug. 
Dissection tools were first sterilised at 250 °C using a glass bead steriliser [Simon Keller Steri 250, 
Switzerland]. These tools were as follows: large and small scissors [Fine Science Tools, Cambridge, 
UK], bracken forceps [Roboz Surgical Instrument Co, Kent, UK] and Dumont forceps [Fine Science 
Tools, Cambridge, UK]. The tools were cooled in a sterile container and left under a UV light. 50 mL 
falcon tubes [Greiner Bio-One, UK] were filled with Dulbecco’s Modified Eagle’s Medium (DMEM) 
[Sigma-Aldrich, UK] and placed on ice; the number of tubes corresponding to the number of animals. 
1.5 mL micro centrifuge tubes [Greiner Bio-One, UK] were also filled with ice cold DMEM, the number 
of tubes corresponding to the number of types of tissue to be dissected (the maximum number being 
four). 
Pregnant Sprague-Dawley rats, bred in-house at Keele University, were sacrificed by approved 
Schedule 1 methods, following guidelines from the UK Animals, Scientific procedures Act, 1986 and 
authorization from Keele University’s local ethics committee. The peritoneum was opened using 
scissors; first horizontally through the skin then vertically to expose the uterine horns containing the 
embryos. Sterilized forceps were used to lift each uterine horn whilst a pair of small scissors was used 
to trim off fat and tissue attached to the abdomen. Uterine horns were transferred into a sterile 
100 mm diameter petri dish [Greiner Bio-One, UK] containing ice cold DMEM [Sigma Aldrich, UK]. 
Scissors and forceps were used to remove one embryo at a time, and embryos were decapitated 
following the Schedule 1 procedure set out in the UK Animals, Scientific procedures Act, 1986 (since 
embryos were older than E11). Resulting tissues were transferred to pre-prepared 50 mL falcon tubes 
containing ice cold DMEM and then transported to a dissection hood. Using the previously sterilised 
tools, the skin and skull of each embryo head were cut open using a horizontal cut slightly above eye 
level to exposure the brain (as seen in Fig.2.7A-B), which was then removed and transferred to a 
fresh 100 mm petri dish containing ice cold DMEM. 
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2.2.2 Brain tissue microdissection 
As mentioned above, four different tissues were dissected from rat embryo brains, namely the CTX, 
MGE, LGE and VM. For the CTX, MGE and LGE, a longitudinal cut was made along the medial dorsal 
cortex, close to the midline. It was opened up to reveal the ganglionic eminence, a heart-shaped 
structure, medial and lateral portions corresponding to MGE and LGE respectively, as seen in 
Fig.2.8C-D. A vertical cut was made to divide the LGE from MGE, and a horizontal cut was made to 
detach the tissues. These tissue pieces were transferred into small micro centrifuge tubes containing 
ice cold DMEM, kept on ice to prevent excess cell death. The tissue surrounding the ganglionic 
eminence forms the CTX, and pieces of CTX distal from the location of the ganglionic eminences (to 
avoid any potential cross contamination of cell types) were cut away and separated from the outer 
layer of meninges, then transferred to a micro centrifuge tube. For the VM, the dissection procedure 
was as follows: two vertical cuts were made on the mesencephalic flexure. Two further cuts were 
made, one horizontally across the flexure and another to isolate the VM tissue (a butterfly shaped 
piece of tissue), as seen in Fig.2.7E-F. This tissue was then placed into a micro centrifuge tube. 
 
Figure 2.7: Dissecting E15/16 rat embryos. A-B demonstrate the removal of the brain from the skull, 
C-D shows the CTX, MGE and LGE dissection procedure and E-F shows the VM dissection procedure. Image 
adapted from (Dunnett and Bjorklund. 1992). 
2.2.3 Cell suspension preparation 
Micro centrifuge tubes containing dissected tissue pieces were washed twice with ice cold 
DMEM-F12 [Sigma-Aldrich] to remove any detritus or meninges, and then incubated with 500 µL 
0.05% DNase/0.1% trypsin [both from Worthington Biochemical Corp., Reading, UK] in solution with 
DMEM-F12 at 37 °C for 20 minutes, inverting the tubes at least three times through incubation to 
ensure good mixing and full tissue exposure. The tissue pieces were then washed three times with 
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100 µL 0.05% DNAse solution to break down any free DNA. The tissues were then re-suspended in 
200 μL of ice-cold DMEM and mechanically dissociated using a Gilson P200 pipette, breaking apart 
the digested tissues, resulting in individual cells. Excess dissociation was avoided to prevent cell 
damage. Dissociated cells were counted using a haemocytometer [Fisher Scientific, UK] while stained 
with trypan blue [Fisher Scientific, UK] to check viability. After counting, the cells were centrifuged at 
1200 rpm at 4 °C for three minutes, the supernatant washed out and the pellet re-suspended in 
200 μL of neuronal culture media (NCM), consisting of: neurobasal [Fisher Scientific, UK] with 1% 
foetal calf serum (FCS), 1% B27 supplement, 1% penicillin/streptomycin/fungicide (PSF) [all from 
Invitrogen, UK], 0.5% L-glutamine [PAA Laboratories, UK] and 0.45% glucose [Sigma-Aldrich, UK] 
solutions. 
When seeding cells onto 13 mm diameter coverslips [Fisher Scientific, UK] within a 24-well plate 
[Fisher Scientific, UK], cells were plated as a micro-drop culture, with 75,000-100,000 cells suspended 
in 50 μL of NCM and placed into the centre of the coverslip for two hours before being flooded with 
500 μL of NCM after cell attachment. Cells were then incubated at 37 °C in a 5% CO2 atmosphere, 
with the NCM media being replaced every two to three days, 500 µL per change. 
When seeding cells onto 5PDs, 100,000 cells were suspended in 50 μL NCM and added directly to the 
port via the access wells, with extra media added after two hours to flood all the ports of the device, 
at approximately 200 μL NCM for side ports and 500 µL NCM for the centre port. Cells were seeded 
into specific ports, as shown in Fig.2.1A. Cells were then incubated at 37 °C in a 5% CO2 atmosphere, 
with the NCM media being replaced every two to three days, 200 µL per side port and 500 µL for the 
centre port. Cells were cultured until ready for the next stage of experimentation. 
2.2.4 6-OHDA treatment 
SN cells were treated with the 6-hydroxydopamine (6-OHDA) neurotoxin to selectively damage 
and/or kill dopamine neurons, in order to mimic Parkinson’s disease. 1.6 mg of 6-OHDA powder 
[Sigma-Aldrich, UK] was dissolved into 8 mL of 0.15% ascorbic acid (antioxidant vehicle) 
[Sigma-Aldrich, UK], making up a 1 mM 6-OHDA solution. NCM was removed from the cells to be 
treated and replaced with a 200 μL solution consisting of 180 μL NCM (serum-free) and 20 μL 
6-OHDA/ascorbic acid solution (thus diluting to a working concentration of 100 μM). The cells were 
incubated in this solution for 20 minutes, the solution was removed and the cells washed twice with 
300 μL NCM, then 500 μL of NCM was added as a feeding medium. The cells were then subject to a 
48 hour post-toxin incubation. 
2.2.5 Live/dead staining 
The LIVE/DEAD Viability/Cytotoxicity Kit for mammalian cells was used (L3224, ThermoFisher 
Scientific, UK) for live-dead experimentation. NCM was removed from samples and replaced with 
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100 µL live-dead solution. Live-dead solution was made up with 10 mL PBS, 20 µL ethidium 
homodimer-1 (EthD-1, the ‘dead’ marker) and 5 µL calcein (the ‘live’ marker). The samples were 
incubated with the live-dead solution at room temperature for 30 minutes, then washed three times 
with PBS and immediately imaged via fluorescent microscopy. 
2.3 Immunocytochemistry 
For fluorescent tagging and imaging, cell cultures first had to be fixed. NCM was removed from the 
cell culture, and cells were washed three times with phosphate-buffered saline (PBS) 
[Sigma-Aldrich, UK] before being fixed in 4% polyformaldehyde (PFA) [Sigma-Aldrich, UK] for 
20 minutes at 4 °C. Cells were then washed three times with tris-buffered saline (TBS) (12 g trizma 
base, with 9 g NaCl [both from MERCK, Germany] in 1 L dH2O), then blocked and permeablised with 
5% normal goat serum (NGS) [Vector Laboratories, USA] and triton-X (1:500) [Sigma-Aldrich, UK] in 
solution with TBS for one hour at 4 °C, without agitation. 
The primary antibody solutions consisted of TBS with 1% NGS, 1:500 triton-X and the selected 
antibody, dilutions and antibody details are described in Table 2.1. 
Table 2.1: Antibodies used in experimentation for immunocytochemistry and fluorescent imaging 
Antibody Clone Dilution Purpose Identifier 
β-tubulin III Chicken anti-
mouse 
polyclonal 














1:500 Dendrite identification ab32454 [abcam, UK] 
Tau Mouse 
monoclonal 
1:500 Axon and dendrite 
identification 





1:300 Dopaminergic neuron 
identification 







1:500 GABAergic neuron 
identification 








1:500 Glutamatergic neuron 
identification 










Primary antibodies were prepared in solution, and then added to the cells after the removal of the 
blocking solution for incubation overnight at 4 °C. The cells were then washed three times with TBS 
to remove any background staining, and then incubated with fluorescent secondary antibody 
solutions, made up of TBS with 1% NGS, triton-X (1:500) and the selected secondary antibody, namely 
FluoProbes 488 (goat anti-mouse, green fluorescence) [FP-SA4000, Interchim, France] or FluoProbes 
547H (goat anti-rabbit, red fluorescence) [FP-SB5010, Interchim, France], both at a dilution ratio of 
1:300, for two hours at room temperature in the dark. Cultures were then washed three times with 
TBS. 
For cultures on coverslips, the coverslips were removed from the 24-well plates and washed with 
dH2O, then dried and mounted onto microscope slides using Vestashield softset mounting medium 
with 4’,6-diamidino-2-phenylindole (DAPI) [Vector Laboratories, UK]. These devices were then sealed 
with nail polish to ensure liquid retention for long term storage, and stored at 4 °C in the dark 
overnight, at which point they were ready for imaging. For cultures in 5PDs, all liquid was removed 
from the ports and enough DAPI hardset mounting medium was added to the cell culture ports to 
cover the cells. These devices were then sealed with a microscope slide on top of the access wells 
and stored at 4 °C in the dark until imaging. 
2.4 Fluorescent microscopy 
A Nikon Eclipse 80i microscope was used to view the fixed and stained cells cultured on either glass 
coverslips or devices. Images were captured using a Nikon DS-U2/L2 camera and analysed using NIS 
Elements (BR3.00, SP3) [Nikon, USA] imaging software as well as ImageJ software [NIH Images]. 
Analysis consisted of counting specific cell types, performed with the MultiPoint tool on ImageJ. 
2.5 MEA extracellular electrophysiological recording 
2.5.1 MEA: Hardware 
Devices and cells were attached to multi-electrode arrays (MEAs) in order to record the spontaneous 
extracellular electrical activity from the primary neural cultures. MEAs used in this project consisted 
of 50 x 50 mm square indium tin oxide (ITO) coated glass with an 8 x 8 grid array of square electrodes 
in the centre, each electrode being 50 µm x 50 µm with 200 µm between each electrode, resulting in 
an array size of 1.8 x 1.8 mm [MEA model MED-P515A, obtained via Stratton Technologies, UK from 
AlphaMed Scientific, MED64, Japan], seen in Fig.2.8C. Two different types of this model of MEA were 
used, one type featured platinum black (PtB) electrodes surrounded by a glass ring, and the other 
type featured carbon nanotube (CNT) electrodes without a ring (the lack of ring allowed attachment 
of 5PDs to the MEA), seen in Fig.2.8A-B. 
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These MEAs were treated in the same way as glass coverslips, both with chemical coatings (PDL/LAM 
or PEI/PDL) and primary cell culture. For PtB ringed MEAs, cells were cultured directly in the centre 
of the ring, on top of the electrode array. For the CNT non-ringed MEAs, these were first coated with 
PEI as described previously, then PDMS devices were adhered to the MEA, on top of the electrode 
array (as seen in Fig.2.8B). Cells were then cultured within the PDMS device, in contact with the 
electrodes. As the cultures grew on the MEAs, their spontaneous extracellular electrophysiological 
activity was recorded using MEA software at select time points over a 0-70 day period. 
 
Figure 2.8: Concerning MEA design. A) Photograph of a ringed MEA (used with PtB electrodes), the 
approximate location of the electrode array itself shown by the black square, scale bar 5 mm. B) Photograph 
of a flat MEA (used with CNT electrodes) with a PDMS 5PD attached, approximate location of electrode array 
indicated by black square, scale bar 5 mm. C) Diagram of the electrode array itself, an 8x8 grid of square 
electrodes, 50 x 50 μm with 200 μm spacing in each direction, resulting in a total array size of 1800 x 1800 
μm. 
2.5.2 MEA: Recordings 
Spontaneous extracellular electrophysiological activity of neural cells cultured on the MEAs was 
recorded throughout this project over a 70 day culture period at regular intervals. These recording 
sessions were always taken before a media change, as changing the media affected recording. On 
days of recording, the MEA bracket was first placed into a sterile flow hood, heated to 37 °C and 
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sterilised with 70% IMS while the amplifiers were activated and the Mobius MEA software was 
opened [Alpha MED Scientific, Japan]. MEA devices were removed from cell culture incubators and 
transported to the MEA bracket in sterile petri dishes wrapped in Parafilm [Sigma-Aldrich, UK] to 
reduce any potential contamination. The MEA bracket was opened and the MEA placed into the 
bracket, each conductive strip in contact with its corresponding pin, and the bracket was closed and 
tightened. 
The activity of the cell cultures growing on the MEA was recorded from all 64 electrodes (across the 
whole array) in a four minute session, for three immediately consecutive sessions, resulting in a total 
of 12 minutes of recording. This allowed for a window where results were represented in triplicate, 
and sufficient length so that any outliers, aberrant signals or noise can be represented evenly against 
the signal data. These recordings were taken via Mobius software, using the modules displayed in 
Fig.2.9 from the Spontaneous_recording/Spike_recording predefined workflow. Fig.2.9A indicates 
the MAIN section, including the ‘Acquire MED64R2 Data’, ‘Export Raw Data’ (allows for export of raw 
data as a variety of file types) and ‘Display All Channels’ (allows for viewing of any recorded activity 
across 64 channels) modules. The ‘Acquire MED64R2 Data’ module allows for modificiations to the 
timing of recording (changing the number and duration of traces), the input range (typically 2.3 mV), 
and the band-pass filtering thresholds (typically 100 Hz low cut and 10,000 Hz high cut). Fig.2.9B 
indicates the EXTRACTION section, including the ‘Extract Spikes Advanced’ module. The main 
purpose of this module is to adjust the threshold at which recorded activity becomes signals rather 
than noise. A typical threshold of 500% of the root mean square (RMS) was established, and only 
data exceeding this threshold was considered signal data (data below this threshold was identified 
as noise and not considered for analysis), these signals being either extracellular action potentials 
(EAPs) or high-amplitude noise and were subject to further analysis. Signals received from the MEA 
are referred to as spikes, with activity referred to as spiking, spike frequency, etc. Fig.2.9C indicates 
the SPIKE section, including the ‘Save Spikes’ (saves spike data after extraction), ‘Compute Spike 
Freqs’ (calculates spike frequency based on an arbitrary 1 s window), ‘Save Spike Freqs’ (saves spike 
feqs once calculated) and ‘Display Spike Measures’ modules. In ‘Display Spike Measures’, spikes 
(signal after extraction) are displayed in a 10 s and 10 ms window, and the spike frequency is also 
displayed over 10 s. This view is only for one channel at a time, which can be changed at any time. 
Once 12 minutes of recording was completed, signal data was saved in the form of a .modat data file 
under ‘Save Raw Data’ in the ‘Acquire MED64R2 Data’ module until analysis. These workflows and 
modules are displayed in full screencapture in Fig.2.9. 
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Figure 2.9: MOBIUS modules involved in the recording process. The Spontaneous_recording/spike_recording workflow is split into three main sections, A) MAIN, B) EXTRACTION 
and C) SPIKE. Each of these sections contains modules involved in the recording of spontaneous extracellular activity from the MEA. Useage is detailed in text body. 
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2.5.3 MEA: Analysis 
Mobius software was used to analyse the raw data exported in a .modat file from the recording 
process. The Spike_analysis/Spike_sorting predefined analysis workflow was used to analyse activity 
recorded across the MEA, this workflow is outlined in Fig.2.10. Fig.2.10A indicates the MAIN section, 
which contains the ‘Display All Channels’ (allows for viewing of any recorded activity across 64 
channels), ‘Export Raw Data’ (similarly to Recording workflow, exports raw data file) and ‘Replay Raw 
Data File’ modules. The ‘Replay Raw Data’ module allows for the selection and replay of individual 
.modat recording files, which can be modified to look at select channels and/or select portions of 
recording traces. Fig.2.10B indicates the EXTRACTION section, which contains the ‘Extract Spikes 
Advanced’ module. This is the same as MEA recording, in which the threshold was set to 500% of the 
RMS, and only data above this threshold is categorised as signal. When replaying .modat files, spike 
signals above the threshold can be analysed, indepdent of the threshold used during recording. 
Fig.2.10C and D indicate the all-important SPIKE section, where the analysis occurs. This section 
includes the ‘Cluster Spikes’, ‘Save Spikes’ (used to save and export spike data), ‘Compute Spike Freqs’ 
and ‘Save Spike Freqs’ modules (both the last two are the same as they were in recording). The 
‘Cluster Spikes’ module is where spikes were sorted into groups of similarly shaped spikes, termed 
‘centroids’. The formation of centroids was controlled by two variables: the similarity radius 
(percentage similarity in shape between spike waveforms) and the minimum number of similar spikes 
necessary for a centroid to be formed. These variables allowed the thousands of spikes per electrode 
per recording to be reduced to a handful of centroids, indicative of the activity within the cultures. 
Throughout this project, centroids were determined by grouping spikes with 80% similarity, and 
creating a centroid when 50 such similar spikes were accumulated. Centroid is henceforth used as 
the term for raw spiking data that has been analysed and grouped into groups of similar spikes. 
Mobius software is hard limited to 20 centroids per recording, indicated by the ‘Mapping’ section 
where centroids (or ‘clusters’) are ranked by number of spikes. Each centroid is given a colour, as 
seen from the single red centroid from Fig.2.10C (from CTX cultures after 21 DIV) and the red then 
blue centroids seen in Fig.2.10D (from SN cultures after 44 DIV). The averaged shape of these 
centroids can be seen in the ‘Extracted Spikes’ section (also colour coded by centroid) and the 
frequency can be seen in ‘Spike Frequency’ section (also colour coded).  
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Figure 2.10: MOBIUS modules involved in the analysis process. The Spike_analysis/spike_sorting workflow is split into three main sections, A) MAIN, B) EXTRACTION and 
C/D) SPIKE. Each of these sections contains modules involved in the analysis of spontaneous extracellular activity from the MEA. Useage is detailed in text body. 
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These centroid files were exported as comma separated value data sheets that were further analysed 
using Microsoft Excel [Microsoft, USA] and Matlab [Mathworks, USA]. These data files listed the 
number of centroids for each of the 64 channels, the number of spikes grouped into each centroid, 
and the centroid waveform as mV over 3.5 ms. These data were analysed in order to determine the 
total number of spikes and centroids produced by each electrode over the entirety of the recording 
session. This data was used to produce the: 
 Percentage activity: with ‘activity’ defined as a custom threshold (number of spikes) for each 
MEA recording, the percentage of electrodes that were active for a recording session. 
 Spatial heatmaps of activity: An 8x8 grid of total spikes recorded per electrode conditionally 
formatted with a traffic light scale, with red for lowest number of spikes and green for 
highest. A visual representation of activity across the MEA. 
 Mean spike frequency: an average of the spikes recorded by each electrode across all 64 
electrodes of the MEA divided by time (720 seconds). 
 Maximum spike frequency: spike number from the single electrode that recorded the most 
spikes across the recording session, divided by time (720 seconds). 
This combination of raw spiking data, sorted centroid data and analysed data was gathered across all 
64 electrodes for cultures involving one or more of CTX, STR, GP and SN primary neural cell types, 
from the first day of culture (0 days in vitro or DIV) for a ten-week period (final recording on 70 DIV). 
This extensive recording created the data set analysed in Chapters 4-6. 
2.6 Statistics 
Statistical significance in the data was determined with GraphPad Prism software [GraphPad 
Software, USA], using two-way analysis of variance (ANOVA) when possible, in order to assess the 
main effect of each independent variable and the presence of any interaction between them. If 
significance was found through this test, posthoc Student’s t-test was performed to determine 
significance and assign asterisks to graphs. 
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Chapter 3: Design and optimisation of a five-port 
microfluidic neural device 
3.0 Introduction 
Having outlined the need for an in vitro device that can model the in vivo basal ganglia (BG) in order 
to study Parkinson’s disease (PD), the first stage was to design such a model, using lithographic and 
microfluidic techniques. 
3.0.1 Designing a basal-ganglia-on-a-chip 
Neurons within the brain are highly organised, both structurally – cells can organise into dense groups 
termed ‘nuclei’ or layered sheet structures such as the cortex – and functionally, with both excitatory 
and inhibitory signals travelling between brain areas in hierarchical or cyclical fashions, controlling 
and modulating signals from other brain areas, both directly and indirectly. 
The basal ganglia (BG), a group of subcortical nuclei, features a high standard of both structural and 
functional organisation. The main nuclei of the BG include the striatum, which receives signals from 
the sensory areas of the cerebral cortex and acts as the primary input for the BG; the globus pallidus 
(GP, consisting of internal (GPi) and external (GPe) sections), composed mostly of GABAergic neurons 
and therefore inhibitory; the subthalamic nucleus (STN), composed mostly of glutamatergic neurons 
and therefore excitatory; and the substantia nigra, which consists of two differently functioning 
parts, namely the pars compacta (SNc) and the pars reticulata (SNr). The SNr serves as a GABAergic 
inhibitory output along with the GPi, conveying signals to the thalamus, which influences 
corticospinal projections and feeds back to the motor areas of the cerebral cortex. The SNc has a 
more specialised role, being an input that provides the neurotransmitter dopamine to the striatum 
as a method of indirect regulation, being either excitatory or inhibitory depending on activation of 
different receptor subtypes on target striatal neurons (Blandini et al. 2000, Smeets et al. 2000, H. F. 
Kim and Hikosaka. 2015). This connectivity is reproduced in Fig.3.1A. 
The importance of the carefully regulated signals in the BG is highlighted when the system breaks 
down. When certain areas of the BG are damaged, it results in a number of classical neurological 
diseases: Huntington’s disease; caused by a degeneration of GABAergic neurons in the striatum 
(Walker. 2007) and Parkinson’s disease; caused by a loss of dopaminergic neurons in the SNc 
(Blandini et al. 2000, Hague et al. 2005). Due to the currently incurable, progressive and prevalent 
nature of these diseases, the BG has received a great deal of scientific attention. Creating an in vitro 
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model of this area would result in a pre-clinical model and a powerful platform for study, both of a 
physiologically healthy and pathologically damaged BG. 
Due to the sheer complexity of the brain, BG circuitry must first be somewhat simplified in order for 
a successful model to be produced. This constitutes a ‘bottom-up’ approach, rebuilding the BG 
connectivity using relevant neural cells, and gradually increasing the complexity of the in vitro model 
until it is a relevant mimic of the BG in vivo. Part of this simplification design process can be seen in 
Fig.3.1A and 3.1B.  
The in vitro model must connect different neural cell populations together via axons, taking into 
account two major technical issues that arise when studying axonal growth and synapse formation: 
firstly the cell bodies should be separated from the neuronal endings so they can be studied locally 
in different compartments to avoid contamination between compartments whilst simultaneously 
connecting them, and secondly the difficulty involved in creating oriented neuronal networks 
involving different neuronal subtypes (Peyrin et al. 2011). The latter point refers to the directionality 
of connections in the BG. For example, as seen in Fig.3.1A, the cortex inputs to the striatum, but not 
vice versa, meaning the signals flow in one direction (a unidirectional connection). By isolating the 
cell bodies, allowing the axonal outgrowths to grow between cell compartments to link them, and 
encouraging these outgrowths to grow preferentially in one direction, an accurate in vitro model of 
the BG can be produced. 
Compartmentalised microfluidic devices have been used to overcome these issues, as discussed 
previously in section 1.7.1 Compartmentalised microfluidic models. These devices culture cells 
within compartments (henceforth referred to as ‘ports’) that are linked by micro-scale channels 
(henceforth referred to as ‘channels’), where the cell bodies remain in the port and extend axons 
through the channels into adjacent ports, avoiding contamination of cells between ports and allowing 
cell populations to connect together via synapses, creating a neural circuit. However, the majority of 
these models are limited to two ports, connecting two cell populations. For a system as complex as 
the BG two cell populations are insufficient, requiring the design of a novel five-port microfluidic 
device with an aim to mimic the connectivity of five main functional nuclei of the BG, as seen in 
Fig.3.1C. This device is designed to support the growth of and isolate different neural cell subtypes 
while also providing a way for neural cell populations to connect to one another via axons, forming 
a circuit that mimics brain connectivity in vivo. 
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Figure 3.1: From an in vivo circuit to an in vitro model, the process of designing a device to mimic BG 
connectivity. (A) A schematic of BG connectivity (BG boundaries indicated by dashed grey box). Arrows 
indicate directed connetivity: green for excitatory glutamatergic, red for inhibitory GABAergic, and blue for 
regulatory dopaminergic. SNc: substantia nigra pars compacta, SNr: substantia nigra pars reticulata, 
GPe/i: globus pallidus exterior/interior, STN: subthalamic nucleus. (B) The connectivity between the five 
main functional nuclei, highlighting the input, middle and output sections. (C) AutoCAD render of a device 
with five ports, organised in the same manner as the simplified in vivo BG circuitry, as seen in B. The thick 
black lines between the two input ports, the middle port, and the two output ports indicate the location of 
micro-channels, which allow for cells to extend axons between ports connected by channels, communicating 

























The five-port device (5PD) was generated within our research group, based on a previous thesis and 
project work by Dr Munyaradzi Kamudzandu (Fabrication of functional basal ganglia circuitry in 
vitro: from nano- and micro-scale topographies to microfluidic devices, Keele University). 
This model features a compartmentalised design with five ports. As seen in Fig.3.1C the two left hand 
ports represent the main inputs to the BG, the cortex (CTX) and the substantia nigra pars compacta 
(SNc, containing dopaminergic neurons). The centre port represents the striatum (STR), which 
receives the inputs and transmits to the outputs. The two right hand ports represent the main 
outputs of the BG, the substantia nigra pars reticulata (SNr) and the globus pallidus (GP). 
Each port consists of a rectangular section and two circular sections (seen in Fig.3.1C and 3.2). The 
rectangular sections are a set distance from the rectangular sections of parallel adjacent ports, and 
the channels are positioned within the space between these sections. The circular sections represent 
locations where access wells will be made in order to add cells, media and other factors to the 
microfluidic sections of the device. These wells are positioned apart in order to avoid any overlap or 
contamination, and to maintain an acceptable wall thickness. Apart from the channels between 
certain ports, each port is isolated from the other ports, resulting in a compartmentalised system. 
Between the two input ports and the centre port are sets of channels, as well as between the centre 
port and the two output ports (as represented by the thick black lines in Fig.3.1C and Fig.3.2B, in 
more detail in Fig.3.2C-D). In this manner, the cell populations cultured within the ports can extend 
axons through the channels and communicate in a manner similar to that of the in vivo BG. These 
channels are tapered, having a different width at the beginning and end of the channel, creating a 
directional pressure intended to mimic the unidirectional connections within the BG, previously seen 
and described in (Hattori et al. 2010, Peyrin et al. 2011). 
The model features four sets of channels, one for each side port, in order to link them to the centre 
port. Each set of channels features 200 channels, making 800 channels across the whole device. Each 
channel is 1.05 mm from end to end, but due to the way that the ports are superimposed onto the 
channels during the fabrication process, only the section of the channel between the ports will 
remain, resulting in channels 450 μm long from port to port. Channels are spaced ~40 μm apart, this 
measurement varying with different experiments using channels of different internal diameters. 
Channels have an internal width of 5 μm at one end and >5 μm at the other end, in order to create a 
tapered channel that exerts directional pressure on the axons extending into channels. There are a 
variety of widths for the larger end of the channels, and part of this experiment was to determine 
which width is optimal for a directional pressure. The available widths were 15 μm, 25 μm and 50 μm 
(Fig.3.2D). 
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3.0.2 Five-Port Device Fabrication 
Once the 5PD was designed with AutoCAD software, two separate masks were designed for 
fabrication purposes, as the 5PDs are made through two stage lithography: one mask for the channels 
(the first stage) and one mask for the ports (the second stage, aligned and superimposed onto the 
channels), both masks can be seen in Fig.3.3. Each mask allows of the fabrication of five 5PDs, three 
with channel width 5-15 μm and one each of channel width 5-25 μm and 5-50 μm. 
 
 
Figure 3.2: Schematics detailing the design of the 5PD. A) The positioning of the five ports in relation to each 
other. The channels were removed in this image to improve clarity. B) A magnified view of the bottom half 
of the device, showing the positioning of two sets of channels in relation to the ports. As the channels are so 
small and densely packed they appear as a single black bar. C) A magnified view of the channels between 
ports, showing the smaller width end on the left and the larger width end on the right. The two vertical lines 
indicate the edges of the ports. D) The dimensions of each of the three available channel types used for 
different experiments (in micrometres). Whilst the channels are over 1 mm in length in the design, only the 
middle 450 μm remains after the two-stage lithography, making this the final length of the channel. All 
channels begin 5 μm wide but can end at 15, 25 or 50 μm wide. These widths were tested to determine which 
exerts the most directional pressure on axon elongation, in order to create a unidirectional network 




Figure 3.3: Photolithography masks and final result. The top left is the channel mask and the top right is the 
ports mask. Each set of alignment crosses align the masks, indicating the location of channels and ports in 
relation to each other, with ports superimposed onto channels. The final result is pictured below, a 100 mm 
diameter silicon wafer with the designs transferred onto the surface via photolithography. 
These masks were involved in the photolithographic fabrication process, detailed previously in 
Chapter 2 (section 2.1.2 Device fabrication: two-stage photolithography). Briefly, the final product 
of the photolithography process was a silicon wafer with the ports and channels design transferred 
onto the surface, ready to be used as a template to mould 5PDs (Fig.3.3). 
Liquid-state polydimethylsiloxane (PDMS) is poured onto the silicon wafer, creating an inverted 
pattern that can be cut out and peeled off once set. This PDMS casting process is repeated many 
times to produce numerous devices. Due to the nature of the photolithographic process, each feature 
on the silicon wafer has a specific height: the channels are 5 μm high and the ports are 150 μm high 
(measured by scanning electron microscopy, SEM). These heights are inverted upon casting with 
PDMS, becoming cavities and airspace when the PDMS is attached to glass. The finished product can 
be seen in Fig.3.4. 
 84 
 
Figure 3.4: The finished 5PD (right hand side) compared to the original 5PD design (left hand side). The 
finished device is a PDMS mould, inverted and sealed to a glass coverslip. Each port was then filled with dye 
representing the colour that corresponds to the original design. Note that the ports were all isolated from 
each other, with no mixing of colours. Channels were present in this device, but they are too small to view. 
By culturing cells from the CTX, STR, GP, SNc and SNr in their respective ports (as seen in Fig.3.1C and 
Fig.3.4), their axons will extend unidirectionally down the channels to connect to adjacent cell 
populations and create an in vitro model of the BG. The same brain nuclei will connect in the same 
manner as they do in vivo. However, for this model to function as an effective in vitro basal ganglia 
for pre-clinical research into Parkinson’s disease, several factors required optimisation. 
3.0.3 Device Optimisation  
Several factors were optimised before the model could function as intended, to ensure the 5PD was 
designed efficiently. These factors can be categorised by: chemical coating, physical channel width 
and ensuring dopaminergic neuron isolation to SNc port. 
3.0.3.1 Chemical coating 
Two important factors to maintain when culturing cells within the 5PD is that the cell bodies should 
stay within the ports they were seeded into (in order to avoid contamination between neuronal 
sub-regions), and that they extend axonal processes through a 450 μm channel into an adjacent port, 
where they can interact and synapse with a different cell population, in order to make a circuit similar 
to the in vivo basal ganglia. The cell source for the model is primary rat (E12-16), the resultant neural 
cells are sensitive and less robust than a cell line (Potter and DeMarse. 2001). Due to this sensitivity, 
these primary cells were rarely seeded onto bare surfaces, requiring a chemically coated surface in 
order to exhibit proliferation and axonal growth. Therefore, an ideal chemical coating for the five-
port device was one that would not cause the primary cells to lose viability upon seeding, promotes 
axonal outgrowth and proliferation, and reduces cell migration. 
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As outlined in Chapter 1 (section 1.1.1 Surface chemical coatings), the most frequently used surface 
chemical coatings are poly-D-lysine (PDL) and laminin (LAM), with other synthetic positively-charged 
chemicals like polyethylenimine (PEI) also used. All of these chemicals are to be tested in combination 
to determine which is the most suitable for cell culture within the 5PDs, identifying which 
combination resulted in the least cell migration and most axonal outgrowth through channels. 
3.0.3.2 Physical channel width 
Two characteristics of axons are exploitable and should be considered when designing channels: 
axons can act as guide cues for other axons (with pioneer axons guiding follower axons through 
fasciculation and axonal bundling) meaning that larger channels accommodate more axons as soon 
as a pioneer axons finds the channel and enters; and axons react differently when meeting surfaces 
at different angles, either growing along the surface when aligned in parallel or deviating from their 
original direction when aligned in perpendicular, meaning sharp angles can be used to dissuade 
axonal growth whereas planar surfaces support axonal growth (N. Li and Folch. 2005, Francisco et al. 
2007, Peyrin et al. 2011, Renault et al. 2015). As such, it was important to optimise the tapered 
channel width to determine which best selects for unidirectional connections. 
Fig.3.2D shows the three channel width types available in fabrication: 5-15 μm, 5-25 μm and 
5-50 μm. While these channels needed to be able to direct axonal processes between adjacent ports, 
it is important to consider the differences between the four side ports (the two input and two output 
ports) and the centre port. Cells cultured in the side ports were only presented with one row of 
channels and therefore only had one possible direction for axonal outgrowth. While this is not an 
issue for the input ports, as they can only grow in their wanted direction (input -> centre), it is an 
issue for the output ports as the only direction for axonal outgrowth is in the opposite, unwanted 
direction (output -> centre). In addition, cells in the centre port are presented with two sets of 
channels, one set coming from the input ports and one set leading to the output ports. The wanted 
direction of connectivity for the device is as follows: input ports -> centre port -> output ports, and 
the channels require orientation in order to create pressure in this direction. This concept is further 
outlined in Fig.3.5. 
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Figure 3.5: Unidirectional connectivity in the 5PD. A) A simplified version of our 5PD, showing the three types 
of port and the channel orientations (channels represented by black triangles, not to scale). Cells within input 
ports can only grow in the wanted direction (as indicated by the grey arrow), and cells within output ports 
can only grow in the unwanted direction (as indicated by the black arrow). Cells within the centre port can 
grow in either direction, and thus can access both larger widths for the wanted direction and smaller widths 
for the unwanted direction. B) The three types of tapered channel available. 
The orientation and dimensions of the tapered channels is important to maintain the unidirectional 
connectivity found in the BG in vivo, and thus it was necessary to determine what channel widths 
best select for and against axonal entry into the channel. While all the channels featured a smaller 
end of 5 μm to select against axonal outgrowth, the choices for the larger end included 15 μm, 25 μm 
and 50 μm. It may initially seem that the wider the channel, the more axons can enter it and the more 
efficient it will be as a directional cue, but axons are known to be responsive to local topography and 
smaller channels may offer increased surface area for axonal guidance (N. Li and Folch. 2005, 
Francisco et al. 2007, Peyrin et al. 2011). 
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3.0.3.3 Presence of dopaminergic neurons in both SNc and SNr ports 
Due to the cell source for this project being rat primary cells (embryonic age E12-16), it can be 
manually challenging to obtain all the necessary tissues. While the CTX, STR and GP can be isolated 
without issue, the other two ports of our in vitro 5PD BG model are the SNc and SNr, both being 
subdivisions of the SN. It is not possible to reliably separate the SNc and SNr through microdissection 
as the region is both too small and intermixed throughout development. This results in the SN as a 
whole being isolated and used in seeding the device, with both the SNc and SNr ports containing a 
mixture of cells from the SN, including both the SNc and the SNr. While the SNr consists of mostly 
GABAergic neurons (similarly to the rest of the BG), the SNc contains the all-important population of 
dopaminergic (DA) neurons, loss of which is a causative factor in Parkinson’s disease. Whilst the 
entirety of the SN contains DA neurons the SNc contains roughly 6-7 times as much as any other 
subdivision of the SN (Nair-Roberts et al. 2008) including the SNr, these DA neurons are essential to 
create an accurate BG model in vitro and for it to function as a disease model. With the SN being 
dissected as a whole, both the SNc and SNr ports would be seeded with SN as a whole, meaning the 
SNr port would contain a much greater proportion of DA neurons compared to in vivo, potentially 
making the model inaccurate. As the model is intended to mimic Parkinson’s disease, having two 
populations of DA neurons introduces issues when DA neurons need to be removed or inactivated in 
order to mimic Parkinson’s pathology (Roeper. 2013). 
DA neurons in the SNr port would need to be removed, or greatly reduced, in order for the model to 
function as intended and be as accurate as possible to the in vivo basal ganglia. Numerous options 
exist for selectively removing a neuronal population in an in vitro culture, including physically 
(chronically via trauma (Hutson et al. 2011) or acutely via scalpels or lasers), chemically (with toxins 
that destroy DA neurons (Bilsland et al. 2002, Y. M. Ding et al. 2004, Hernandez-Baltazar et al. 2015, 
Filograna et al. 2016)) or electrophysiologically (by blocking the DA neuron signals, they would 
become ‘dark neurons’ that don’t signal and therefore aren’t sensed by the other neurons in the 
device, essentially the same as removing the DA neurons entirely (El Ayadi et al. 2001, Momiyama. 
2002, Guzman et al. 2010)). Due to the generalised and severe nature of physical methods, only 
chemical or electrophysiological methods were considered. 
3.0.4 Chapter Three Aims and Objectives 
The aim in this chapter is to optimise the 5PD previously designed by our research group, in order to 
better mimic basal ganglia circuitry. The factors to optimise include chemical coating (to reduce 
migration and promote axonal outgrowth), physical channel width (to control the directional of 
axonal outgrowths) and characterising the cells obtained from dissection. All these factors are 
necessary to optimise in order to generate a device that can model physiologically relevant basal 
ganglia circuitry. 
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3.1 Experimental Methods 
3.1.1 Device fabrication 
The devices were fabricated using two stage lithography (section 2.0.2 Two-stage 
photolithography), by first exposing the channels onto a silicon wafer, and then exposing the ports 
on top of the channels. These templates were used to cast polydimethylsiloxane (PDMS) devices, 
which were then sealed to chemically-coated glass microscope slides and sterilised (section 2.0.3 
Bonding and sealing).  
3.1.2 Primary cell culture 
Primary neural cells were dissected from rat embryos, ranging from E12-E16 depending on the 
experiment, and then dissociated and seeded onto 5PDs or coverslips (section 2.2 Primary cell 
culture). The following areas were dissected: cortex (CTX), lateral ganglionic eminence (LGE), medial 
ganglionic eminence (MGE) and ventral midbrain (VM). These areas develop into the cortex (CTX), 
striatum (STR), globus pallidus (GP) and substantia nigra (SN) respectively, making up all five ports of 
the device. The cells were cultured until sufficiently confluent and mature to image or experiment 
with, at which point they were fixed and stained. 
3.1.3 Immunocytochemistry 
Cells were fixed, blocked and stained with the relevant antibodies (section 2.3 
Immunocytochemistry). Cells were stained for DAPI (blue, marks nuclei), β-tubulin (marks neural 
cells), and GFAP (marks glial cells). During cell characterisation other stains were used, for GABA 
(GABAergic neurons), TH (DA neurons), VGLUT2 (glutamatergic neurons) and Py (GP cells containing 
phosphor-tyrosine). Cells were then incubated with secondary antibodies in order to confer red or 
green fluorescence, and imaged with a fluorescent microscope (section 2.4 Fluorescent microscopy). 
3.1.4 Statistical analysis 
Once data was gathered, Student’s t-test was used to compare single pairs of results (e.g. PDL/LAM 
vs PEI/PDL for the same condition) and two-way analysis of variance (ANOVA) was used to determine 
significant effects over whole data sets, with ANOVA results displayed as (ANOVA x,y F=Z, p=q) where 
x is the number of groups, y is the sum of sample sizes, Z is the F statistic and q is the p value, where 
p < 0.05 is significant (section 2.6 Statistics). 
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3.2 Results 
3.2.1 Device fabrication 
As the dimensions of the 5PD micro-channels approached sub-micron resolution, scanning electron 
microscopy (SEM) was used to determine if the channels were fabricated with similar dimensions to 
the original AutoCAD design, as shown in Fig.3.6. Five different 5-50 µm devices were imaged with 
an average width of 4.96 ± 0.02 µm, demonstrating the accuracy and reproducibility of the technique. 
 
Figure 3.6: SEM images from a 5PD with 5 µm to 50 µm width channels. (A) Top-down view of the channels, 
indicating the 450 µm channel length between the ports, (B) showing the distribution of channels between 
ports, (C) the 5 µm width end of a channel, also showing the 5 µm height of the channel (observed at a 45° 
angle). Magnification and scale observed at the bottom right of each image. 
The fabrication process accurately reproduced the 5-50 µm channel widths and 450 µm channel 
length, as well as the number, shape and distribution of the channels and the ports. The 5-15 and 
5-25 µm width channels were also fabricated to the same level of accuracy and reproducibility 
(images not shown). Throughout experimentation, each end-stage PDMS device was carefully 
inspected via light microscopy (SEM was not used throughout as it was a destructive technique that 
rendered the PDMS devices unsuitable for cell culture) for any deviations or imperfections, such as 
collapsed or incomplete channels, and these devices were disposed. Through the accuracy of the 
lithography and a stringent quality control process, each device was identical to other devices at a 
micron level. 
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The three stages of fabrication (AutoCAD software design, photolithographic transfer of the patterns 
onto a silicon wafer and PDMS casting of the patterns) can be seen conserved in Fig.3.7, via SEM. 
Figure 3.7: The conservation of a pattern throughout the 5PD fabrication process. Alignment crosses were 
used to align the channels layer to the ports layer during the photolithography process. From left to right, 
the crosses are: original AutoCAD software design, hardened SU-8 photoresist on silicon wafer, PDMS from 
mould. In this manner, the design was translated from software, through mould fabrication, and into the 
final PDMS device form. For the latter two images, magnification and scale can be observed in the bottom 
right corner. 
3.2.2 Cell characterisation 
Note: all characterisation cell experiments were seeded onto PEI/PDL coated surfaces. 
3.2.2.1 Cell specific markers 
To determine the accuracy of dissecting CTX, LGE, MGE and VM tissues from foetal rat brains (E12-16) 
(the tissues that develop into CTX, STR, GP and SN respectively) the resultant tissues from sample 
dissections were subject to characterisation via antibody staining. The following antibodies were 
used for each cell type: vesicular glutamine transporter 2 (VGLUT2) for CTX, phosphotyrosine (PY) for 
GP, gamma aminobutyric acid (GABA) for STR, and tyrosine hydroxylase (TH) for SN. The results can 
be seen in Fig.3.8. CTX, GP and SN all stained positive for their specific marker (VGLUT2, PY and TH 
respectively), confirming that they are indeed the correct cell type as intended, with the levels 
quantified in Fig.3.8A. All four cell types stained positive for GABA, but the signal was significantly 
increased for STR cells. The proportions of GABAergic neurons within each cell type is shown in 







































































Figure 3.8: Quantified data from cell specific staining experiment (images in Fig.3.9). A) Proportions of each 
specific neuron type for each area by way of comparison. B) Proportions of GABAergic neurons in each cell 
type, based off GABA antibody staining (n=4) (*): p<0.05 (compared to CTX and SN). 
Despite the importance of DA neurons in the basal ganglia, these neurons only make up a small 
proportion of the SN (10-20%), while the other three areas have a larger proportion of 
inhibitory/excitatory neurons. In addition, as all four cell types contained a portion of GABAergic 
neurons, the levels of these neurons were also compared, as seen in Fig.3.8B. STR and GP showed 
significantly higher levels of GABAergic neurons when compared to CTX and SN, as STR and GP are 
inhibitory nuclei of the basal ganglia, possessing mostly GABAergic neurons. 
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Figure 3.9: Cell specific staining of CTX, STR, GP and SN cells. 100,000 cells were seeded onto 13 mm coverslips and imaged after 8 DIV. Cells were stained two sets of fluorescent 
markers, first DAPI (blue, marks cell nuclei), GABA (red, GABAergic neuron marker), and PY (green, GP marker), then DAPI (blue, marks cell nuclei), VGLUT2 (green, glutamatergic 
neuron marker) and TH (red, dopaminergic neuron marker). The red squares indicate which cell type is intended to stain for which marker, scale bars are all 100 μm. Images are 
representative of n=4. 
 
 93 
3.2.2.2 Neuron-astrocyte ratio 
The neuron/astrocyte ratio within the cultures was quantified by staining for neurons with 
β-tubulin III (microtubule component found only in neurons) and for astrocytes with glial fibrillary 
acidic protein (GFAP, found in astrocyte filaments) as shown by Fig.3.10. The effect of cell type on 
the neuron-glia ratio was not significant (ANOVA (3,16), F=2.99, p=0.06) showing a constant 
neuron-astrocyte ratio between CTX, STR, GP and SN of approximately a 40:50 astrocytes:neurons 
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Figure 3.10: The neuron/astrocyte percentage proportion across all four cell types after 8 DIV. 100,000 cells 
were seeded onto 13 mm coverslips and labelled with β-tub (neuronal marker) and GFAP (astrocyte marker), 
then counted via fluorescent microscopy (n=4). 
3.2.2.3 Dopaminergic neuron analysis 
Due to their importance for this project, cells from the SN were subject to additional characterisation 
in order to determine the proportion of DA neurons obtained from tissues of rats at different 
developmental ages (E12-16), and the proportion of DA neurons within a culture on a surface over 
time, both displayed in Fig.3.11. The raw images used to generate the data in Fig.3.11 are shown in 
Fig.3.11A-B. 
The effect of time on neural cell proportions was significant (ANOVA 3,24, F=5.83, p=0.004), with 
significantly more DA neurons at days 3 and 4 vs 1 and 2 (shown by asterisk on Fig.3.11A). For the 
first two days after seeding, SN cultures had high levels of neurons compared to astrocytes, but no 
visible DA neurons (no neurons that stained positive for TH). Over time, the neuron/astrocyte ratio 
changed, with astrocytes proliferating in culture, and, DA neurons became visible to TH staining 
during this time, with approx. 20% of neurons being DA neurons at days 3-4 in vitro (DIV). Fig.3.11B 
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shows that there were more DA neurons available at earlier developmental ages (E12-14) when 
compared to later ages (E16), but it should be noted that this difference was not significant. 
 
Figure 3.11: Changes in SN neural cultures over time during in vitro culture. 100,000 SN cells were seeded 
onto 13 mm coverslips and imaged after 1, 2, 3 and 4 DIV. Images 1-4 refer to their number of days of growth. 
Blue is DAPI (cell nuclei stain), green is β-tubulin (neuron stain) and red is TH (dopaminergic neuron stain). 
Both the number of cells overall and the number of DA neurons increases over time, the scales are 100 µm. 
A) Quantified proportions of astrocytes, neurons and DA neurons over time, B) quantified proportions of DA 
neurons after 4 DIV taken from different embryonic ages, namely E12, E14 and E16. 
 
3.2.3 Chemical coating optimisation 
A combination chemical coating of PDL and laminin (LAM) was compared to an alternative 
combination of PEI and PDL. 
3.2.3.1 Cell body migration 
13 mm coverslips coated with either PDL/LAM, PEI or PEI/PDL were seeded with 100,000 E16 CTX 
cells to determine the extent of cell migration. The coverslips were stained and imaged after 21 days 
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of growth, as seen in Fig.3.12. While cells migrated across the whole surface of the PDL/LAM coated 
coverslip, creating a random distribution of neurons and astrocytes, cells seeded onto PEI and 
PEI/PDL coated coverslips remained where they were seeded (in the centre of the coverslip) and the 
neurons extended axons out towards the edge of the coverslip. PEI/PDL coated coverslips appeared 
to feature longer axons than PEI coated coverslips, making PEI/PDL coating the preferential 
combination out of the three surface coatings, as it limited migration and promoted axonal 
outgrowth, ideal for circuit formation. 
 
Figure 3.12: Comparing chemical coatings. 100,000 E16 CTX cells were seeded into the centre (marked by 
white cross) of three different 13 mm coverslips, A) PDL/LAM-coated, B) PEI-coated, C) PEI/PDL-coated, and 
imaged after 21 DIV: blue for DAPI (nuclei), green for β-tubulin (neurons) and red for GFAP (astrocytes), 
representative of n=3. A) PDL/LAM-coated, neurons and astrocytes spread across the surface of the coverslip 
B) PEI-coated surface, majority of cell bodies and astrocytes remained adhered where seeded, neurons 
extend axons into surroundings, elongated neurites seen in insert. C) PEI/PDL-coated, similar to B except the 
axonal halo was larger. Main image scale bar is 1 mm, insert scale bar is 100 μm. D) Time lapse imaging of 
100,000 E16 CTX cells seeded onto PDL/LAM or PEI/PDL-coated coverslips (n=6). Migration distance from 
original seeding location of ten cells recorded every ten minutes via light microscopy. Error is standard error, 
too small to see on PEI/PDL data points (except initial point). 
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Fig.3.12D shows a quantified experiment where PDL/LAM and PEI/PDL coated coverslips were 
compared in order to determine the extent of cell migration for each. The position of the cells were 
tracked over the first 350 minutes immediately after seeding in a time-lapse with brightfield images 
taken every 10 minutes. Individual cells were tracked in ImageJ software, and the distance that cells 
moved from their original seeding location over time was recorded. 20 cells over 9 repeats were 
tracked. 
As seen in Fig.3.12D, the effect of chemical coating over time was extremely significant 
(ANOVA 33,136, F=91.18, p<0.0001), with each data point from 10 minutes onwards being 
significantly different (p < 0.0001). Both the effects of time and chemical coating alone on migration 
were extremely significant (ANOVA 33,136, F=107.8, p<0.0001 for time), (ANOVA 1,136 F=11278, 
p<0.0001 for chemical coating). This shows that the migration distance was significantly higher over 
time for cells seeded onto PDL/LAM coated surfaces compared to cells seeded onto PEI/PDL coated 
surfaces. Cells on PDL/LAM migrated the furthest in the first hour after seeding, whereas on PEI/PDL 
the lower levels of migrations were consistent throughout the experiment. 
This migration experiment was repeated in 5PDs using all four cell types, namely CTX, STR, GP and 
SN. The cells were seeded into the centre port of 5PDs, and any cells that travelled through a channel 
into an adjacent port were determined to be migratory. All three available channel widths were used, 
namely 5-15 μm, 5-25 μm and 5-50 μm, in order to also determine if channel width had any extra 
effect (explored in more detail later, in channel directionality assessment), and 5PDs were again 
coated with either PDL/LAM or PEI/PDL. The results of this experiment can be seen in Fig.3.13. 
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Figure 3.13: Cell migration of all four cell types when seeded into the centre port of 5PDs with different 
chemical coatings and different width channels. 100,000 cells were seeded into the centre port and those 
that had migrated into a side port were counted after 8 DIV. ‘5 to 15’ indicates that cells had entered the 
15 µm channel opening and exited the 5 µm end, and vice versa. Post hoc t-tests indicated by asterisks, 
compare PDL/LAM and PEI/PDL for the same width. (*): p<0.05, (**): p<0.01, (***): p<0.001, 
(****): p<0.0001, (n=6). 
PEI/PDL vs PDL/LAM chemical coating across different channel widths had a significant effect on the 
percentage of cells that migrated to adjacent ports after seeding, for all four cell types (ANOVA (5,79), 
(CTX F=7.15, p<0.0001), (STR F=3.6, p=0.0068), (GP F=3.23, p=0.0124), (SN F=8.5, p<0.0001)). PEI/PDL 
coating resulted in a significantly lower percentage of migratory cells when compared to PDL/LAM 
coating (p < 0.0001). In addition, channel width did not affect migration on PEI/PDL coated devices, 
but smaller channel widths on PDL/LAM coated devices showed significantly more migration 
compared to larger channel widths, for all cell types (p < 0.001). 
Cells seeded onto PEI/PDL-coated 5PDs consistently exhibited approx. 20% migratory cells whereas 
PDL/LAM coatings resulted in much higher levels of migratory cells on all channel widths, as high as 
50-60% in some cases. As PEI/PDL migration was independent of channel width, this 20% may 
represent a baseline of near unavoidable migration regardless of the channels. 
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3.2.3.2 Cell monolayer morphology 
In addition, cell morphology also differed between cells on PDL/LAM or PEI/PDL coated surfaces, as 
seen in Fig.3.14, with images showing cultures on differently chemically coated surfaces. Cells seeded 
onto PEI/PDL migrated less resulting in an even monolayer of cells, whereas PDL/LAM cells grouped 
together into large aggregates that extended axons to other aggregates. 
 
Figure 3.14: 100,000 E16 CTX cells cultured on PDL/LAM (left) or PEI/PDL (right) coated surfaces and 
brightfield imaged after 8 DIV. Images are representative of n=6, scale is 100 μm. 
3.2.3.3 Neuronal process outgrowth 
The effect of chemical coating was also tested on neuronal process (axonal) outgrowth from neuronal 
cells. The average number of processes per channel in 5PDs coated with PDL/LAM or PEI/PDL was 
calculated from fluorescent imaging from 5PDs with all three available channel widths (see Fig.3.15). 
It should be noted that for this experiment, the SN tissue was dissected at E16, an optimal 
developmental age for CTX, STR and GP but suboptimal for SN (peak neurogenesis at E12-14 (Gates 
et al. 2006)). 
PEI/PDL vs PDL/LAM chemical coating across different channel widths had a significant effect on the 
number of axons extending through microchannels for CTX, (ANOVA 2,12 F=4.3, p=0.039), GP, 
(ANOVA 2,12 F=13.18, p=0.0009) and SN devices (SN ANOVA 2,12 F=82.02, p<0.016), not significant 
for STR devices (p=0.12). The effect of chemical coating alone on the number of axons extending 
through microchannels was only significant for CTX (ANOVA 2,12 F=21.83, p=0.0001) and GP devices 
(GP ANOVA 2,12 F=13.58, p=0.0008), while the effect of channel width alone was significant for all 
four cell types, an effect that is further investigated in the Channel Directionality Assessment 
section. Conditions where PEI/PDL-coated devices had significantly more processes per channel 
compared to PDL/LAM-coated devices (t-test, indicated by asterisks on Fig.3.15) were as follows: 
15, 25, 50 μm channels for CTX and 15, 50 μm channels for GP, with no significant difference seen 
for STR and SN. 
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Figure 3.15: Effect of chemical coating and channel width on axonal processes per channel within 5PDs. 
100,000 cells were seeded into the centre port and extended axonal processes into the side ports, which 
were counted and averaged per channel after 21 DIV. Post hoc t-tests indicated by asterisks, (*): p<0.01, 
(***): p<0.001, comparing PDL/LAM to PEI/PDL in each case, (n=4).  
PEI/PDL surfaces therefore had a significant effect on the number of axonal processes produced by 
cells (particularly CTX and GP cells) irrespective of channel width. This combination of restricting 
migration while accelerating axonal process growth made PEI/PDL a clear improvement for a 
chemical coating over PDL/LAM. 
3.2.4 Primary cell culture 
CTX, STR, GP and SN cells were seeded onto one of three PEI/PDL-coated environments in order to 
see how the cells grew: flat featureless coverslips (as seen in Fig.3.16); the centre ports of 5PDs (as 
seen in Fig.3.17); and all ports of a 5PD (as seen in Fig.3.18A) in order to see how the cells interacted 
with the channels and PDMS walls, along with increased magnification views in Fig.3.18B-C. 
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Figure 3.16: Fluorescent images of 100,000 E16 neural cells on PEI/PDL coated coverslips after 21 DIV. 
Blue: DAPI (marks cell nuclei), Green: β-tubulin III (neuronal marker), Red: GFAP (astrocytic marker). A and 




Figure 3.17: Fluorescent images of 100,000 E16 CTX cells seeded into the centre port of PEI/PDL coated 5PDs 
and imaged after 21 DIV. Blue: DAPI (marks cell nuclei), Green: β-tubulin (neuronal marker), Red: GFAP 
(astrocytic marker). Cells were seeded onto the top side of the channels in A-E, and to the left of the channels 
in F. Image F highlights the behaviour of axons in the PDMS channels, following the walls until the channel 
exit. Images are representative of n=6, scale bars all 100 μm. 
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Figure 3.18: Whole 5PD imaging via an XY tile scan across an entire 5PD. A) Fluorescent image of an entire 
5PD seeded with E16 CTX cells, 100,000 CTX cells were seeded into each port andimaged after 21 DIV. Image 
is at 10:1 scale compared to real 5PD, scale bar is 1 mm. B) Magnified view of A indicated by dashed white 
square on A. Shows interface between input, centre and output ports, scale bar 100 μm. C) Magnified view 
of B indicated by dashed white dashed square on B. Shows neurons extending into channels, scale bar is 





3.2.4.1 Rate of axonal outgrowth 
The number of neuronal cell bodies and axons also differed between each cell type when the neurons 


































































































































Figure 3.19: Cell number and axonal outgrowth compared between all four cell types, on all available channel 
widths. 100,000 E16 cells were seeded into the centre port of each device, imaged and counted after 21 DIV. 
A) Cells within 200 µm of channel entrances were deemed proximate, counted and averaged. B) Axons that 
extended the length of each channel were counted and averaged. (n=4), (***): p<0.0001, (****): p<0.00001. 
Fig.3.19A showed that all four cell types had similar numbers of cell bodies within 200 µm of channel 
entrances, with a trend showing that more cells were proximal to larger width channels. There was 
a significant effect of both the channel width and cell type on the average number of cell bodies close 
to channels (Channel width ANOVA 5,140 F=27.24, p<0.0001), (Cell type ANOVA 3,140 F=4.9, 
p=0.003), showing that wider channels could accommodate more cells. Analysis also showed that 
there was no significant difference between the cell types on similar channel widths (t-test, no 
asterisk on graph) 
While the number of cells proximate to each channel was the same for each cell type, the number of 
axons per channel was remarkably different, as seen in Fig3.19B. CTX neurons produced a much 
higher number of axonal outgrowths, with greather numbers of processes per channel compared to 
STR, GP and SN. There was a significant effect of both the channel width and cell type on the average 
number of processes per channel (Channel width ANOVA 5,48 F=45.08, p<0.0001), (Cell type ANOVA 
3,48 F=83.24, p<0.0001), and CTX neurons produced significantly more processes than other cell 




3.2.5 Channel directionality assessment 
As previously outlined, cells seeded into the centre port of the five-port device had two options for 
growth, a wall of channel openings of either 15, 25 or 50 µm width, or a wall of channel openings of 
5 µm width. Cells were seeded into the centre port and imaged after 21 days of growth to determine 
if there was any directional pressure presented by the tapered channels. 
Axons and/or neurites (referred to as ‘processes’) that entered, travelled the entire length of the 
channel and exited were counted. Firstly, the number of processes per channel was compared for all 
three channel widths, in both channel directions, between all four cell types, as seen in Fig.3.20. 
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Figure 3.20: Effect of channel width (in both directions) on the number of axonal processes extending the 
entire length of a channel. 100,000 E16 cells were seeded into the centre port of each device and imaged 
after 21 DIV.A) Wanted direction of growth, through the larger end to the 5 µm end. B) Unwanted direction 
of growth, through the 5 µm end to the larger end of a channel, (n=4). (*): p<0.05, (***): p<0.001, 
(****): p<0.0001. 
For the wanted direction (Fig.3.20A), both the channel width and cell type had a significant effect on 
the average number of processes per channel (Channel width ANOVA 2,24 F=30.01, p<0.0001), (Cell 
type ANOVA 3,24 F=31.88, p<0.0001), with each channel width resulting in significantly different 
numbers of processes per channel (see asterisks on Fig.3.20A). 
For the unwanted direction (Fig.3.20B), both the channel width and cell type also had a significant 
effect on the average number of processes per channel (Channel width ANOVA 2,24 F=77.2, 
p<0.0001), (Cell type ANOVA 3,24 F=51.73, p<0.0001), with 5-50 µm channels containing significantly 
more processes than 5-15 µm and 5-25 µm channels (see asterisks on Fig.3.20B). These data 
suggested that the only channel dimensions that can control axonal outgrowth are 5-15 µm channels, 
as in all other channel sizes CTX and GP extend in undesirable directions more, while STR and SN are 
seemingly unaffected by channel size. 
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5-15 µm was the only channel width that exerted any directional pressure on axons, by having more 
axons that extend in the wanted direction (larger to smaller, 15 µm to 5 µm) than the unwanted 
direction (smaller to larger, 5 µm to 15 µm). The number of axons that travelled in the desirable 
direction were divided by the number that travelled in the undesirable direction, to generate a 
directionality ratio (seen in Fig.3.21). 
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Figure 3.21: The directional pressure exerted by channels of different widths, for all four cell types, based on 
data from Fig.3.20 (n=4). A directionality ratio of 1 means that a channel exerts no pressure on the direction 
of axonal growth (indicated by the dashed horizontal line), whereas values >1 mean a directional pressure 
in a wanted direction, and values <1 mean a directional pressure in an unwanted direction. P values 
generated from post hoc t-tests. 
While the effect of cell type on the directionality ratio was insignificant (ANOVA 3,24, F=0.55, p=0.65), 
the effect of channel width on directionality ratio was extremely significant (ANOVA 2,24, F=28.49, 
p<0.0001). Multiple comparisons also show that there were significant differences between 15 µm 
vs 25 µm and 15 µm vs 50 µm, but not between 25 µm vs 50 µm. These data and analysis showed 
that 15 µm channels present the best directionality ratio, with anything over 1 exerting directional 
pressure in the desirable direction. Despite the ability of larger channels to contain more axons and 
therefore potentially direct a greater number of cells into contact with adjacent ports, larger width 
channels exerted less directional pressure on the cells, when compared to 5-15 µm channels. 
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3.3 Discussion 
3.3.1 Chemical coating 
Cells seeded onto PEI/PDL coated surfaces exhibit decreased migration on both coverslips and 5PDs 
when compared to PDL/LAM coated surfaces, making PEI/PDL a preferable surface coating, with PEI 
used widely in the literature (Ruegg and Hefti. 1984, Bledi et al. 2000, Vancha et al. 2004, B. Liu et al. 
2008, Takayama et al. 2012, Kanagasabapathi et al. 2013). Cell bodies that migrated fully down 
channels into adjacent ports caused contamination between neuronal subtypes, such as CTX cells 
entering the STR port. By coating cell growth surfaces with chemicals with high density positive 
charges that physically restrict cells from migrating allowed for a more accurate model, in which cells 
stayed where they were seeded and extended axons into adjacent ports as intended. PEI is a 
synthetic polymer, designed to have a much greater density of positively charged branches than PDL 
or laminin, and as such it is far more attractive to the primary cells, which exhibit a negative charge 
on their cell surface membrane (Jeong et al. 2001). PEI was more suitable to restricting cell migration, 
with PEI/PDL coated surfaces significantly reducing cell migration when compared to PDL/LAM 
coated surfaces (Fig.3.12 and 3.13). 
Despite these properties, cells seeded into the centre port of PEI/PDL coated 5PDs were still found 
in adjacent ports (approx. 25% of cells were determined as being migratory in 5PDs, as seen in 
Fig.3.13). Upon further inspection, these cells did not migrate into adjacent ports after attaching to 
the surface but were sucked into channels by capillary action immediately after seeding into ports, 
when the cell bodies were still in solution. PEI/PDL surface coating only functioned as a means to 
inhibit migration once the cell bodies came into physical contact with the surface, if the cells moved 
in suspension above the coated growth surface without encountering it, no feasible coating was able 
to further restrict cells travelling to adjacent ports, especially STR cells, which were seeded into the 
centre port and had double the number channels to be drawn into via flow. The only way to fully 
contain all cell bodies in the port they were seeded into would be a form of gated channel, where 
the channel ends are blocked during seeding until the cells are all attached to a surface, upon which 
time the channels are opened to allow axonal outgrowth. This kind of channel design is possible with 
PDMS, seen in the development of “lifting gate” microvalves combined with pumps in order to have 
a channel that can be opened and closed with pressure (J. Kim et al. 2012), along with numerous 
other applications of pumps in PDMS devices (Kartalov et al. 2006). Despite these limitations, PEI/PDL 
coating still served as the best means to restrict migration, in comparison to PDL/LAM. 
In addition to these migration-restricting qualities, PEI/PDL coated surfaces also resulted in neurons 
producing a greater number of axonal processes compared to PDL/LAM coated surfaces (see 
Fig.3.15), an effect also observed in retinal explants (Vancha et al. 2004). This factor was also related 
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to axonal length: an axonal process was only counted and recorded once it had fully travelled the 
length of a channel and emerged into an adjacent port. There may be a situation where there were 
equal numbers of axonal processes per channel between PEI/PDL and PDL/LAM coated surfaces, but 
if the axons on PDL/LAM were shorter, they may have entered the channel but never traveled the 
full length and not emerged on the other side, and thus not be recorded. With this in mind, it was 
more accurate to say that PEI/PDL coated surfaces resulted in a greater number of axonal processes 
per neuron, and/or axonal processes of a greater length overall (Ruardij et al. 2000, Sun et al. 2012). 
As these were both positives when constructing a neural circuit in vitro, PEI/PDL coated surfaces were 
superior compared to PDL/LAM regardless of the specific effect the surface had on neurons. With 
these results in mind, PEI/PDL was used as the preferential surface chemical coating for the rest of 
the project. 
3.3.2 Characterising specific neural subtypes 
The fact that every cell type stained for the proteins they should have specifically stained for 
indicated that the dissection protocol was robust and could be relied upon for the length of the 
project. As the CTX and SNc were the only sources of excitatory glutamatergic and modulatory 
dopaminergic nuclei respectively in this experiment, they were the only ones to stain positive for the 
glutamatergic neuron marker VGLUT2 and dopaminergic neuron marker TH respectively. It should 
be noted that on occasion dopaminergic neurons have co-expressed GABAergic or glutamatergic 
markers, but as these cells are such a rarity (< 1%) and are found mostly in other areas of the midbrain 
than the VM, this was not a concern (Nair-Roberts et al. 2008). 
Characterising STR and GP neurons was more challenging, as they are both inhibitory GABAergic 
nuclei, and indeed even CTX and SN contain populations of GABAergic neurons (as seen in the GABA 
staining in Fig.3.8B and Fig.3.9), as does most of the brain (Mallet et al. 2006, Wonders et al. 2008, 
Ellens and Leventhal. 2013). Staining for GABA resulted in similar intensities between STR and GP (as 
seen in GABAergic proportions Fig.3.8B), and a more specific marker was necessary. The 
phosphorylated form of the amino acid tyrosine (phosphotyrosine) has been shown to be present in 
the GP (Moss et al. 1990, Nagao et al. 1998), and this was used as a marker to differentiate GP from 
STR. 
The decreased number of DA neurons with increasing developmental age (Fig.3.11B) may not have 
been a significant reduction, but the difference was still present due to the fact that peak 
neurogenesis of SNc dopaminergic neurons is closer to E12 than E14 (Gates et al. 2006), despite 
earlier studies suggesting that E14 represents the peak. By E14, dopaminergic neurons in the SNc 
were projecting axons (> 1 mm at this time point) and innervating the ventral forebrain, consequently 
by dissecting at this age (or later) these axonal outgrowths and early input-output connections were 
severed, resulting in a damaged cell population and reduced viability. By dissecting earlier at E12, DA 
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neurons and neural precursors are still isolated to the SN, resulting in a cleaner dissection, a more 
viable culture, and a greater number of dopamine neurons in vitro (Gates et al. 2006, Hegarty et al. 
2013), with Gates et al noting that up to 80% of SNc DA neurons are generated on E12 in 
Sprague-Dawley rats. 
As the neurons in these cultures do not typically proliferate while glial cells do (Anda et al. 2016), 
each culture carried a chance of being overtaken by glial cells as they proliferated while neuron 
numbers remained relatively static. While the initial SNc neuron:astrocyte ratio was approx. 25:75 
after 1 DIV, it had changed to 40:50 after 4 DIV, showing how rapidly astrocytes could proliferate (see 
Fig.3.11A). After 4 DIV, CTX, STR, GP and SNc all exhibited a neuron:astrocyte ratio of approx. 40:50 
(see Fig.3.10), consistent with the literature (S. H. Chen et al. 2013, Y. Huang and Wang. 2016), with 
the remainder consisting of cells with only DAPI staining (most likely microglia or oligodendrocytes). 
A visual representation of the neuron:astrocyte ratio at a later date (8 DIV) shows that the ratio is 
reasonably static, with healthy neurons extending on top of the layer of astrocytes (see Fig.3.16). 
3.3.3 Channel directionality assessment 
The ability to direct axonal outgrowth in one main direction was vital for producing this in vitro BG 
model, and as such having an optimised channel width allowed for more efficient communication 
between ports. 
Axonal growth in channels was directed mostly by the walls of the channels, with cell bodies 
remaining in ports and extending axons into empty space until they came into contact with neuron 
cell bodies, glial cells, other axons, or a PDMS wall/channel. Axons rarely extended straight from a 
neuron into a channel, with the majority of axons following the PDMS wall into the channel until the 
channel exit (see Fig.3.17F). This affinity of axons to grow along PDMS walls may have been due to 
PDMS being a softer material than glass, with neural cells showing a preference for softer substrates 
(Balgude et al. 2001, Lantoine et al. 2016). 
Axons that grew and encountered other axons used them as guidance cues. In this process, (termed 
fasciculation), axons arrange themselves into large bundles. Due to the confining nature of the 
channels, fasciculation appeared to occur often within the channels, the axons adopting this 
behaviour when forced into a smaller space containing many other axons (Francisco et al. 2007, 
Honegger et al. 2016, Renault et al. 2016). This sudden reduction in size of the immediate cell physical 
microenvironment was mostly encountered when an axon extended from a port into a channel, 
where the channels were many magnitudes smaller than the ports. However, this decrease in size 
also occurred when axons were growing into the wider entrance of tapered channels, where the 
gradually decreasing size of the channel from 50 µm, 25 µm or 15 µm to 5 µm encouraged the axons 
to fasciculate into a bundle, and thus when exiting the channel the axonal bundle unraveled (see 
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Fig.3.17A-E). This unravelling of axonal bundles at channel exits resulted in a high density of axons 
proximate to the channel exits (see Fig.3.19B) and consequently a high likelihood of these axons 
encountering adjacent cell populations, which were also proximate to channel exits (see Fig.3.19A). 
This combination of fasciculation and softer PDMS lead to the presence of many axons within 
channels of any size. 
Each channel could accommodate many axons, and wider channels contained greater number of 
axons due to increased physical space (see Figs.3.15, 3.19 and 3.20). However, the ability to contain 
a greater number of processes did not appear to guarantee a directional pressure, with a greater 
number of axons growing in an unwanted direction in 5-50 µm channels (see Figs.3.20 and 3.21). 
Wider 5-25 µm and 5-50 µm channels provided poor directionality ratios, with 5-25 µm appearing to 
have little influence on directionality and 5-50 µm selecting for the unwanted direction for CTX and 
GP neurons (see Fig.3.21), unacceptable factors when designing a model that aims to reproduce 
unidirectional BG circuitry. It is unclear exactly why these wider channels had lower directionality 
ratios, as the 5 µm entrance was identical between each channel size (as assessed with SEM, see 
Fig.3.6) and the width simply increased at a different rate once past the entrance. One theory is that 
the axons may have been able to sense the channel dimensions before entering the channel, maybe 
due to an increase in the concentration of certain biochemical factors or the differing capillary action 
between devices with different channel widths. Another consideration is the wall to channel 
ratio: because all three model designs have the same number of channels that are the same distance 
apart (from channel centre to channel centre) but differing channel widths, there is a greater length 
of PDMS wall between 15 µm channel openings than between 50 µm channel openings. This differing 
wall to channel ratio is important for axonal guidance, as axons that come into contact with a wall 
will extend along the wall and into the channel entrance, whereas axons that enter directly into a 
channel have less contact guidance cues. In this manner 15 µm channel openings present axons with 
more walls and therefore more guidance into channels, potentially leading to a greater directional 
pressure. Regardless, the data indicated that only the 5-15 µm channel exerted positive directional 
pressure on the cells. 
It should be noted that as all cell types were taken at E15/16, SNc cells naturally grew at a decreased 
rate when compared CTX, GP and STR cells, due to the best developmental age to take SN cells being 
E12-14 (Gates et al. 2006). In subsequent experimentation cells were dissected at their optimum 
developmental stage, as the end goal was to culture all the cell types together in a single device, 
creating an in vitro BG mimic. 
The microfluidic device supported culture of different sub-types primary neuronal cells, as well as 
exerting control over the orientation of axons through micro grooves. The aims of this chapter were 
achieved, with the optimal chemical coating for circuit formation being PEI/PDL, and the optimal 
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channel widths to control the directionality of axonal outgrowth were 15-5 µm channels. Primary 
neural cultures obtained from rat were successfully characterised. This optimisation work was carried 
through the rest of the project, with all subsequent dissections following the same protocol, seeded 
onto PEI/PDL-coated surfaces, and when 5PDs were used they had 15-5 µm channels. 
3.4 Conclusions 
In summary, there were many factors to optimise when designing a microfluidic in vitro model of the 
BG. After the experiments laid out in this chapter, the following can be concluded: The current 
fabrication protocol for the 5PDs was sufficient to create reproducible features down to 5 µm in size; 
all future 5PD and cell experimentation should involve a PEI/PDL coating as it inhibits cell migration 
while promoting axonal outgrowth; current dissection protocols were sufficient to extract the 
relevant neural sub-types in physiologically relevant proportions; and all future 5PDs should feature 
5 µm to 15 µm channel dimensions, as these best exerted directional pressure on axonal outgrowth 
and allowed for the formation of a unidirectional circuit. By using these optimised and tested factors, 
the model functioned more efficiently when mimicking the in vivo BG. 
Recreating the compartmentalisation and connections of the BG nuclei in vitro would result in a 
powerful pre-clinical research platform. This study set out to assess the design and fabrication of a 
novel compartmentalized microfluidic device intended to serve as such a model. This study also 
demonstrated the benefits of microfluidic devices compared to other cell culture systems, e.g. 
conventional well plates and flasks. Microfluidic devices offer design flexibility, due to their template 
design via AutoCAD, to address specific challenges. The microfluidic model presented here provides 
a foundation, and first steps towards developing complex circuitry that can potentially be used to 
model neurodegenerative diseases such as Huntington and Parkinson’s diseases in vitro. 
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Chapter Four: Long term study of separate neural 
culture functionality 
4.0 Introduction 
In order to determine if this in vitro model of the basal ganglia (BG) was functional, it was vital to 
record the spontaneous electrophysiological activity of the cells in culture, at every stage of their 
growth and maturation. Only if it can be determined that the neurons were in communication with 
each other as they are in vivo, then the model could be characterised as functional. 
Continuing from the outline of electrophysiology in Chapter One, this Chapter provides further detail 
on the spontaneous electrophysiological activity of each of the relevant neural cell types from the 
nuclei of the BG: the cortex (CTX), striatum (STR), globus pallidus (GP) and substantia nigra (SN). This 
activity compared in vivo to in vitro findings and to extracellular recordings, as the recording method 
of choice for these experiments was a multi-electrode array (MEA), which recorded the spontaneous 
extracellular electrophysiological activity from an entire culture across the long term. 
4.0.1 Typical electrophysiology of basal ganglia nuclei 
It should be noted that neurons of the GPe, GPi, STN and SNr are autonomous pacemakers, allowing 
for control of BG activity via the output nuclei, GPi and SNr (Gerfen and Surmeier. 2011). All of the 
cell types within the BG feature differences in spiking frequency, bursting and duration of activity. 
4.0.1.1 Cortex (CTX) 
Corticostriatal glutamatergic projection neurons can be intratelencephalic (IT, projecting within the 
telencephalon) or pyramidal tract-like (PT); form all across the CTX (conveying information from 
somatosensory (Sippy et al. 2015), auditory (Znamenskiy and Zador. 2013) and visual (Reig and 
Silberberg. 2014) cortical regions); and project to all parts of the STR (the STR being unique as the 
only subcortical area to receive both IT and PT input projections), making a summary of CTX 
electrophysiological activity difficult due to the scope (Shepherd. 2013). 
Briefly, IT and PT neurons have several different electrophysiological properties: PT neurons have 
more hyperpolarisation-activated currents compared to IT neurons, PT neurons have faster spiking 
compared to IT neurons, and PT neurons feature a sustained/accelerating repetitive spiking pattern 
while IT neurons feature a phasic/adapting repetitive spiking pattern (Shepherd. 2013). These 
excitatory neurons also differ from the GABAergic interneurons they share the CTX with, with studies 
showing that the GABAergic interneurons feature short-duration spikes compared to longer-duration 
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in CTX glutamatergic neurons. These differences can be detected with either intra- or extracellular 
recording methods by observing the different waveforms and have been used to differentiate 
between fast-spiking interneurons and PT neurons in the CTX when measured extracellularly 
(Mitchell et al. 2007). 
4.0.1.2 Striatum (STR) 
The GABAergic medium spiny projection neurons (MSNs) that make up 90% of the STR fire sparsely, 
requiring coordinated excitatory synaptic input from the CTX to initiate spiking. Both the D1 and D2 
type MSNs display largely similar electrophysiological properties with no significant difference in cell 
capacitance, baseline, input resistance or action potential (AP) amplitudes (Cepeda et al. 2008). The 
only significant difference is that D2 neurons are more excitable, being less depolarised than D1 
neurons and having a lower threshold for firing. In addition, both D1 and D2 neurons react with 
strikingly different electrical patterns upon both dopamine treatment, with dopamine binding to D1 
or D2 receptors resulting in stimulation or inhibition of the post-synaptic neuron respectively 
(Crittenden and Graybiel. 2011). These differing patterns are also observed during dopamine 
depletion (Orr et al. 1987). It should be noted that these MSNs are the only output system of the STR, 
the remaining 10% of fast-spiking interneurons do not project to other BG nuclei (Ellens and 
Leventhal. 2013). 
In vitro, STR neurons have displayed both regular, irregular and burst firing, a burst being a group of 
spikes that register ≥10 Hz and cannot be measured as individual spikes but instead as a cluster, with 
MSNs shown to have an important role in bursting and correlating burst firing for information 
processing in the BG (B. R. Miller et al. 2008). Notably, the cholinergic interneurons of the STR are 
endogenously active and will spontaneously generate spiking activity without synaptic input, 
indistinguishable to their activity in vivo, suggesting that irregular spontaneous spiking in the STR may 
be responsible for endogenous activity (Bennett and Wilson. 1999). This activity is likely linked to 
spontaneous and driven activity from CTX inputs, resulting in STR interneurons and MSNs having 
temporal signatures in vivo, dependent on CTX activity. Indeed, in vitro MSNs show exaggerated 
glutamate-dependent responses (the main glutamatergic inputs to the STR being the subthalamic 
nucleus (STN) and CTX), more depolarized resting membrane potentials, reductions in potassium (K+) 
currents and increased intracellular Ca2+ levels, when compared to MSNs in vivo (Ariano et al. 2005, 
B. R. Miller et al. 2008). 
MSNs grown in organotypic cultures show similar morphological and electrophysiological 
characteristics similar to those seen in vivo (Plenz and Kitai. 1998, Sharott et al. 2012), this similarity 
between in vivo and in vitro electrophysiological properties is reassuring for the development of the 
in vitro BG model. With this consideration, MSN and interneurons in vitro likely generate similar firing 
rates to in vivo MSNs and interneurons, with the in vivo rates being approx. 0.01-2.0 Hz for MSNs 
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(B. R. Miller et al. 2008) and 10-20 Hz for interneurons (also termed fast-spiking neurons or FSNs) 
(Gage et al. 2010) in vivo, with the STR as a whole recorded at 0.7 Hz (Walters et al. 2007). This range 
has been corroborated by in vitro extracellular recordings of STR neuronal cultures, which identified 
two separate modes of electrophysiological activity: phasically activated neurons (PANs) with broad 
APs and low spike frequency (0.5-1 Hz) and tonically active neurons (TANs) with higher spike 
frequencies (5-15 Hz). The majority of TANs were found to be cholinergic interneurons which fire in 
a synchronised pattern without oscillation, these interneurons make up 5-20% of the STR, meaning 
that the source of PAN activity are MSNs, which consist of the majority of the STR (Boraud et al. 
2002). With these results in mind, STR neural cultures on MEAs should achieve approx. 0.5-2 Hz spike 
frequency on average if MSNs are in contact with electrodes, with higher frequencies generated by 
cholinergic interneurons. 
4.0.1.3 Globus Pallidus (GP) 
While the internal (GPi) and external (GPe) sections of the GP are near structurally identical, both 
composing of a majority of GABAergic neurons, they are functionally distinct with different firing 
properties in vivo. 
GPi neurons exhibit high frequency spontaneous activity without pauses and can burst at very high 
rates, features that are enhanced by dopamine depletion (Bergman et al. 1994, Kliem et al. 2007, 
Nambu. 2007). BG output neurons (GPi and SNr) both exhibit high levels of spontaneous activity even 
in anesthetised rats, with GP and SNr firing at 26 Hz and 24 Hz respectively (Walters et al. 2007). 
GPe neurons tend to synchronise to local field potentials (LFPs), namely the sum of electric activity 
of multiple neurons within a proximate area (Flandin et al. 2010, Mallet et al. 2012). In addition, two 
electrophysiologically heterogenous populations of GABAergic cells exist within the GPe in vivo, 
namely the GPe-TI and GPe-TA, named for firing during the inactive (TI) and active (TA) components 
of CTX slow wave activity oscillations respectively. GPe-TI neurons make up ~75% of spontaneously 
active GPe neurons, express parvalbumin and project downstream to the SNr, GPi and STN, firing in 
antiphase with the latter. GPe-TA neurons make up ~20% of spontaneously active GPe neurons, 
express preproenkephalin, project upstream to STR MSNs and interneurons, and fire in phase with 
STN neurons. Thus, the GPe consists of two interacting systems that work together to co-ordinate 
activity across the BG in a cell-type-specific manner (Mallet et al. 2012, Nevado-Holgado et al. 2014). 
However, in our in vitro model, GP cells will be first studied in isolation, and then with a connection 
to STR cells, meaning that this response to CTX activity oscillations will be unobservable as the two 
cell populations were not connected, although a response to the LFP should still be seen. 
In vivo recordings note that single GP neurons can typically fire at high frequencies (15-45 Hz) in a 
tonic manner and oscillate with other GP neurons at similar (20 Hz) frequencies, but populations of 
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GP neurons can also generate slow wave activity, which ranged from 0.4-1.6 Hz (Mallet et al. 2006, 
Mallet et al. 2008, Mallet et al. 2012). However, these values were dependent on input and output 
signals from the in vivo brain and by taking extracellular recordings from GP in isolation in vitro the 
results are likely to differ. 
Extracellular recording identifies GPi neurons with random yet high frequency spiking with little 
oscillation or synchronisation. GPe neurons display regular and irregular spiking alongside bursting 
and discharging activity (Boraud et al. 2002). These GPe neurons show a lower frequency of spiking 
than GPi neurons, but more bursting and more pauses, occasionally pausing for up to 500 ms 
between bursts (signifying inactivity or a quiescent period). 
Due to our dissection protocol taking the GP as a whole (by dissecting the medial ganglionic eminence 
at E16 in the rat), in our MEA experiments there will likely be a mix of high-frequency firing from GPi 
neurons and lower-frequency firing from GPe neurons (both GPe-TI and GPe-TA functional types), 
lower than their in vivo firing frequencies of approx. 15-45 Hz and also featuring 0.4-1.6 Hz slow wave 
activity. 
4.0.1.4 Substantia nigra (SN) 
In a conscious rodent in vivo, SNr GABAergic neurons feature spontaneous high frequency, short 
duration firing (~1 ms and 25-30 Hz) enhanced by dopamine depletion (Bergman et al. 1994, Maurice 
et al. 2003, Kliem et al. 2007). Conversely, SNc DA neurons in vivo show low frequency, pacemaker 
long-duration firing (~2.5 ms and 1-4 Hz) (Boraud et al. 2002, F. M. Zhou and Lee. 2011). The SNc DA 
neurons also feature frequent bursting, both spontaneous and reward-related, even in anesthetised 
animals in vivo. These bursts are followed by a slow after-hyperpolarisation and a pause in 
spontaneous firing, but it should be noted that these subsequent activities have been found to be 
due to different mechanisms (Morikawa and Paladini. 2011). 
In in vitro preparations, firing frequencies are lower, with GABAergic SNr neurons at 10-15 Hz and DA 
SNc neurons at ~2 Hz (S. Ding et al. 2011, Lee et al. 2011). GABAergic SNr neurons also have a more 
negative threshold and a larger spike amplitude (F. M. Zhou and Lee. 2011). The regular firing at low 
frequencies allows for maintenance of dopamine levels in the STR, and consequently this firing is 
heavily regulated by upstream processes outside the BG (S. Hong et al. 2011, Beeler et al. 2012). The 
low-frequency oscillations of SNc DA neurons identify them as robust autonomous pacemakers, as 
they maintain this activity even in the absence of spiking, leading to the rhythmic background of firing 
necessary for sustained release of dopamine in the BG (Guzman et al. 2009). 
Extracellular recordings of SNr neurons show a similarity to GPi, displaying random yet high frequency 
spiking with little oscillation or synchronisation. Extracellular recording of SNc DA neurons have 
identified triphasic spikes, where the spike waveform oscillates from positive-negative-positive 
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voltage, forming three phases in the waveform. These spikes have a long duration (2-5 ms) and slow 
spiking frequency (0.5-10 Hz) (Boraud et al. 2002). As our GP preparations, in our MEA experiments 
the SN will be taken as a whole (by dissecting the ventral midbrain from E14 rats), resulting in SN 
MEAs recording high-frequency SNr activity along with lower-frequency SNc firing. As these firing 
frequencies are lower in vitro compared to in vivo, we should expect approx. 10-15 Hz from SNr 
neurons and ~2 Hz from SNc neurons. 
4.0.2 Extracellular recording 
While neural electrophysiology was classically performed with patch-clamping and inserting 
electrodes into cells for precise intracellular measurements, these techniques are unsuitable for 
recording across a whole cell culture or co-culture over the long term. An alternative comes in the 
form of extracellular recording, markedly different to intracellular recordings with the latter being 
monophasic and usually displaying a higher amplitude by several orders of magnitude, as seen in 
Fig.4.1. Extracellular recording allows recording from neurons without impaling them with 
microelectrodes, resulting in the ability to record from vast numbers of cells over the long term, 
where neurons can be characterised based on their activity in isolation and connectivity, as well as 
during maturation. This allows for data with high spatial and temporal resolution as many electrodes 
can be deployed at once, such as with the multi-electrode array (MEA). 
 
Figure 4.1: Simultaneous intra- and extracellular recording of an action potential. A) The four dashed vertical 
lines show synchronisation of intra- and extracellular signals at four points: onset, peak, phase change and 
return to baseline, recorded from a cat ventral horn motoneuron. Image adapted from (Terzuolo and Araki. 
1961). B) Average of 849 intra- and extracellularly recorded spikes. τr and τd indicate rise and decline phases 
of intra signal which closely align to extra signal, along with the peaks of both signals. The extra signal is also 
compared to the 1st derivative of the intra signal (dotted trace), which matches closely on the initial negative 
phase and mismatches at later phases, but rematches at the point of late phase change, indicated by the 
black triangle. 15 mV scale corresponds to intra, 0.03 mV scale corresponds to extra, time corresponds to 
both. Recorded from CA1 pyramidal neurons in anaesthetised Sprague-Dawley rats. Image adapted from 
(Henze et al. 2000). 
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However, much data is lost by recording from outside of the cell membrane rather than within the 
cell. At the membrane level, any activity below the threshold necessary for the firing of an action 
potential (AP) is not recorded, as only spiking and firing activity is loud enough to be recorded above 
the general electric noise of the extracellular environment. Therefore, only APs are recorded by 
extracellular methods. 
But are these recorded APs the same as APs recorded by intracellular methods? The extracellular 
electrode can only record currents/voltages that are induced to flow in the extracellular space around 
an active neuron, namely an extracellular medium with low resistance. When the neuron is inactive, 
the membrane potential across the entire membrane in contact with the electrode is uniform at the 
resting potential and no current is flowing inside or outside of the cell. When the neuron is activated, 
the axon is depolarised at some point along its membrane and there is a potential difference between 
the depolarised region and the resting region, causing current to flow. The current flows from the 
resting regions to the depolarised region, also termed the ‘source’ (the resting membrane regions 
that are the source of the resulting current) and the ‘sink’ (the depolarised regions where the current 
flow sinks in towards the membrane) respectively. This flow of current acts outward from the source 
into the extracellular space and can be recorded extracellularly (Israel et al. 2011). This concept of 
current sinks and sources is outlined in Fig.4.2. 
 
Figure 4.2: Extracellular current sinks and sources. Both rectangles represent axons, + represents membrane 
at a resting potential, - represents a region of depolarised membrane in response to activity. The INACTIVE 
axon has a uniform charge as the membrane is at the resting potential, no current is flowing in the 
extracellular space, and nothing is recorded. The ACTIVE axon has a section of depolarised membrane. 
Current flows from the resting areas to the depolarised area, (from the source to the sink). This flow of 
extracellular current can be recorded by extracellular electrodes. Based on images from (Israel et al. 2011). 
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When recording from a section of membrane that is acting as a source, the signal is positive (as 
current is flowing outwards from the source it is read as more positive than surrounding resting 
membrane, creating a signal) and when recording from a sink, the signal is negative. The portion of 
depolarised membrane that acts as a sink moves along the axon until it reaches a synapse. Depending 
on where the extracellular electrode is recording from, this can result in two different kinds of signal: 
triphasic signals (recording from axon) and biphasic signals (recording from cell body). 
When an extracellular electrode is recording from a length of axon, the signal changes from initially 
positive (the section just before a sink), negative (the sink), and back to positive (as the sink moves 
past the electrode), resulting in a positive-negative-positive triphasic signal. When the electrode is 
recording from a cell body, the cell body is the initial sink when receiving APs from other neurons, so 
the signal changes from initially negative (the cell body acting as a sink upon depolarisation from 
another neuron) to positive (as the sink moves down the axon). This concept is outlined in Fig.4.3. 
 
Figure 4.3: Diagram showing how different types of extracellular signals are generated, A-C shows generation 
of a triphasic signal from an axon, D-E shows generation of a biphasic signal from a cell body. A) sink moves 
towards the electrode, B) sink is at the electrode, resulting in a negative reading, C) sink moves past 
electrode, completing the triphasic signal, the membrane then repolarises to the resting membrane potential 
baseline. D) Sink generated at the cell body by another neuron via a synapse, E) sink moves past electrode, 
completing the biphasic signal, the membrane then repolarises to the resting membrane potential. Based on 
images from (Israel et al. 2011). 
The extracellular triphasic waveform corresponds to an intracellular monophasic waveform, as seen 
in Fig.4.1A. Due to the fact that each single neuron features only one cell body (roughly 10 µm in 
diameter) and a long axon (up to millimetre scale) with many branches, it is more likely that an 
extracellular electrode is in contact with an axon than with a cell body. 
Recording from a neural culture in vitro will result in both triphasic and biphasic AP signal waveforms 
depending on the position, size and number of the cells, axons and electrodes. A real neuron is far 
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more complex than suggested in Figs.4.2 and 4.3, and each electrode can be in contact with more 
than one cell/axon at once, resulting in a dynamic and intricate system in which a wide variety of 
signal waveforms can be obtained, differing widely in frequency, amplitude and positive/negative 
phase. To outline this point, Fig.4.4 shows the differences in extracellular signal waveforms received 
depending on their position in relation to the neuron cell body. 
 
Figure 4.4: Simultaneous recording from six extracellular electrodes of a CA1 pyramidal neuron. The left 
shows the six averaged waveforms received from each corresponding electrode on the right, which shows 
their location in relation to the cell body. Electrode 6 is closest to the cell body, as seen by the amplitudes 
on the right. The distance from electrode 1 to electrode 6 is 25 µm. Scales shown at bottom of image, which 
is adapted from (Henze et al. 2000). 
The overall amplitude decreases as the electrode moves away from the cell body, along with the 
increase and decrease slopes of the extracellular AP, resulting in a drastic change in signal depending 
on the location of the electrode. This response has also been observed after theoretical modelling 
(Gold et al. 2006). However, these electrodes had very small spacing, six electrodes within 25 µm. By 
spacing electrodes further apart they can come into contact with more cell bodies, not to mention in 
a complex in vitro culture each electrode is likely to be recording from more than one neuron. With 
this complex system in mind, the extracellular electrode must be of a quality where it can produce 
data with a high signal to noise ratio, high selectivity for certain signals, and high stability over long 




The fundamentals and uses of multi-electrode arrays (MEAs) were previously outlined Chapter One 
(Section 1.2.3 Multi-electrode arrays (MEAs)). In summation, an MEA is an interface between a cell 
culture and electronic circuitry, through which an entire cultured network can be functionally 
assessed over time. 
Many types of MEA exist, but for these experiments the MEA used features an ordered 8 x 8 grid of 
square electrodes, each electrode being 50 x 50 µm with 400 µm spacing between electrodes, a 
similar example of which can be seen in Chapter Two (Fig.2.8) and example data from Chapter One 
(Fig.1.11). 
Some of the largest commercially available electrodes are 50 µm2 square electrodes, larger 
electrodes being better for extracellular recording of entire neural cultures as physically larger 
electrodes have a better chance of being near neurons and signalling cells. By using larger electrodes, 
we can record from more neurons simultaneously. As noted by Obien et al., using electrodes larger 
than 50 µm2 square has a tendency to average out peak APs with nearby smaller amplitude signals 
and reduce the signal received, affect the impedance and increase the noise levels (Obien et al. 2015). 
By using 50 µm2 square electrodes with 400 µm spacing, we can effectively record from an entire 
culture while still receiving single-cell resolution in the instance that the electrode is in the correct 
location. 
MEAs detect any changes in the extracellular field caused by current flow (typically from sources to 
sinks) from the nearest cell/s with ionic processes, usually neurons. The detected potential depends 
on the magnitude, phase and distance (within 100 µm (Henze et al. 2000)) from the recording 
electrode/s. Data recorded from these electrodes requires amplification, as extracellular 
electrophysiological signals are several orders of magnitude below intracellular data in amplitude, 
thus intracellular APs are measured using millivolts whilst extracellular signals are measured in 
microvolts (Pettersen and Einevoll. 2008). This amplified signal is then band-pass filtered, rejecting 
any data below 100 Hz or above 10,000 Hz. The former involves noise generated by extracellular local 
field potentials (LFPs) as extracellular signals often lend noise to the LFP, and whilst relationships 
exist between spiking and the LFP (particularly with cortical neurons (Einevoll et al. 2013)), only 
spiking activity is recorded in these experiments. The amplified and filtered spiking activity is then 
digitised and output as a digital signal within MEA software. 
When signals received from active cells by MEAs is amplified, all aspects of the recording are 
amplified, including the noise. This makes the signal to noise ratio (SNR) a vital facet of extracellular 
recording, as too much noise will drown out the signal when amplified or noise could be mistaken 
for signal itself. An extensive review concerning MEAs from Obien et al. outlines three main forms of 
 120 
noise that MEAs are subject to, at each stage of the cell-interface-MEA system: biological noise, 
electrode-electrolyte interface noise and device noise (Obien et al. 2015). 
Biological noise broadly consists of electrical activity from other cells around the recording 
electrodes, (also referred to as ‘background noise’). This type of noise varies with cell type, size, 
morphology (such as density of dendritic trees), firing rates, the LFP and general biological chaos. 
Some of this noise, such as low frequency LFP noise, can be filtered out with band pass filtering. 
Electrode-electrolyte interface noise involves the interface that exists between the cell media (liquid) 
and the surface of the electrode (metal), general electrical vibrations from nearby equipment or 
power/mains lines and signal travelling to the amplifier. As most of this noise is low frequency it can 
be filtered out, or otherwise reduced by having a minimal distance between electrode and amplifier, 
electrical grounding and/or shielding of MEA equipment. In addition, any noise generated by the 
liquid-metal interface is reduced by the inclusion of reference electrodes. These reference electrodes 
are large electrodes that are located distant from the central electrode array and are not in contact 
with any signalling cells, which serve only to detect any noise within the liquid and liquid-metal 
mediums and subtract that noise from the signal. 
Device noise involves noise being added by the amplifier or MEA equipment itself and is affected by 
the size and density of the electrode array, size of electrodes and the transmission of data if there 
are bandwidth or other software constraints. Overall, while most forms of noise can be removed by 
utilising proper MEA equipment with appropriate levels of software filtering and hardware shielding, 
the only form of noise that cannot be altogether removed is the biological noise caused by the cells. 
However, there are further software solutions employed by MEA software that can reduce biological 
noise and the SNR, until only signal remains. 
Due to high levels of noise in an in vitro MEA experiment, filtration and spike detection software is 
utilised to determine what is signal and what is noise. The spike detection method involves 
establishing a threshold and only accepting data as a ‘spike’ if it can pass this threshold. The threshold 
can be established in a number of ways, such as X times the standard deviation (STD) or root mean 
square (RMS) of the background noise. All data beyond this threshold is assumed to be spontaneous 
extracellular spiking activity, which is subject to further filtration and analysis. The usual method of 
analysis is spike sorting, where received spikes are sorted into groups based on waveform shape in 
order to further reduce the SNR and also eliminate any false positives that may exist in the spiking 
signals. For these experiments these groups of similar shaped spikes are termed ‘centroids’. By 
analysing the raw spiking data and the centroid data from individual electrodes and across the entire 
array, a complex and comprehensive view of electrical activity across the culture can be built. 
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Common output data from these recordings include spike frequency, spike amplitude, duration of 
spiking, inter-spike interval, spike patterns and specific spike waveforms. This assumes that these 
spikes are single APs fired in relative isolation or randomly, but neurons can also fire bursts, namely 
periods of rapid (>10 Hz) AP spiking followed by quiescent periods. These bursts can be assessed in 
the same way as spikes, analysing their frequency, amplitude, duration, inter-burst interval, pattern 
and waveforms. Bursts can be generated by single neurons or by the culture as a whole, defined as 
network bursting. In this manner, the extracellular activity of an entire neural culture can be assessed 
over the long term, producing large quantities of dense data that can be filtered and analysed to 
determine the cell activity, functionality, connectivity, and any similarities to in vivo activity. 
4.0.4 In vitro models with extracellular recording 
Numerous in vitro neural models include many powerful features and an elegant design, but can lack 
forms of functional assessment, especially the extracellular recording of spontaneous activity from 
cells cultured within the model, and particularly over the long term (long term being more than a few 
weeks, in order to allow embryonic cells to functionally mature in vitro and draw more accurate 
comparisons to adults in vivo). As such, recent microfluidic in vitro models are often paired with MEAs 
in order to ensure the cells are functional, forming synapses and connecting in a similar way to in vivo. 
Goyal et al. present a relevant example, where they express the need for several improvements to 
in vitro neural model design. Using the classic example from Taylor et al, namely a two-port 
microfluidic device with each port linked by microchannels (Taylor et al. 2005), previously discussed 
and displayed in Chapter One, Goyal et al. discuss improvements. These include: more knowledge 
about the effect of microchannel geometry on the cellular microenvironment and their influence on 
neuronal cultures; maintaining neurons within the models for long periods of time so that the data 
can be used along with longitudinal neuronal studies and other neuronal analysis in vitro (normally 
only possible with conventional culture systems); and tracking the electrophysiological properties of 
the neurons within the model, also over the long term (Goyal and Nam. 2011). These three factors 
are indeed some of the most-needed improvements to classic and current in vitro microfluidic neural 
devices. 
To this end, Goyal et al. used soft-lithography to fabricate two-port PDMS devices with 50, 100 or 
200 µm uniform width channels (50 µm in height) between the ports, and cultured E18 rat 
hippocampal neurons in these PDL-coated devices for five weeks, recording the spontaneous 
extracellular electrophysiological activity from the channels with MEAs. Cells were seeded into the 
devices in order to achieve 250-300 cells/mm2 within the channels, as seen below in Fig.4.5. 
 122 
 
Figure 4.5: A compartmentalised microfluidic in vitro neural model with extracellular recording capabilities 
within microchannels. A) MEA electrodes aligned to 100 µm wide non-tapered channels containing neurons 
after 17 DIV, scale bar 100 µm. Electrodes marked 1, 2 and 3 correspond to the raw electrical activity in B. 
B) raw electrical activity at 7, 17 and 28 DIV. The black bar on the left hand traces (which show 2 secs of 
activity) indicates the location of zoomed in traces (shows 100 ms activity), seen to the right. 
However, despite the modifications made to the model and experimental design, there is still room 
for improvement. Goyal et al. only made eight devices, two of which did not show activity and two 
of which were only recorded from for 3-4 weeks, meaning only four were recorded from for the full 
five weeks. In addition, only electrical data from 7, 17 and 28 DIV was shown, from only three 
electrodes, and only the spike rate in spikes per second, burst rate in bursts per minute and raw data 
(Goyal and Nam. 2011). These protocols are insufficient to determine the activity across an entire 
culture over the long term but are certainly a step in the right direction. Further analysis of other 
studies involving compartmentalised in vitro neural models with extracellular recording methods can 
be seen in Table 4.1, where they are also compared to the work set out in this chapter. 
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Table 4.1: Assessing in vitro neural devices with integrated extracellular recording methods. 
STD: standard deviation, RMS: root mean square. Spacing determined as distance from electrode 
centre to centre. 
Model description Cell type used Electrophysiological 
assessment method 
Culture time 
(days in vitro) 
Reference 
Model composed of 
an ITO-MEA with a 
glass ring and cells 
seeded directly onto 
MEA, no 
microfluidics. 
E18 rat cortical 
neurons 
MEA, 8x8, 30 µm diameter 
with 180 µm spacing. 
Analysed at 5x STD. 
49 DIV, 
recorded at 5, 
11, 49 DIV. 






directly on top of 
electrodes for 
single-cell resolution. 




cells per mL) 
MEA, 4x4. Dimensions not 
mentioned, fabricated 
in-house. 
Not mentioned (Jing et al. 
2009) 
Two-port microfluidic 










MEA, dimensions not 
noted. Data shown from 
only three electrodes. 
Analysed data at 5x STD. 
35 DIV (only half 
devices went to 
full time), 
recorded at 7, 









E19 rat cortical 
neurons (200 
cells/mm2) 
MEA, 8x8, 30 µm diameter 
with 200 µm spacing, 30 
electrodes per device port. 
10 minute recording 






apathi et al. 
2011) 







MEA, 8x8, 50 µm diameter 
with 150 µm spacing 
35 DIV, 
recorded twice 
a week from 
7-35 DIV. 
(Ito et al. 
2013) 
Two-port microfluidic 







and P19 cell line 
(100-200 cells 
per mm2)  
MEA, two 4x8 arrays (one 
in each port), 30 µm 
diameter 180 µm spacing, 
analysed at 6x STD. 
18 DIV, 
recorded at 11 
and 18 DIV. 




et al. 2012) 
Two-port microfluidic 






(up to 1000 
cells/mm2 
MEA, 8x8, 30 µm diameter 
200 µm spacing, 3 minute 
recording analysed at 9x 
RMS. 
Up to 21 DIV (Brewer et 
al. 2013) 
Two-port microfluidic 
device, 10 µm width 
channels, integrated 
PEI-coated MEA 
E18 rat cortical 
and thalamic 
neural cultures 
(200 cells per 
mm2) 
MEA, 8x8, 30 µm diameter 
200 µm spacing, 30 
electrodes per port., 
analysed at 8x RMS. 
Up to 35 DIV, 
only recorded 
from 14 DIV 
(Kanagasab
apathi et al. 
2013) 
Microbead structure 
placed onto standard 
MEA to make 3D 





2D MEA: 8x8, 30 µm 
diameter 200 µm spacing. 
Analysed at 8x STD, not 
spike sorted. 








E16 rat cortical, 
striatal, pallidal 
and E14 nigral 
neuronal/glial 
cultures. 
MEA, 8x8, 50 µm 
diameter with 400 µm 
spacing. 3x 4 minute 
recording sessions, 











For this experimentation to best be effective, cells should be cultured and recorded over the long 
term, with long term being longer than five weeks, the current most popular end point. Recording 
for double the length of time (ten weeks or 70 DIV) would allow for a better perspective as to how 
the cells react to longer time frames in vitro, how they mature and how the culture changes. Analysis 
of MEA data should be more robust, with most studies showing raw data and the change of basic 
variables over time (such as spike frequency), not showing the spatial localisation of activity, spike 
sorting methods, or relationships between spikes and bursts and inter-activity intervals. 
The model should show the presence of any plasticity or long-term potentiation amongst the cells 
cultured within, in order to indicate if this model is a good model of cells maturing as they do in vivo. 
Whilst this model is a five-port device (5PD), it is necessary to first establish a baseline of activity from 
each cell type in isolation before recording from a connected network of two or five cell types at 
once. Namely, what kind of extracellular activity does each cell type (CTX, STR, GP and SN) produce 
when cultured in isolation over the long term? This chapter consists of these separate recordings, 
followed up by dual cultures in Chapter Five. 
Primary cells from the cortex or BG were assessed on MEAs in isolation for a period of 70 days to 
determine their baseline of activity when cultured as a single population (in other words, just CTX, 
STR, GP or SN on each MEA), and the MEA data analysed. These data are discussed below. 
4.0.5 Chapter Four aims and objectives 
The aim of this chapter was to establish an electrophysiological activity baseline for CTX, STR, GP and 
SNc cells over the long term (up to 70 days). The spontaneous extracellular activity of these cultures 
was measured individually with MEAs over ten weeks, to compare against co-culture activity in 
Chapter Five and Parksinsonian co-culture activity in Chapter Six, to determine the effects of 
connectivity and loss of striatonigral dopaminergic neurons respectively, on the spontaneous 
extracellular electrophysiological activity of these cells over the long term. 
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4.1 Experimental Methods 
The methods involved in this chapter were previously outlined in Chapter Two. A brief summary of 
the key methods is outlined here. 
4.1.1 MEA surface preparation 
As seen in section 2.1.1 device preparation: chemical coating, MEAs were sterilised with 70% IMS 
for 15 minutes, air dried and coated first with 0.05% PEI for 1 hour at room temperature, then 0.1 
mM PDL overnight at 37°C, washing between each stage. MEAs were then air dried and ready for cell 
culture. 
4.1.2 Primary cell culture 
As seen in section 2.2 Primary cell culture, tissue was dissected from Sprague-Dawley rat embryos: 
E16 for CTX, lateral and medial ganglionic eminences (LGE and MGE), corresponding to the CTX, STR 
and GP respectively; and E14 for the ventral midbrain (VM), corresponding to the SN. These tissues 
were dissociated and 100,000 cells were seeded directly onto the electrode array at the centre of the 
MEA, within a glass or PDMS ring. The ring was then flooded with growth media and the cells 
incubated at 37°C, 5% CO2. 
4.1.3 Electrical activity measurement with MEA 
Recordings of cell electrophysiological activity (section 2.5.2 MEA: Recordings) were taken once a 
week from 0 DIV to 70 DIV, before a media change. MEAs were moved to a heated bracket (at 37°C) 
attached to amplifiers and digitisers. Activity was recorded for four minutes in triplicate, totalling 12 
minutes of recording. 
4.1.4 MEA data management and analysis 
Spontaneous electrophysiological data obtained from neural cultures was analysed using Mobius 
software (section 2.5.2 MEA: Analysis). Data was band-pass filtered below 100 Hz and above 10 kHz, 
and the spike detection threshold was set at 500% of the root mean square. These spikes were 
further filtered into centroids (discrete filtered groups of spikes), each centroid consisting of >50 
spikes that are >80% in similarity. These centroids were assessed to determine the number, 




4.2.1 Primary cell culture 
100,000 CTX, STR, GP or SN cells were seeded onto 8 x 8 MEAs and attached to the surface and 
electrodes. An example of cell density after 6 DIV is displayed in Fig.4.6. 
 
Figure 4.6: 100,000 STR cells after 6 DIV on an MEA. The area shown in B is indicated by the white dashed 
square in A. Black squares are individual electrodes of the MEA. Scale bars 100 µm. 
As seen previously in Chapter Three (section 3.2.3.2, Fig.3.14), cells seeded onto PEI/PDL coated 
surfaces proliferated in an even monolayer, coating the MEA. The high density of cells ensured that 
all electrodes were at least in contact with axons, if not in contact with one or more cells. This density 
increased slowly over the 70-day culture, with most cells being post-mitotic and not displaying much 
proliferation. The state of the MEA at a very late stage, taken at 120 DIV with CTX cells, can be seen 
in Figs.4.7 and 4.8 below and acts as a comparison. 
After 120 DIV every surface of the MEA was covered in neurons and astrocytes, with the latter in 
clear majority. All electrodes were covered in many cells and the neurons had long processes, some 
extended from one electrode to another. These neurons remained towards the centre of the culture, 
on the electrodes. The far edges of the culture consisted mostly of large astrocytes, as seen in 
Fig.4.7E, where astrocytes extended into the space next to the culture and no neurons were seen. 
Essentially, while astrocytes proliferated and spread across the whole MEA, neurons remained where 
they were seeded on the electrode array in the centre of the MEA. This means that across the whole 
70 DIV of recording, electrodes were in contact with neurons and their activity was recorded. 
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Figure 4.7: 100,000 CTX cells after 120 DIV on an MEA, stained with GFAP (red, shows astrocytes), β-tubulin 
(green, shows neurons) and DAPI (blue, shows cell nuclei), with electrodes indicated by white squares. A-E 
show different sets of 6 electrodes across the the MEA. F shows a reference electrode. Scale bars 100 µm. 
To measure the viability of these cells after 120 DIV on an MEA, live/dead staining was performed to 
determine the percentage viability of cells across the MEA, and cell viability across the MEA was 
analysed (seen in Fig.4.8). 
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Figure 4.8: Live/dead data for 100,000 CTX cells after 120 DIV. A) Live/dead images with live and dead cells 
in green and red respectively, and electrodes as black squares. The pictures are arranged as they were taken, 
with the top image from the top edge of the MEA, the two centre images from the centre and the bottom 
image from the bottom edge of the MEA. B) Percentage viability of cells depending on their location within 
the MEA, from four centre images and two images from each edge, with more viable areas shown in green 
and less viable areas in red. C) Taking the four centre images as ‘centre’ and the eight edge images as ‘edge’, 
a comparison in percentage cell viability between edge and centre (*): p<0.01. Data from other cell types not 
shown, image representative of n=4. 
Cells were significantly less viable in the centre of the MEA than the edge after 120 DIV, as the culture 
was denser in the centre of the MEA. Despite this lower viability, data was still recorded from all 
electrodes across the MEA, and it should be noted that this was a representation of a super-late stage 
MEA experiment at 120 DIV, with other experiments terminated at 70 DIV where the density was 
likely lower and the percentage viability higher. In summary, primary neural cells were successfully 
cultured on PEI/PDL coated MEAs over the long term (70 DIV). 
4.2.2 Spatial activity localisation on MEAs 
Activity was recorded from each of the 64 electrodes on every MEA, resulting in the ability to trace 
not only the timing of the onset of activity, but on which electrodes that activity was located, in order 
to track activity across each MEA over time. Raw activity can be seen in Appendix. 
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4.2.2.1 Heatmaps 
Heatmaps were generated by taking the number of spikes recorded by each electrode and applying 
a traffic light scale, with green, yellow and red representing the highest, average and lowest activity 
respectively. These heatmaps are displayed from 0-70 DIV for each cell type in Figs.4.9-4.12. 
CTX cells featured a later onset of activity compared to STR, GP and SN cells, with activity only seen 
by 21 DIV (as opposed to 11-15 DIV in other cell types) (see Fig.4.9). Activity began at 21 DIV, spread 
to more electrodes on 27 DIV, and then decreased from 27-70 DIV. High activity areas increased from 
21-70 DIV, with more high activity areas seen at later days such as 44 and 51 DIV. While experiment 
B had lost the majority of activity on 65 and 70 DIV, experiments A and C showed consistent activity 
throughout, in the same regions. Generally, activity was generated on 21 DIV and was widespread, 
then high levels of activity were generated consistently in a specific region while activity in other 
regions decreased. While the number of active electrodes fell over time, the spike frequency 
increased, suggesting that activity is being adopted by certain electrodes. 
For STR, onset of activity occurred around 11 DIV (see Fig.4.10). Activity continued to spread across 
the MEA until around 21-27 DIV, after which activity was confined to specific locations consistently 
until 70 DIV. The peak of activity occurred around 38 DIV. Experiment C had diminished activity from 
51-70 DIV, while experiments A and B retained activity throughout. 
For GP, activity began by 11 DIV for experiment A and 15 DIV for experiments B and C (Fig.4.11). 
Activity did not spread across the MEA for B and C, but areas of high activity were highly consistent. 
For A, activity spread from 11-31 DIV, with high activity seen from days 38-44 DIV. 
For SN, onset of activity occurred around 11 DIV (Fig.4.12). Activity spread across the MEA until 
around 27 DIV, occupying nearly 100% of electrodes. For A and B, activity continued until 70 DIV, 
decreasing for 44-58 DIV. Areas of high activity were consistent. For C, activity was high across the 
whole MEA for 27-51 DIV, data after this point is not available. 
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Figure 4.9: CTX activity heatmaps. Each square is an 8 x 8 grid representing an MEA. Horizontal values 4-70 represent days in vitro (DIV) and A-D represent separate MEAs from 
repeat experiments. Red->yellow->green formatting indicates min->mean->max levels of spiking activity. Min, mean and max for each repeat as follows: A) 0, 524, 9551. 
B) 0, 111, 5847. C) 0, 102, 2060. D) 0, 65, 4060. 
 
 
Figure 4.10: STR activity heatmaps. Each square is an 8 x 8 grid representing an MEA. Horizontal values 4-70 represent days in vitro (DIV) and A-D represent separate MEAs from 
repeat experiments. Red->yellow->green formatting indicates min->mean->max levels of spiking activity. Min, mean and max for each repeat as follows: A) 0, 137, 6002. 









Figure 4.11: GP activity heatmaps. Each square is an 8 x 8 grid representing an MEA. Horizontal values 4-70 represent days in vitro (DIV) and A-D represent separate MEAs from 
repeat experiments. Red->yellow->green formatting indicates min->mean->max levels of spiking activity. Min, mean and max for each repeat as follows: A) 0, 975, 18924. 
B) 0, 213, 8238. C) 0, 123, 6995. D) 0, 35, 2666. 
 
Figure 4.12: SN activity heatmaps. Each square is an 8 x 8 grid representing an MEA. Horizontal values 4-70 represent days in vitro (DIV) and A-D represent separate MEAs from 
repeat experiments. Red->yellow->green formatting indicates min->mean->max levels of spiking activity. Min, mean and max for each repeat as follows: A) 0, 1146, 30450. 







4.2.2.2 Percentage activity across the MEA 
Spatial activity data could also be presented as percentage activity across the MEA, as seen in 
Fig.4.13. This represents the proportion of electrodes across the MEA that were recording 
spontaneous activity above a threshold over the 70 DIV (as such it does not take into account the 
amplitude or frequency of this activity, only the presence or absence of activity). 
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Figure 4.13: Average percentage of MEA electrodes that recorded spontaneous activity over time, for each 
cell type (n=4). Asterisks represent post-hoc t-tests and in this case, compare SN to the other three cell types 
(*): p<0.01, (**): p<0.001. 
The cell type had a significant effect on the percentage of active electrodes over time (ANOVA (3,8), 
F=8.908, p=0.0063). There were significant differences between CTX/STR/GP and SNc, the largest 
difference being between CTX and SNc. SNc had a greater number of active electrodes at all time 
points when compared to CTX, STR and GP, with the latter cell types having similar trends of onset, 
peak and slow decline. 
CTX neurons had a later onset and peak of activity at 21 DIV. While CTX peaked above STR and GP 
levels on 21 DIV (60% of MEA active), it persistently decreased from 21 DIV until 70 DIV, finishing 
with the lowest number of active electrodes overall (10% of MEA active). STR neurons had an earlier 
onset than CTX and GP (11 DIV) but again peaked at 21 DIV (45% of MEA active). After a sharp decline 
at 33 DIV levels remained consistent until 70 DIV (20% of MEA active). GP neurons were very similar 
to STR in the early phase, with onset at 15 DIV and the usual peak at 21 DIV (45% of MEA active). 
After this point levels remained consistent until 51 DIV where a decline begins, only to rise again at 
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65 DIV (30% of MEA active). SNc neurons differed to CTX, STR and GP and had the highest percentage 
of active electrodes across all four cell types at every time point after onset (significant differences 
marked by asterisks on Fig.4.13). SNc onset was earlier than CTX and GP (11 DIV) with the highest 
initial reading of 45%, rising and peaking later than other cell types at 33 DIV (90% of MEA active), 
and declining at a far slower rate from 33-70 DIV (finished at 75% of MEA active). 
4.2.3 Average spike frequency 
Each electrode recorded a set number of spikes per recording. By taking an average of the spikes 
across all 64 electrodes of the MEA, the level of spiking across the whole MEA was quantified. 
Knowing the length of the recording session time (740 seconds) the average spike frequency (spikes 
per second) was calculated. These averaged spikes over time can be seen in Fig.4.14. 
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Figure 4.14: Average spike frequency across MEAs over time for CTX, STR, GP and SN (n=4). Asterisks 
represent post-hoc t-tests and in this case, compare SN to the other three cell types (*): p<0.05, (**): p<0.01, 
(****): p<0.0001. 
The effect of the cell type on the average spike frequency (Hz) was significant (ANOVA (3,8) 
F=5.028, p=0.0302), with significance differences between SNc and other cell types on 29, 32 and 
65 DIV (indicated by asterisks). 
CTX spike frequency was the lowest of all cell types from onset (21 DIV) until end (70 DIV), except for 
a peak (0.77 Hz) at 51 DIV. After onset, CTX neuron firing increased in frequency until 51 DIV and then 
decreased until 70 DIV (finished at 0.2 Hz). 
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STR firing was more frequent than CTX from onset (15 DIV) until 38 DIV, where firing peaked at 
0.78 Hz. The average frequency remained consistent from this peak until a decrease at 70 DIV 
(finished at 0.43 Hz). On the whole STR neurons appeared to fire at a higher frequency than CTX 
neurons, but lower than GP and SN. 
GP neuron activity had the lowest frequency of all cell types from onset (15 DIV) until 28 DIV, until 
GP increased to a high peak at 38 DIV (peaked at 2 Hz), greater than CTX and STR levels of firing. Spike 
frequency then decreased sharply until 51 DIV, where levels remained consistently low until end 
(finished at 0.55 Hz). Except for the large peak in firing from 28-51 DIV, GP culture firing frequency 
was similar to CTX cultures. 
SN cells had the highest spike frequencies of all four cell types, with greater spike frequencies at 
every time point after onset (15 DIV). After onset spiking frequency increased sharply to a peak at 
28 DIV (peaked at 4.54 Hz), many times higher than CTX, STR or GP. Spiking then decreased to 2.5 Hz 
on 38 DIV and remained at this level consistently until end (finished at 1.97 Hz). This high level of 
spiking shows that SN cells were more active than CTX, STR and GP cells. 
Spike frequency measurements consisted of taking an average across all 64 electrodes of an MEA. 
Due to the fact that not all electrodes registered activity, many zero values were present, which 
decreased the average. In order to display the activity in an alternate way, the maximum activity per 
day is also displayed, showing only the electrode that had the maximum number of spikes for each 
recording session. 
4.2.4 Maximum spike frequency 
In order to give an alternate display of the spike frequency without taking a non-zero average, the 
maximum recorded spike frequency each day was recorded, as seen below in Fig.4.15. 
The effect of the cell type on the maximum spike frequency over time was not significant (ANOVA 
(3,8) F=1.812, p=0.2230). Despite this, there was still a trend towards SN neurons having a greater 
maximum spiking frequencies than each other cell type, especially on 29-32 DIV. 
CTX maximum spike frequency was the lowest of all cell types from onset (21 DIV) until a peak at 
51 DIV (peaked at 8 Hz), and increased steadily from onset to peak. The level of firing then decreased 
from 51-70 DIV (finished at 4.5 Hz). 
STR maximum spike frequency was greater than CTX from onset (15 DIV), increased from onset until 
a plateau from 28-44 DIV (peaked at 9.78 Hz), then slowly decreased from 44-70 DIV (finished at 
7 Hz). STR showed the most consistent maximum spike frequency over time, remaining level after 
the initial increase from onset. 
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Figure 4.15: Maximum spike frequency across MEA over time for CTX, STR, GP and SNc (n=4). No significance 
indicated. 
While GP maximum spike frequency was lower than STR from onset (15 DIV), it increased above STR 
during an increase between 28-38 DIV, peaking at 38 DIV (peaked at 12 Hz). The trace then decreased 
on 44 DIV and remained at a consistent level until end (finished at 7 Hz). The peak of GP maximum 
spiking on 38 DIV was equivalent to SN maximum spiking at this time. 
As with the average spiking, SN maximum spiking was consistently higher than other cells at all time 
points, except on 58 DIV onwards where it fell below STR. SN onset was 15 DIV (same frequency as 
STR) and increased until a peak at 33 DIV (peaked at 20.8 Hz). After this peak the level of maximum 
spiking decreased until 58 DIV and then experienced a small late peak (finished at 10.85 Hz). This 
data shows that one electrode recorded over 20 spikes a second for a full 12 minutes, demonstrating 
the high levels of activity that can be achieved even by a single cell type in isolation, in vitro. 
As well as analysing the activity of neural cultures across the MEA over the long term, it is also 
important to understand connectivity and potential plasticity in this dynamic system. The location of 
the maximum activity was not fixed and changed electrode location over time, displayed in Fig.4.16. 
For each cell type, the maximum activity did not remain in the same location for more than three or 
four consecutive recordings. However, there are clusters of maxima, such as the bottom left corner 
of CTX, where the maximum activity consistently is recorded. 
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Figure 4.16: Locations of maximum activity for each day of recording, on each cell type, across the MEA. Each 
8x8 grid represents an MEA, with the highlighted squares indicating electrodes that registered maximum 
activity, the number showing the day the activity was recorded on. The arrows show how the maximum 
changed locations, from the earliest day (21 for CTX, 11 for others) to the latest day (70). 
In the early stages of activity (11-21 DIV) the location of the electrode that recorded the highest level 
of activity continuously changes, but in the mid and late stages of activity the location is more 
conserved, in some cases remaining on the same electrode for 3-4 recordings in a row. However, this 
may only be due to neurons dying or glial cells proliferating/moving around over time. 
4.2.5 MEA bursting activity 
As well as firing random spontaneous spikes, each cell type could also ‘burst’, where a burst is a 
bundle of spikes too close to measure separately. In this experiment a burst was defined as a bundle 
of more than 10 spikes in a second, namely a spike frequency of 10 Hz or above. The electrical activity 
recorded from each cell type contained numerous bursts, which were averaged and counted in order 
to calculate the average number of bursts for each cell type over time (Fig.4.17). 
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Figure 4.17: Bursting activity across the MEA over time. A) Average number of bursts over time for each cell 
type, B) average number of spikes per burst for each cell type. Asterisks represent post-hoc t-tests and 
compare each cell type to the other three cell types (****): p<0.0001. (n=4). 
While the effect of cell type on the average number of bursts over time was not significant (ANOVA 
(3,4) F=1.5, p=0.34), the interaction between cell type over time on the average number of bursts 
was extremely significant (ANOVA (39,52) F=4.38, p<0.0001). The two significant differences 
between all four cell types were the peaks from SN (31 DIV, 115 bursts) and GP (38 DIV, 107 bursts), 
significance marked on Fig.4.17A. This demonstrated that while SN had significantly greater spike 
frequencies and early burst numbers (see Fig.4.14 and 4.15), all four cultures otherwise fired bursts 
at similar rates as the experiments progressed. 
As with spike frequency (from Figs.4.14 and 4.15), the burst number has an onset, a peak and a 
decline as the cell activity matured. CTX bursting steadily increased from onset (21 DIV) until a late 
peak at 58 DIV (peaked at 30 bursts), then decreased from 58-70 (final result of 13 bursts). STR 
bursting also steadily increased from onset (15 DIV) to a peak on 38 DIV (peaked at 22 bursts), 
followed by a decrease and plateau from 44-70 DIV (final result of 12 bursts). GP bursting increased 
sharply from onset (15 DIV) to a high peak at 38 DIV (peaked at 107 bursts), then decreased sharply 
to 51 DIV and remained at a low level until end (final result of 5 bursts). SN cells had the greatest 
numbers of bursts from 21-27 DIV, and the greatest peak at 31 DIV (114 bursts), then decreased to a 
plateau from 44-70 (final result 31 bursts). 
The number of spikes per burst was notably similar, with all four cell types plateauing after onset and 
remaining at a steady level until end, showing that there was a near constant number of spikes 
contained within each burst, between 15-20 spikes on average. The effect of cell type on the average 
number of spikes per burst over time was not significant (ANOVA (3,4) F=0.5678, p=0.66). 
4.2.6 Centroid number 
As part of the processing of the spike signals, spikes were sorted into groups of similar spikes termed 
centroids (a centroid was formed when there were >50 spikes with >80% similarity), as seen in 
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Fig.4.18. The maximum number of centroids that could be produced by each electrode was 20, and 
by tracking the number of centroids over time across the experiment, the variation in signalling could 
be determined (with less centroids meaning less signal variation). As the cells matured over time the 
signal variation changes could be assessed. The average number of centroids over time for each cell 
type is displayed in Fig.4.19. 
 
Figure 4.18: How a centroid is generated. Raw data that exceeds a threshold (indicated by dashed black lines) 
is counted as a spike, and these spikes are grouped into groups of similar spikes, or centroids. This spike 

























1 2 S T R

































































CTX STR GP SN
Early 0.32 1.05 1.02 0.81
Mid 2.14 1.99 3.20 2.14
Late 1.80 1.58 1.66 2.19
 
Figure 4.19: Number of centroids formed from spike sorting of the spontaneous activity of all four cell types 
over time. Each time point has 64 data points stacked into a vertical column depending on the number of 
centroids generated by each electrode. In order to more clearly indicate the differences between each stage, 
the early (11-21 DIV), mid (25-44 DIV) and late (50-70) stages are indicated by the rectangular column drawn 
around each stage. The horizontal black line within each box indicates the mean number of centroids for this 
period (n=3), with these means summarised in the table. 
Early CTX had a low mean number of centroids as onset of activity was 21 DIV rather than 15 DIV 
from other cell types. All cell types started with a low number of centroids during the early phase, 
with an increase to the mid phase, and a decrease to the late phase. As a greater number of centroids 
indicates more signal variety (spikes are sorted into more groups), these results suggest that there 
was less signal variation in the late stage compared to the mid stage. 
 
4.2.7 Centroid shapes 
As well as tracking the number of centroids over time, the waveform (or shape/profile) of major 
centroids was also tracked over time. Centroids were observed to assume a total of six different 
shapes, determined by phase and sign. If a centroid waveform crossed the x-axis and exceeded 10 μV 
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in either direction, it was determined to have begun a new phase. Based on this categorisation there 
were six possible types of centroid, namely positive/negative monophasic, 
positive-first/negative-first biphasic and positive-first/negative-first triphasic (see Fig.4.25). In this 
section, examples of centroid waveform change over time are displayed, along with the 
categorisation of these waveforms into one of the six categories. The top four centroids for each cell 
type at days 15, 21, 44 and 70 are displayed below (from an active electrode), with mono-, bi- and 
triphasic centroids represented by red, green and blue respectively. 
4.2.7.1 Centroid shape over time 
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Figure 4.20: CTX centroid waveforms over time from an active electrode, E50. All centroids analysed were 
monophasic and are in red, dashed lines indicate a positive spike, legend indicates how many spikes made 
up the centroid. 
As with other experiments, there was no activity at 15 DIV due to CTX onset being 21 DIV. There were 
only two monophasic centroids for electrode 50 on days 21, 44 and 70, and in each case the negative 
monophasic centroid contained the most spikes. 21 and 44 DIV are very similar in waveform and 
amplitude, but the negative monophasic centroid had a greater amplitude and recovery at 70 DIV. 
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Figure 4.21: STR centroid waveforms over time from an active electrode, E19. Red, green and blue centroids 
were monophasic, biphasic and triphasic respectively, values in the legend showing how many spikes were 
sorted into each centroid. 
STR displayed activity on all days, also following the trend of negative centroids containing more 
spikes than positive centroids. There were more centroids on 21 and 44 DIV compared to the two 
seen at 15 and 70 DIV. 21 DIV showed four centroids of similar shapes while 44 DIV showed two 
positive centroids with spikes at a similar time but had very different waveforms from 1.5-3.5 ms, 
showing how centroids can differ post initial spike. 
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Figure 4.22: GP centroid waveforms over time from an active electrode, E64. Red, green and blue indicate 
mono-, bi- and tri-phasic centroids respectively, with values in the legend showing how many spikes were 
sorted into each centroid. 
GP displayed activity on all days, and the negative centroids contained a greater number of spikes 
than the positive centroids. The amplitude of the negative centroids increased from DIV 21 to 44, 
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whilst the main positive centroid remained unchanged. Of interest are the multiple waveforms on 
display, with DIV 44 showing mono-, bi- and tri-phasic spikes. 
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Figure 4.23: SN centroids over time from an active electrode, E44. Red, green and blue indicate mono-, bi- 
and tri-phasic centroids respectively (with green dashed used to differentiate between similar), with values 
in the legend showing how many spikes have been sorted into each centroid. 
SN only showed one positive and one negative centroid on each day, following the trend of negative 
centroids having more spikes than positive centroids. The negative centroid waveform remained 
unchanged over time with only the amplitude and number of spikes changing, while the positive 
centroid underwent a change at 21 DIV. 
4.2.7.2 Whole-MEA centroid shape assessment 
Whilst much can be elucidated by assessing centroid waveforms from individual active electrodes, a 
clearer picture could be gathered by looking at the centroid waveforms across the whole MEA. This 
was a time-consuming process, as such only one example is provided, namely from CTX DIV 44. This 
whole MEA centroid waveform analysis is displayed in Fig.4.24. As before, only the top four centroids 
are displayed for each electrode, superimposed onto the relevant electrode location along with the 
heatmap for DIV 44. 
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Figure 4.24: Centroid waveforms across a whole MEA, from CTX DIV 44, n=1. Each electrode was labelled 
from 1-64 and display the centroid(s) produced by that electrode. The same heatmap used in Fig.4.13 
(CTX A DIV 44) was used as the background, with red-> yellow-> green indicating min (0), mean (524) and 
max (9551). 
4.2.7.3 Centroid shape categorisation 
The sum of all centroids generated by different cell types on MEAs throughout all 70 days of recording 
were sorted into six types of centroid (positive/negative monophasic, positive-first/negative-first 
biphasic and positive-first/negative-first triphasic) via Python (code for sorting written by Dr Dimitra 
Blana, acknowledged), resulting in an overall view of the proportions of different centroids generated 
by different cell types. The different centroid types are first outlined in Fig.4.25, with the 
categorisation data seen in Fig.4.26. 
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Figure 4.25: The six centroid types generated by cells on MEAs throughout this experiment. Monophasic 
centroids are red, biphasic centroids are green and triphasic centroids are blue. Centroids were sorted into 
these three categories based on shape. 
There are several notable differences between the centroids generated by each cell type: 
 All four cell types had greater proportions of centroids with negative spikes (negative 
monophasic, negative-first biphasic and positive-first triphasic) compared to their positive 
counterparts 
 There were mainly monophasic and biphasic centroids with a small proportion of triphasic 
centroids 
 CTX cultures generated a larger proportion of monophasic centroids compared to other cell 
types 
 SN cultures generated a larger proportion of biphasic centroids compared to other cell types 
(potentially due to a lack of negative-first triphasic centroids) 
 Proportions of monophasic centroids generated by STR, GP and SN were very similar 
 GP cultures generated the most centroids, more than double STR 
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Figure 4.26: Centroid shape categorisation. All centroids from 70 days of recording were sorted into six types, 
the numbers on pie segments indicating the number of centroids in each category (with total number of 
centroids below each pie) (n=4). 
4.2.7.4 Centroid full duration at half maximum 
Centroid spike amplitude and duration (duration of spike, also seen as ‘width’ on graphs with x-axis 
of time) can change over time, and the final centroid analysis is to measure the full duration at half 
maximum (FDHM) of centroid spikes. The FDHM is a standard measure for pulse waveforms where 
the independent variable is time and is obtained by taking a point at half the maximum spike 
amplitude and measuring the duration at this point. This measure therefore determines the duration 
of the spike (whether the spike is ‘thin’ or ‘wide’), and processing centroid FDHM over time 
determines any changes in centroid shape independent of phase or sign (data displayed in Fig.4.27). 
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Figure 4.27: Centroid full duration half maximum (FDHM) over time for each cell type, significance 
generated from post-hoc t-tests comparing one cell type to all others, (**): p<0.01, (n=3). 
The majority of centroids for all four cell types appeared to have a FDHM of approximately 0.5 ms, 
with the interaction between cell types over time having a significant effect on the FDHM of 
generated centroids (ANOVA (30,40) F=7.34, p<0.0001). CTX was significantly lower on day 15 as no 
activity had yet been generated, whereas STR had significantly higher FDHM from 65-70 DIV, 
indicating some change in the culture resulting in ‘wider’ spikes. 
4.3 Discussion 
4.3.1 Primary cell culture 
Primary CTX, STR, GP and SNc cells all grew well on PEI-coated MEAs. The main difference between 
culturing on MEAs and glass coverslips was that it was essential to seed cells right into the centre of 
the MEA, so that the electrodes were in contact with the cells. Unless the electrodes were in physical 
contact with the cell bodies or axons, they would not be able to measure the cell spontaneous 
activity. In order to best record from the cells, they were seeded into the exact centre of the MEA. 
PEI/PDL chemical coating meant that there was no migration, with only glial cells growing outside of 
the initial seeding area (see Fig.4.7E-F). The use of a micro-drop culture eliminated the migration in 
suspension seen in Chapter Three (section 3.2.3.1 Cell body migration, Fig.3.13), as the liquid 
medium was only a small 50 µL drop that did not extend beyond the edges of the central electrode 
array. 
Initially, cells were far from the reference electrodes, but after over 100 days in culture, astrocytes 
had spread to the reference electrodes (as seen in Fig.4.7F). Astrocytes in contact with the reference 
electrode may interfere with the noise cancellation role of these reference electrodes, which ideally 
have a fixed composition for the whole experiment, or it may mean that the reference electrodes are 
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also subtracting any biological noise generated by the astrocytes from the other electrodes, resulting 
in only neuronal signals being recorded. It is uncertain at what specific DIV the astrocytes spread to 
the reference electrode but as the images were taken after 120 DIV (see Fig.4.7F) it is possible that 
for the 0-70 DIV recording period the reference electrodes were entirely free of any cell interference. 
Regardless, all four cell types were successfully cultured for over 70 days on MEAs at the same 
density, allowing for long-term observation of a developing neural network. 
4.3.2 Electrophysiological assessment 
There was a total of 14 recording sessions for all MEAs, recording at least once a week over the 70-day 
culture period. Recording days were 0, 4, 7, 11, 15, 21, 27, 31, 38, 44, 51, 58, 65 and 70. Days 0-7 
showed no activity from any cell type, with electrical activity starting at 11-15 DIV for STR, GP and 
SN, and 21 DIV for CTX. Please refer to Appendix One for the raw data from single electrodes from 
separate cultures and Appendix Three for the whole MEA at each of the same time points. 
4.3.2.1 Differences in onset of activity 
CTX cells consistently produced electrical signals on or after 21 DIV, unlike STR/GP/SN, which were 
active as soon as 11 DIV in some cases, 15 DIV in all cases. CTX onset was later because in vitro and 
in vivo CTX cells take longer to mature, often taken around E18-19 for experimentation with solely 
cortical cells (Hatanaka and Murakami. 2002, Chiappalone et al. 2006, Anda et al. 2016). For 
experiments in this thesis CTX cells were taken at E16 due to logistics of tissue collection. Thus, the 
CTX cells may have required a longer time scale in order for CTX cells to functionally mature and start 
signalling, resulting in the onset being between days 15 and 21, rather than 11-15 in other cell types, 
which mature quicker than CTX in vitro and in vivo. Once past 21 DIV, CTX cells were signalling and 
could be assessed with all the other cell types. 
4.3.3 Localisation of activity 
The heatmaps seen in Figs.4.9-4.12 demonstrate how the activity changed in every electrode over 
time. This is a vital perspective to view data from as each of the 64 electrodes were receiving a wealth 
of information and while it was not possible to display data in detail from each electrode, it was 
possible to give a general overview of how the network communication on the MEA changed over 
time. 
As before, the heatmaps first showed that CTX onset was later (21 DIV) as discussed above, while 
STR, GP and SN displayed onset from 11-15 DIV. Trends observed in detail from just one electrode 
were observed across the whole MEA. Due to biological variation at every level from the original 
maternal rat to the way cells dispersed onto the MEA after seeding, there were clear differences in 
the MEA repeats with the same cell type, as a neuronal network was unlikely to form the same way 
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twice. Taking this inherent difference between repeats into account, there were several larger-scale 
differences or trends that could be observed, both over time and between the different cell types. 
Each cell type followed a similar trend over time:  
1. Initial early onset of low-frequency activity in few locations 
2. Spread of activity across the MEA 
3. Increase in spike frequency in certain locations 
4. ‘Concentration’ of activity towards these certain locations (as less electrodes continue to 
remain active) 
5. Stable state as certain locations produced the majority of activity 
In essence, activity spread across the MEA and then focused onto a certain point while activity 
elsewhere decreased. When activity was focused to a certain point, the spike frequency of those 
points increased. This peak and decline of the number of active electrodes can be observed in other 
in vitro studies utilising MEA technology (Biffi et al. 2013) and appears to be partly dependent on cell 
density, a vital factor when forming a functional network. Another reason for this activity format was 
that neural circuits could be formed by first producing a rough activity-independent wiring map 
characterised by synaptic connections, followed by activity-dependent elimination (often termed 
‘pruning’) of inappropriate or inefficient connections and reinforcing of efficient and maintained 
synapses (Tessier and Broadie. 2009), where this pruning stage may be responsible for the decrease 
in the number of active electrodes and the reinforcing may be responsible for the increase in spiking 
in certain MEA regions. 
This activity suggested that a form of plasticity (neurons that fire together, wire together) or long-
term potentiation (LTP) developed within the network. At first most electrodes were firing at an 
average frequency and producing a number of different activity patterns across the MEA depending 
on which neurons were functionally synapsed and networked to which other neurons. Some of these 
patterns of activity were spontaneously strengthened from synapse to synapse persistently over 
time, and resulted in one particular, more efficient pattern producing far more spikes than other 
patterns. This may have further resulted in other patterns potentially being suppressed/depressed 
(long-term depression (LTD) being the opposite of LTP) or re-routing their activity pattern through 
the strengthened pattern. The end result was several high-activity electrodes surrounded by lesser 
activity, and with less electrodes receiving activity than the initial spread at the start. Whilst less 
electrodes were active, electrodes recording activity recorded far more activity than the others. This 
kind of LTP or plasticity can be invoked in vitro with brain slices via stimulation (W. Chen et al. 1994, 
Abrahamsson et al. 2016) or recorded spontaneously (Teyler et al. 1977, Lalanne et al. 2016). 
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An alternative explanation for the localisation of activity across the MEA over time was that there 
was a decrease in the number of neurons over time, while their metabolism and functionality 
remained constant, which resulted in hotspots of activity where neurons are not lost spontaneously 
to aging, and dark spots where populations of neurons were lost to aging. As a result, the network 
re-adapted and only surviving neurons were firing, potentially at a higher frequency than before due 
to a greater load (Lesuisse and Martin. 2002, Chiappalone et al. 2006). 
For CTX, STR and GP, these trends of peaking and decreasing in percentage activity were seen both 
in their heatmaps (Figs 4.9-4.12) and the graph showing the percentage of active electrodes over 
time (Figs.4.13). There was an initial period where no electrodes were active, followed by a sharp 
increase and early peak (around 20-30 DIV, indicating the spread phase). The number of active 
electrodes then fell persistently over time (indicating the time frame where LTP/plasticity/cell death 
may be taking place) until 70 DIV where far fewer electrodes were active. When the percentage of 
active electrodes was compared to the overall average spike frequency across the MEA over time, 
there is a clear trend showing that while the spread of activity is decreasing, the overall frequency 
was increasing: i.e. there is a focusing of activity of certain locations on the MEA. 
As with the raw spiking, SN neurons on MEAs displayed unique activity compared to CTX, STR and GP 
neurons on MEAs. While SN cultures on MEAs did show a period of no active electrodes (0-7 DIV) 
followed by a sharp increase at 11 DIV, the number of active electrodes continued to rise and peaked 
at nearly 100% active electrodes, i.e. full MEA coverage. This trend was significantly different to the 
other cell types, with SN neurons on MEAs displaying ~ 70% active electrodes after 70 DIV (compared 
to 20-30% for CTX, STR, GP). It is unknown if this lack of SN activity spread decrease has been 
replicated by other groups. While this may suggest a lack of LTP or ‘focusing’ of activity onto specific 
locations, the spiking frequency rose in proportion with the spread of activity, the opposite trend 
compared to CTX, STR and GP. Heatmaps showed that there were indeed certain locations with 
higher activity, these were simply not accompanied by a decrease in the spread of activity across the 
MEA, as both the spread of activity and spike frequency increased over time. This suggests that SN 
cells may have experienced LTP but no LTD, neuron spiking only increased in spike frequency. 
However, a proportion of the SN neurons are GABAergic and may have been able to inhibit the 
activity of the other neuronal types (e.g. DA neurons) within SN cultures in some fashion (Ellens and 
Leventhal. 2013). 
4.3.4 Spiking and bursting frequencies 
For all cell types the average spike frequency increased over time from onset (15-21 DIV) to peak 
(30-50 DIV) (Fig.4.14). This was potentially due to the fact that cells were functionally maturing in 
vitro (Chiappalone et al. 2006), as the activity was from the same location each time and neurons 
unlikely to migrate due to the PEI/PDL coating. The main variables that changed over time were most 
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likely the number of glial cells, the size/number/density of axons and dendrites, and the 
number/density/maturity of synapses formed between neurons. This more highly connected 
network would have formed between 20-40 DIV and resulted in an increase in detectable 
extracellular action potentials (EAPs). However, from 40-70 DIV the frequency did not increase, 
remaining static or decreasing, even though it is unlikely that the network formed at 20-40 DIV 
underwent large structural changes between 40-70 DIV. In vitro studies on primary rat CTX neuron 
cultures have demonstrated that neuronal cell density, connectivity and number of synapses per 
neuron have all been shown to increase over the first four weeks in culture, but then decrease after 
this time as part of the maturation process (Muramoto et al. 1993, Ichikawa et al. 1993, Chiappalone 
et al. 2006), demonstrated by a lower firing rate and related to activity-dependent processes and 
homeostatic plasticity (Marom and Shahaf. 2002, Turrigiano and Nelson. 2004), with experiments 
observing these effects up to 35 DIV. These studies present a timeline where there is a very low 
density of immature synapses on 7 DIV, followed by increases in the number and maturity of synapses 
after each week in vitro, further followed by decreases in the number of synapses after 5 weeks in 
vitro. This closely follows the trend of activity seen here, where there is an onset of activity within 
the first two weeks, a peak in activity within the 3rd-4th weeks and a gradual decrease until the 10th 
week and the end of recording. Chiappalone et al. (2006) states that, without any external sensory 
stimulus, an in vitro network matures firstly with modulation and shaping of synaptic connectivity 
(weeks 1-2, early development) and then with maturation of synaptic connectivity (weeks 4-5, ‘late’ 
development) (Chiappalone et al. 2006). 
Unfortunately, weeks 6-10 of in vitro primary neural electrophysiological assessment are mostly 
unaccounted for in the literature, where studies rarely exceed 35 DIV. One study cultured E16 mouse 
CTX neurons for 60 DIV, and demonstrated that levels of GAPDH (used as a metabolic marker), 
synaptophysin (a synapse marker) and glutamate receptors (necessary for CTX glutamatergic neuron 
functionality) peaked around 25 DIV and remained unchanged through to 60 DIV, indicating that the 
in vitro neural culture system matured, established synapses and were viable across the long term, 
i.e. up to 60 DIV (Lesuisse and Martin. 2002). Notably, this study also showed that only approx. 
40-50% of the original cells (from 5 DIV) survived until 60 DIV, levels of β-tubulin and GFAP (neuron 
and astrocyte markers respectively) were constant from 5-60 DIV, and levels of NeuN declined from 
40-60 DIV, suggesting the loss of a subset of neurons. Lesuisse et al. (2002) conclude that older 
cultures (up to 60 DIV) have fewer neurons than younger cultures (20-25 DIV) due to spontaneous 
age-related loss of neurons, but the remaining neurons are metabolically and structurally robust. It 
should be noted this study was performed with immunostaining only and features no functional 
assessment components. As a result it is important to take into account that by 70 DIV in our models, 
cells are very likely to be dying in a spontaneous age-related manner and future experiments should 
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characterise network at each time point. A look at 120 DIV (Fig.4.8) shows that there are many dead 
cells by this time point, particularly towards the centre of the MEA where viability was only 50-60%. 
Of particular interest was the activity of SN, which had significantly greater average levels of spike 
frequency than CTX, STR or GP from onset to the final recording. The main differences between the 
cell types that may explain these functional differences are that SN cells were taken at E14 (peak SN 
neurogenesis) rather than E16; neurons in the SN do not originate from the cerebral hemispheres or 
medial or lateral ganglionic eminences (MGE or LGE) like CTX, STR and GP neurons, instead originating 
from the ventral midbrain (VM); and SN neurons contain the only source of dopaminergic neurons 
out of all four cell types (Ellens and Leventhal. 2013). Whilst STR, GP and SN all contain GABAergic 
neurons, there are clear differences in activity for each cell type when cultured separately in vitro. 
The difference in activity presented by SN neural cultures will be discussed further in section 4.3.5.1.  
In summary, both the average and maximum spike frequency increased over time from approx. 15-30 
DIV and plateaued/decreased from 50-70 DIV. As outlined in the introduction (section 4.0.1 Typical 
electrophysiology of basal ganglia nuclei), predicted values for in vitro extracellular recording of 
basal ganglia nuclei were gleaned from the literature. Our experimental values match all these 
predictions, showing the robust nature of our spike frequency data (outlined in Table 4.2). 
Table 4.2: Predicted vs actual spike frequencies. Predicted values from the literature (from in vitro 
extracellular studies where possible) compared to the average (MEAN, Fig.4.14) and maximum (MAX, 
Fig.4.15) spike frequencies from peak to final result from our MEA experiments. 
Basal ganglia nuclei Predicted spike frequency (Hz) Actual spike frequency (Hz) 
Striatum ~0.5-2 for MSNs (Miller et al. 2008), 
10-20 for cholinergic interneurons 
(Walters et al. 2007, Gage et al. 2010). 
MEAN: 0.43-0.78  
MAX: 7.00-9.78 
Globus pallidus (GPe 
and GPi) 
26 for GPi (in vivo), less for GPe 
(Walters et al. 2007). Also show slow 
0.4-1.6 firing (Mallet et al. 2006, Mallet 
et al. 2008, Mallet et al. 2012). 
MEAN: 0.55-2.00 
MAX: 7.00-12.00 
Substantia nigra (SNr 
and SNc) 
10-15 for SNr GABAergic (Boraud et al. 
2002), ~1-4 for SNc dopaminergic (Ding 




The STR, GP and SN all contain populations of low and high frequency firing neurons: STR contains 
slow-firing MSNs and fast-firing cholinergic interneurons, GP contains slow-firing GPe GABAergic 
neurons and fast-firing GPi GABAergic neurons, and SN contains slow-firing SNc dopaminergic 
neurons and fast-firing SNr GABAergic neurons. For the STR, the slow-firing population is in clear 
majority (90% of the STR consists of MSNs), while the GP and SN are more likely equally split between 
the GPe/GPi and SNc/SNr respectively. 
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One way to interpret the data from Table 4.2 is that by taking an average of the frequencies across 
the MEA, the slower-firing population is represented, while by taking the maximum spike frequency 
the faster-firing population is represented. Our STR MEA results line up closely to in vitro and in vivo 
data from the literature (summarised in section 4.0.1.2 Striatum (STR)) with this interpretation, the 
average spike frequency generated by MSNs (~0.7 Hz predicted vs ~0.6 Hz experimental) and the 
maximum frequency generated by interneurons (~15 Hz predicted vs ~8.4 Hz experimental). By 
selecting only the maximum spike frequency received each day from a single electrode, it was 
possible that this is selecting for electrodes that were receiving signals from the STR interneurons, 
which fired at a much faster rate than STR MSNs (Gage et al. 2010). Indeed, the location of the 
maximum spike frequency on STR MEAs was one of the most consistent (Fig.4.16), suggesting that 
these maximum activity locations were in fact electrodes in contact with populations of STR 
interneurons, rather than MSNs that were firing at more than ten times the average rate. 
SN experimental data from our SN MEAs also closely aligned to the literature, if average spike 
frequencies were selecting for SNc dopaminergic neurons (~2.5 Hz predicted vs ~3.3 Hz experimental) 
and maximum frequencies were selecting for SNr GABAergic neurons (~12.5 Hz predicted vs 15.8 Hz 
experimental). SN MEAs displayed significantly higher spike frequencies over time compared to CTX, 
STR and GP. 
There was less data available for in vitro extracellular activity from GP, especially from GPi and GPe 
subunits, as such the data on Table 4.2 is not as accurate as STR and SN data. Mean frequencies of 
firing on GP MEAs were much lower than GPi firing in vivo, but as STR and SN have both been shown 
to fire less in in vitro preparations than in vivo animal models (S. Ding et al. 2011), it is reasonable to 
assume that GP firing was also attenuated in vitro. The large differences between the mean and max 
values from GP MEAs may have been selecting for GPe (1 Hz predicted vs 1.3 Hz experimental if slow 
wave activity) and GPi neuron populations (26 Hz predicted from in vivo vs 9.5 Hz experimental) 
respectively. This maximum activity was more mobile across GP MEAs over time, suggesting that 
there may have been widespread populations of GPi neurons on the MEA. 
4.3.4.1 Greater nigral spiking frequencies 
SN cultures exhibited greater average and maximum spike frequencies at virtually every time point 
compared to cultures from the CTX, STR and GP. One possible explanation is the presence of 
dopaminergic (DA) neurons in SN cultures. There exist multiple firing schemes for midbrain DA 
neurons, which can either exhibit regular pacemaker-like firing activity (1-5 Hz) (Berretta et al. 2010) 
or irregular clusters of high-frequency spikes, referred to as ‘bursts’ (10-20 Hz) (Blythe et al. 2009, 
Marinelli and McCutcheon. 2014). These bursts temporarily increase DA levels in the midbrain and 
can activate certain post-synaptic DA receptors, counteract re-uptake mechanisms and are generally 
vital for DA neuron function (Grace and Bunney. 1983, Dreyer et al. 2010, Marinelli and McCutcheon. 
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2014). Interestingly, genetically modified DA neurons that cannot produce dopamine lose the ability 
to fire bursts, showing only pacemaker activity and a significantly lower spike frequency and inter-
spike time (Paladini et al. 2003, Marinelli and McCutcheon. 2014). In addition, the SN contains 
GABAergic interneurons that have a firing rate of approx. 10 Hz, although these interneurons should 
also account for some level of activity in the STR, GP and even CTX cultures as STR and GP are 
predominantly GABAergic nuclei and CTX contains small populations of GABAergic interneurons 
(Berretta et al. 2010, Ellens and Leventhal. 2013). This combination of fast random firing and frequent 
bursting from two different cell populations, the presence of dopamine, the different developmental 
age (E14 vs E16) and the different developmental region (mesencephalon vs telencephalon) may 
have been responsible for SN neurons having significantly greater average and maximum spiking 
frequencies when compared to CTX, STR and GP neurons, which all have very different roles in basal 
ganglia circuitry. Generally, the reason for a significantly increased spiking frequency in SN cultures 
is challenging to determine, considering that midbrain DA neuron activity is distinctly heterogeneous, 
with variations in activity across individuals, physiological states, development and time (Marinelli 
and McCutcheon. 2014). 
4.3.4.2 Bursting activity 
The number of bursts fired and the number of spikes per burst in each recording session was not 
significantly different between all four cell types. As bursting activity was the same yet there were 
significant differences in overall spiking frequencies, (SN and GP had higher spike frequencies overall 
compared to CTX and STR), SN and GP must have featured significantly more random spikes and 
sub-burst clusters of spikes (<10 Hz) compared to CTX and STR (Ellens and Leventhal. 2013). 
4.3.5 Centroid assessment 
For convenience, spikes were grouped into groups of similar spikes, or ‘centroids’ (see Fig.4.18). For 
this experiment the parameters to create a centroid were a group of more than 50 spikes that were 
more than 80% similar to each other. Various levels of similarity were tested, showing that the 
number of spikes necessary to create a centroid did not largely affect the number of centroids (as 
similar spikes often numbered in the 100s to 1000s), but altering the percentage similarity had a large 
effect on the number of centroids formed. The software in use [Mobius, AlphaMED] only calculated 
up to a maximum of 20 centroids, and when using 50% similarity nearly every electrode from every 
experiment resulted in the full 20 centroids. When using 90-100% similarity, there were rarely more 
than 1-2 centroids and large amounts of data were filtered out. The current value of 80% represented 
a compromise between having too much data and too little after processing. 
As centroids were representative of the waveforms/profiles/shapes of spikes being produced by 
neural cells in culture, the greater the number of centroids the greater the variation in spiking 
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activity. As outlined in the introduction (see Figs.4.2 and 4.3), EAPs can be monophasic/biphasic 
(from cell bodies and/or synapses, see Fig.4.3 right hand side) or triphasic (from axons, see Fig.4.3 
left hand side), and with a negative or positive voltage. This resulted in six different main spike 
waveforms, mostly depending on the location of the electrode in relation to the neuron cell body 
(see Fig.4.4). As the neurons were cultured on a PEI-coated surface, they did not migrate and 
subsequently were always the same distance from the electrodes from day 0 to day 70 (Lelong et al. 
1992, Vancha et al. 2004, B. F. Liu et al. 2006). As the neuron cell bodies did not move, any variation 
in spike waveforms was most likely due to functional maturation or glial proliferation, with cells 
making more synapses that became more mature over time. If two neurons synapsed over an 
electrode, or a neuron extended an axon over an electrode, the received signals may have changed. 
As such, changes in the number and waveform shapes of centroids created from spiking activity 
presented a new perspective to assess the neural culture functional activity from. 
For every cell type, the number of centroids decreased from early (11-21 DIV) to mid (25-44 DIV) to 
late (50-70 DIV) phases (Fig.4.19). This effectively meant that the variation in spikes produced by the 
cells was decreasing. This may mean that the cells were producing less spikes, but the spike and burst 
frequency data (Figs.4.14, 4.15 and 4.17) clearly showed that the cultures were generally producing 
more spikes over time as they functionally matured in vitro. As the spike variability was decreasing 
and the spike frequency was increasing over time, this may be another piece of evidence that the 
cells were experiencing a form of plasticity or LTP/LTD, with certain waveforms and patterns of 
activity being ‘selected’ over time and strengthened until they were the only centroids remaining, 
with other centroids being supressed/depressed (Teyler et al. 1977, Lalanne et al. 2016). This 
occurred across every cell type, with the late stages producing significantly less spikes than the early 
stages, indicating that each cell type was maturing functionally in vitro. 
The shapes of certain centroids also changed over time (Fig.4.20-4.24), but as this data was assessed 
for one electrode across only four different time points for each cell type (due to the time-consuming 
nature of MEA data processing and the sheer volume of data produced), there was a compromise 
between experiments taking too long to complete, and data not being fully representative of the 
MEA as a whole. Centroid shapes were consistent but also changed gradually over time, such as CTX 
(see Fig.4.20), where from 21-70 DIV there were consistently two monophasic centroids, the negative 
one containing more spikes than the positive one, and the positive spike peaking at approx. 30 µV. 
The changes occurred in the negative centroid, which increased in amplitude from approx. -30 µV to 
-50 µV from 44-70 DIV, had a sharper peak, and hyperpolarised to ~8 µV rather than returning to the 
baseline as before. In this manner, certain aspects of centroid shape remained unchanged 
throughout the experiment, whereas other aspects changed. Lewandowksa et al. refer to this change 
of shape over time in vitro as spike ‘evolution’, observing the change in spike shapes recorded from 
E18 rat CTX cultures in channels until 28 DIV (Lewandowska et al. 2015). They also noted that spike 
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amplitude increased over time from 18-37 DIV, spikes had distinct reproducible shapes depending 
on whether they were recording from cell bodies or axons, and complex spike shapes can originate 
from a single cell or from a linear superposition of multiple axonal signals. These findings agree with 
our study, where centroid shapes from CTX, STR, GP and SN MEAs increased in amplitude from 21-44 
or 21-70 DIV (Figs.4.20-4.24, mostly increased in the negative phase), had consistent shapes 
depending on the location of the electrodes, and featured complex spike shapes from STR and GP 
MEAs (Figs.4.21-4.22). This ‘evolution’ of spike shape over time and the dependence of spike shape 
on soma/axon proximity is also consistent with data gathered from other PDMS microchannel 
devices with MEA recording capabilities (Bakkum et al. 2013, Habibey et al. 2015, L. Pan, Alagapan, 
Franca, Leondopulos, DeMarse, Brewer and Wheeler. 2015a, N. Hong et al. 2017b). 
The number of phases of each centroid also differed between cell types, with CTX cells displaying 
positive and negative monophasic centroids, SN cells displaying positive monophasic and negative-
first biphasic centroids while STR and GP displayed all three types, typically with positive monophasic, 
negative-first biphasic and positive-first triphasic centroids. Theoretically, any triphasic centroids 
were generated from axons while mono/biphasic centroids were generated from cell bodies and/or 
synapses. The distinction between ‘what part of a neuron generated what signal’ in these in vitro 
cultures is very difficult to determine as every electrode was in contact with a mix of axons, cell bodies 
and synapses (see Figs.4.6 and 4.7), but in Chapter Five we show that by isolating the cell bodies and 
the axons in separate compartments we can indeed see triphasic centroids from axons and 
mono/biphasic centroids from cell bodies. These generated spikes have also been identified by 
in vitro MEA work from other devices (Lewandowska et al. 2015, Deligkaris et al. 2016) as well as 
through in vivo recordings (Robbins et al. 2013, Dipalo et al. 2017). Interestingly the in vivo recordings 
from Robbins et al. identified monophasic spikes as from pyramidal cells and biphasic spikes as from 
interneurons, suggesting that centroid shape can identify where the signal originated as well as what 
type of cell it originated from. 
Typically, monophasic centroids had a negative peak, biphasic centroids were negative-first with a 
smaller positive recovery and triphasic centroids were ‘positive-first’ followed by a main negative 
spike, the majority of each centroid type being negative. However, positive mirrors of mono- and 
biphasic centroids were also observed (positive monophasic centroids in all four cell types 
Fig.4.20-4.23, positive-first biphasic centroids in STR, GP and SNc Fig.4.21-4.23), albeit containing less 
spikes than negatively-spiking centroids. Most recorded centroids had negative spikes because EAPs 
and extracellular activity were generated by sinks and sources (see Figs.4.2 and 4.3), with spikes 
being negative due to an influx of current from a source to a sink resulting in a negative change in 
the membrane potential (Nam and Wheeler. 2011). Positive EAPs may have been partially generated 
by repolarising potassium (K+) currents, with potassium blockers slightly reducing the amplitude of 
positive EAP peaks, but EAP peaks were also eliminated by sodium (Na+) channel blockers, indicating 
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that there is a strong sodium component to positive EAPs (Sitnikov et al. 2016). The biophysical origin 
of these positive centroids remains to be determined due to the complex extracellular membrane 
ion currents. 
4.3.5.1 Amplitude differences: intracellular vs extracellular 
An AP is defined as an event that occurs once a neuron’s transmembrane potential reaches a 
threshold, either due to stimuli or other inputs such as synapses or gap junctions (Obien et al. 2015). 
Intracellular action potentials (IAPs) and EAPs occur across similar time-frames but differ in amplitude 
(see Fig.4.1). 
As opposed to taking a measurement from the interior of a single neuron, an EAP is affected by the 
morphology and type of the neuron as well as distance from electrode and presence of other neurons 
and glial cells, all potentially on the same electrode (see Fig.4.4) (Pettersen and Einevoll. 2008). EAPs 
also feature a low-pass filtering effect where spike-width increases the further the signal is measured 
from the cell body (again, see Fig.4.4), and EAP amplitude is proportional to the cross-sectional area 
of all dendrites connected to the cell body, with neurons featuring many, thicker dendrites having 
larger amplitude spikes and vice versa. EAPs and IAPs are recorded by very different methods, and 
this results in a very different spike profile and amplitude. 
Over time on the MEA, in vitro neural cultures may develop spatially localised plasticity with low 
variability waveform specific and higher frequency firing within certain tight regions of 
4-5 electrodes, while the rest of MEA has higher variability and lower activity. This activity comes in 
the form of mono-, bi- or triphasic EAPs, with more complex activities producing more complex 
waveforms. 
4.4 Conclusions 
By recording from CTX, STR, GP and SN cultures in isolation for up to 70 DIV, a robust baseline of 
activity to compare data from subsequent experiments to was established. A vast amount of data 
was generated (recording from 64 electrodes for 14 recording sessions for 4 different cell types over 
>4 repeats each), which is presented in a raw format and also after several different kinds of 
processing, namely spike sorting into centroids, extracting spike frequencies, burst numbers, 
generating heatmaps of whole MEAs over time, as well as determining centroid phase, type and 
duration. 
These extracellular recording experiments were able to confirm the neuronal subtypes within each 
population using a functional method (see Table 4.2) which was also reproducible despite the 
presence of inherent biological noise. This in vitro model therefore represents a powerful platform 
for study and through development can effectively translate to other studies. 
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By studying the spontaneous extracellular electrophysiological activity generated by each of these 
basal ganglia nuclei in isolation in vitro over the long term (up to ten weeks), we are now better able 
to produce a model of basal ganglia circuitry. Each of the metrics outlined in the results will be 
compared to the same metrics generated from co-culture work in Chapter Five and Parkinsonian 
work in Chapter Six.  
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Chapter Five: Long-term study of connected neural 
co-culture functionality 
5.0 Introduction 
The basal ganglia (BG) consists of specific nuclei connected in signal pathways, so that input from the 
cortex can be filtered and integrated in order to output to the brainstem and spinal cord. These 
pathways also need to be modelled over the long term in order to better mimic the BG. 
After analysing CTX, STR, GP and SN in isolation as separate cultures the next step was to combine 
two cell types together on an MEA, using the five-port device (5PD), in order to measure the 
spontaneous electrophysiological activity of a co-culture. This was then compared to the seperate 
culture work (Chapter Four) to determine the electrophysiological effects of connecting these basal 
ganglia using the 5PD. 
The relevant in vivo pathways being modelled by these co-cultures are the corticostriatal pathway 
(CTX-STR), striatopallidal pathway (STR-GP) and the nigrostriatal/striatonigral pathways (SNc-STR and 
STR-SNr), all major connections and signal pathways within the basal ganglia (BG) that have vital roles 
in vivo. This aims of this chapter were to re-create these BG pathways using our 5PD and model their 
electrophysiological activity in vitro. 
5.0.1 Corticostriatal (CTX-STR) signal pathway 
5.0.1.1 Corticostriatal structure 
The BG and frontal CTX operate together to execute planned motor activity and other goal-directed 
behaviour in vivo, as such the connection between the CTX and the STR (where the CTX inputs 
information to the BG) is a vital and complex pathway. The corticostriatal pathway involves pyramidal 
glutamatergic neurons of the CTX projecting to and synapsing with the GABAergic medium spiny 
neurons (MSNs) of the STR (which make up 90% of STR neurons, the other 10% being GABAergic and 
cholinergic interneurons) (Yager et al. 2015). These CTX projections originate from numerous areas 
of the CTX and form synapses with MSNs across the entire STR, forming dense dendritic trees and 
topographically complex yet organised connections within the STR (Haber. 2016). Notably, the STR 
also receives a nearly equal number of projections from the glutamatergic neurons of the thalamus 
(namely the thalamostriatal pathway) with cortico- and thalamostriatal connections intermixing on 
MSN dendritic trees (Smith et al. 2004). 
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Figure 5.1: Example pathways within the BG. Note the numerous projections from locations across the CTX 
to areas across the STR. STN: subthalamic nucleus, GPi/e: globus pallidus internal/external segment, 
SNr/c: substantia nigra pars compacta/reticulata NAcc: nucleus accumbens, VTA: ventral tegmental area, 
RR: retrorubral nucleus. Direct pathway involves STR projecting to GPi/SNr, which project to the thalamus. 
Indirect pathway involves STR projecting to GPe and STN, which then project to the GPi/SNr. Light blue 
arrows are glutamatergic, red is GABAergic and pink is dopaminergic. Image adapted from (David. 2009). 
Each of the many excitatory projections from the CTX contain a massive number of neurons, with a 
CTX projection estimated to consist of 5000 CTX neurons, which converge on a single STR neuron. 
Despite these projections consisting of huge bundles of CTX neurons, each CTX neuron within the 
bundle only forms a single synapse on the receiving STR neuron, each projection has the potential to 
activate only that single STR neuron, and there is only a 10% chance of these projections overlapping 
with adjacent STR neurons (Randall et al. 2011). Thus, CTX projections to STR are huge and dense but 
highly organised and structured. 
The STR is unique in that it is the only subcortical area where two types of CTX pyramidal 
glutamatergic neuron projections converge: the STR receives projections from both pyramidal tract 
(PT) neurons and intra-telencephalic (IT) neurons. PT neurons are found in lower layer 5 of the CTX 
that project ipsilaterally to the STR and IT neurons are found in upper layer 5 of the CTX that project 
bilaterally to the STR (Khibnik et al. 2014). In addition to receiving both PT and IT neurons, STR MSNs 
consist of two morphologically identical yet functionally distinct types, namely direct-pathway MSNs 
(dMSNs or D1 MSNs), which project directly to the output nuclei of the basal ganglia (GPi and SNr) 
and express D1-type dopamine (DA) receptors; and indirect-pathway MSNs (iMSNs or D2 MSNs), 
which project to the GPe (which then projects to the STN, which then projects to the GPi and SNr) 
and express D2-type DA receptors (Shepherd. 2013), both seen above in Fig.5.1. This results in 
potentially complex sets of interactions between input glutamatergic PTs and ITs of the CTX and 
GABAergic dMSNs and iMSNs of the STR, across many dense functional territories of the STR. This 
complexity is further increased by the uncertain nature of IT and PT neuron preference for 
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connectivity with either dMSNs and/or iMSNs (Lei et al. 2004, Ballion et al. 2008, Rangel-Barajas and 
Rebec. 2016). 
Regardless, the CTX inputs to the STR from numerous different functional and spatial zones and with 
different glutamatergic neuron subtypes, while the STR receives these inputs across different 
functional (direct and indirect pathways) and spatial zones and with different GABAergic MSN 
subtypes. These structurally dense yet organised corticostriatal synapses make up the main input to 
the BG.  
5.0.1.2 Corticostriatal function 
Functionally speaking, CTX excitatory inputs shape STR activity and subsequently activity of the BG 
as a whole. Studies show that corticostriatal plasticity is necessary for abstract skill learning and 
planning of movement (Koralek et al. 2012), including control of motor decisions in response to 
activity in the somatosensory, auditory, motor and visual cortices (Znamenskiy and Zador. 2013, 
Khibnik et al. 2014). 
5.0.1.3 Corticostriatal electrophysiology 
The massive and organised excitatory inputs from the CTX are vital for MSN electrophysiological 
activity patterns and therefore for STR activity itself. MSNs have a high potassium (K+) conductance 
at rest and as such are usually in a hyperpolarised state. In order to shift to a depolarised state and 
fire action potentials (APs), MSNs require excitatory glutamatergic input from the CTX. Initial 
glutamate input shifts MSNs to their depolarised state and additional glutamate results in firing, 
albeit at a lower frequency than other BG nuclei such as GPi/GPe and SNc/SNr, MSNs averaging 
around 15 Hz in vivo (Rangel-Barajas and Rebec. 2016). In order to avoid excessive excitation and 
chronically hyperactive MSNs, high-frequency GABAergic interneuron firing as well as the GABAergic 
MSNs themselves modulate their own activity via inhibitory GABA. Due to MSNs requiring excitation 
to fire, STR activity is entrained by CTX activity, with CTX oscillations resulting in depolarised or 
hyperpolarised STR MSNs and continued CTX activity resulting in extended periods of STR activity. At 
corticostriatal synapses, a single volley of activity from the CTX increases the glutamate released by 
the next volley, leading to enhanced post-synaptic depolarization with repetitive stimulation (J. Ding 
et al. 2008). 
Studies estimating the number of CTX neurons needed to drive activity in a single STR neuron range 
from 85-1000 synapses, and approximately 15-30 simultaneous inputs to reach a depolarisation 
threshold that allow the STR neuron to fire (Randall et al. 2011). More work is necessary to determine 
the effect and strength of the excitatory connection between CTX and STR neurons. Work from this 
project intend is intended to contribute to the understanding of CTX-STR connectivity, via CTX-STR 
co-culture with the compartmentalised 5-port device (5PD). In vitro work has shown that both mixed 
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(Randall et al. 2011) and compartmentalised-yet-connected (Virlogeux et al. 2018) CTX and STR 
co-cultures have a similar resting activity to the in vivo system, as well as demonstrating excitatory 
firing from CTX neurons to STR neurons in a unidirectional capacity in vitro. 
Recent models have adopted compartmentalised microfluidic devices in order to study CTX-STR 
co-cultures in order to study Huntington’s disease (HD), a condition caused by degeneration of STR 
MSNs and specific CTX neurons (Virlogeux et al. 2018). Defects in the corticostriatal pathway causing 
debilitating and progressive neurodegenerative disease is a clear sign of the importance of this 
pathway and what we stand to gain and learn from modelling it in our functional in vitro model. 
5.0.2 Striatopallidal (STR-GPe/i) signal pathway 
5.0.2.1 Striatopallidal structure 
Receiving signals from the CTX and STN, the STR is the main input nuclei to the BG. Information is 
transferred and filtered through the BG from input (STR) to output (GPi/SNr) by two major signal 
pathways: the direct and the indirect pathways. Both pathways consist of GABAergic projection MSNs 
from the STR to GP nuclei and are therefore both inhibitory. 
The indirect pathway is where iMSNs (or D2 MSNs) project from the STR to the GPe (then to the STN 
and then GPi/SNr, as seen in Fig.5.2) (Sano et al. 2013). These projecting iMSNs inhibit GPe activity, 
reducing GPe inhibition of STN activity (the STN normally acting to excite GPi/SNr activity) resulting 
in increased GPi/SNr activity output to the thalamus and suppressed movement. Studies show 
ablating iMSNs of the STR results in motor hyperactivity. 
The direct pathway is where dMSNs (or D1 MSNs) project from the STR directly to the GPi/SNr. This 
pathway involves directly inhibiting the activity of the GPi/SNr output nuclei, resulting in decreased 
GPi/SNr activity and increased movement, namely the opposite effect of the indirect pathway (Ellens 
and Leventhal. 2013). As a result, the direct and indirect pathways are also referred to as the ‘go’ and 
‘no-go’ pathways respectively. However, these dMSNs also innervate the GPe in passing. 
Data on rodent striatopallidal projections is limited but suggests a tripartite organisation of STR 
projections to GPe, where MSN neurons from the medial, lateral and ventral regions of the STR 
project to neurons from the same regions on the GPe (Gittis et al. 2014). 
5.0.2.2 Striatopallidal function 
The direct and indirect pathways are functionally distinct and work in concert, carefully regulating 
the planning and execution of movement by careful inhibition of select nuclei within the BG. 
However, while the pathways have long been considered functionally separate, they have been 
shown to not be anatomically separate. Some anatomical studies on mice suggest that most (and 
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maybe all) MSNs of the STR project to the GPe, with some being part of the indirect pathway that 
projects directly to the GPe, and others being part of the direct pathway and sending collaterals to 
the GPe on their way to the GPi/SNr (Kupchik et al. 2015), suggesting a degree of overlap between 
indirect and direct pathways (Bertran-Gonzalez et al. 2010). Labelling of 120 STR MSN projection 
neurons in mice showed that 37% projected exclusively to the GPe (indirect) and 3% projected 
exclusively to the GPi/SNr (direct). The remaining 60% projected to the GPi/SNr and collaterally to 
the GPe, bridging both the direct and indirect pathways (Cazorla et al. 2014). These relationships are 
outlined in a simpler BG diagram on Fig.5.2. 
By culturing STR in one port and GP in another, using our 5PD, we could assess these direct and 
indirect pathways in isolation.  
5.0.3 Striatonigral (STR-SNr) 
While the two sections of the GP (GPi and GPe) are largely similar in cellular composition and can 
represent each other in this model, the SN represents a larger issue. In vivo the SN consists of one 
mostly GABAergic nuclei (SNr) and one mostly dopaminergic nuclei (SNc) (Ellens and Leventhal. 
2013). By dissecting the SN as a whole the result is a mix of SNr GABAergic and SNc dopaminergic 
neurons. This mixture has been used in previous chapters to represent the SNc, as this model is 
fundamentally aiming to model Parkinson’s disease (caused by the loss of dopaminergic neurons 
projecting from the SNc to the STR and modelled by the nigrostriatal SNc-STR co-culture). The mixture 
cannot be used to represent the SNr, which does not include any dopaminergic neurons and would 
be inaccurate, while the SNc is a mixture of dopaminergic and GABAergic. As such, modelling the 
STR-SNr striatonigral pathway is rather difficult, especially when the direct and indirect pathways are 
already modelled by the STR-GP striatopallidal co-culture where the GPi performs the same role as 
the SNr, namely a GABAergic output of the BG. While it is possible to selectively remove the 
dopaminergic neurons with 6-hydroxydopamine (6-OHDA), this experimental technique was largely 
confined to Chapter Six on SNc seperate cultures and SNc-STR co-cultures in order to mimic 
Parkinson’s disease. As a consequence, modelling the STR-SNr pathway was outside the scope of this 
project due to time constraints and lack of experimental value. 
5.0.4 Nigrostriatal (SNc-STR) 
The nigrostriatal pathway consists of dopaminergic neurons from the SNc projecting to and synapsing 
with the GABAergic MSNs of the STR, with these projecting neurons transporting dopamine (DA) to 
the STR. The presence of numerous postsynaptic DA receptors in the STR mean that SNc activity 
results in DA release and downstream modulation of STR activity. There are multiple types of DA 
receptor in the STR, major receptor sub-types being D1 (forms the direct pathway) and D2 (forms the 
indirect pathway) but neurons of the STR can also express D3 (Booze and Wallace. 1995), D4 (Rivera, 
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Cuellar et al. 2002) and D5 (Rivera, Alberti et al. 2002) DA receptor subtypes, resulting in DA release 
to the STR having a multitude of effects and being necessary for a functioning BG and consistent 
motor behaviours (Rice and Cragg. 2008). A summary of the distribution of these five DA receptors 
can be found in (Tritsch and Sabatini. 2012). 
A single nigrostriatal projection influences many STR neurons simultaneously of both D1 and D2 
types, with nigrostriatal neurons having dense dendritic trees allowing for many connections with 
the STR. Studies have shown this dendritic arbour to be approximately 1.12 mm3 in volume, allowing 
one SNc neuron to access ~75,000 STR neurons of both D1 and D2 types, due to their dense 
intermixing (Korchounov et al. 2010). This presents a different method of connectivity to 
corticostriatal projections, which contain many neurons but only one synapse each, whereas SNc 
projections can contain fewer axons but many more synapses. 
With DA having numerous effects on the STR and single SNc neurons synapsing with tens of 
thousands of STR neurons, DA release from the SNc has a marked effect on STR activity. At rest, there 
are nanomolar (nM) concentrations of DA in the STR (a concentration which best interacts with D1 
receptors and the direct pathway) and upon movement activity there are micromolar (μM) 
concentrations of DA in the STR (a concentration preferred by D2 receptors and the indirect pathway) 
(Korchounov et al. 2010). The nigrostriatal pathway is therefore vital for the BG to process motor 
function and planning of movement, with degradation of this pathway resulting in reduced 
movements observed in Parkinson’s disease. Therefore this pathway has been subject to intense 
research over the decades, and by culturing an SN-STR model within the 5PD, we can potentially 
accelerate this research. 
A summary outlining these pathways is presented schematically in Fig.5.2. 
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Figure 5.2: Diagram of connectivity within BG. Green arrows are glutamatergic and excitatory, red arrows 
are GABAergic and inhibitory (also indicated by diamond-head arrows), the blue arrow is dopaminergic and 
modulatory. Coloured areas indicate those regions of the BG used in the 5PD, namely CTX, STR, GP and SNc/r. 
5.0.5 Designing connected co-cultures 
Taking into account BG connectivity and the nuclei being modelled throughout this experiment, the 
three most useful signal pathways to model are the corticostriatal (CTX-STR), nigrostriatal (SNc-STR), 
and striatopallidal (STR-GP) pathways, allowing for the modelling of two input pathways and one 
output pathway. In order to best model these pathways, both relevant cell types should be seeded 
into the five port device (5PD), with the ‘input’ port presented with larger channel widths and the 
‘output’ port presented with smaller channel widths. Corticostriatal and nigrostriatal should be 
CTX-STR and SNc-STR respectively, while striatopallidal should STR-GP. Design of these co-cultures 
can be seen in Fig.5.3. 
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Figure 5.3: Layout of co-cultures on MEA. A) Basal ganglia circuitry within the brain in vivo, green, red and 
blue connections are inhibitory, excitatory and dopaminergic respectively, the coloured rectangles represent 
the five nuclei being modelled, namely the CTX, STR, GP, SNc and SNr. The grey dashed square represents 
the boundaries of the basal ganglia. B) the two input, central and two output nuclei being modelled by our 
five port device, same labelling used in A. C) The five port device, ports labelled with the relevant cell type, 
namely CTX or SNc into the input port (left hand side), STR into the central port and GP into the output port 
(right hand side), in order to make CTX-STR, SNc-STR or STR-GP co-cultures. The dashed square represents 
the magnified area in D. D) The location of the MEA within the five-port device, to scale. The 64 electrodes 
occupied both a side port and the central port, but the location is suboptimal due to MEA bracket limitations, 
ideally both the side and centre port would share an equal amount of electrodes. This issue with MEA 
alignment is discussed in Chapter 7 and is due to MEA hardware. Scale bar for C and D is 1 mm. 
 
5.0.6 Chapter Five Aims and Objectives 
Building on the previous work presented in Chapter Four on CTX, STR, GP and SNc in isolation, this 
chapter aimed to study the spontaneous extracellular electrophysiological activity of CTX-STR, 
STR-GP and SNc-STR co-cultures in 5PDs over the long term in culture (up to 70 DIV). 
 
 166 
5.1 Experimental Methods 
The methods involved in this chapter were previously outlined in Chapter Two. 
5.1.1 Device surface preparation 
As seen in section 2.1.1 device preparation: chemical coating, MEAs were sterilised with 70% IMS 
for 15 minutes, then dried and coated first with 0.05% PEI for 1 hour (at rtp), then 0.1 mM PDL 
overnight at 37 °C, washing between each stage. MEAs were then dried and ready for cell culture. 
5PDs were cast from PDMS and attached to the centre of the MEA, then flushed with sterile water 
and incubated to remove any air or bubbles. 
5.1.2 Primary cell culture 
As seen in section 2.2 Primary cell culture, tissue was dissected from E16/14 Sprague-Dawley rat 
embryos: E16 for CTX, lateral and medial ganglionic eminences (LGE and MGE), corresponding to the 
CTX, STR and GP respectively; and E14 for the ventral midbrain (VM), corresponding to the SN. These 
tissues were dissociated and 100,000 cells were seeded directly into the relevant port on the 5PD, 
namely an input port for CTX/SNc, central port for STR and output port for GP. This made three co-
cultures, namely CTX-STR, SNc-STR and STR-GP. After seeding the ports were flooded with growth 
media and the cells incubated at 37° C, 5% CO2. 
5.1.3 Electrical activity measurement with MEA 
Recordings of cell electrophysiological activity (section 2.5.2 MEA: Recordings) were taken once a 
week from 0 DIV to 70 DIV, before a weekly media change. MEAs were moved to a heated bracket 
(at 37 °C) attached to amplifiers and digitisers. Activity was recorded for four minutes in triplicate, 
totalling 12 minutes of recording, using MED64 hardware with Mobius software. These data were 
stored on the MEA PC for analysis. 
5.1.4 MEA data management and analysis 
Spontaneous electrophysiological data obtained from neural cultures was analysed using Mobius 
software (section 2.5.2 MEA: Analysis). Data was band-pass filtered to remove data below 100 Hz 
and above 10 kHz, and the spike detection threshold was 500% of the root mean square. These spikes 
were further filtered into centroids (discrete filtered groups of spikes), each centroid consisting of 
>50 spikes that are >80% in similarity. These centroids were assessed to determine the number, 
frequency, amplitude and waveform of both spikes and bursts. 
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5.2 Results 
5.2.1 Primary cell culture 
CTX, STR, GP and SNc neural cells were successfully cultured within five-port devices (5PDs) sealed 
to MEAs in co-culture, namely CTX-STR, STR-GP and SNc-STR. Images of E16 CTX cells on MEA 
electrodes were used to demonstrate the relationship between cells, channels and electrodes 
(Fig.5.4). 
 
Figure 5.4: 100,000 E16 CTX cells cultured on MEAs, imaged with brightfield after 8 DIV. A) Electrode in 
contact with cell bodies and axons at high density, B) electrode within channel in contact with just axons, 
C) electrode not in contact with cell body or axon but both are in close proximity, D) electrode in contact 
with network of axons and few cell bodies, E) six electrodes all in contact with cell bodies and axons. Scale 
bars 100 µm. 
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Most electrodes were in contact with cells, but on occasion cells would grow in a way that meant 
they avoided contact with the electrodes as seen in Fig.5.4C. Electrodes were in position on both 
sides of the micro-channels as displayed by Fig.5.5, which shows the layout of electrodes in relation 
to the channels, in a device where CTX cells were seeded onto the left-hand side and STR cells onto 
the right-hand side. 
 
Figure 5.5: 100,000 E16 CTX and STR cells cultured on MEAs (CTX seeded to left of channels STR to right) and 
imaged with brightfield after 8 DIV, images aligned to channels. A-C and D-F represent the channels of two 
separate devices (with C showing the boundary between the upper and lower side ports). Images are aligned 
in relation to their position on the MEA. All scales 100 µm. 
5.2.2 Heatmaps 
Each co-culture consisted of two cell ports linked by channels, with one port consisting of STR neural 
cells and one of either CTX, GP or SNc neural cells. As well as noting how the activity varies across the 
whole MEA, with co-cultures the pattern of activity was also be analysed across each port and the 
channel section, resulting in multi-sectioned heatmaps and spiking data from each side of the 
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channels and within the channels themselves. Heatmaps from CTX-STR, STR-GP and SNc-STR devices 
can be seen in Fig.5.6, with each port and the channels outlined in black to indicate the sections of 

















































































































































































































































Figure 5.6: Averaged representative heatmaps (n=4) from CTX-STR, STR-GP and SNc-STR from 4-70 DIV. 
Traffic light scale indicates where activity ranged between high (green), average (yellow) or low (red). The 
three schematics above indicate the orientation and cell types contained within the 5PD on the MEA. 
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5.2.3 Percentage activity, average and maximum spiking frequency 
The percentage activity across the MEA was calculated from the heatmap data by establishing a 
threshold for activity. This data is combined with the average and maximum spike frequencies over 
time across each port and the channels of the MEA, and correltion analysis to determine similarities 
between areas and which area drives activity, as seen in Fig.5.7. 
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Figure 5.7: Percentage activity, average spike frequency and maximum spike frequency over time for 
CTX-STR, STR-GP and SNc-STR co-cultures on MEAs. Data was taken from each port and channels between 
ports, each graph is combined with a table of correlation coefficients (the greater the value, the greater the 
level of correlation, max value 1). A) CTX-STR percentage activity, B) STR-GP percentage activity, C) SNc-STR 
percentage activity, D) CTX-STR average spike frequency, E) STR-GP average spike frequency, F) SNc-STR 
average spike frequency, G) CTX-STR max spike frequency, H) STR-GP max spike frequency, I) SNc-STR max 
spike frequency. Asterisks represent results of multiple post-hoc t-tests, (*): p<0.01, (**): p<0.001, 
(***): p<0.0001, compared to other conditons at the same time point. (n=4). 
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5.2.3.1 Percentage activity 
Percentage activity was assessed for both cell ports to determine any differences. All co-cultures 
displayed a clear onset, peak and decrease in the percentage of MEA electrodes recording activity 
(Figs.5.7A-C) For CTX-STR co-cultures (Fig.5.7A graph) the cell type had a significant effect on the 
percentage activity (ANOVA (2,3) F=10.68, p=0.0432), with the STR port having significantly more 
activity from 50-57 DIV. The correlation between the cortical port and the channels (CTX-channels) 
was higher than both the channels and the STR port (channels-STR), and the CTX port and the STR 
port (Fig.5.7A table). For STR-GP cultures (Fig.5.7B graph) there was no significant effect of cell type, 
all correlations were high (Fig.5.7B table), but the peak of percentage activity was lower than CTX-
STR or SNc-STR cultures (76.7% vs 93% and 95.7% respectively). Lastly, in SNc-STR co-cultures 
(Fig.5.7C graph) the cell type also had a significant effect on the percentage activity (ANOVA (2,6) 
F=7.927, p=0.02) with the STR port having significantly lower activity from 42-50 DIV, and the 
correlation between SNc-channels was greater than SNc-STR or STR-channels (Fig.5.7C table). 
5.2.3.2 Average spiking frequency 
Average spiking frequency was calculated by taking the average number of spikes across each area 
and determining the number of spikes per second over a 12 minute (720 second) recording session. 
All co-cultures displayed an onset of activity after 11 DIV (Figs.5.7D-F), rose to a peak after 20-40 DIV 
and then fell to negligible spiking levels from 50-70 DIV. For CTX-STR and SNc-STR co-cultures, the 
interaction between the cell type and time was significant (CTX-STR ANOVA (22,33) F=4.42, p<00001) 
(with CTX spiking being significantly greater after 30 DIV (Fig.5.7D)), (SNc-STR ANOVA (22,66) 
F=1.723, p=0.0469) (with STR spiking being significantly greater after 20 DIV (Fig.5.7F)), but there was 
no significant effect on STR-GP co-cultures (Fig.5.7E). CTX-STR and SNc-STR co-cultures also had the 
highest correlation between input-channels (as opposed to channels-output) and similar 
levels/timings of peak activity (9.51 Hz at 29 DIV vs 12.3 Hz at 36 DIV respectively). STR-GP co-cultures 
had the lowest level of average spike frequency, only peaking at 3.38 Hz. 
5.2.3.2 Maximum spiking frequency 
As average spiking also included all the electrodes that recorded no activity (zero spikes), the 
maximum spike frequency from each recording session was also analysed to see how the activity 
changed over time (Figs.5.7G-I). Similarly to average spike frequencies, CTX-STR (Fig.5.7G) and 
SNc-STR (Fig.5.7I), co-cultures had a significant interaction between cell type and time (CTX-STR 
ANOVA (22,33) F=5.56, p<00001) (with STR and CTX spiking being significantly greater after 50 DIV 
and 57 DIV respectively (Fig.5.7G)), (SNc-STR ANOVA (22,66) F=5.162, p<0.0001) (with STR spiking 
being significantly greater after 21 DIV (Fig.5.7I)), but there was no significant effect on STR-GP 
co-cultures (Fig.5.7H). Notably in SNc-STR devices, STR spiking was extremely high after 21 DIV, 
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reaching 179±60 Hz compared to STR peaks of 30.6±3 Hz in CTX-STR devices and 15±10 Hz in STR-GP 
devices. 
5.2.4 Bursting activity 
Bursts were defined as periods of activity of over 10 Hz (a bundle of more than ten spikes produced 
within a second) and the number of bursts over time for each co-culture was assessed, along with 
the number of spikes per burst over time. These graphs can be seen in Fig.5.8. 
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Figure 5.8: Bursting activity (split into number of bursts fired and number of spikes per burst) over time for 
CTX-STR, STR-GP and SNc-STR co-cultures on MEAs. Data was taken from each port and channels between 
ports, each graph is combined with a table of correlation coefficients (the greater the value, the greater the 
level of correlation, max value 1). A) number of bursts fired by CTX-STR, B) number of bursts fired by STR-GP, 
C) number of bursts fired by SNc-STR, D) spikes per burst from CTX-STR, E) spikes per burst from STR-GP, 
F) spikes per burst from SNc-STR. Asterisks represent results of multiple post-hoc t-tests, (*): p<0.01, 
(**): p<0.001, (***): p<0.0001, compared to other conditons at the same time point (n=4). 
Similarly to spike frequencies, the numbers of bursts had an onset (after 11-15 DIV), peak (from 30-40 
DIV) and decline (50-70 DIV). Unlike spike frequencies CTX-STR co-cultures had no significant 
differences in the number of bursts fired over time, but there was a significant interaction between 
cell type and time for STR-GP (ANOVA (22,33) F=9.74, p<0.0001) and SNc-STR co-cultures (ANOVA 
(22,33) F=3.23, p=0.0012). The GP port of STR-GP devices had extremely low bursting activity, 
negligible from 21-70 DIV, and the STR port of SNc-STR devices had significantly lower bursting from 
21-29 DIV. Peak numbers of bursts were 37 bursts (36 DIV) for CTX-STR, 44 bursts (36 DIV) for STR-GP 
and 116 bursts (29 DIV) for SNc-STR, with the latter having a far greater level of bursting over time of 
the three co-cultures. 
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The number or spikes per burst was consistent over time for STR-GP and SNc-STR co-cultures, 
averaging at 30 spikes per burst over time from onset until 70 DIV. However, the number of spikes 
per burst changed significantly in the channels and CTX areas of CTX-STR devices from 44-50 DIV, 
where the average number of spikes per burst increased to 73. 
5.2.5 Centroid number 
Spikes were sorted into centroids and analysed to determine how the number of centroids changes 
over time. The number of centroids over time across each of the co-cultures can be seen on Fig.5.9. 






















































































































































































































































Figure 5.9: Number of centroids for CTX-STR (A-C), STR-GP (D-F) and SNc-STR (G-I) co-cultures, for the 
left-hand input port (A, D, G), channels (B, E, H) and right-hand output port (C, F, I). Each time point shows 
how many centroids were registered by each electrode. The early (15-29 DIV), mid (36-51 DIV) and late 
(58-70) stages are indicated by the rectangular outlines, with the horizontal black line indicating the averaged 
number of centroids for each section. (n=4), representative average images. 
In the majority of cases, the number of centroids at the late stage (50-70 DIV) was significantly lower 
than the number of centroids at the early (11-25 DIV) and/or mid (29-44 DIV) stage, except for the 
channels of SNc-STR devices where there was no significant change but otherwise a clear trend. This 
shows that for every co-culture, spike shape variability was decreasing in all three parts of the 
co-culture (left port, channels, right port) over time. STR neurons in STR-GP devices displayed a low 
number of centroids throughout experimentation, suggesting that there was little activity in this port 
but the variability still fell at the end stage. 
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5.2.6 Centroid shape categorisation 
As with the previous chapter, centroids were sorted into six categories (positive/negative 
monophasic, positive-first/negative-first biphasic and positive-first/negative-first triphasic), 
depending on their number of phases and sign (see Fig.4.25 for more information). Centroid 
proportions for the left-hand port, channels and right-hand port for CTX-STR, STR-GP and SNc-STR 
are displayed in Fig.5.10. 
Centroids generated in channels were mostly triphasic centroids, indicating that channels contained 
many axons. Channels should contain a much higher concentration of axons than other areas as they 
are the link between two ports and designed for axonal outgrowth, and axons generate triphasic 
waveforms (refer to Fig.4.3). 
In addition, the proportion of centroid shapes produced by STR neurons changed depending on STR 
connectivity to CTX, SNc or GP, where in CTX-STR and SNc-STR devices STR has similar centroid 
proportions to CTX and SN respectively, and in STR-GP devices STR has less centroids overall.  
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Figure 5.10: Centroid shape categorisation. All centroids from 70 days of recording from each part of each 
co-culture were sorted into six types. Numbers on pie segments indicating the numbers of centroids in that 
category (with the total number of centroids below each chart), (n=4). 
 175 
5.2.7 Centroid full duration at half maximum 
The full duration at half maximum (FDHM) is a means of measuring the width of the peaks that make 
up centroids (as the x-axis is time, the width is also the duration). In this manner, any changes in the 
width of centroid peaks can be assessed. The FDHM was extracted and processed to determine if 
centroid shape changes over time, and if there are differences between both ports and the channels, 
with data displayed in Fig.5.11. 
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Figure 5.11: Centroid full duration at half maximum (FDHM) over time for each area (input, channels, and 
output) of each co-culture, (A-C). D shows a table of correlation coefficients comparing input-channels, 
channels-output and input-output, with a value of 1 being perfect correlation. 
There were no significant differences in the FDHM of centroids generated from the ports and 
channels of each co-culture. Centroids mostly ranged from 0.5-1.0 ms (Fig.5.11A-C) and were closely 
correlated between input-channels and channels-output (Fig.5.11D). 
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5.3 Comparisons of separate cultures and connected co-cultures 
In this section, MEA electrophysiological data from separate cell populations (reported in Chapter 
Four) are compared to data from connected cell populations, namely CTX vs CTX-STR, GP vs STR-GP, 
SNc vs SNc-STR and STR vs STR in each co-culture. This comparison is to determine how each aspect 
of activity has altered by connectivity to other BG neural cell types, using the Chapter Four separate 
culture MEA data as a baseline. 
5.3.1 Percentage activity 
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Figure 5.12: A comparison between the percentages of active electrodes over time for separate (CTX, STR, 
GP or SN) and connected (co-cultures of CTX-STR, STR-GP, and SNc-STR) cultures on MEAs. Each separate 
culture is compared with the relevant port of the corresponding co-culture, with separate STR compared to 
the STR port within each co-culture (n=4). Asterisks are generated from post-hoc t-tests 
(*): p<0.01, (**): p<0.001, (***): p<0.001. 
CTX within CTX-STR co-cultures had an earlier onset of activity than separate CTX cultures (Fig.5.12A), 
and while the effect of connectivity on the number of active electrodes was not significant (ANOVA 
(1,3) F=7.35, p=0.07), there was a trend for connected CTX to have greater activity across the MEA. 
Both cultures peaked on 21 DIV (separate 62 ± 5% vs connected 88 ± 3%) then decreased from peak 
to final recording. GP within STR-GP co-cultures and separate GP cultures had similar onset and 
activity throughout (Fig.5.12B), with connectivity not significantly changing the percentage of active 
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MEA electrodes over time (ANOVA (1,4) F=0.67, p=0.46). For SN within SNc-STR co-cultures and 
separate SN cultures (Fig.5.12C), the effect of connectivity was not significant (ANOVA (1,4) F=3.60, 
p=0.13). Both SN cultures displayed an onset of activity by 11 DIV, but separate SN cultures had 
greater activity across the MEA at early (11-15 DIV) and late (50-70 DIV) phases. Comparing separate 
STR cultures with connected STR co-cultures (Fig.5.12D), the effect of connectivity had a significant 
effect on the percentage of active electrodes across the MEA (ANOVA (3,7) F=18.21, p=0.001). 
Separate STR cultures had significantly lower activity than connected STR from 27-38 DIV, while STR 
in CTX-STR co-cultures had significantly greater activity than separate STR on 21 DIV, and then 44-65 
DIV. 
5.3.2 Average spike frequency 
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Figure 5.13: A comparison between the average spike frequencies over time for separate (CTX, STR, GP or 
SN) and connected (co-cultures of CTX-STR, STR-GP, and SNc-STR) cultures on MEAs. Each separate culture is 
compared with the relevant port of the corresponding co-culture, with separate STR compared to the STR 
port within each co-culture (n=4). Asterisks are generated from post-hoc t-tests (n=4). (*): p<0.01, 
(**): p<0.001, (***): p<0.0001. 
Compared to separate CTX culutres, CTX average spike frequency was significantly increased through 
connectivity to STR cultures in CTX-STR devices (ANOVA (1,3) F=99.08, p=0.002). This significant 
increase is clearly seen from 21-65 DIV (Fig.5.13A), with separate CTX cultures peaking at 0.77 ± 2 Hz 
(51 DIV) while CTX cultures in CTX-STR co-cultures peaked at 9.51 ± 0.5 Hz (27 DIV). This significant 
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effect of connectivity was not seen between separate GP and connected STR-GP co-cultures 
(Fig.5.13B), but connected GP cultures did have a marginally higher (3.4 ± 2 Hz vs 1.9 ± 3 Hz) and far 
earlier (27 vs 44 DIV) peak of firing. For separate SN and connected SNc-STR cultures, despite the 
extremely high peak in spike frequency on 38 DIV (12.3 ± 1.5 Hz), there was not a significant effect 
of connectivity. However, there was a significant effect of connectivity on the average spike 
frequency for STR cultures (ANOVA (3,7) F=31.71 p=0.0002), with STR innervated by SNc or CTX 
cultures firing at a significantly higher frequency from 21-27 DIV or 50-70 DIV respectively. STR in 
STR-GP co-cultures was not significantly different to separate STR, indicating that innervation by CTX 
and/or SN neurons had a significant effect on spiking activity. 
5.3.3 Maximum spike frequency 
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Figure 5.14: A comparison between the maxium spike frequencies over time for separate (CTX, STR, GP or 
SN) and connected (co-cultures of CTX-STR, STR-GP, and SNc-STR) cultures on MEAs. Each separate culture is 
compared with the relevant port of the corresponding co-culture, with separate STR compared to the STR 
port within each co-culture (n=4). Asterisks are generated from post-hoc t-tests (n=4). (*): p<0.01, 
(**): p<0.001, (***): p<0.0001. 
Despite the increased maximum spike frequency of CTX in CTX-STR co-cultures from 39-60 DIV 
(peaking at 22.5 ± 2.5 Hz vs 7.3 ± 4.2 Hz), the effect of connectivity on CTX maximum spike frequency 
was not significant. This was also the case for GP cultures, where connectivity did not have a 
significant effect on maximum spike frequency, both were at similar levels throughout. However, for 
SN cultures, connectivity did have a significant effect on maximum spike frequency (ANOVA (1,4) 
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F=11.45, p=0.03). For SNc connected to STR in co-cultures, spike frequency was significantly 
increased at both early (25 ± 6 Hz at 15 DIV) and late timepoints (peak at 68 ± 6.6 Hz on 39 DIV) but 
fell to negligible levels from 50-70 DIV, compared to the relatively consistent spiking activity of 
separate SN cultures. STR connectivity also had a significant effect on maximum spike frequency 
(ANOVA (3,7) F=6.7, p=0.02), with SNc-STR having the highest levels of max spike frequency. 
Maximum spiking from SNc-STR co-cultures were significantly greater from 35-44 DIV (57 ± 35 Hz 
then 61 ± 50 Hz respectively), and with an extremely high peak on 21 DIV (177 ± 70 Hz). STR maximum 
spiking was also increased through connectivity to CTX, but decreased through connectivity to GP. 
5.3.4 Bursting 
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Figure 5.15: A comparison between the average numbers of bursts fired over time for separate (CTX, STR, GP 
or SN) and connected (co-cultures of CTX-STR, STR-GP, SNc-STR) cultures on MEAs. Each separate culture is 
compared with the relevant port of the corresponding co-culture, with separate STR compared to the STR 
port within each co-culture (n=4). Asterisks are generated from post-hoc t-tests (n=4). (*): p<0.01, 
(***): p<0.0001. 
CTX separate cultures and CTX-STR connected co-cultures had similar levels of bursting (Fig.5.15A), 
with connectivity not having a significant effect on the average numbers of burst fired. CTX-STR 
bursting did peak earlier than separate CTX bursting (39 vs 65 DIV) but otherwise bursting was similar 
between conditons. For GP, connectivity had a significant effect on burst firing (ANOVA (1,2) F=11.88, 
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p=0.04), with bursting reduced to negligible levels in STR-GP co-cultures (Fig.5.15B). Separate GP 
culture bursting was significantly greater from 39-50 DIV, peaking at 70 bursts (44 DIV). Connectivity 
also had a significant effect on SN bursting (ANOVA (1,2) F=35.39, p=0.02), the difference being that 
connected SNc-STR cultures had significantly greater bursting than separate SN cultures, with 112 
bursts on 39 DIV. Overall SN cultures had more bursting than other cell types (Fig.5.15C). 
Interestingly, there was a trend amongst STR cultures for peak bursting on 39 DIV, but connectivity 
did not have a significant effect on bursting in STR cultures.  
As well as comparing the average number of bursts fired over time, the average number of spikes 
per burst over time was also compared between separate cultures and connected co-cultures, as 
seen in Fig.5.16. This measure determines the length of the ‘spike trains’ contained within bursts, 
which can differ between different areas of the basal ganglia (van Pelt et al. 2005, Blythe et al. 2009, 
Ellens and Leventhal. 2013, Abrahamsson et al. 2016). 
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Figure 5.16: A comparison between the numbers of spikes per burst (always ≥10) over time for separate (CTX, 
STR, GP or SN) and connected (co-cultures of CTX-STR, STR-GP, SNc-STR) cultures on MEAs. Each separate 
culture is compared with the relevant port of the corresponding co-culture, with separate STR compared to 
the STR port within each co-culture (n=4). 
All comparisons did not feature a significant difference of the number of spikes per burst due to 
connectivity. Most separate cultures featured bursts with a consistent ~20 spikes per burst, whilst 
connected cultures had a greater variation, with CTX connected to STR peaking at 55 ± 10 spikes per 
burst (Fig.5.16A), and SNc connected to STR peaking at 38 ± 20 spikes per burst (Fig.5.16C).  
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5.3.5 Centroid shape categorisation 
The effect of connectivity was also observed on the number of phases of activity centroids and the 
proportion of these phases, as seen in Fig.5.17. 
 
Figure 5.17: Centroid shape categorisation. All centroids from all 70 days of recording from each part of each 
culture/co-culture was sorted into six types. A) CTX vs CTX in CTX-STR devices, B) GP vs GP in STR-GP devices, 
C) SNc vs SNc in SNc-STR devices, D) STR vs STR in each co-culture. Numbers on pie segments indicating the 
numbers of centroids in that category (with the total number of centroids below each pie), (n=4). 
Fig.5.17A: Similar overall level of centroids, CTX-STR has larger proportion of triphasic centroids but 
lower proportion of biphasic centroids compared to CTX. Fig.5.17B: GP in STR-GP has much fewer 
centroids and more monophasic centroids than GP. Fig.5.17C: Similar overall level of centroids, 
SNc-STR has larger proportion of triphasic centroids and lower proportion of biphasic centroids 
compared to SNc. Fig.5.17D: STR in STR-GP devices has less centroids overall and similar proportions 
to STR in CTX-STR devices. STR in SNc-STR devices has a higher proportion of triphasic and biphasic 
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centroids compared to CTX-STR and STR-GP, but less biphasic centroids than STR alone. Overall, it 
appears that connectivity increased the number of triphasic centroids and did not change the overall 
number of centroids, apart from in STR-GP devices. 
5.3.6 Centroid full duration at half maximum 
The centroid peak duration (FDHM) was also compared between separate and connected cultures to 
determine any changes (Fig.5.18). 
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Figure 5.18: A comparison between the average full duration at half maximum (FDHM) of centroids over time 
for separate (CTX, STR, GP or SN) and connected (co-cultures of CTX-STR, STR-GP, and SNc-STR) cultures on 
MEAs. Each separate culture is compared with the relevant port of the corresponding co-culture, with 
separate STR compared to the STR port within each co-culture. Asterisks are generated from post-hoc t-tests 
(n=4). (*): p<0.01, (***): p<0.0001. 
Connectivity had a significant effect on the FDHM of CTX cultures (ANOVA (1,2) F=830.5, p=0.001), 
with CTX connected to STR in CTX-STR co-cultures having significantly greater FDHM from all 
recordings bar the latest (65-70) and 21 DIV. This indicates that centroids generated from connected 
CTX have a significantly longer duration at their peak. GP, SN and STR did not feature a significant 
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changes in FDHM from connectivity, indicating that centroids were largely similar in duration 
whether generated by separate cultures or connected co-cultures. 
5.4 Discussion 
The in vivo brain relies on complex 3D connectivity between specific structural and functional zones, 
areas and territories. Neural cells have long been shown to thrive when they can synapse and connect 
with other neural cells, as a consequence cell density is very important when working in vitro (Biffi et 
al. 2013). With this in mind, culturing a single neural cell type in isolation (in Chapter Four) is a far 
cry from the complex constellation of activity in the brain, but an important first step. Recent in vitro 
neural models also involve culturing multiple cell types, such as neurons, astrocytes and microglia (J. 
Park et al. 2018). By connecting two different neural cell types together in our 5PD on an MEA we 
have taken the first step to increase the complexity of our model, with neural cells now able to 
communicate with different types of cells rather than just themselves, bringing the model closer to 
the in vivo situation. 
Each nuclei of the basal ganglia receives thousands of afferent axons projecting from upstream 
nuclei, and in turn sends thousands of efferent axons to their downstream nuclei (Ellens and 
Leventhal. 2013). Reducing this system to two neural cell types connected by 400 channels is still far 
from the complexity in the basal ganglia, but in turn is far more complex than the initial basic work 
in Chapter Four and work produced by other groups (Goyal and Nam. 2011, Kanagasabapathi et al. 
2011). By manageably increasing the complexity in this manner, we could identify the changes that 
occur in the spontaneous electrophysiological activity of the neural cells, now that they were 
connected to their appropriate target nuclei and closer to their in vivo environment. 
5.4.1 Co-culturing 
Two different neural cell types were cultured into each 5PD, on a PEI/PDl-coated MEA as the growth 
surface. This work represents a development of both earlier results chapters: with these primary cells 
previously cultured successfully within 5PDs, extending through channels into adjacent ports 
(Chapter Three, see Figs. 3.17-3.18); and primary cells successfully cultured successfully on 
PEI/PDL-coated MEAs over the long term (Chapter Four, see Fig.4.6-4.8). Cells were cultured for up 
to 70 DIV and extended axons through the microchannels to communicate with adjacent cell 
populations (see Figs.5.4B and 5.5) while their extracellular spontaneous activity was recorded. The 
main issue presented by these models was the location of the electrodes. 
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5.4.2 MEA electrode location 
As an unfortunate consequence of the MEA bracket hardware design, the location of the 5PD on the 
MEA was limited to a 30 mm diameter circle, with the centre of the circle being the location of the 
64-electrode array itself. As there are 64 (8 x 8) electrodes and two ports containing cells, the ideal 
situation would be 28 (8 x 3) electrodes in each port and a single 8 x 1 column within the channels 
between these ports. However, it was necessary to place the 5PD over the centre of the MEA (as 
placing it too far in any direction would result in the bracket not fitting over the MEA and recording 
unable to take place), so most of the electrodes were located in the centre port, with a few columns 
in the upper side port and a few electrodes not in contact with any cells, being covered by PDMS or 
being in the lower side port (as seen in Fig.5.19). 
 
Figure 5.19: Location of the MEA within the 5PD. A) desired location, in the centre of the side port and with 
roughly half the electrodes on each side with some in the channels. B) actual location, with most electrodes 
in the centre port and 2-3 columns in the side port, along with 4-10 electrodes of the lower right-hand corner 
encroaching into the lower right-hand port and therefore not recording from anything. This actual position 
is due to hardware restrictions and represents the location of the MEA throughout recording of each 
co-culture. 
With the current MEA design this restriction is unavoidable, the only option for future work being to 
re-design the MEA so that there are equal numbers of electrodes within all five ports, mentioned in 
more detail in Chapter Seven. 
 185 
5.4.3 Activity localisation 
Heatmaps and analysis of percentage activity allowed for tracking of activity across the MEA. This 
tracking held more significance than in the previous chapter as there were now three different zones 
located across each MEA, namely CTX/GP/SNc neurons, channels, and STR neurons. The heatmaps 
for CTX-STR, STR-GP and SNc-STR co-cultures showed onset and high activity in a row directly across 
the MEA from port to port (see Fig.5.6). The highest levels of activity were in and near the channels, 
most likely due to the fact that the majority of synapses between the two neural cell types formed 
as projection neurons exited the channels and met with the adjacent cell population (Lu et al. 2009). 
Activity was greatest proximate to channels, likely due to this being the area where STR cells are 
encountering the most CTX synapses and subsequently highest concentrations of glutamate (J. Ding 
et al. 2008). After these close connections were established, activity spread across the STR port. This 
spread of activity is also indicated by the percentage activity, where ~90% activity in the STR port is 
maintained from 21-51 DIV, unlike CTX and channels which decrease by 36 DIV. This is likely because 
the STR is the only port receiving excitation via glutamate release, as the channels consisted of CTX 
axons. Despite this excitation, levels still fell in STR ports from 51-70 DIV, perhaps due to an aging 
culture, glial cell proliferation, more active GABAergic inhibitory activity or less active glutamatergic 
stimulus. 
STR-GP co-cultures showed onset by 11 DIV, but activity had not spread across the MEA until 29 DIV, 
was only maintained until 42 DIV before disappearing as soon as 50 DIV, with few active electrodes 
from 50-70 DIV. This may be a sign of inhibition, with the spread of activity decreasing rapidly after 
being established due to synapses and GABA inhibitory action maturing. Areas of high activity were 
in a row and adjacent to channel entrances/exits, suggesting that this is where synapse formation 
was most dense. 
SNc-STR co-cultures showed pronounced high-frequency activity in a row across the MEA, with one 
row of electrodes producing the most activity from onset until 42 DIV. As this is a central row with 
the channels in the middle, this may have been initial formation of a SNc cell network projecting 
through the channels to the STR neurons. As cells were seeded from the wells into the ports, the aim 
was to ensure that the densest areas of the culture were those in the bottom of the port as this is 
where the electrodes were (Fig.5.19B). This density may have resulted in a network stretching across 
a row of electrodes and through the channels, while there was little activity or network formation 
elsewhere until 29 DIV. To my knowledge this has not been reproduced elsewhere. 
5.4.4 Spiking activity 
With spontaneous electrophysiological activity of each cell type in isolation outlined in Chapter Four, 
this data presents an opportunity to observe any changes in this activity when cell types were 
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connected together using our 5PD and compare data from the same cell type when in isolation and 
when connected to STR neural cultures. These comparisons of spiking activity are discussed in the 
following sections. 
5.4.4.1 CTX vs CTX-STR 
Every aspect of CTX spontaneous extracellular electrophysiological activity was increased by 
connecting CTX neurons to a population of STR neurons via our 5PD, indicating the effect of 
connectivity within neural networks on the strength and maturation of synapses between neurons 
and their subsequent activation, as also described by (Fauth and Tetzlaff. 2016). However, while 
synapse formation regulated activity between neuronal populations, the opposite is also true, with 
activity able to regulate synapse formation, in some cases even before the synapses themselves are 
formed (Tessier and Broadie. 2009, Andreae and Burrone. 2014). In addition, synapses do not form 
easily after a first encounter between different neuronal subtypes, synapse formation is an extended 
process of numerous meetings until synapses form and functionally mature (Lu et al. 2009). 5PDs 
consisted of a smaller surface area than the ring used for separated culture, but the cell density was 
kept constant between the two experiments. As the use of the 5PD and microchannels were unlikely 
to increase CTX activity, the increased activity is most likely to be due to connectivity to STR neural 
cultures, with CTX activity shown to increase with connectivity to relevant brain areas (M. N. Miller 
et al. 2008). 
Recordings from electrodes within 5PD channels were similar to CTX data as the channels mostly 
contained CTX axons (Fig.5.4B), due to the unidirectional nature of the channel width and the fact 
that CTX cultures have been shown to produce far more axons than other cell types (Chapter Three, 
Fig.3.19). After seeding, CTX axons fasciculated and bundles entered into channels before exiting the 
channels, unravelling and synapsing with STR neural cells. As such, data recorded from the channels 
was similar to data recorded from the CTX port as the channels were full of CTX axons. This process 
of bundling in microchannels has also been observed in other neural in vitro models with channels of 
similar widths (J. Park, Koito, Li and Han. 2009a, J. Park, Koito, Li and Han. 2009b, J. Park et al. 2012). 
5.4.4.2 GP vs STR-GP 
When comparing separate GP neural cultures and connected STR-GP co-culture devices, connectivity 
initially increased GP neuron activity, and this initial increase was likely due to the act of physical 
connection to another cell type, as seen in the increase in activity present in CTX-STR co-cultures 
(Fauth and Tetzlaff. 2016). But after ~3-4 weeks GP activity decreased, with lower frequencies and 
less burst firing, to our knowledge this is the first time this has been observed in vitro. Compared to 
other co-cultures, STR-GP consistently displayed the lowest levels of average and maximum spike 
frequency, burst number and spikes per burst. The subsequent decrease in activity may be a 
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consequence of STR neuron activity. STR neurons consisted of inhibitory GABAergic MSNs (Ellens and 
Leventhal. 2013), therefore GP activity may have been inhibited by the action of STR neuron inputs. 
This inhibitory action of GABAergic neurons has been shown in vitro (Dubinsky. 1989). With these 
MSNs projecting to GP GABAergic neurons, spontaneous STR firing could have decreased GP bursting 
and spike frequency over time. The initial higher activity that the GP co-cultures demonstrated may 
have been due to STR MSN synapses not yet being sufficiently mature to transmit GABA across the 
synapse, or GABA not yet being a true inhibitory neurotransmitter, as GABA is initially excitatory in 
development (Maric et al. 2001, Ben-Ari. 2002). Overall, it appears that connectivity initially 
increased GP firing activity, but once functional synapses were formed the STR MSN firing inhibited 
GP activity and resulted in decreased spike frequencies and burst firing. 
5.4.4.3 SNc vs SNc-STR 
SNc-STR had the highest peak levels of activity of all co-cultures, with greater average and maximum 
spike frequencies and more bursting. SNc connectivity to STR was facilitated by the potentially 
chemoattractive effect that the STR has been shown to have on SN neurons in nigrostriatal circuit 
formation (Gates et al. 2004). After the peak in firing activity, SNc-STR co-culture activity levels fell 
below separate SNc activity levels, with virtually no spiking or bursting from SNc-STR co-cultures from 
50-70 DIV while there was activity observed from separate SNc during the same timeframe. SNc had 
shown more activity than other cell types before (Chapter Four Figs.4.12-4.15), and with connectivity 
to STR neurons the SNc neurons showed greater initial activity, similarly to GP and CTX neurons when 
in a co-culture. However, the drop in SNc activity during the late phase (50-70 DIV), was similar to GP 
neurons. One possibility is that SNc neurons may also have been subject to inhibition from STR MSNs 
as was seen with GP neurons, but as SNc is in the input port in this co-culture (SNc-STR as opposed 
to STR-GP), it should be less likely that STR MSNs traversed the tapered channels in the opposite to 
intended direction. Separate SNc neurons also decreased in spiking frequency during 50-70 DIV, but 
at a slower rate. Another possibility is that some aspect of SNc-STR connectivity may be enhancing 
this natural decrease in firing for SNc neurons when connected to STR neurons, the precise 
mechanism for this remains to be explored, potentially the decrease in STR neuron firing lessened 
DA release and therefore SNc neuron firing. One explanation for this stark change in spiking activity 
over time is the nature of dopamine release in vitro, with studies showing that in vitro nigrostriatal 
cultures display increased DA release at and after 24 DIV compared to 9 DIV due to more mature 
functional dopaminergic synapses forming (Struzyna et al. 2018). 
5.4.4.4 STR vs CTX-STR vs STR-GP vs SNc-STR 
The STR ports of each co-culture were also compared to determine how CTX, GP and SNc neural 
cultures affect STR neuron activity once connected. Overall, in comparison to separate STR, all 
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aspects of STR activity were decreased in STR-GP co-cultures and increased in CTX-STR and SNc-STR 
co-cultures. 
STR neurons within CTX-STR devices featured much greater average and maximum spike frequency 
when compared to seperate STR neurons and STR-GP cultures, as well as SNc-STR (from 29 DIV 
onwards). This was most likely due to CTX containing excitatory glutamatergic neurons, which had 
projected through the channels into the STR port and released glutamate, depolarising STR neurons 
and reducing the threshold necessary to fire, resulting in more firing (Meldrum. 2000, Rangel-Barajas 
and Rebec. 2016). This increase in firing also increased over time, with STR eventually having greater 
maximum spiking than CTX, with a late peak on 51 DIV. STR neurons from STR-GP devices had the 
lowest average and maximum spiking activity of all three co-cultures, potentially inhibited by the GP 
GABAergic neurons in a negative feedback loop (Ellens and Leventhal. 2013).  
STR within SNc-STR devices had the most spiking in early time-points, these early peaks contained by 
far the highest rate of firing of all co-cultures, having an average of ~12 Hz and a maximum of over 
200 Hz. It was unclear why STR activity was so high when connected to SNc neural cultures, one 
potential explanation is that dopamine is only acting on the D1 receptors of a subset of STR neurons 
associated with the direct motor pathway and promoting their activity. This suggests that there was 
more complex activity in this co-culture rather than just excitation or just inhibition. The average 
level of spiking was highest at the channels. Average activity of STR and SNc neurons displayed 
different peaks, with STR activity peaking early on 21 DIV and SN activity peaking at 36 DIV. This 
suggests that STR neurons were initially excited by SN neurons and later inhibited as SNc activity 
increased, a concept reinforced by the initial formation of excitatory nigrostriatal connections in vivo 
(during the second postnatal week of mice) (Kozorovitskiy et al. 2015), the complex modulatory 
effect DA has on STR MSNs (Tritsch and Sabatini. 2012) and the fact that nigrostriatal connections 
made in development can be pared back based on the level of synapse reinforcement (Money and 
Stanwood. 2013). This can either mark a shift from dopamine affecting D1-type MSNs to D2-type 
subset of MSNs, or the point at which GABA generated by STR MSNs shifted from excitatory to 
inhibitory. 
A particularly notable feature of SNc-STR co-cultures is the maximum spiking. While SNc and channels 
achieved a peak of ~70 Hz (36 DIV), already double that of CTX-STR and STR-GP co-cultures, activity 
from the STR port of SN-STR co-cultures peaked earlier and far higher at 212 Hz (21 DIV). The rat 
brain in vivo can fire up to several hundred times a second (Boudewijns et al. 2013), so this is within 
acceptable bounds. 
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5.4.5 Centroid assessment 
The shape of each electrophysiological spike recording can be useful in defining the activity of the 
neural cultures, as such the many spikes were categorised into centroids which give further 
information into the activity of the devices. Centroid number, phase, sign and shape were all assessed 
over time for each device. The number of centroids were lower in mid and late stages compared to 
early stages of culture (Fig.5.9), showing that the spike variation decreases as the spike frequency 
increases and the network matures in vitro (Chiappalone et al. 2006), the same trend seen in separate 
MEA work (Chapter Four, section 4.2.6 Centroid number, Fig.4.19), now observed across two ports 
and the channels linking them. 
Centroid shape categorisation (Fig.5.10) indicated that the channels contained a majority of triphasic 
centroids, which agreed with the theory set out in Chapter Four (section 4.0.2 Extracellular 
recording, Fig.4.3), that axons resulted in triphasic extracellular waveforms and cell bodies and/or 
synapses resulted in monophasic and/or biphasic centroids. The channels housed axons from the 
input port, as indicated by the triphasic centroids. Centroid proportions in ports differed, most 
notably CTX and SN input resulted in changes in STR, with STR having similar proportions of centroids 
to CTX cultures when functionally linked to CTX cultures, and similar to SN when linked to SN. This 
indicates that STR activity is changed by innervation from CTX/SN axons, further demonstrating 
functional connectivity. In STR-GP co-cultures this functional connection is less clear as there were 
less centroids overall when compared to CTX-STR and SN-STR co-cultures, but STR and GP still feature 
similar proportions of centroids. These co-cultures are functionally connected. Centroid full duration 
at half maximum (FDHM) was not significantly changed by functional connectivity, indicating that the 
centroids were similar in spike duration, even if there were changes in centroid phase and sign. 
5.5 Conclusions 
Overall, by increasing the complexity of our model from a single cell type to two, it is clear that this 
resulted in the production of more complex electrical activity when compared to culturing one 
separate cell type in isolation. Work in this chapter built on previous MEA work (Chapter Four) by 
connecting two neighbouring basal ganglia nuclei in order to create a rudimentary basal ganglia 
circuit.  In this chapter we have advanced from a single separate cultured cell type to two cell types 
connected by our microfluidic 5PD, with all activity recorded by MEAs. These devices have 
appropriately re-created relevant circuits for the basal ganglia, namely the corticostriatal, 
nigrostriatal and striatopallidal pathways of the basal ganglia. 
Comparing to the separate cultures form the previous chapter, connectivity resulted in increased 
amplitude and frequency of spiking and bursting activity from CTX and SN cultures, as well as in STR 
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cultures when connected to CTX or SN. Conversely, connectivity resulted in decreased spiking overall 
for GP cultures and STR when connected to GP. These changes were likely due to the natures of each 
of these cell types, and the rise and fall of activity over time reflected the maturation of synapses and 
the formation of functional connectivity.  
The extracellular recordings could clearly identify the specific neuronal types in appropriate 
connection with each other, and as with Chapter Four these recordings were reproducible. In this 
manner, these connected co-cultures better represent the activity of the basal ganglia in vivo than 
the separate cultures, by including two physiologically relevant connected neural cell types rather 
than one. This resulted in more complex MEA activity and interaction between the two populations 
(inhibition, excitation etc) over the long term, which more accurately models activity from the basal 
ganglia as s rudimentary neural circuit, marking a vital step towards mimicking basal ganglia activity 
in vitro.  
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Chapter Six: Mimicking Parkinson’s disease 
6.0 Introduction 
After successfully modelling numerous basal ganglia (BG) pathways, namely the corticostriatal 
(cortex-striatum or CTX-STR), striatopallidal (striatum-globus pallidus or STR-GP) and nigrostriatal 
(substantia nigra pars compacta-striatum or SNc-STR) pathways in the previous chapter 
(Chapter Five), the next step was to focus on the nigrostriatal pathway and enable study of 
Parkinson’s disease (PD) by creating a pathological nigrostriatal model. This pathological 
PD-mimicking device involved damaging/destroying the SNc dopaminergic neurons projecting to the 
STR, which in vivo is known as the cause of PD symptoms (Jackson-Lewis et al. 2012, Blesa and 
Przedborski. 2014, Van Kampen and Robertson. 2017). 
To summarise the information from the previous chapter concerning the nigrostriatal pathway 
(Chapter Five section 5.0.4 Nigrostriatal (SNc-STR)), the nigrostriatal dopamine (DA) pathway 
involves DA neuron projections from the SNc to the STR, with DA release in the STR necessary for 
BG-mediated motor behaviour (Rice and Cragg. 2008). Within the BG, DA transporters (DATs) are 
expressed exclusively by the DA neurons of the SNc, with the STR containing many DA receptors 
(DARs) both synaptically and extrasynaptically (Rice and Cragg. 2008), with examples of DA synapses 
shown in Fig.6.1. When this nigrostriatal DA delivery system breaks down, the result is progressive 
and functional damage that can result in the numerous symptoms seen in Parkinson’s disease (see 
Chapter One for more details). 
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Figure 6.1: Illustrations of DA synapses on the spine of a STR MSN. The conventional model has controlled 
DA release limited to the synaptic area, with DATs and DARs also limited to this area. However, studies have 
shown that DATs and DARs are located extrasynaptically and DA release can ‘leak’ across a wide area, 
resulting in the updated view of the dopamine synapse on the right, with a 3D cloud of DA reaching to distal 
DATs and DARs on the DA neuron itself and surrounding neurons. This DA is only taken up by DATs on the 
DA neuron itself, and at quite a slow rate, allowing DA release to affect neurons both synaptically and 
extrasynaptically over time. Figure adapted from (Rice and Cragg. 2008). 
6.0.1 Electrophysiology of Parkinson’s disease 
Damaging nigrostriatal cells and depleting DA within the BG have serious electrophysiological 
consequences, which can be measured in our model via the MEA. The extreme activity changes upon 
DA depletion are also covered in numerous reviews (Boraud et al. 2002, Ellens and Leventhal. 2013, 
Lindahl and Hellgren Kotaleski. 2017). 
In the BG, DA from the SNc chiefly acts on the STR to increase D1-type (direct pathway) MSN firing 
and decrease D2-type (indirect pathway) MSN firing, being doubly pro-movement by exciting the ‘go’ 
pathway and inhibiting the ‘no-go’ pathway, by suppressing the SNr/GPi inhibitory outputs of the BG. 
This concept was covered in further detail in Chapter One (section 1.5.1.2 Striatum) and Chapter Five 
(sections 5.0.2.1 Striatopallidal structure and 5.0.4 Nigrostriatal). 
DA depletion therefore leads to decreased activity from D2-type MSNs, GPe, thalamus and the CTX, 
and increased activity from D1-type MSNs, SNr/GPi and the STN. This ‘rate change’ model of PD in 
the BG can be seen in Fig.6.2. These changes have been shown both in MPTP- and 6-OHDA-treated 
models (Mallet et al. 2006, Pasquereau and Turner. 2011, Ellens and Leventhal. 2013). 
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Figure 6.2: Changes in BG circuitry during PD. A) The normal signal pathways in the BG, with CTX and SNc 
projecting to the STR, and the indirect/direct pathways filtering through to the GPi/SNr output nuclei, which 
signal the thalamus (to activate the brainstem/spinal cord). Red arrows are GABAergic (inhibitory), green 
arrows are glutamatergic (excitatory) and the sole blue arrow is dopaminergic, the connection lost in PD. 
Uniform arrow thickness indicates that these signals are all tonically active. B) Electrical activity in pathways 
in the BG after a loss of nigrostriatal neurons (indicated by the black cross) and depletion of dopamine in the 
STR. D1-type indirect pathway MSNs and D2-type direct pathway MSNs have increased and decreased firing 
rates respectively. As a consequence, the GPe is more inhibited and the STN is less inhibited therefore more 
excitatory. The GPi/SNr are less inhibited by the STR and more excited by the STN, resulting in the thalamus 
being more inhibited and the CTX less excited, leading to decreased movement. All electrical activity changes 
are indicated by arrow thickness. 
Studies also show changes in bursting behaviour. In a connected circuit, bursts are brief 
high-frequency (>10 Hz) bundles of spikes often followed by a pause or quiescent period. These 
bursts are mostly measured extracellularly across the BG as intracellular methods are too limited. DA 
depletion leads to enhanced bursting in the GPe, STN and SNr/GPi, namely across the entire indirect 
pathway of the BG. (Wichmann and Soares. 2006, Tachibana et al. 2011, Ellens and Leventhal. 2013). 
Excessive bursting after dopamine depletion is also found in the thalamus (Vitek et al. 2012) and 
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consequently CTX pyramidal tract (PT) neurons (Pasquereau and Turner. 2011) (driven by the 
thalamus). This bursting activity in highly organised BG circuitry results in damaging 
positive-feedback cycles, where GPe (indirect pathway) and CTX excessively stimulate the STN due 
to bursting, resulting in STN hyperactivity and increased inhibition of the thalamus and 
brainstem/spinal cord by the GPi/SNr. 
DA-depleted BG activity also includes oscillations, namely periodical repeats of activity (often 
confused with bursts due to similar frequencies) occuring at numerous frequencies (including 
frequencies comparable to tremor) in both the single unit and local field potential (LFP) activity of 
GPi and STN neurons, associated with bradykinesia and rigidity (Jenkinson and Brown. 2011). This 
oscillatory activity is linked to increased bursting, with the GPe-STN bursting also oscillating. 
Both these bursting and oscillatory activities can also be synchronous in PD, where spiking or LFPs 
occur simultaneously/synchronously. This kind of behaviour is rare in the healthy brain in vivo, with 
normal behaviour involving inputs and outputs in order for electrical activity, with this activity 
occurring in rapid succession but not simultaneously (Bar-Gad et al. 2003). After DA depletion in BG 
models, activity in the GPi, GPe and STN can become highly synchronised (Pessiglione et al. 2005, 
Ellens and Leventhal. 2013), theorised to relate to motor deficits, due to loss of BG nuclei specificity. 
Broadly speaking, there are several vital components to model when studying the electrophysiology 
of PD. It is vital to remove/damage dopaminergic nigrostriatal neurons in order to deprive the STR of 
DA without damaging the STR itself; to record the spontaneous electrophysiological activity from 
both the SNc and the STR while the two populations are linked and after the nigrostriatal connections 
are damaged; and to identify changes in the spontaneous electrophysiological activity between 
physiological and pathological states. In the model described in this thesis, this equates to a normal 
SNc-STR model and a SNc-STR model where the SNc port has been treated with 6-OHDA in order to 
remove the DA neurons and subsequent nigrostriatal connections. This chapter analyses the data 
received from such a co-culture, where acute PD was mimicked with the use of 6-OHDA on our 5PD 
containing two connected cultures of SNc and STR neurons respectively, combined with an MEA. 
6.0.2 Chapter Six Aims and Objectives 
In previous chapters, a baseline of BG nuclei activity in separation was established (Chapter Four), 
followed by creating a rudimentary BG circuit by linking two adjacent BG nuclei through our 5PD 
(Chapter Five). In this chapter, the aim was to use SNc-STR co-cultures to mimic Parkinson’s disease 
through 6-OHDA treatment of the SNc port, where the 6-OHDA neurotoxin was intended to damage 
or destroy nigrostriatal SNc projections, mimicking acute PD, and using the resultant model to 
determine any electrophysiological changes that occurred. 
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6.1 Experimental Methods 
The methods involved in this chapter were previously outlined in Chapter Two. 
6.1.1 Device surface preparation 
As seen in section 2.1.1 device preparation: chemical coating, MEAs were first sterilised with 70% 
IMS for 15 minutes, dried and coated first with 0.05% PEI for 1 hour (at rtp), then 0.1 mM PDL 
overnight at 37 °C, washing between each stage. MEAs were then dried and ready for cell culture. 
5PDs were cast from PDMS and attached to the centre of the MEA, then flushed with sterile water 
and incubated to remove any air or bubbles. 
6.1.2 Primary cell culture 
As seen in section 2.2 Primary cell culture, tissue was dissected from E16/14 Sprague-Dawley rat 
embryos: E16 lateral ganglionic eminences (LGE) for STR and E14 ventral midbrain (VM), for SN. These 
tissues were dissociated and 100,000 cells were seeded directly into the relevant port on the 5PD, 
namely input port for SN and central port for STR. After seeding the ports were flooded with growth 
media and the cells incubated at 37° C, 5% CO2. 
6.1.3 Electrical activity measurement with MEA 
Recordings of cell electrophysiological activity (section 2.5.2 MEA: Recordings) were taken once a 
week from 0 DIV to 70 DIV, before a media change. MEAs were moved to a heated bracket (at 37 °C) 
attached to amplifiers and digitisers. Activity was recorded for four minutes in triplicate, totalling 12 
minutes of recording, using MED64 hardware with Mobius software. These data were stored on the 
MEA PC for analysis. 
6.1.4 6-OHDA treatment 
As seen in section 2.2.4 6-OHDA treatment, 6-OHDA was dissolved in 0.15% ascorbic acid and diluted 
to 100 µM in serum-free media before being added to the SN port and incubated. After incubation 
6-OHDA was removed and cells washed with culture media. MEA readings were taken immediately 
before, after and 24h, 48h after treatment, alongside usual 0-70 DIV readings. Immunocytochemistry 
and fluorescent imaging used to identify GABAergic neurons (using anti-GABA) and DAergic neurons 




6.2.1 Primary cell culture 
E16 STR and E14 SNc neural cells were successfully cultured in ports of 5PDs, with SNc in an input 
port and STR in the central port. SNc neurons extended processes through channels and into the STR 
port, making up the nigrostriatal pathway. Cells were in contact with electrodes in both the SNc, STR 
and channels in between, as seen in Fig.6.3, which shows viable SNc and STR cells cultured with MEA 
electrodes. 
 
Figure 6.3: 100,000 primary STR and SNc cells seeded onto 5PD MEAs, and brightfield imaged after 8 DIV. 
A) STR neurons and an electrode for scale near channels, B) SNc neurons and an electrode, C) SNc neurons 
and electrodes at a lower magnification. All scale bars at 100 µm. 
As GABAergic neurons should not be affected by optimised 6-OHDA treatment, it was vital to track 
the levels of GABAergic neurons within the model, to ensure that damage from 6-OHDA was specific 
to DAergic neurons. GABAergic and DAergic neurons in SNc cultures were identified with antibody 
immunostaining, shown in Fig.6.4, indicating the different neuronal subtypes. Cultures included a 
mix of GABAergic and DAergic neurons, quantities stated in the graph included in Fig.6.4.  
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Figure 6.4: Fluorescent imaging of primary SN cultures to identify GABAergic and DAergic neurons. Each 
image represents 100,000 SN neural cells after 4 DIV, stained with DAPI (blue), GABA (green, GABAergic 
neurons) and TH (red, DAergic neurons). Each culture presents a mixture of GABAergic and DAergic neurons. 
Scale bar 100 µm. 
6.2.2 6-OHDA optimisation 
The SNc port was treated with 6-OHDA in order to selectively remove DA neurons. However, use of 
6-OHDA in vitro required several optimisation steps, where 6-OHDA was tested on early (6 DIV) SNc 
cultures to determine the optimum antioxidant vehicle, dosage concentration and exposure time. 
For each experiment, the levels of GABAergic neurons and DA neurons were assessed, with any 
significant loss of GABAergic neurons signifying non-selective damage, while loss of DA neurons but 
unaffected GABAergic neuron levels signifying selective damage. Image data from these experiments 
can be seen in Fig.6.5. 
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Figure 6.5: Fluorescent images of the 6-OHDA optimisation process. Each image is representative of n=4, shows 100,000 primary SN cells imaged after 6 DIV, after specific 
treatment with 6-OHDA neurotoxin. Blue: DAPI, Red: TH (DAergic neurons), scale bar 100 µm. GABAergic data not shown. 
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6.2.2.1 Vehicle 
The chosen antioxidant was based on a paper from Ding and colleagues (Y. M. Ding et al. 2004), 
where their successful in vitro methodology involved use of 0.15% ascorbic acid as a vehicle for 
6-OHDA. SNc cells were exposed to 6-OHDA with and without the vehicle to determine its efficacy, 
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Figure 6.6: Efficacy of 0.15% ascorbic acid as an antioxidant vehicle for 6-OHDA. E14 SNc cells were treated 
with cell media (control), ascorbic acid (vehicle control), 6-OHDA (to determine the effects without a vehicle) 
or 6-OHDA dissolved in ascorbic acid vehicle (to determine vehicle efficacy). For 6-OHDA and 6-OHDA+vehicle 
treatments, cells were exposed to 100 µM 6-OHDA for 20 minutes with and without vehicle respectively as 
outlined by (Y. M. Ding et al. 2004). Two-factor ANOVA (treatment and neuron type) indicated statistical 
significance, posthoc t-tests indicated by (*): p <0.01, (**): p <0.001, (n=4). GABA: GABAergic neurons, DOPA: 
dopaminergic neurons. 
The presence of the vehicle alone had no significant effect on the viability of GABAergic and DAergic 
neurons. Exposing the cells to just 6-OHDA without a vehicle resulted in widespread cell death, 
removing all DAergic neurons but also a significant proportion of GABAergic neurons 
(27±7 % surviving). A combination of 6-OHDA dissolved within the vehicle resulted in only DAergic 
neurons being significantly affected, reducing DA neuron numbers to 45±8 % and allowing for 
selective damage as intended. Based on these results, 0.15% ascorbic acid was used throughout this 
chapter as a vehicle for 6-OHDA from this point onwards, in order to selectively damage only SNc DA 
neurons. 
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6.2.2.2 Dosage concentration 
SNc cultures (6 DIV) were then treated with different concentrations of 6-OHDA for the same length 
of time (20 minutes) in order to determine the optimal concentration for 6-OHDA usage (Fig.6.7). 
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Figure 6.7: 6-OHDA dosage concentration optimisation. E14 SNc cells were treated with cell media (control), 
ascorbic acid (vehicle control) and 6-OHDA in vehicle (20 minute incubation time) at different concentrations, 
from 50-500 µM. Two-factor ANOVA (concentration and neuron type) indicated statistical significance, 
posthoc t-tests used vs control, (*): p<0.01, (***): p <0.0001, (n=4). 
The interaction between the different neuron types and the concentration of 6-OHDA had an 
extremely significant effect on percentage cell viability (ANOVA (5,68) F=11.6, p<0.0001), as did the 
concentration of 6-OHDA alone (ANOVA (5,68) F=40.8, p<0.0001). Compared to the control, DA 
neuron levels were significantly reduced by concentrations of 6-OHDA above 50 µM, and GABAergic 
neurons were also significantly reduced at concentrations of 6-OHDA above 100 µM. This means that 
6-OHDA concentrations above 100 µM exhibited a trend of non-specific damage. The concentration 
that resulted in specific damage to DA neurons while avoiding damage to other cell types was 
100 µM, with lower concentrations not damaging DA neurons sufficiently and higher concentrations 
damaging all cell types. Thus, the optimal concentration of 6-OHDA for specific DA neuron damage 
in these experiments was 100 µM. 
6.2.2.3 Exposure time  
As the antioxidant action of ascorbic acid as a vehicle for 6-OHDA was theorised to only be effective 
for 15-20 minutes in solution before degeneration (Y. M. Ding et al. 2004), the exposure time for the 
two previous 6-OHDA experiments (Figs.6.6 and 6.7) was 20 minutes. This exposure time was varied 
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from 5 to 60 minutes in order to determine the optimum exposure time (while keeping concentration 
at 100 µM), seen in Fig.6.8. 
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Figure 6.8: 6-OHDA exposure length optimisation. E14 SNc cells were treated with cell media (control), 
ascorbic acid (vehicle control) and 100 µM 6-OHDA in vehicle with different incubation times, from 
5-60 minutes. Two-factor ANOVA (exposure time and neuron type) indicated statistical significance, posthoc 
t-tests used vs control, (*): p<0.01, (***): p<0.0001, (n=4). 
The interaction between neuron types and different 6-OHDA exposure timings showed a significant 
effect on the percentage cell viability (ANOVA (5,66) F=2.48, p=0.04) and the effect of 6-OHDA 
exposure timing alone was extremely significant (ANOVA (5,66) F=34.92, p<0.0001). DAergic neuron 
levels were significantly affected at all 6-OHDA exposure lengths. GABAergic neuron levels were 
significantly affected at 30-60 minutes exposure, indicating that there was non-specific damage 
occurring beyond 15-20 minutes exposure. Only 30% of GABAergic neurons survived after 60 minutes 
of exposure. Despite this loss, only exposure times above 15 minutes resulted in a loss of DA neurons 
greater than 50%, with 15 minutes exposure only resulting in 33% of DA neurons lost. Due to this, 
the optimal exposure timing to 6-OHDA required to destroy a sufficient number of DA neurons to 
mimic PD is likely between 15-30 minutes. 
6.2.2.4 Exposure length with 0-70 DIV MEA cultures 
The previous three 6-OHDA experiments optimised 6-OHDA usage in vitro on 6 DIV cultures, based 
on experiments performed in the literature. However, later experiments performed on MEAs 
required cultures to be significantly older than 6 DIV in order to mature and develop spontaneous 
electrophysiological activity, with any treatment with 6-OHDA before 21 days of culture having no 
merit, as the effect on the electrical activity would not be seen as there would be little activity to 
effect. However, when performing 6-OHDA experiments on live cells on MEAs it can be challenging 
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to directly assess cell viability and cell number. Cells on MEAs could not be fixed or immunostained 
during the experiment due to a need to record live activity from cells both before and after exposure 
to 6-OHDA, and cell cultures were too dense for numbers to be determined with brightfield imaging. 
Due to denser, more functionally mature and networked cultures being exposed to 6-OHDA for up 
to 48 hours in the literature, both 20 minute and 24 hour exposures were tested to determine if 
6 DIV-optimised variables (especially exposure time) would still allow for a similar 6-OHDA action on 
older MEA cultures, in this case 25 DIV. These experiments can be seen in Fig.6.9A-D, which shows 
representative images, and Fig.6.9E, which quantifies these results. 
 
Figure 6.9: Effect of 6-OHDA on more mature cultures, namely after 25 DIV. 100,000 SN cells were cultured 
on MEAs and imaged after 25 DIV. Cells were either untreated (control) or exposed to 100 µm 6-OHDA for 
24 hours (+6-OHDA 24 hrs). Blue: DAPI and Red: TH (DAergic neurons). Images are representative of n=4. 
Graph shows quantified data from images (GABA and 20 min images not shown). Asterisk indicates post-hoc 
t-test compared to the control (*): p<0.05 
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The effect of the different 6-OHDA conditions on DAergic neurons was significant (ANOVA (3,16) 
F=3.878, p=0.03), while having no significant effect on GABAergic neurons. With 24-hour 6-OHDA 
exposure determined to be effective whilst avoiding excessive non-specific damage to GABAergic 
neurons, the experiment was repeated on SNc-STR MEAs. For cells on MEAs any effect of 6-OHDA 
was determined via any changes in electrophysiological activity recorded via the MEA. As this was an 
indirect approach to determining the effect of 6-OHDA, death of DAergic neurons was assumed based 
on the previous experiment (seen in Fig.6.9) and not confirmed for each MEA experiment. SNc 
cultures connected to STR cultures in 5PDs on MEAs were exposed to 100 µM 6-OHDA for 20 minutes 
or 24 hours at 21 DIV to determine the effect of 6-OHDA on a matured and denser networked culture 
on MEAs, seen in Fig.6.10. 
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Figure 6.10: SNc cultures treated with 100 µM 6-OHDA for 20 minutes or 24 hours on day 25 in culture. 
A) Percentage of electrodes recording activity over time, B) average spike frequency over time, C) maximum 
spike frequency over time. Dotted line at day 21 indicates time of 6-OHDA exposure. Statistical significance 
was measured in comparison between 24h and 20m conditions, (*): p<0.05, (**): p<0.01, (****): p<0.0001. 
The interaction between 6-OHDA incubation length and culture time in vitro indicated that there was 
a significant effect on the percentage activity of SNc neural cultures (ANOVA (7,14) F=4.72, p=0.007), 
with significantly less activity from 30-31 DIV in cultures that received 6-OHDA exposure for 24 hours 
on day 25. There was also a significant effect on average SNc neuron spiking over time after 
treatment (ANOVA (7,14) F=18.24, p<0.0001), with significantly less spiking from 29-31 DIV; and a 
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significant effect on maximum SNc neuron spiking (ANOVA (7,14) F=23.99, p<0.0001), with 
significantly less maximum spiking across the same time period (29-31 DIV). 
The 24-hour exposure time to 6-OHDA resulted in decreased percentage activity of electrodes (from 
60% to 20% activity) and decreased spike frequencies (average from 3 Hz to 1 Hz, max from 20 Hz to 
5 Hz), indicating that active neurons within the culture had been damaged sufficiently to not produce 
spontaneous activity, therefore a good model to mimic PD. From this MEA data alone it is clear that 
increased exposure times were necessary when working with mature functional MEA cultures rather 
than the 0-10 DIV cultures that were used for optimisation. From this point on, all 6-OHDA work on 
functionally mature MEA cultures involved an exposure time of 24 hours. 
6.2.2.5 Serum-free assessment 
It was important to note that during 6-OHDA exposure serum-free media is used to minimize any 
interference from serum proteins and allow 6-OHDA access to DA neurons. In order to determine if 
SNc cell cultures were adversely affected by 24 hours serum-free, 21 DIV SNc cultures on MEAs were 
placed in serum-free conditions for 24 hours. Activity, average spiking and maximum spiking were 
measured, as shown in Fig.6.11. 
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Figure 6.11: 24 hour serum-free assessment. Dotted line indicates 24 hour exposure to serum free culture 
conditions. Activity (%) columns are drawn against the left y-axis scale, average and maximum spike 
frequency lines are drawn against the right y-axis scale. 
24 hours without serum did not significantly affect the percentage activity or spike frequency of SNc 
cultures on MEAs, therefore any effect from 6-OHDA incubation is likely to be due to the toxin rather 
than the serum-free environment. 
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6.2.3 Activity heatmaps 
Heatmaps from 6-OHDA-treated SNc-STR co-cultures were compared to control SNc-STR co-cultures 
in Fig.6.12. After 25 DIV, the SNc port was exposed to 6-OHDA for 24 hours (26 DIV) with the next 
recording taken 48 hours after exposure (29 DIV). The 6-OHDA-treated heatmaps displayed onset of 
activity at 11 DIV and increased in activity until 21 DIV, same as the control. After 6-OHDA treatment 
the number of active electrodes in the SNc port decreased (21-29 DIV), with more inactive electrodes 
seen by 36 DIV. This low activity in the SNc port did not recover from 36-70 DIV. Channel activity 
decreased in the same manner, but activity in the STR port was unaffected on 36 DIV and did not 
decrease until by 50 DIV. This activity of the STR port was similar to control SNc-STR devices, 
suggesting that cells in the STR port were largely unaffected by 6-OHDA while the SNc port and 
channels were heavily affected. 
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Figure 6.12: SNc-STR co-culture activity heatmaps. Each square is an 8 x 8 grid representing an MEA. Horizontal values 4-70 represent days in vitro (DIV) and A-C represent separate 
MEAs from repeat experiments, either control MEAs (from Chapter 5 co-cultures) and 6-OHDA treated MEAs (with 6-OHDA treatment at 25 DIV, indicated by the dashed line). 
Red->yellow->green formatting indicates min->mean->max levels of spiking activity. Min, mean and max for each repeat as follows: CONTROL: A) 0, 781, 57204. B) 0, 1167, 43403. 
C) 0, 2747, 257161. 6-OHDA A) 0, 285, 21636. B) 0, 394, 96545. C) 0, 1097, 20561. 
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6.2.4 Percentage activity across MEA 
The percentage of active electrodes per recording was determined from the heatmaps, producing 
the graphs seen in Fig.6.13, comparing each of the sections of the device to control devices. 
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Figure 6.13: Percentage activity of SNc-STR MEAs treated with 6-OHDA on day 25 over time, compared to 
untreated control devices. A) % activity for SNc port vs control, B) % activity for channels vs control, C) % 
activity for STR port vs control, D) comparison between 6-OHDA-treated SNc-STR devices with correlation 
analysis, shown in below table. 6-OHDA treatment time is indicated by the dashed line, 6-OHDA was always 
applied only to the SNc port. Asterisks indicate post-hoc t-tests comparing each timepoint to the control 
(*): p<0.05, (**): p<0.01, (***): p<0.001 (n=3). 
The use of 6-OHDA had a significant effect on the percentage of active electrodes in the SNc port 
(Fig.6.13A) (ANOVA (1,4) F=16.49, p=0.015) and the channels (Fig.6.13B) (ANOVA (1,4) F=24.87, 
p=0.008) compared to control devices. After 6-OHDA application on 25 DIV, activity was significant 
lower from 29-50 DIV for both SNc and channels, indicating a loss of activity. After 50 DIV, control 
activity decreased to similarly low levels. For the STR port (Fig.6.13C), there was no significant effect 
of 6-OHDA treatment, with activity being similar to the control in of onset, peak and decrease. 
Looking at the correlation within 6-OHDA-treated SNc-STR co-cultures (Fig.6.13D), SNc and channel 
activity was closely correlated, but activity in the STR port did not follow this trend. 
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6.2.5 Average spike frequency 
As with percentage activity, both average and maximum spike frequency were measured across both 
the SN and STR ports across two time points, seen in Fig.6.14. 
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Figure 6.14: Average spiking activity of SNc-STR MEAs treated with 6-OHDA on day 25 over time, compared 
to untreated control devices. A) Average spike frequency for SNc port vs control, B) Average spike frequency 
for channels vs control, C) Average spike frequency for STR port vs control, D) comparison between 6-OHDA-
treated SNc-STR devices with correlation analysis, shown in below table. 6-OHDA treatment time is indicated 
by the dashed line, 6-OHDA was always applied only to the SNc port. Asterisks indicate post-hoc t-tests 
comparing each timepoint to the control (****): p<0.0001 (n=3). 
6-OHDA treatment significantly reduced the average spiking frequency in the SNc (Fig.6.14A) (ANOVA 
(1,4) F=11.3, p=0.02) and channels (Fig.6.14B) (ANOVA (1,4) F=19.62, p=0.01) sections of SNc-STR 
devices. Control SNc average spiking peaked at 12.3 ±2 Hz, whereas the peak of activity for 6-OHDA 
treated devices was only 4 ±3 Hz. However, there was no significant effect of 6-OHDA on STR average 
spike frequency from the STR port (Fig.6.14C). When looking at the SNc-STR device as a whole, there 
was a peak in all areas on 29 DIV after 6-OHDA treatment, and correlation was highest between SNc 
port and channels (Fig.6.14D). 
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6.2.6 Maximum spike frequency 
In order to determine high levels of activity beyond the average, the maximum spike frequency 
obtained per day was also analysed, seen in Fig.6.15. 
S N c






























C o n tro l




C h a n n e ls






























C o n tro l









































C o n tro l
6 -O H D A
S N c -S T R  6 -O H D A
















































Figure 6.15 Maximum spiking activity of SNc-STR MEAs treated with 6-OHDA on day 25 over time, compared 
to untreated control devices. A) Max spike frequency for SNc port vs control, B) Max spike frequency for 
channels vs control, C) Max spike frequency for STR port vs control, D) comparison between 6-OHDA-treated 
SNc-STR devices with correlation analysis, shown in below table. 6-OHDA treatment time is indicated by the 
dashed line, 6-OHDA was always applied only to the SNc port. Asterisks indicate post-hoc t-tests comparing 
each timepoint to the control (****): p<0.0001 (n=3). 
6-OHDA had a significant effect on maximum spike frequency in the SNc port (Fig.6.15A) (ANOVA 
(1,4) F=79.8, p=0.001) and channels (Fig.6.15B) (ANOVA (1,4) F=21.7, p=0.009). While the SNc port 
of control devices peaked at 66 ±12 Hz, 6-OHDA treated condition peaked at 23.4 ±5 Hz. Despite this 
significant effect on SNc and channels, STR ports were unaffected, both peaking at similarly extremely 
high levels (179 ±33 vs 160 ± 103 Hz for control vs 6-OHDA). 
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6.2.7 Bursting activity 
Defining bursting activity as any portion of activity that exceeded a bundle of 10 spikes per second 
(10 Hz), both the number of bursts and number of spikes per burst were assessed for the SNc-STR 
MEAs treated with 6-OHDA on day 25, seen in Fig.6.16. 
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Figure 6.16: Bursting activity activity of SNc-STR MEAs treated with 6-OHDA on day 25 over time, compared 
to untreated control devices. A-D indicate the average burst number over time, while E-H indicate the 
average number of spikes per burst over time. A+E) SNc port vs control, B+F) channels vs control, C+G) STR 
port vs control, D+H) comparison between 6-OHDA-treated SNc-STR devices with correlation analysis, shown 
in below table. 6-OHDA treatment time is indicated by the dashed line, 6-OHDA was always applied only to 
the SNc port. Asterisks indicate post-hoc t-tests comparing each timepoint to the control, (**): p<0.01  
(****): p<0.0001 (n=3). 
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6-OHDA had a significant effect on the average number of bursts for the SNc port (Fig.6.16A) (ANOVA 
(1,4) F=40.65, p=0.02)and the channels section (Fig.6.16B) (ANOVA (1,4) F=23, p=0.04), effectively 
reducing bursting to negligible levels after 6-OHDA treatment on 25 DIV. This trend was even seen in 
the STR port (Fig.6.16C), but was not significantly different to control devices. As seen in the 
correlation analysis (Fig.6.16D), the SNc port and channels were highly correlated, unlike channels 
and STR port (0.98 vs 0.65 respectively). 
6-OHDA did not have any significant effect on the number of spiokes per burst, bursts appeared to 
contain between 10-30 spikes throughout the experiment after onset, regardless of treatment. 
Because the number of spikes per burst from SNc did not change significantly, the decrease seen in 
spike frequency appeared to be due to the decrease in the number of bursts fired from SNc cells. The 
corresponding lack of change in STR spike frequency was also likely due to the lack of change in 
bursting activity upon 6-OHDA treatment to the adjacent SNc port. 
6.2.8 Centroid number 
The number of centroids over time was recorded for the SNc, channels and STR ports of SNc-STR 
devices, both for an untreated control and a 6-OHDA-treated device, as seen in Fig.6.17. 
Compared to the control, 6-OHDA treatment resulted in a significant change in the number of 
centroids produced by the cells in the SNc port from 29-50 DIV and channels from 29 DIV, with no 
change in the STR port. 6-OHDA treatment to the SNc port appeared to perturb the number of 
centroids produced by SNc neurons, and this number remained significnatly different until 70 DIV, 
whereas a similar effect in the channels was recovered by 50 DIV. The unchanged STR neuron activity 
in response to 6-OHDA is consistent with previous findings. 
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Figure 6.17: Number of centroids for SNc-STR centroids, both 6-OHDA-treated (B,D,F) and control (A,C,E). 
A+B) Number of centroids from SNc port, C+D) number of centroids from channels, E+F) number of centroids 
from STR port. Rectangles indicate early (15-25), mid (28-42) and late (50-70) stages, horizontal lines within 
rectangles indicate the mean of each stage (summaried in Table 6.1), dashed vertical lines indicate day 25, 
when 6-OHDA was applied to SNc port. 
 
Table 6.1: Average centroid number comparison between control and 6-OHDA-treated SNc-STR MEA devices. 
Significant differences between control and treated were calculated with ANOVA. 
SNc CH STR
DIV Control 6-OHDA p-value Significance DIV Control 6-OHDA p-value Significance DIV Control 6-OHDA p-value Significance
21 2.2 2.1 0.65 ns 21 2.3 2.4 0.64 ns 21 2.2 2.14 0.68 ns
29 3.8 2 <0.0001 **** 29 4.4 2 0.014 * 29 2.6 2.4 0.131 ns
50 1.2 2.9 0.0022 ** 50 1.2 3 0.15 ns 50 2.41 2.3 0.144 ns





6.2.9 Centroid shape categorisation 
Centroids were sorted into six categories (positive/negative monophasic, positive-first/negative-first 
biphasic and positive-first/negative-first triphasic) depending on their number of phases and sign (see 
Fig.4.25 for more information). Centroid proportions for the SNc port, channels and STR port for 
control SNc-STR and 6-OHDA-treated SNc-STR devices are displayed in Fig.6.18. 
For the SNc port, 6-OHDA decreased the number of centroids from 630 (from control SNc) to 214, 
with 81% of these being monophasic and the remainder being bi- or tri-phasic (compared to 46% 
monophasic for the control). A similar effect was seen in the channels, where the total number of 
centroids was reduced by 6-OHDA treatment (442 vs 74) and the proportion of monophasic centroids 
was greater (35% vs 65%). As channels should mostly contain axons and produce a majority of 
triphasic signals, this reduction is indicative of axonal death or loss of signals along axons. STR also 
saw a loss of centroids (563 vs 336) and more monophasic centroids (45% vs 64%) but this effect was 
less than the effects seen in SNc or channels, for example the number of SNc, channel and STR 
centroids compared to control were 34%, 16% and 60%, indicating a greater loss in SNc/channels. 
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Figure 6.18: Centroid shape categorisation. All centroids from 70 days of recording were sorted into six types, 






6.2.9.2 Centroid full duration at half maximum 
The centroid full duration at half maximum (FDHM) was analysed for SNc-STR co-cultures to 
determine the effect of 6-OHDA treatment on the ‘width’ of centroid spikes, data in Fig.6.19. 
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Figure 6.19: Centroid full duration at half maximum (FDHM) over time, for each area of control and 
6-OHDA-treated SNc-STR co-cultures (day of treatment indicated by dashed line). 
The FDHM for control SNc-STR devices showed a trend of increasing over time, and this trend was 
perturbed by 6-OHDA treatment. In 6-OHDA devices the FDHM decreased and plateaued at 
approximately 0.5 ms for SNc ports and channels, but increased for STR neurons from 25-50 DIV until 
decreasing from 50-70 DIV. The reason for this effect is unclear, but 6-OHDA treatment appeared to 
shorten SNc and channel centroids while lengthening STR centroids. 
6.2.10 Late 6-OHDA exposure 
Further experiments were performed to determine the effects of 6-OHDA at a much later time point, 
in this case after 65 days of culture (results on Fig.6.20). This experiment treated cultures with 
6-OHDA after 65 DIV to determine if more mature cultures resisted the effect of 6-OHDA compared 
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Figure 6.20: Effect of 6-OHDA treatment on day 65. Each graph shows the percentage activity (plotted on left 
y-axis) and the average and maximum spike frequencies (plotted on right y-axis) over time, with the dotted 
line indicating the 6-OHDA treatment. The left and right graphs show the effects in the SNc and STR ports 
respectively. Images not shown. 
6-OHDA appeared to have as much of an effect on SNc cultures after 65 DIV as after 25 DIV, with SNc 
activity decreasing sharply while STR activity was unaffected. 
6.3 Discussion 
By attempting to selectively remove the DA neurons of the SNc port in a SNc-STR co-culture device, 
a limited acute model of Parkinson’s disease (PD) could be created. The main limitation was that this 
model only featured the nigrostriatal pathway, and as a consequence any downstream effects to the 
GPe, STN and GPi/SNr could not be observed. In addition, due to the use of 6-OHDA this was an acute 
model of PD, destroying/damaging SNc cells within a few hours as opposed to over the course of 
many years as seen in PD in vivo. Most devices were assumed to feature DAergic cell death based on 
the optimisation (Fig.6.9), in the future experiments should be run in tandem so that the DAergic 
neurons can be characterised at each time point. Nonetheless, this SNc-STR co-culture in a five-port 
device (5PD) on a MEA and treated with 6-OHDA proved an effective model in highlighting the 
changes in functionality to the STR and SNc after 6-OHDA treatment. 
6.3.1 6-OHDA optimisation 
While 6-OHDA has been used in many animal models by direct injection into the SNc or STR, 6-OHDA 
use in vitro is less explored and required numerous steps of optimisation for use in this model and 
other in vitro studies (Y. M. Ding et al. 2004). 
The first issue was with the tendency of 6-OHDA to rapidly oxidise when made into a solution (even 
as a powder 6-OHDA is sensitive to light and has a short storage life), producing peroxides, oxygen 
radicals and other reactive oxygen species (ROS). While these products would certainly be sufficient 
to damage the DA neurons of our in vitro cultures, these products would be in the media and would 
therefore damage every cell type in the culture, including GABAergic SNc and STR interneurons, STR 
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MSNs of both types and glial cells. Therefore, to ensure specificity of the toxin, it was necessary to 
delay 6-OHDA oxidation until the dopamine transporters (DATs) of DA neurons have taken up 
6-OHDA and oxidation could occur within these neurons, resulting in specific DAergic neuronal 
damage (Fig.6.6). Ding et al. indicated that antioxidants such as ascorbic acid/ascorbate could delay 
this oxidation for up to 20 minutes, (Y. M. Ding et al. 2004). They show that when dissolved in 
standard media 6-OHDA breaks down almost completely within 5 minutes, but with 0.15% ascorbic 
acid 82% of 6-OHDA remained after 20 minutes. Our own optimisation process came to a similar 
conclusion, with exposure to 100 µM of 6-OHDA (within a 0.15% ascorbic acid vehicle) for 15-30 
minutes being the optimal conditions to selectively eliminate the DA neurons in a 6 DIV SNc culture 
(Figs.6.7 and 6.8). This resulted in a selective effect of 6-OHDA where GABAergic neuron levels were 
not significantly changed while DA neuron levels decreased significantly to 25-50% of the control. 
This optimisation process was necessary as the literature has opposing pieces of evidence concerning 
the optimum exposure time and concentration that 6-OHDA should be used when working in vitro. 
Where one study observed total loss of cells after a 6-hour exposure to 100 µM 6-OHDA (H. G. Kim 
et al. 2010), another observed only a 40% loss under the same conditions (D. Chen et al. 2015). One 
study observed no effect of 6-OHDA at 10 µM and significant effects at 40 µM (24-hour exposure 
time on 6 DIV culture) (Rodriguez-Pallares et al. 2007) whereas other studies observed a significant 
loss of DA neurons after 24 hour exposure to 10 µM 6-OHDA (D. Chen et al. 2015) or 200 µM 6-OHDA 
for a similar exposure time (Chan et al. 2009). 
In vitro 6-OHDA work is limited in that the treated in vitro cultures are typically only a week old, 
ranging from 2-7 DIV. Ding et al. summarises 14 studies of 6-OHDA application and subsequent 
cytotoxicity in vitro, and including the authors work themselves, no study advanced beyond 21 DIV 
before 6-OHDA treatment with the vast majority applying 6-OHDA between 2-7 DIV (Y. M. Ding et al. 
2004). While this is ideal to demonstrate the power of 6-OHDA’s selectivity in vitro, our functional 
in vitro model of the BG operated over a longer timeframe, up to ten weeks. 6-OHDA could be used 
on the SNc port of the SNc-STR model at an early stage (before 21 DIV), but as functional activity had 
not matured until after 21 DIV, it would be uncertain what electrophysiological effect the 6-OHDA 
was having and if the model could be labelled as ‘functional’ after treatment. In order to use 6-OHDA 
to destroy the nigrostriatal connections and determine the electrophysiological effects, it was 
necessary to use 6-OHDA in vitro on cultures beyond 21 DIV. 
Using the previously optimised variables, SNc cells were exposed to 100 µM 6-OHDA in a 0.15% 
ascorbic acid vehicle for 20 minutes, but there was no significant decrease in the levels of DAergic 
neurons (Fig.6.9). This may have been due to insufficient 6-OHDA levels in solution, but as there was 
little effect over several repeats it was necessary to re-optimise. A 20 minute exposure time may 
have been ineffective due to a far higher number and density of cells after 25 days of culture, with 
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intricately networked neurons and unexposed DATs, or a larger protective ‘buffer zone’ of astrocytes 
and other glia between 6-OHDA and the relevant DA neurons. This presence of glial cells in our model 
makes it a better mimic of the in vivo brain, as opposed to the majority of neuron-only work done 
in vitro. Glial cells play an important protective role in vivo, with astrocytes shown to have specific 
reactions to neurotoxins like 6-OHDA, such as ‘activation’ (determined by upregulation of astrocytic 
marker GFAP) upon 6-OHDA-induced neurodegeneration in vivo (Henning et al. 2008), and with 
astrocyte dysfunction in vivo accelerating DAergic degeneration upon 6-OHDA exposure (Kuter et al. 
2018). As such, tracking the intensity of GFAP expression over 6-OHDA treatment in our model would 
be a useful experiment to run in the future, keeping in mind the complex astrocyte-microglia-neuron 
relationship at play in vivo and in our model. In vitro, 6-OHDA has been shown to significantly reduce 
the viability of rat primary astrocytes (the same type used in this work), as well as astrocytoma cell 
lines C6 (rat) and U251 (human) (Raicevic, Mladenovic, Perovic, Harhaji et al. 2005, Raicevic, 
Mladenovic, Perovic, Miljkovic et al. 2005, Rodriguez-Pallares et al. 2007). Primary astrocytes 
underwent cell death via apoptosis due to 6-OHDA-induced oxidative stress, in turn because of 6-
OHDA autooxidation products hydrogen peroxide (H2O2), superoxide anion (O2*-) and hydroxyl radical 
(OH*) (Saito et al. 2007). However, in our model the use of an antioxidant vehicle results in less 
autooxidation products free in the cell media, potentially protecting astrocytes from non-specific 
action of 6-OHDA (Ding et al. 2004). Whilst astrocytes are negatively affected by 6-OHDA, they exert 
a protective effect on DAergic neurons via the secretion of protective biochemical factors. Seeding 
primary astrocytes with primary midbrain neurons in vitro resulted in increased cell survival upon 6-
OHDA exposure (Datta et al. 2018), something that should also be occurring in our model. 
Interestingly, while astrocytes from fore, mid and hindbrain regions all exerted an overall protective 
effect on midbrain neurons, when repeated with SNc DAergic (TH+) neurons, astrocytes from the 
midbrain exerted a significantly greater protective effect due to increased BDNF secretion in 
response to 6-OHDA exposure. As our SNc port contains both neurons and glia from the midbrain 
region, it is reasonable to assume that the astrocytes are exerting a similar protective effect. 
Astrocytes have also been shown to secrete GDNF in the presence of 6-OHDA, with GDNF having a 
similar neuroprotective effect (Sandhu et al. 2009). 
Despite the effects of the increased number of glial cells in the more mature cultures, 6-OHDA was 
not having a significant effect (Fig.6.9) and variables had to be changed. As vehicle concentration was 
matched to the 6-OHDA concentration, the only variable that could be changed easily was the 
exposure time. Some in vitro studies in the literature had up to 48 hours of exposure time (Ding et 
al. 2004), but as this project was limited by time contraints there was no time to attempt to optimise 
several longer 6-OHDA exposure times 20 minutes and 48 hours. As such, 24 hours was used as a 
compromise. As this exposure time significantly exceeded 20 minutes, the vehicle may have been 
ineffective and 6-OHDA may have oxidised in solution and caused widespread damage. However, as 
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seen in Fig.6.9, increasing the exposure time significantly reduced the levels of DAergic neurons, 
while not significantly affecting the levels of GABAergic neurons. This new exposure time of 24 hours 
was used throughout the rest of the experimentation, due to its specificity and effect on SNc DAergic 
neurons. In addition, despite 6-OHDA incubation for 24 hours in the SNc port of SNc-STR co-cultures, 
spiking activity of the STR port was unaffected. There are a number of potential explanations for this: 
1) 6-OHDA may have been entirely taken up by DATs in the initial stages of exposure in the SNc port, 
meaning that no 6-OHDA ever travelled down channels into the STR port; 2) 6-OHDA may have fully 
oxidised within the SNc port and the free ROS did not travel down the channels into the STR port due 
to insufficient capillary action and/or SNc axons plugging the channels; 3) 6-OHDA may have spread 
to all ports within 24 hours but not at concentrations sufficient to cause damage STR neurons after 
travelling through the channels. This 24 hour exposure time also significantly affected 65 DIV cultures 
(see Fig.6.20), one that must be far more networked and robust than an early-stage co-culture. 
6.3.2 Effects of 6-OHDA on functionality 
6-OHDA treatment (on day 25, 24 hour exposure) had numerous effects on the electrophysiological 
activity of SNc-STR co-culture devices as recorded by MEAs, compared to control SNc-STR devices 
that were untreated (but still left serum-free for 24 hours). 
6.3.2.1 Localisation 
As seen from heatmaps (Fig.6.12) and percentage activity graphs (Fig.6.13), changes were seen in 
SNc and channel activity by 29-35 DIV, with significantly less active electrodes in the SNc port and 
channels. This loss of activity may have been due to the loss of DA neurons in the SNc port. As seen 
in Fig.6.13, channel activity was closely correlated to SNc activity compared to STR activity (0.93 vs 
0.70) suggesting that these unidirectional channels mostly contained DA projection neurons from the 
SNc rather than GABAergic projection MSNs from the STR, and damage to the cell bodies in the SNc 
port may have resulted in the extended axons ‘dying back’ and retracting from the channels. All areas 
had a general decline in activity from peak (30-40 DIV) to 70 DIV, as seen in previous SNc-STR 
co-culture work (Chapter Five, section 5.2.3.1 Heatmaps, Fig.5.6). The decrease in activity from mid 
to late stages normally seen in SNc-STR cultures was accelerated by 6-OHDA from 29-50 DIV, with 
control activity levels naturally falling to similar levels from 60-70 DIV. 
6.3.2.2 Spiking/bursting 
6-OHDA treatment resulted in a significant decrease in both average and maximum spike frequencies 
from the SNc port, with average spiking not exceeding 1 Hz after treatment despite firing at over 5 Hz 
beforehand. The STR port was unaffected, with activity even increasing after 25 DIV. This decrease 
in SNc and channel activity is most likely due to the death of DAergic neurons in the SNc port, 
suggesting that a large portion of spiking activity from the SNc port is due to either DA neurons 
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activity or DA release influencing spiking frequency. It is more challenging to determine the effect of 
6-OHDA on SNc spiking activity when treating the SNc port after 65 DIV, as by this late stage spiking 
has already naturally decayed (Marom and Shahaf. 2002, Turrigiano and Nelson. 2004, Chiappalone 
et al. 2006). Despite this, there is still a decrease in average and maximum spiking after 6-OHDA 
treatment at 65 DIV. 
These average and maximum spiking frequencies were a sum of all spiking, such as spontaneous 
random spikes, oscillations, or regular bursts. While challenging to assess single random spikes, burst 
data can be extracted and processed (assuming that each bundle of spikes where more than ten 
spikes occur within a second (≥10 Hz) is a burst) so that the effect of 6-OHDA on bursting can indicate 
if the decreases in spike frequency are due to decreases in burst number. After 6-OHDA treatment 
the average number of bursts fell while the number of spikes per burst remained constant, resulting 
in a reduction of the overall average and the maximum spike frequency. 
6.3.2.3 Centroid assessment 
In both separate and connected cell populations, centroids and variability in spiking decreased over 
time from early/mid to late (seen in Fig.4.19, Fig.5.9 and Fig.6.17A). This trend was mostly conserved 
in centroids from 6-OHDA-treated SNc cultures (Fig.6.17B), but there were significant differences in 
the centroid number on day 29 (48 hours after 6-OHDA treatment) for the SNc port and channels 
when compared to control. This indicates that while the centroid number was initially perturbed by 
6-OHDA treatment in the short term, the centroid number was decreasing over time naturally for the 
control (as seen in low frequencies from 50-70 DIV), resulting in low centroid numbers regardless of 
6-OHDA treatment in the late stage. The impact of 6-OHDA treatment was seen most clearly 
immediately after treatment, similarly to the effect of 6-OHDA on spiking and bursting, where levels 
dropped to similar activity seen on 50-70 DIV in the control. STR centroid numbers were unaffected 
by 6-OHDA treatment. The most significant effects on centroid number can be seen in Table 6.1, 
which outlines that 6-OHDA had a significant effect on the mean number of centroids from the SNc 
port on 29 DIV (p<0.0001) until 50 DIV (p=0.002), indicating that there was a long-lasting effect on 
the average number of centroids. 
The proportion of mono/bi/triphasic centroids also changed after 6-OHDA treatment (Fig.6.18). 
While the SNc port from control SNc-STR devices produced a variety of centroid types, after 6-OHDA 
treatment the vast majority of centroids were positive/negative monophasic centroids (46.2% vs 
81.2%), and the number of centroids overall decreased (630 vs 214). This is the same for channels, 
where centroids change from 60.2% triphasic (the typical signal received from axons) to only 32.4% 
triphasic, indicating that there may be less SNc DAergic neuron axons within the channels. While the 
proportions of centroids for the STR port is similar to the SNc port for the SNc-STR control device 
(also observed in Chapter Five 5.4.5 Centroid Assessment), changes in SNc port centroid proportions 
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after 6-OHDA treatment may have influenced STR activity (as there were more monophasic 
centroids, (45.2% vs 63.6%) similarly to SNc) or may have no influence (as STR has more biphasic and 
triphasic centroids than SNc (33% vs 25%). 6-OHDA also had an effect on centroid FDHM (Fig.6.19), 
with 6-OHDA treatment reducing the FDHM of centroids from the SNc port and channels (shorter 
centroids), while increasing the FDHM of centroids from the STR port (longer centroids). It is 
unknown why this occurred, and further experimentation is required. 
6.3.2.4 Summary 
6-OHDA had a significant effect on spiking and bursting immediately after exposure, but these 
aspects of electrophysiological activity were lowered to levels that the cultures naturally decreased 
to over the long term (by 50 DIV) without any treatment. 
As this model only featured SNc and STR it represents an incomplete model of PD, there are many 
inputs and outputs missing (e.g. CTX input to STR) which can heavily influence firing of SNc and STR 
in the absence of DA or nigrostriatal DA neurons. This focused nigrostriatal model needs further 
development in order to see the effects of DA loss across all five ports of the 5PD. However, 6-OHDA 
had further long-term effects on SNc-STR devices that were not seen in control devices, such as the 
centroid number, shape and phase. This indicates that as well as decreasing the number of spikes 
and bursts, the type of spike and burst produced by SNc-STR co-cultures also changed, both in shape 
and number of phases, most likely due to destruction of the maturing functional network of neurons. 
It is uncertain if these unexpected changes mimic changes to the in vivo BG, and this data is an 
interesting effect of 6-OHDA that should be further explored. 
6.4 Conclusion 
By making use of the 6-OHDA neurotoxin, the SNc-STR nigrostriatal co-culture device could attempt 
to mimic PD. By treating our SNc-STR devices with 6-OHDA, destroying the DA neurons, and tracking 
the changes in the electrophysiological activity over ten weeks in culture, we have generated a 
long-term acute in vitro model of PD, potentially for use as a platform of study towards PD. This marks 
the first step of this device towards a pre-clinical model of PD, with further work the model will be 
able to accelerate PD research.  
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Chapter 7: General discussion and conclusions 
7.0 General discussion 
The aim of this thesis was to use in vitro modelling to create an experimental platform to accelerate 
pre-clinical study of neurodegenerative disease, particularly Parkinson’s disease (PD). We developed 
a five-port device (5PD) capable of isolating and connecting different neural cell populations via 
micro-channels, all of which could be recorded from via integrated electrodes in the form of an MEA. 
This enabled not only a morphological assessment of network connectivity, but importantly 
interrogation of the living neural network functionality (and dysfunction). 
The work covered in this thesis involved the design of the 5PD (Chapter Three), functional 
assessment of separate cell populations (Chapter Four) to serve as a comparative baseline for the 
next chapters, functional assessment of connected co-cultures within 5PDs (Chapter Five) and 
functional assessment of a specific chemically-treated connected co-culture designed to mimic the 
loss of nigrostriatal neurons in PD (Chapter Six). 
7.0.1 Chapter Three: Device design and optimisation 
This chapter presented the re-design and optimisation of a 5PD following on from previous work 
(Kamudzandu. 2015) in order to more accurately and efficiently mimic basal ganglia (BG) circuitry. 
While such compartmentalised microfluidic devices have been in use for more than ten years (Taylor 
et al. 2003, Taylor et al. 2005, J. W. Park et al. 2006), featuring numerous ports (Y. H. Kim et al. 2011) 
and tapered microchannels (Peyrin et al. 2011), to my knowledge this is the first example of a 
five-port device where the side ports connect to a centre port via tapered microchannels. These novel 
devices can also house from 1-5 separate sets of cells and have an integrated MEA for continuous 
functionality analysis. These devices required optimising from both an engineering and biological 
perspective before they would be suitable to act as mimics of BG circuitry. 
7.0.1.1 Engineering the five-port device 
The compartmentalised microfluidic device represents an alternative to the collection of randomly 
connected neurons and glia found in standard dissociated neural cultures, by providing a 3D 
substrate that physically confines neural cells to pre-designed locations. In the case of tapered 
microchannels, the device also connects cell populations in a controlled manner while confining 
them, but there are better options for internal channel structure for unidirectional neurite growth, 
as discussed later. By culturing cells in a device there is far more control of connectivity as opposed 
to a standard dissociated culture, and it is this control that will allow for better pre-clinical research 
as more effective and efficient experiments can be designed. 
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This method of physically trapping neural cultures in a 3D substrate cage is not new, and the vast 
majority of modern neural devices (Hasan and Berdichevsky. 2016) are fabricated in the same way 
as the proto-device developed by Taylor and colleagues in 2003: by soft lithography, resulting in a 
polydimethylsiloxane (PDMS) stamp/shape that can contain cell/tissue cultures (J. Park, Koito, Li and 
Han. 2009b, Brewer et al. 2013, Habibey et al. 2015, L. Pan, Alagapan, Franca, Leondopulos, DeMarse, 
Brewer and Wheeler. 2015a). Our 5PDs used the same fabrication techniques, as this technique 
resulted in sub-micron resolution, reproducible, non-toxic, transparent, cheap and disposable 
devices that were quick and easy to fabricate while retaining complex patterns and could be sealed 
to glass or an MEA. 
Most of the compartmentalised devices from the literature remain similar to the original design from 
Taylor and colleagues, namely two ports linked by microchannels, (Kanagasabapathi et al. 2011, 
Deleglise et al. 2014, Tang-Schomer et al. 2014, Renault et al. 2015). Our device pushed the number 
of ports up to five, with two side ports linked by channels to the centre, which is also linked to the 
opposing set of two side ports. To my knowledge this combination of five ports linked by four sets of 
channels is a novel design and increases the ability of the model to mimic entire networks or circuits, 
rather than just two cell populations. 
As well as the ports, we presented tapered channels ranging from 15, 25 and 50 μm wide at one end 
to 5 μm wide at the other end. This design was based on work done by Peyrin and colleagues (Peyrin 
et al. 2011) who designed one of the first sets of unidirectional/tapered/diode/asymmetrical 
channels (15 μm to 3 μm) that had 97% selectivity for one direction. While re-creating channels with 
the same dimensions would have been desirable, the lowest width we could reliably fabricate was 
5 μm, and thus after optimisation our optimal unidirectional channel dimensions were 15-5 μm, 
which still only resulted in a selectivity of ~76% (25-5 μm and 50-5 μm resulting in 59% and 50% 
respectively) for axons. This decreased selectivity compared to Peyrin and colleagues might be due 
to the inability to decrease the smaller width to as low as 3 μm, but as axons are approximately 
0.5 μm in diameter (Pesaresi et al. 2015) it is difficult to determine how much difference the extra 
2 μm would make. From the results presented in this thesis, the method of influencing the 
directionality of axonal outgrowth needs further work, possibly by adopting one of the many other 
more recent channel shape paradigms, including barbed (le Feber et al. 2015), closed-loop (Renault 
et al. 2016), reverse-fishbone (E et al. 2015) and ‘new’ diode (Na et al. 2016) designs. For this 5PD, 
unidirectionality is only vital for the centre and right-hand ports, as cells in the left hand ports can 
only extend axons in the correct direction (Pamies et al. 2014). 
7.0.1.2 Biology of neurons cultured within devices 
Despite the walls of the device being fabricated from PDMS, the growth surface for our device was 
glass, a substance much harder than the in vivo brain and not one that delicate primary neural 
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cultures adapted well to without prior coating (Lantoine et al. 2016). Poly-D-lysine (PDL) and laminin 
(LAM) were both available, previously used by our group, represented a gold standard and were 
supported in the literature as promoting adhesion and axon generation (Sun et al. 2012). As such, 
initial experiments were performed with PDL/LAM, until migration became an issue. Neural cultures 
on PDL/LAM would migrate, rendering the idea of a compartmentalised and isolated culture 
pointless. A comparison between PDL/LAM and polyethylenimine (PEI)/PDL indicated that the latter 
was superior, both massively inhibiting migration while promoting neurite outgrowth, and 
established in the literature (Ruegg and Hefti. 1984, Bledi et al. 2000, T. Zhou et al. 2012). However, 
cells still migrated in solution and were unaffected by PEI/PDL surfaces until they came into contact 
with the surface. The best way to confine cells to their ports would be with gated channels, where 
channels are blocked until cells have settled and attached to the surface, and channels are then 
unblocked, as seen in the lifting-gate micro-valve design (J. Kim et al. 2012). 
CTX, STR, GP and SN cells were successfully dissected from primary rat embryos, characterised and 
seeded into 5PDs where they attached, extended axons and were maintained over the long term (up 
to 10 weeks). With the majority of other studies halting after 5 weeks in vitro (Goyal and Nam. 2011, 
Ito et al. 2013, Kanagasabapathi et al. 2013) (see Table 4.2 for more details), the experiments 
outlined in this thesis better analyse the condition and function of connected neural cultures over 
the long term, vital when studying PD due to its progressive nature. Each cell type reacted differently 
in culture, with CTX cultures extending significantly more axons through channels, SN dopaminergic 
neurons not expressing marker enzyme tyrosine hydroxylase (TH) until 3-4 days in vitro (DIV), and an 
initial astrocyte:neuron ratio of 50:40. 
As other devices featured less than five ports they also featured less than five cell types, meaning 
that not only is the 5PD design novel it marks the first time, to my knowledge, that CTX, STR, GP and 
SN cells have all been cultured together within the same device in vitro. Most BG studies took place 
with in vivo rat models (Moustafa et al. 2014) as opposed to designing complex cell models. By 
culturing CTX, STR, GP and SN neural cell types together, more control can be exerted over the 
construction of BG circuitry in vitro, and experiments are less limited in scope due to accessibility. 
7.0.2 Chapter Four: Long-term study of separate neural culture functionality 
It was necessary to establish an electrophysiological baseline of separate CTX, STR, GP and SN neural 
culture functional activity over the long term, in order to determine how their activity evolved over 
time as the synapses and network formed, matured and aged. This baseline for separate cells could 
then be compared to data from the same cell types when connected with the 5PD, and when treated 
with neurotoxins in order to mimic PD. To establish this baseline, dissociated neural cultures were 
grown separately on MEAs and their spontaneous extracellular electrical activity was recorded over 
the long term. 
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MEAs allow for easy culture-wide extracellular recordings to be taken over the long term and are a 
widely-used tool that interfaces between cultured cells and recording circuitry (Fejtl et al. 2006, 
Obien et al. 2015). Dissociated neural rat cultures on MEAs in vitro have shown selective adaption 
(Eytan et al. 2003), network plasticity in response to stimulation (Chiappalone et al. 2006, 
Chiappalone et al. 2008), spontaneous plasticity (Madhavan et al. 2007) and even short-term 
memory (Dranias et al. 2013). With these studies showing similar results to similar experiments 
in vivo, it indicates that in vitro extracellular recordings are comparable to some aspects of the in vivo 
situation, and that our in vitro model of BG circuitry can be a robust model that mimics components 
of BG activity in vivo. 
Our CTX, STR, GP and SN separate neural cultures on MEAs displayed spontaneous activity ranging 
from random spiking to regular bursting and whole network bursts, with each facet of activity 
changing over time through the long term (up to 70 DIV). With the majority of ‘long-term’ in vitro 
neural culture extracellular recordings stopping after 35 DIV (Jimbo. 2007, Ito et al. 2013, Frega et al. 
2014a), and the longest found in the literature to be up to 60 DIV (Lesuisse and Martin. 2002), our 
70 day cultures represent the longest that in vitro neural cultures have been cultured for, with 
integrated MEA recording. This adds to the novelty of our device and shows that it is possible to 
access the BG circuitry for longer in vitro, a useful factor when dealing with progressive neural 
diseases that worsen over the long-term. 
All cell types began to fire spontaneously from 11-15 DIV, except CTX where onset of activity was 
around 21 DIV due to CTX maturing later in vivo compared to STR, GP and SN (Anda et al. 2016). CTX 
had this delay in maturity as CTX, STR and GP were taken at embryonic age (E) 16, when peak 
neurogenesis for CTX is E18 (Hatanaka and Murakami. 2002, Anda et al. 2016), and CTX cultures 
consequently had this delay in onset of activity as they matured in vitro. Spontaneous activity from 
all cell types increased and then decreased in frequency and amplitude, in line with recorded in vitro 
changes to the number, density and maturation of synapses over time (Chiappalone et al. 2006). 
However, there is less information available concerning the onset of spontaneous activity from the 
STR, GP and SN, as many studies involve stimulation rather than passive recording of spontaneous 
activity. Studies with E18 hippocampal cells show activity as early as 9 DIV, but do indicate similar 
trends, with an early peak in the percentage of active electrodes followed by a plateau and a decrease 
(N. Hong et al. 2017a). 
Spontaneous electrophysiological data obtained from MEAs also potentially revealed that the in vitro 
cultures were exhibiting plasticity, where certain spontaneous activity patterns were strengthened 
over time and electrodes recorded more spikes in certain locations. This localisation and focusing of 
activity to certain locations highlights an advantage of MEAs as recording both temporal and spatial 
changes in spontaneous activity, and has been observed in other studies on cell models (Lesuisse and 
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Martin. 2002, Chiappalone et al. 2006) and brain slices (Abrahamsson et al. 2016, Lalanne et al. 2016), 
some claiming it to be dependent on cell density (Biffi et al. 2013). 
Spiking and bursting activity from the STR, GP and SN were consistent with previously recorded 
in vitro and in vivo recordings (Boraud et al. 2002, Walters et al. 2007), all three cell types showing 
different frequencies of firing most likely due to the dual populations of functionally distinct cells in 
each culture: STR cultures consist of slower firing medium spiny neurons (MSNs) (B. R. Miller et al. 
2008) and faster firing cholinergic interneurons (Gage et al. 2010), GP cultures consist of slower GPe 
and faster firing GPi neurons (both GABAergic neurons) (Mallet et al. 2012, Mallet et al. 2006) and 
SN cultures consist of slower SNc dopaminergic neurons and faster SNr GABAergic neurons (Lee et 
al. 2011, S. Ding et al. 2011, F. M. Zhou and Lee. 2011). 
SN cultures showed increased spontaneous activity when compared to CTX, STR and GP, with SN 
culture spiking and bursting frequencies being consistently higher than CTX, STR and GP, 
corroborated by the literature (Blythe et al. 2009, Berretta et al. 2010, Marinelli and McCutcheon. 
2014). In addition, SN activity was more widespread across the MEA for longer, and it is unclear why 
activity did not follow the same ‘focusing’ trend seen in other cell types. 
Another finding was that centroid shapes (i.e. groups of similar spike patterns) changed over time, 
also seen by Lewandowska and colleagues who recognised the process of spike ‘evolution’ where 
spike shapes changed over 28 DIV. There is little published information concerning changes in any 
form of spontaneous activity from 35 DIV onwards, meaning that long-term changes were 
challenging to corroborate in our experiments from 35-70 DIV or reinforce with data from other 
studies, which did show a process of evolution over the first 5 weeks (Chiappalone et al. 2006, 
Lewandowska et al. 2015) 
7.0.3 Chapter Five: Long-term study of connected neural co-culture 
functionality 
Having obtained valuable baseline electrical data for separate cells, reported in Chapter Four, the 
simultaneous measure of co-cultures and structurally connected populations were carried out using 
the 5PD. Devices were combined with MEAs to determine any changes in activity over the long term 
for connected dual co-cultures, namely CTX-STR, STR-GP and SNc-STR. As the basics of long term 
electrophysiology were discussed in the previous section, this section will mainly focus on the 
effect(s) of connectivity between two neural cell types and what changes did or did not occur to the 
spontaneous electrophysiological activity. 
Broadly, connectivity resulted in the following changes in activity: 
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 CTX: earlier onset, greater amplitude and more frequent spiking and bursting activity 
throughout 
 GP: greater amplitude and more frequent spiking and bursting for initial 3 weeks followed by 
reduced activity in all areas afterwards 
 SN: greater amplitude, more frequent spiking and bursting activity by 5 weeks (~35 DIV) but 
decreased activity afterwards 
 STR: all aspects of activity increased when innervated by CTX and SN cultures, all aspects of 
activity decreased when connected to GP cultures. 
While CTX-STR and SNc-STR devices resulted in increased activity for both ports, with CTX exciting 
STR via glutamatergic input and SNc modifying STR activity via dopaminergic input, STR-GP resulted 
in inhibition for both ports likely due to GABAergic activity which has been demonstrated in vitro as 
inhibitory (Dubinsky. 1989, Sims et al. 2008). While there was increased activity for the first 5 weeks, 
activity generally decreased over the next 5 weeks, an effect to my knowledge not displayed in the 
literature. 
Studies using PDMS devices with channels on MEAs had similar findings, Goyal and colleagues noting 
that as the confined neurons matured the spike and burst rates increased, attributing it to increased 
synapse maturation and density over the first few weeks in culture (Goyal and Nam. 2011). However, 
Goyal and colleagues only measured from 8 devices containing one cell type, while the work reported 
in this thesis looked at much longer term cultures with multiple cell types. Dworak and colleagues 
noted spike frequencies from 3-22 Hz, amplitudes of 100-200 μV and synchronous bursting from 
10-14 DIV (from 21 devices) all of which align with our findings (Dworak and Wheeler. 2009). Most 
significantly, Takayama and colleagues demonstrated that connecting neural cell populations 
together increases periodic synchronized bursting after forming functional networks within 2 weeks 
and maintaining this activity for up to 4 weeks (Takayama et al. 2012). These works reinforce the data 
generated from our connected co-cultures, with display similar activity trends. 
Devices using cells from basal ganglia circuitry, connecting cortex and thalamus, showed that bursting 
from the CTX region propagated to thalamic cells (Kanagasabapathi et al. 2013). This study also 
showed that even CTX-CTX devices had an input-output relationship, with one port acting as input 
and controlling the activity, despite both ports containing identical cells. The identity of the input 
port was dependent on neurite arborisation and strength of synaptic connections. This thesis also 
demonstrated such input-output modulation of activity, with activity from STR cultures changing 
depending on the cell type that was the input (CTX or SN), as seen in Chapter Five (section 5.2.8.2 
Centroid shape categorisation and section 5.3 Comparisons of separate cultures and connected 
co-cultures, where the effects of connectivity on STR cultures are highlighted). 
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Hong and colleagues reported a decrease in activity from microchannel electrodes between 
3-4 weeks, stated to be potentially due to the small number of channels in their device resulting in 
neuronal cultures forming stronger networks within ports rather than between ports (N. Hong et al. 
2017b). This phenomenon was also shown by Pan et al. who noted that the greater the number of 
channels the stronger the connectivity, the greater the probability of bursting propagating between 
wells, shorter delays between spikes and faster onset in connected wells (L. Pan, Alagapan, Franca, 
Leondopulos, DeMarse, Brewer and Wheeler. 2015b), all features noted in this chapter, indicating 
that our device has sufficient channels to connect two cell populations functionally. The maximum 
number of channels used by Pan and Hong in their devices were ~50, and as our device features four 
sets of 200 channels the neural cultures were better connected and able to network across multiple 
distinct cell populations. 
In summary, as the 5PD features more electrodes, more channels and more cell types, it represents 
an advancement for in vitro neural models based on the current work in the field. This will be useful 
for the development of more state-of-the-art advanced in vitro neural models in order to study 
neurodegenerative disease at a preclinical level and accelerate the research into such conditions as 
Parkinson’s disease (Ellens and Leventhal. 2013, Bahmad et al. 2017, Lazaro et al. 2017) 
7.0.4 Chapter Six: Modelling Parkinson’s disease 
With many expensive and time-consuming clinical trials focused on Parkinson’s disease (PD) and not 
sufficiently achieving or generating new therapies, treatments or preventative measures, it is time 
to develop better preclinical platforms for study, enabling PD research to better filter out useful 
treatments, stem cell therapies, neuroprotective factors etc. before the clinical stage. The 5PD 
described in this thesis presents a powerful option for a preclinical platform of study, once chemically 
modified to better suit the study of PD. With separate culture and connected co-culture baselines of 
activity as reference, the final step was to mimic PD. With the use of 6-OHDA well established both 
in literature and effectively optimised in our experiments, it was a simple matter to attempt to 
destroy the dopaminergic (DA) neurons of nigrostriatal SNc-STR co-cultures and record any effects 
on the spontaneous extracellular electrophysiological activity, having created an acute model of PD 







Table 7.1: The electrophysiological effects of 6-OHDA treatment to the SNc port of SNc-STR devices 
Effects of 6-OHDA 
treatment 
Suggested reasoning Implications Seen in 
literature? 
Decreased number of 
active SNc and channel 
electrodes 
Less DA neurons, which exist 
in SNc port and extended 
axons into channels 
Killing of DA neurons 
results in ‘dying back’ of 
DA projection axons 
No, too few 
studies look at 
percentage 
activity 
Decreased SNc spike 
frequency 
Less DA neurons firing, less 
bursts (see below) 
DA neurons contribute 
to SNc overall spike 
frequency 
Low SN firing 
seen in vivo 
(Aristieta et al. 
2016)  
Decreased SNc burst 
firing but similar 
numbers of spikes per 
burst 
Insufficient networking to 
produce bursts with same 
frequency after DA neuron 
death 
Bursting is a major 
component of spike 
frequency, removing 




in vivo (Lobb 
and Jaeger. 
2015) 
Increased SNc centroid 
number immediately 
after treatment, lower 
numbers overall 
DA neuron death perturbing 
signal variability as network 
potentially has to reform, 
then recover to normal 
function. 
Networks degenerate 
over the long term 
whether treated or not 
Increase in 
variability 




of biphasic and triphasic 
centroids in SNc port 
and channels 
Less cell bodies and axons 
result in less detectable 
centroids as there was also 
lower spike frequency. 
Biphasic and triphasic 
centroids generated by 






Decreased SNc FDHM 
(‘thinner’ spikes) 
Unknown, potentially due to 
network reformation after 
DA neuron loss 
DA neuron loss can 






Effects seen with both 
25 DIV and 65 DIV 
treatment 
More mature networks still 
vulnerable to 6-OHDA  
Acute models can be 






Only effect to STR 
activity was increased 
FDHM and less triphasic 
centroids 
6-OHDA has very specific 
action. Larger FDHM 
potentially in response to 
smaller FDHM of SNc. Less 
triphasic centroids due to 
less SNc axons in STR port 
Model mimics the effect 
of PD with specific 






Decreased spontaneous activity (specifically, decreased spike and burst frequencies) of SNc cultures 
when treated with a neurotoxin is a natural consequence of destroying DA neurons and thus 
decreasing the number of neurons that can fire. This decreased firing is displayed on theoretical firing 
rate and dynamic activity models of PD (Nambu et al. 2015), animal models (Branch et al. 2016) and 
human models (Woodard et al. 2014), which all display differences in spontaneous bursting and 
spiking after DA neuron loss. 
 230 
While there are numerous examples of in vitro compartmentalised models coupled to MEAs, there 
are very few studies that treat such models with 6-OHDA in an effort to model PD. The main use of 
MEAs in PD study appears to be for the stimulation aspect of MEAs, usually implanted in vivo for 
deep brain stimulation (DBS) on rodents or primate models (Zhang et al. 2018). As such there is little 
in vitro literature to compare the results of this chapter to, but insight can be generated from in vivo 
models. Most of these studies involve stereotactic injection of 6-OHDA into the SN or STR (in order 
to bypass the blood brain barrier and target specific neurons), with large differences. When injected 
into the SN there is complete and rapid lesion of the nigrostriatal pathway within 12 hours, and loss 
of DA terminals on the STR 2-3 days later. When injected into the STR there is slow, progressive 
damage to the nigrostriatal pathway, making injection of 6-OHDA into the STR a more relevant model 
of PD as it is more progressive and also induces PD symptoms (Cannon and Greenamyre. 2010, Tieu. 
2011). These models show decreased SNc firing and bursting but increased SNr firing and bursting 
(Ellens and Leventhal. 2013). As our model does not separate SNc and SNr but treats SN as a whole 
with 6-OHDA, it appears there was either a non-specific effect of 6-OHDA and SNr GABAergic neurons 
were lost, or only SNc DA neurons were lost and this had a large effect on the spiking and bursting 
in vitro. 
7.1 Limitations of the model 
While the work presented here represents a robust and reproducible model of basal ganglia circuitry 
and a method of preclinical research into PD, the model was still limited by a number of factors: 
 Our basal ganglia circuitry model did not take into account the subthalamic nucleus 
 The lowest channel width possible to reliably fabricate was limited to 5 μm, would preferably 
be <5 μm as seen in other publications (Peyrin et al. 2011) 
 Tapered channels potentially not as effective as other channel designs for exerting 
directional pressure and making a unidirectional circuit 
 Cells in the right-hand ports of the 5PD could only extend axons in the unwanted direction 
 10-20% of cells migrated between ports while in solution and before contacting with the 
attractive PEI/PDL-coated growth surface 
 Cells on MEA could only be imaged while live by brightfield and could not be fixed (and killed) 
for fluorescent imaging without halting the spontaneous activity, experiments with recording 
and imaging would be run separately but in tandem 
 MEA was not located in a desirable location within 5PDs due to hardware constraints 
(discussed in 7.2 Future Work) 
 Not possible to directly determine if dopaminergic cells were damaged/destroyed by 
6-OHDA within each device while recording, as any fixing and staining would halt activity 
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 Only two cell types were seeded as opposed to a maximum of five 
7.2 Future work 
The work in this thesis represents only a portion of the work done to develop a novel, functional 
in vitro Parkinsonian model. The original aim was to fill the model with CTX, STR, GP, SNc and SNr cell 
types (to more completely represent the physiological BG), then to damage/destroy the dopamine 
neurons of the SNc via 6-OHDA treatment (to model the effects of nigrostriatal dopamine neuron 
loss on further downstream and upstream nuclei, modelling the pathological BG), and finally to 
attempt to recover function in the model, returning the functionality from damaged pathological to 
healthy physiological BG. In this manner our device would become a platform for study of Parkinson’s 
disease, where designer drugs and pharmaceuticals, new therapies, stem cell treatments and 
neuroprotective factors could all be tested at a pre-clinical level in order to accelerate research into 
Parkinson’s and have more efficient clinical trials. As this original aim was altered due to experimental 
and time constraints, the immediate future work would be to achieve this original aim, developing 
the full BG, a Parkinsonian BG model and attempt to restore this disease model to normal function. 
For a specific piece of future work, the issue of MEA electrode location when paired with the 5PD (as 
outlined in Chapter Five (section 5.4.2 MEA electrode location, Fig.5.19) would require a re-design 
of the electrode array to better suit the shape of the 5PD. This re-design process was started and 
completed during this project, but the greater noise level of these custom MEAs meant that the 
experiments in this thesis took place with the MEA layout displayed in Fig.5.19B. For future work 
filling the entire device with all five cell types (CTX, STR, GP, SNc and SN with dopamine neurons 
removed to represent SNr), these new custom MEAs will be necessary to reach the full potential of 
this 5PD model. The custom MEA design for the future is outlined in Fig.7.1. 
In addition, our device allows for any five neuronal cell populations to be connected in a specific 
unidirectional manner via channels while isolating cell bodies within ports. As the device was 
designed with the BG in mind, a natural next step would be to further model the corticostriatal (CTX-
STR) connections in a full BG model, and then damage this connection (along with STR and CTX 
neurons) in order to mimic Huntington’s disease. Thus, our device can be used as a pre-clinical 
platform for study for multiple progressive neurological diseases, in an effort to push towards more 
effective treatment strategies. 
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Figure 7.1: MEA redesign for future experimentation. This new custom MEA involved splitting the 64 
electrodes split into four groups of 12 (6 x 2, one for each side port) and two groups of 8 (4x2, both for the 
centre port). The photolithographic mask design for these electrodes is on the left-hand side, and the final 
placement of these electrodes within the 5PD is on the right-hand side. These groups of electrodes were 
aligned with the channels entrances and exits, but no electrodes within channels. Electrode diameter and 
grouped electrode spacing is the same as the original 8x8 grid, 50x50 µm per electrode and 200 µm spacing.  
 
As discussed in the introduction, there are many potential modelling systems available for PD 
research, including (but not limited to) neurotoxin-based animal models, gene-based animal models, 
cell line models, primary cell models, stem cell models, reprogrammed cell (iPSC) models, 
organotypic tissue slice models and organoid models. Good examples of these are summaried by 
(Ghatak et al. 2018). 
Despite this wide range of available models, none of them can comprehensively represent all aspects 
of the human disease. This is due to PD being a very complex and multifactorial human disease, and 
while the approach of cell modelling provides a powerful tool for PD research, without the use of 
human nigrostriatal DAergic neurons these models cannot fully reflect the pathogenesis in PD. The 
most reliable way to generate such human DAergic neuron models would be through iPSCs, which 
can be generated directly from PD patient cells (from non-invasive manners such as finger prick, hair, 
urine or mouth swab) (Xiao et al. 2016). iPSC-derived neurons have been used in vitro to model PD 
and have produced some interesting results, some concerning the role of mitophagy in PD (Xiao et 
al. 2016), and some through artificial ageing via long-term culture and progerin expression (Miller et 
al. 2013), similarly to the long-term culture used in this thesis. As well as modelling, iPSC-derived 
human neurons have also been used to discover and screen potential PD therapeutics. By testing 
experimental therapies on patient-derived iPSC DAergic neurons before their use on the patient 
themselves, the efficacy of certain treatments can be ensured before they are administered. 
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However, due to the expensive and time-consuming process of generating iPSCs for each individual 
PD patient, this kind of screening is unlikely until iPSC technology improves. A combination of this 
iPSC screening with compartmentalised microfluidic in vitro models would allow for a more powerful 
platform, combining the individualised specificity of iPSCs with the in vivo basal ganglia structural 
mimicry of the microfluidic device, allowing for the formation of a nigrostriatal circuit as opposed to 
an isolated culture of iPSC-derived human neurons, which mimics the genotypic but not the structural 
interactions. Another option for screening consists of sequencing patient-derived iPSCs to determine 
if a PD patient can be categorised in certain genotypic subgroups and given more effective treatments 
(Xiao et al. 2016). 
One of the aims with our model was to damage the SNc-STR circuitry with 6-OHDA in order to mimic 
PD, but another unachieved aim was to restore the function of these damaged models using cell 
replacement, therapies or neuroprotective factors. iPSCs have enjoyed successful usage in cellular 
replacement therapies for PD, partly due to the unlimited supply of patient-specific neurons offered. 
Grafted iPSCs differentiated into DA neurons and rescued motor deficits in rat PD models (Wernig et 
al. 2008), similarly iPSC-derived NSCs also differentiated into DA neurons and survived for 6 months 
in primate models, albeit with no significant improvement in behaviour (Kikuchi et al. 2011), 
indicating that iPSCs can potentially integrate and restore function in some damaged systems, but a 
stringent clinical study paradigm is necessary. By testing these iPSC replacement therapies at a pre-
clinical level in our device, iPSC replacement can be accelerated. 
In addition, the use of iPSCs allow for patient-specific human models to be generated. These human 
models still have the limitations that other in vitro models have when compared to rodent in vivo 
studies, but offer a novel alternative approach and increased relevance to PD, a human disease. 
Other ways to better humanise PD models would be to make PD models less acute and more 
progressive to better mimic the human condition in vivo. Models with subacute/chronic symptoms 
are developed by applying low doses of neurotoxin over a long period of time (Iravani et al. 2005, 
Barraud et al. 2010, Vezoli et al. 2011, Blesa et al. 2012), often with non-human primates. 
These diseases are modelled in animals first, despite being a human disease. Simply put, animal 
model systems are the closest to humans that we are able to study. Many of these models are 
necessary as it is very unlikely that a single model, be it toxic or genetic, can fully recapitulate the 
complexity of human PD (Blesa et al. 2012, Jackson-Lewis et al. 2012, Blesa and Przedborski. 2014). 
Future models will likely combine different methodologies and include both neurotoxin-induced and 
genetically induced insults, taking into account aging and environmental insults. Despite the 
similarity of non-human primates to humans and their ability to develop PD-like symptoms, the 
rodent model is employed far more often. Aside from the ethical, time and financial benefits, the 
rodent models are useful to test theories and initially screen potential PD treatments and therapies, 
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while lacking the behavioural and symptomatic components of PD such as the non-human primates. 
Monkeys essentially represent the last stage in PD treatment before anything is administered to 
humans (Bezard and Przedborski. 2011). Naturally, when looking to the future of research it is ideal 
to consider a large reduction in animal usage in compliance with the 3Rs, and an increase in the 
number of effective and powerful human models of PD, whether through reprogrammed human 
patient iPSCs or human-derived cell likes such as SH-SY5Y. 
The end goal of our model system is to be used for pre-clinical research into PD and to eventually 
reduce animal use once humanised. In an effort to address gaps in PD knowledge, more investigators 
are approaching PD using such interdisciplinary approaches with a variety of models. 
7.3 Conclusion 
This project has gathered data from more cell types in more combinations over a longer time frame 
than any other project, to this author’s knowledge. The vast body of data generated across this 
project allows for new insights into the workings of BG nuclei in vitro over the long term, including 
neuronal functionality in separate and connected cultures and the effects of dopaminergic loss on 
this functionality. 
This kind of in vitro cell model can become part of a departure from using a large number of animal 
models for each experiment, now that cell models can attain such levels of complexity and generate 
relevant data. My hope is that these models can grow in complexity until there are models for specific 
CNS-related experimentation, and that this kind of pre-clinical work can accelerate research into 
currently incurable neurological diseases.  
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Appendices 
These appendices consist of images of raw MEA activity. 
 Appendix 1: Raw images of MEA activity from separate MEA cultures (linked to Chapter 4), 
indicating 20 s of activity, 0.5 s and 10 ms, for 15, 21, 44 and 70 DIV 
o 1.1: CTX 
o 1.2: STR 
o 1.3: GP 
o 1.4: SN. 
 Appendix 2: Raw images of MEA activity from connected MEA cco-ultures (linked to 
Chapter 5), indicating 240 s of activity from an electrode of a port for 15, 21, 44 and 70 DIV 
o 2.1: CTX port of CTX-STR device 
o 2.2: GP port of STR-GP device 
o 2.3: SNc port of SNc-STR device 
 Appendix 3: Images of centroids from connected co-cultures on MEAs with some discussion 
of what they show 
o  2.1: CTX port of CTX-STR device 
o 2.2: GP port of STR-GP device 
o 2.3: SNc port of SNc-STR device 
 Appendix 4: Images of raw data across an entire MEA generated by Python code, showing 
240 seconds of activity for 15, 21, 44 and 70 DIV. 
o Appendix 1: CTX (separate culture) on days 15, 21, 44 and 70 
o Appendix 2: STR (separate culture) on days 15, 21, 44 and 70 
o Appendix 3: GP (separate culture) on days 15, 21, 44 and 70 
o Appendix 4: SN (separate culture) on days 15, 21, 44 and 70 
o Appendix 5: CTX-STR (connected co-culture) on days 15, 21, 42 and 70 
o Appendix 6: STR-GP (connected co-culture) on days 15, 21, 42 and 70 





Appendix 1.1: Raw spontaneous spiking extracellular activity recorded from cells isolated from the CTX. Rows indicate culture activity at DIV 15, 21, 44 and 70, while columns indicate 
the time of each trace, namely 20 s, 0.5 s and 10 ms. X-axis is 0.1 to -0.2 mV. Activity shown is taken from an active electrode  and is representative of the average activity each day. 






Appendix 1.2: Raw spontaneous spiking extracellular activity recorded from cells isolated from the STR. Rows indicate culture activity at DIV 15, 21, 44 and 70, while columns indicate 
the time of each trace, namely 20 s, 0.5 s and 10 ms. Each trace ranges from 0.1 to -0.2 mV. Activity shown is taken from an active electrode and is representative of the average 






Appendix 1.3: Raw spontaneous spiking extracellular activity recorded from cells isolated from the GP. Rows indicate culture activity at DIV 15, 21, 44 and 70, while columns indicate 
the time of each trace, namely 20 s, 0.5 s and 10 ms. Each trace ranges from 0.1 to -0.2 mV. Activity shown is taken from an active electrode and is representative of the average 






Appendix 1.4: Raw spontaneous spiking extracellular activity recorded from cells isolated from the SN. A-D show the spiking activity at DIV 15, 21, 44 and 70 respectively. Each trace 
lasted for 240 s (measured in milliseconds in the figure) and ranged from 0.1 to -0.15 mV. Activity shown is representative of the average activity each day. Number of active 






Appendix 2.1: 240 seconds of raw activity from the CTX port of a CTX-STR device. Activity from electrode 42 at 15, 21, 42 and 70 DIV, scaled from -0.2 to 0.2 mV. Images of raw 




Appendix 2.2: 240 seconds of raw activity from the GP port of a GP-STR device. Activity from electrode 27 at 15, 21, 42 and 70 DIV, scaled from -0.2 to 0.25 mV. Images of raw activity 





Appendix 2.3: 240 seconds of raw activity from the SN port of a SN-STR device. Activity from electrode 35 at 15, 21, 42 and 70 DIV, scaled from -0.2 to 0.2 mV. Images of raw activity 




The largest four centroids for each co-culture are displayed for days 15, 21, 42 and 70 (if there were 
less than four centroids then all centroids were displayed). A new phase was defined by the measured 
potential crossing the x-axis and exceeding ≥10 μV in either direction. 
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Appendix 3.1: Centroid waveforms for CTX-STR co-culture from electrode 43 across four time points. Red, 
green and blue signify mono-, bi- and tri-phasic centroids respectively, legend indicates how many spikes 
make up the centroid. 
CTX-STR centroids began with a high level of variability, displaying mono-, bi- and triphasic centroids 
with both positive and negative spikes. 15 DIV centroids are unaligned and varied, with large negative 
and positive spikes. By 21 and 42 DIV the centroids are more similar in amplitude and alignment with 
only mono- and biphasic centroids remaining by 42 DIV. By 70 DIV there was no signal remaining 
from this electrode. 
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Appendix 3.2 Centroid waveforms for GP-STR co-culture from electrode 43 across four time points. Red, 
green and blue signify mono-, bi- and tri-phasic centroids respectively, legend indicates how many spikes 
make up the centroid. 
GP-STR centroids decreased in amplitude, variability and number of spikes per centroid over time. 
15 DIV centroids featured mono-, bi- and triphasic waveforms, with one biphasic centroid ranging 
from 200 to -80 µV, a greater amplitude than any other cell type. By 21 DIV this range decreased to 
100 to -100 µV with only monophasic and biphasic centroids remaining, and by 42 DIV this range was 
30 to -30 µV with mainly monophasic centroids and a triphasic centroid, decreasing further to zero 
by 70 DIV. 
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Appendix 3.3: Centroid waveforms for CTX-STR co-culture from electrode 43 across four time points. Red, 
green and blue signify mono-, bi- and tri-phasic centroids respectively, legend indicates how many spikes 
make up the centroid. 
SNc-STR centroids contained the most spikes out of all cell types (as indicated by the legends), and 
did not contain any monophasic spikes until 42 DIV, suggesting complex networking. There were few 




Appendix 1.1: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a CTX neural culture, 
after 15 DIV. 
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Appendix 1.2: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a CTX neural 




Appendix 1.3: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a CTX neural 




Appendix 1.4: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a CTX neural 




Appendix 2.1: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a STR neural 




Appendix 2.2: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a STR neural 




Appendix 2.3: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a STR neural 




Appendix 2.4: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a STR neural 




Appendix 3.1: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a GP neural 




Appendix 3.2: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a GP neural 




Appendix 3.3: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a GP neural 




Appendix 3.4: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a GP neural 




Appendix 4.1: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a SN neural 




Appendix 4.2: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a SN neural 




Appendix 4.3: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a SN neural 




Appendix 4.4: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a SN neural 




Appendix 5.1: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a CTX-STR neural 




Appendix 5.2: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a CTX-STR neural 




Appendix 5.3: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a CTX-STR neural 





Appendix 5.4: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a CTX-STR neural 




Appendix 6.1: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a STR-GP neural 




Appendix 6.2: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a STR-GP neural 
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Appendix 7.1: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a SNc-STR neural 




Appendix 7.2: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a SNc-STR neural 




Appendix 7.3: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a SNc-STR neural 




Appendix 7.4: 240 seconds of raw activity from all 64 electrodes of an MEA seeded with a SNc-STR neural 
co-culture, after 70 DIV. 
 
